{
  "meta": {
    "title": "61_Neetpg_Mock-1_Advanced_Difficulty_-_22-05-2025",
    "url": "https://brainandscalpel.vercel.app/61-neetpg-mock-1-advanced-difficulty-22-05-2025-095d9f7b.html",
    "scrapedAt": "2025-11-29T17:24:01.508Z"
  },
  "questions": [
    {
      "id": 81155,
      "choices": [
        {
          "id": 323300,
          "text": "<p><span style=\"font-size:14.0pt;\">At point D</span></p>"
        },
        {
          "id": 323301,
          "text": "<p><span style=\"font-size:14.0pt;\">Between point A and point B</span></p>"
        },
        {
          "id": 323302,
          "text": "<p><span style=\"font-size:14.0pt;\">Between point B and point C</span></p>"
        },
        {
          "id": 323303,
          "text": "<p><span style=\"font-size:14.0pt;\">Between point C and point D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old woman has a resting heart rate of 70 beats/min, arterial pressure is 130/85 mm Hg, and body temperature is normal. Her pressure-volume diagram of the left ventricle is shown below.<strong>&nbsp;</strong>When does the second heart sound occur in the ventricular pressure–volume relationship?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Fcv4x2j.png\" width=\"728\" height=\"631\"></strong></span></p>",
      "unique_key": "Q7433111",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) At point D</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The second heart sound (<strong>S2</strong>) is caused by the <strong>closure of the aortic (and pulmonary) valves</strong> at the <strong>end of systole</strong> when ventricular ejection ends. Let's review the cardiac cycle phases in the <strong>pressure-volume loop</strong>:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Point B to C</strong>: Isovolumetric contraction → Ventricular pressure rises but volume remains constant.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point C to D</strong>: <strong>Ejection phase</strong> → Aortic valve is open, blood leaves the ventricle, volume decreases.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point D</strong>: <strong>End of systole</strong> → Aortic valve <strong>closes</strong>, marking the <strong>second heart sound</strong> (<strong>S2</strong>).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point D to A</strong>: Isovolumetric relaxation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point A to B</strong>: Diastolic filling → Mitral valve opens, volume increases.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>point D corresponds to aortic valve closure</strong>, which produces the <strong>second heart sound (S2)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>second heart sound (S2)</strong> occurs at <strong>point D</strong> of the pressure-volume loop, corresponding to <strong>closure of the aortic valve</strong> at the end of systole.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It marks the beginning of <strong>isovolumetric relaxation</strong> of the left ventricle.</span></li></ul>",
      "correct_choice_id": 323300,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81155/Neet_Pg_Mock_1_Q6_Physiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81155/Neet_Pg_Mock_1_Q6_Physiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80981,
      "choices": [
        {
          "id": 322608,
          "text": "<p><span style=\"font-size:14.0pt;\">Founder effect in an island population</span></p>"
        },
        {
          "id": 322609,
          "text": "<p><span style=\"font-size:14.0pt;\">Introduction of new alleles due to migration</span></p>"
        },
        {
          "id": 322610,
          "text": "<p><span style=\"font-size:14.0pt;\">Random mating within a large gene pool</span></p>"
        },
        {
          "id": 322611,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased survival of heterozygotes compared to homozygotes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following scenarios is least likely to violate Hardy-Weinberg equilibrium?</span></p>",
      "unique_key": "Q6837842",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Random mating within a large gene pool</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Random mating within a large gene pool does not violate equilibrium.</strong> This is exactly what Hardy-Weinberg assumes—<strong>random mating</strong> in a <strong>large population</strong> ensures that allele frequencies remain stable.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>Hardy-Weinberg equilibrium</strong> holds true in populations where five key conditions are met:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Large population size</strong> (no genetic drift)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Random mating</strong> (no assortative mating or inbreeding)</span></li><li><span style=\"font-size:14.0pt;\"><strong>No mutations</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>No natural selection</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>No migration/gene flow</strong></span></li></ol></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20142057.jpg\" width=\"536\" height=\"452\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Founder effect in an island population: Violates equilibrium.</strong> The founder effect involves a <strong>small number of individuals</strong> establishing a new population. This results in a <strong>reduced gene pool</strong> and increases <strong>genetic drift</strong>, violating the “large population” assumption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Introduction of new alleles due to migration: Violates equilibrium.</strong> Migration leads to <strong>gene flow</strong>, introducing new alleles into the population, violating the “no gene flow” assumption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased survival of heterozygotes compared to homozygotes:</strong> <strong>Violates equilibrium.</strong> This is an example of <strong>natural selection</strong> (specifically, heterozygote advantage), which disrupts genotype frequencies across generations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Random mating in a large gene pool</strong> is a core assumption of Hardy-Weinberg equilibrium and is least likely to violate it, while evolutionary forces such as <strong>migration, selection, and genetic drift</strong> cause significant deviations.</span></p>",
      "correct_choice_id": 322610,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80981/PSM_Mock_1_Q20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80981/PSM_Mock_1_Q20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81096,
      "choices": [
        {
          "id": 323064,
          "text": "<p><span style=\"font-size:14.0pt;\">Carnitine palmitoyl transferase I</span></p>"
        },
        {
          "id": 323065,
          "text": "<p><span style=\"font-size:14.0pt;\">Acyl Co-A dehydrogenase&nbsp;</span></p>"
        },
        {
          "id": 323066,
          "text": "<p><span style=\"font-size:14.0pt;\">Carnitine palmitoyl transferase II</span></p>"
        },
        {
          "id": 323067,
          "text": "<p><span style=\"font-size:14.0pt;\">Carnitine acylcarnitine translocase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which enzyme is not involved in shuttling fatty acids into the mitochondrial matrix for β-oxidation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6542283",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Acyl Co-A dehydrogenase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6l92q5l.png\" width=\"536\" height=\"722\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The diagram shows the carnitine shuttle system, which is responsible for transporting long-chain fatty acids from the cytosol into the mitochondrial matrix, where β-oxidation occurs.</span></li><li><span style=\"font-size:14.0pt;\">Acyl Co-A Dehydrogenase</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Location:</strong> Mitochondrial matrix</span></li><li><span style=\"font-size:14.0pt;\"><strong>Function:</strong> Catalyzes the first step of β-oxidation, dehydrogenating Acyl-CoA to form a trans double bond between the α and β carbons.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Involved in shuttle?</strong>&nbsp;No – it acts after the fatty acid has already entered the matrix.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Carnitine palmitoyl transferase I:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Location:</strong> Outer mitochondrial membrane</span></li><li><span style=\"font-size:14.0pt;\"><strong>Function:</strong> Converts Acyl-CoA to Acyl-carnitine by transferring the fatty acid to carnitine.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Involved in shuttle?</strong> Yes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Carnitine palmitoyl transferase II:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Location:</strong> Inner mitochondrial membrane (matrix side)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Function:</strong> Converts Acyl-carnitine back to Acyl-CoA and carnitine, allowing the fatty acid to enter β-oxidation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Involved in shuttle?</strong> Yes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Carnitine acylcarnitine translocase:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Location:</strong> Inner mitochondrial membrane</span></li><li><span style=\"font-size:14.0pt;\"><strong>Function:</strong> Transports Acyl-carnitine into the mitochondrial matrix while moving free carnitine back to the cytosol in a counter-transport manner.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Involved in shuttle?</strong> Yes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The carnitine shuttle system, is essential for the mitochondrial import of long-chain fatty acids.</span></li><li><span style=\"font-size:14.0pt;\">Key enzymes involved include CPT I, CPT II, and the translocase.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Acyl-CoA dehydrogenase is not involved in transport—it functions after the fatty acid enters the matrix, initiating β-oxidation.</span></li></ul>",
      "correct_choice_id": 323065,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81096/NEET_PG_Mock_1_Q3_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81096/NEET_PG_Mock_1_Q3_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81102,
      "choices": [
        {
          "id": 323088,
          "text": "<p><span style=\"font-size:14.0pt;\">TPP interferes with transketolase activity</span></p>"
        },
        {
          "id": 323089,
          "text": "<p><span style=\"font-size:14.0pt;\">TPP is a coenzyme for pyruvate and alpha-ketoglutarate dehydrogenase</span></p>"
        },
        {
          "id": 323090,
          "text": "<p><span style=\"font-size:14.0pt;\">TPP interferes with energy production from amino acids</span></p>"
        },
        {
          "id": 323091,
          "text": "<p><span style=\"font-size:14.0pt;\">TPP interferes with alcohol metabolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A malnourished patient presents with symptoms of fatigue, muscle weakness, and neurological impairment. Laboratory investigations suggest decreased energy production due to a vitamin deficiency. The deficiency affects thiamine pyrophosphate (TPP), which plays a crucial role in energy metabolism. Which of the following best explains how TPP deficiency leads to reduced ATP production?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4801964",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) TPP is a coenzyme for pyruvate and alpha-ketoglutarate dehydrogenase</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Thiamine (Vitamin B1)</strong> is converted in the body to its active form, <strong>thiamine pyrophosphate (TPP)</strong>. TPP functions as a <strong>coenzyme</strong> for several key enzymes involved in <strong>aerobic energy metabolism</strong>, particularly:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Pyruvate dehydrogenase</strong>: Converts <strong>pyruvate to acetyl-CoA</strong>, linking glycolysis to the citric acid cycle.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Alpha-ketoglutarate dehydrogenase</strong>: A critical enzyme in the <strong>citric acid cycle</strong>, converting α-ketoglutarate to succinyl-CoA.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Branched chain alpha ketoacid dehydrogenase</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Without sufficient TPP, both pathways are impaired, leading to:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Decreased acetyl-CoA production</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Reduced TCA cycle activity</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Decreased ATP synthesis</strong>, especially in tissues with high energy demands like the brain and heart</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This explains the <strong>energy deficit and neurological manifestations</strong> seen in thiamine deficiency disorders such as <strong>beriberi</strong> and <strong>Wernicke-Korsakoff syndrome</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. TPP interferes with transketolase activity:</strong> Incorrect. While TPP <strong>does act as a coenzyme for transketolase</strong> in the <strong>pentose phosphate pathway</strong>, this is <strong>not the primary reason</strong> for reduced <strong>ATP/energy production</strong>. The <strong>main effect</strong> is due to impaired function of <strong>dehydrogenase enzymes</strong> in central energy pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. TPP interferes with energy production from amino acids:</strong> Incorrect. TPP is <strong>not primarily involved</strong> in amino acid catabolism. Its main roles are in <strong>carbohydrate metabolism</strong> and <strong>TCA cycle</strong> enzymes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. TPP interferes with alcohol metabolism:</strong> Incorrect. TPP does <strong>not directly affect alcohol metabolism</strong>. However, <strong>alcoholism can cause thiamine deficiency</strong>, but this is a <strong>risk factor</strong>, not a mechanism of energy loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thiamine deficiency leads to impaired energy production because TPP serves as a coenzyme for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, enzymes essential for aerobic glucose metabolism and ATP synthesis.</span></p>",
      "correct_choice_id": 323089,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81102/NEET_PG_Mock_1_Q9_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81102/NEET_PG_Mock_1_Q9_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80968,
      "choices": [
        {
          "id": 322556,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, and R is the correct explanation of A</span></p>"
        },
        {
          "id": 322557,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true, but R is not the correct explanation of A</span></p>"
        },
        {
          "id": 322558,
          "text": "<p><span style=\"font-size:14.0pt;\">A is false, but R is true</span></p>"
        },
        {
          "id": 322559,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are false</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion (A): Reverse triage is often applied in military or disaster settings to prioritize the most severely wounded for treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reason (R): This strategy ensures that scarce medical resources are reserved for those with the highest survival chances.&nbsp;</span></p>",
      "unique_key": "Q2005338",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A is false, but R is true</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Assertion (A) is false</strong> because <strong>reverse triage</strong> does <strong>not</strong> prioritize the most severely injured. In fact, <strong>it deprioritizes or delays care</strong> for severely injured individuals when <strong>resources are limited</strong> and focuses instead on treating the <strong>less severely injured</strong> who can <strong>recover quickly</strong> or return to essential roles (e.g., combat, healthcare).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reason (R) is true</strong>. The purpose of reverse triage is to <strong>maximize the use of scarce medical resources</strong> by treating individuals who have a <strong>high probability of survival</strong> with limited intervention. It aims to increase the total number of lives saved or preserve operational capacity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reverse triage</strong> is a strategic method used in mass casualty, war, or resource-scarce settings where <strong>those most likely to benefit from limited resources are prioritized</strong>, often deferring care for the critically injured.</span></p>",
      "correct_choice_id": 322558,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80968/PSM_Mock_1_Q16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80968/PSM_Mock_1_Q16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81028,
      "choices": [
        {
          "id": 322796,
          "text": "<p><span style=\"font-size:14.0pt;\">Only A, C, D and E are true</span></p>"
        },
        {
          "id": 322797,
          "text": "<p><span style=\"font-size:14.0pt;\">Only A, B and C are true</span></p>"
        },
        {
          "id": 322798,
          "text": "<p><span style=\"font-size:14.0pt;\">Only B, C and D are true</span></p>"
        },
        {
          "id": 322799,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements (A to E) are true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the anatomy of the nasopharynx are true?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Thornwaldt cyst arises from the same area as the nasopharyngeal bursa, which is a remnant of the notochord.</span></li><li><span style=\"font-size:14.0pt;\">The fossa of Rosenmuller is located anterior to the torus tubarius and is the most common site of origin of juvenile nasopharyngeal angiofibroma (JNA).</span></li><li><span style=\"font-size:14.0pt;\">The sphenopalatine foramen is formed by the pterygoid part of sphenoid bone and the perpendicular plate of palatine bone.</span></li><li><span style=\"font-size:14.0pt;\">The pterygopalatine fossa connects laterally with the infratemporal fossa via the pterygomaxillary fissure and medially with the nasopharynx via the sphenopalatine foramen.</span></li><li><span style=\"font-size:14.0pt;\">Passavant’s ridge helps in preventing nasal regurgitation during swallowing by separating nasopharynx from oropharynx.</span></li></ol>",
      "unique_key": "Q3350242",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only A, C, D and E are true</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement A.</strong> <strong>Thornwaldt cyst arises from the same area as the nasopharyngeal bursa, which is a remnant of the notochord:&nbsp;</strong>This<strong>&nbsp;</strong>is true, as the <strong>Thornwaldt cyst</strong> originates from the <strong>nasopharyngeal bursa</strong>, which is a remnant of the notochord.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement C.</strong> <strong>The sphenopalatine foramen is formed by the pterygoid part of sphenoid bone and the perpendicular plate of palatine bone:</strong> This is correct. The <strong>sphenopalatine foramen</strong> is formed by the <strong>pterygoid part of the sphenoid bone</strong> and the <strong>perpendicular plate of the palatine bone</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement D.</strong> <strong>The pterygopalatine fossa connects laterally with the infratemporal fossa via the pterygomaxillary fissure and medially with the nasopharynx via the sphenopalatine foramen:</strong> This is also true. The <strong>pterygopalatine fossa</strong> connects medially to the <strong>nasopharynx through the sphenopalatine foramen</strong> and laterally to the <strong>infratemporal fossa via the pterygomaxillary fissure</strong>, making it a crucial communication pathway.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement E.</strong> <strong>Passavant’s ridge helps in preventing nasal regurgitation during swallowing by separating nasopharynx from oropharynx:</strong> This is correct. The <strong>Passavant’s ridge</strong> plays a key role in swallowing by separating the nasopharynx from the oropharynx and preventing nasal regurgitation of food.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement B.</strong> <strong>The fossa of Rosenmuller is located anterior to the torus tubarius and is the most common site of origin of juvenile nasopharyngeal angiofibroma (JNA):&nbsp;</strong>This<strong>&nbsp;</strong>is false because the <strong>fossa of Rosenmuller</strong> lies <strong>posterior</strong> to the torus tubarius and is actually the <strong>most common site of origin for nasopharyngeal carcinoma</strong>, not juvenile nasopharyngeal angiofibroma (JNA). JNA typically arises from the <strong>sphenopalatine foramen</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thornwaldt cyst originates from the nasopharyngeal bursa, a remnant of the notochord.</span></li><li><span style=\"font-size:14.0pt;\">Fossa of Rosenmuller is posterior to torus tubarius and is the common site of nasopharyngeal carcinoma, not JNA. JNA arises from the sphenopalatine foramen.</span></li><li><span style=\"font-size:14.0pt;\">Sphenopalatine foramen is formed by pterygoid part of sphenoid and perpendicular plate of palatine bone.</span></li><li><span style=\"font-size:14.0pt;\">Pterygopalatine fossa connects medially to nasopharynx (via sphenopalatine foramen) and laterally to infratemporal fossa (via pterygomaxillary fissure).</span></li><li><span style=\"font-size:14.0pt;\">Passavant’s ridge blocks nasopharynx during swallowing, preventing nasal regurgitation.</span></li></ul>",
      "correct_choice_id": 322796,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81028/Neet_Pg_Mock_1_Q5_Ent.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81028/Neet_Pg_Mock_1_Q5_Ent.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80939,
      "choices": [
        {
          "id": 322440,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-4, C-2, D-5, E-1</span></p>"
        },
        {
          "id": 322441,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-1, C-3, D-4, E-5</span></p>"
        },
        {
          "id": 322442,
          "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-5, C-4, D-2, E-3</span></p>"
        },
        {
          "id": 322443,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-2, C-4, D-1, E-5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match each child placement institution (Column A) with the age group or eligibility criteria it most appropriately serves (Column B):<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A – Institutions</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Borstal</span></li><li><span style=\"font-size:14.0pt;\">Remand Home</span></li><li><span style=\"font-size:14.0pt;\">Foster Home</span></li><li><span style=\"font-size:14.0pt;\">Orphanage</span></li><li><span style=\"font-size:14.0pt;\">Adoption</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B – Age Group / Eligibility</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Newborns to older children in need of permanent family</span></li><li><span style=\"font-size:14.0pt;\">Children temporarily removed from guardians due to crisis or neglect</span></li><li><span style=\"font-size:14.0pt;\">Boys over 16 years with serious behavioral issues</span></li><li><span style=\"font-size:14.0pt;\">Children temporarily held under court supervision, often awaiting trial</span></li><li><span style=\"font-size:14.0pt;\">Abandoned or orphaned children requiring group housing</span></li></ol>",
      "unique_key": "Q4980796",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A-3, B-4, C-2, D-5, E-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A. Borstal → 3. Boys over 16 years with serious behavioral issues:&nbsp;</strong>Borstals are <strong>juvenile reform institutions</strong> for <strong>males aged 16 and above</strong> who cannot be managed in certified schools. They aim to rehabilitate through structured training and discipline, often for <strong>3 years</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B. Remand Home → 4. Children temporarily held under court supervision, often awaiting trial:&nbsp;</strong>Remand homes are meant for <strong>temporary custody</strong> during judicial processes. Children are observed and supported <strong>while under investigation</strong>, not yet sentenced.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C. Foster Home → 2. Children temporarily removed from guardians due to crisis or neglect:&nbsp;</strong>Foster care places children in <strong>temporary family-like settings</strong>, especially during <strong>abuse, neglect, or legal disputes</strong>, without transferring legal parental rights.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D. Orphanage → 5. Abandoned or orphaned children requiring group housing:&nbsp;</strong>Orphanages are <strong>long-term institutional setups</strong> for children <strong>without family support</strong>, providing shelter, basic education, and care, often in a <strong>non-family</strong> environment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>E. Adoption → 1. Newborns to older children in need of permanent family:&nbsp;</strong>Legal <strong>adoption</strong> is a permanent arrangement for children (from <strong>infancy to adolescence</strong>) needing <strong>full familial and legal integration</strong>, including <strong>inheritance rights</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Child Placement &amp; Juvenile Institutions:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-19%20182408.png\" width=\"1080\" height=\"955\"></p>",
      "correct_choice_id": 322440,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80939/PSM_Mock_1_Q9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80939/PSM_Mock_1_Q9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80980,
      "choices": [
        {
          "id": 322604,
          "text": "<p><span style=\"font-size:14.0pt;\">To promote child rights in schools and education systems</span></p>"
        },
        {
          "id": 322605,
          "text": "<p><span style=\"font-size:14.0pt;\">To serve as a multisectoral roadmap for preventing all forms of child abuse</span></p>"
        },
        {
          "id": 322606,
          "text": "<p><span style=\"font-size:14.0pt;\">To regulate international adoption and child relocation policies</span></p>"
        },
        {
          "id": 322607,
          "text": "<p><span style=\"font-size:14.0pt;\">To promote inclusive schooling under the Right to Education Act</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A public health policymaker is reviewing a global strategy “INSPIRE” as supported by organizations like WHO, UNICEF, and the World Bank. Which of the following best describes the overarching purpose of the INSPIRE framework?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2999200",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) To serve as a multisectoral roadmap for preventing all forms of child abuse</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>INSPIRE framework</strong> is a globally endorsed package of seven strategies for ending <strong>violence against children</strong>. Developed by leading international organizations, it provides a <strong>comprehensive, multisectoral roadmap</strong> to address <strong>all forms of abuse</strong>, including physical, sexual, and emotional violence.</span></li><li><span style=\"font-size:14.0pt;\">The acronym <strong>INSPIRE</strong> stands for:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>I</strong> – Implementation and enforcement of laws</span></li><li><span style=\"font-size:14.0pt;\"><strong>N</strong> – Norms and values</span></li><li><span style=\"font-size:14.0pt;\"><strong>S</strong> – Safe environment</span></li><li><span style=\"font-size:14.0pt;\"><strong>P</strong> – Parent and caregiver support</span></li><li><span style=\"font-size:14.0pt;\"><strong>I</strong> – Income and economic strengthening</span></li><li><span style=\"font-size:14.0pt;\"><strong>R</strong> – Response and support services</span></li><li><span style=\"font-size:14.0pt;\"><strong>E</strong> – Education and life skills</span></li></ul></li><li><span style=\"font-size:14.0pt;\">These strategies span <strong>legal, social, educational, and economic domains</strong>, ensuring a holistic, prevention-focused approach.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aLrC9IW.png\" width=\"956\" height=\"336\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. To promote child rights in schools and education systems:&nbsp;</strong>This is a <strong>subset</strong> of one of the seven strategies (education and life skills) but <strong>not</strong> the overall purpose of the framework.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. To regulate international adoption and child relocation policies:&nbsp;</strong>This is unrelated. INSPIRE does <strong>not focus</strong> on adoption or international legal protocols—it focuses on <strong>violence prevention</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. To promote inclusive schooling under the Right to Education Act:&nbsp;</strong>This is an Indian legislative goal, <strong>not</strong> the scope of INSPIRE, which is a <strong>global multisectoral prevention tool</strong>, not specific to schooling access.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>INSPIRE framework</strong> is a <strong>WHO-led global strategy</strong> designed as a <strong>multisectoral, evidence-based approach to prevent and respond to violence against children</strong>, addressing law, norms, environments, families, economics, services, and education.</span></p>",
      "correct_choice_id": 322605,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80980/PSM_Mock_1_Q19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80980/PSM_Mock_1_Q19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80921,
      "choices": [
        {
          "id": 322368,
          "text": "<p><span style=\"font-size:14.0pt;\">Foxtail Millet</span></p>"
        },
        {
          "id": 322369,
          "text": "<p><span style=\"font-size:14.0pt;\">Finger Millet</span></p>"
        },
        {
          "id": 322370,
          "text": "<p><span style=\"font-size:14.0pt;\">Pearl Millet</span></p>"
        },
        {
          "id": 322371,
          "text": "<p><span style=\"font-size:14.0pt;\">Little Millet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A community health survey identifies a high prevalence of iron-deficiency anemia among women of reproductive age. Incorporating which millet into their diet could help alleviate this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5227291",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pearl Millet</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Pearl millet</strong> (Pennisetum glaucum), commonly known as <strong>bajra</strong>, is notably rich in iron, making it an effective dietary component for combating iron-deficiency anemia, especially among women of reproductive age.</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Iron Content:</strong> Biofortified varieties of pearl millet contain approximately <strong>16.9</strong> <strong>mg of iron per 100g</strong>, which is about double the iron content found in other major cereal staples.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bioavailability:</strong> Studies have shown that the iron in pearl millet is highly bioavailable, with absorption rates sufficient to meet a significant portion of daily iron requirements.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Health Impact:</strong> Regular consumption of iron-rich pearl millet has been demonstrated to improve iron status and cognitive performance, and to reverse iron deficiency among schoolchildren and women.&nbsp;</span></li></ul></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-19%20174154.png\" width=\"277\" height=\"280\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Foxtail Millet:</strong> While nutritious, foxtail millet has a lower iron content compared to pearl millet and is less effective in addressing iron-deficiency anemia. It provides 2.8 mg of iron per 100 g.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Finger Millet (Ragi):</strong> Finger millet is exceptionally high in calcium but does not match pearl millet in iron content. It provides 3.9 mg of iron per 100 g.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Little Millet:</strong> This millet has moderate nutritional value but is not particularly high in iron. It provides 9.3 mg of iron per 100 g.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pearl millet</strong> stands out among millets for its high iron content and bioavailability, making it an effective dietary intervention for combating iron-deficiency anemia, particularly in women of reproductive age.</span></p>",
      "correct_choice_id": 322370,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80921/PSM_Mock_1_Q3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80921/PSM_Mock_1_Q3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80990,
      "choices": [
        {
          "id": 322644,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate laparoscopic appendectomy&nbsp;</span></p>"
        },
        {
          "id": 322645,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate open appendectomy&nbsp;</span></p>"
        },
        {
          "id": 322646,
          "text": "<p><span style=\"font-size:14.0pt;\">Elective appendectomy after 6 months</span></p>"
        },
        {
          "id": 322647,
          "text": "<p><span style=\"font-size:14.0pt;\">Antibiotics and observation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 15-year-old male presents with right lower quadrant pain, fever, and leukocytosis for the past 3 days. Imaging reveals an ill-defined inflammatory mass in the right lower abdomen, consistent with appendicular phlegmon. What is the most appropriate initial management strategy for this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6049643",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Antibiotics and observation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Conservative management of Oschner Sherrin with <strong>antibiotics and observation</strong> is the standard initial approach for appendicular phlegmon.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This allows the acute inflammation to subside, reducing the risk of complications such as bowel injury or difficult dissection during immediate surgery.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Elective appendectomy is performed after the inflammation resolves to prevent recurrent episodes, usually after 4-6 weeks.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Immediate laparoscopic appendectomy:</strong> Even though minimally invasive, laparoscopic surgery during acute inflammation is risky due to poor tissue planes, high complication rates, and potential bowel injury. Immediate surgery is not recommended for phlegmon.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Immediate open appendectomy:</strong> Open surgery in the acute phase carries similar risks as laparoscopic surgery, including complications and difficulties in distinguishing inflamed from normal tissues. It is not the first-line approach for phlegmon.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Elective appendectomy after 6 months:</strong> Elective surgery is an important part of the management plan but is <strong>not the initial strategy</strong>. It is performed after successful conservative treatment to prevent recurrence usually after 4-6 weeks, making it a secondary step in management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Appendicular phlegmon refers to a localized inflammatory mass resulting from acute appendicitis. It forms when the inflamed appendix is surrounded by adjacent organs, omentum, and bowel loops, effectively \"walling off\" the infection to prevent widespread peritonitis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The initial approach involves conservative treatment with antibiotics and observation. This helps reduce inflammation and allows the phlegmon to resolve. After recovery, elective appendectomy is recommended to prevent recurrence.</span></li></ul>",
      "correct_choice_id": 322647,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80990/Surgery_NEET_PG_Mock_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80990/Surgery_NEET_PG_Mock_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80942,
      "choices": [
        {
          "id": 322452,
          "text": "<p><span style=\"font-size:14.0pt;\">Lassa fever</span></p>"
        },
        {
          "id": 322453,
          "text": "<p><span style=\"font-size:14.0pt;\">Crimean-Congo hemorrhagic fever</span></p>"
        },
        {
          "id": 322454,
          "text": "<p><span style=\"font-size:14.0pt;\">Nipah virus</span></p>"
        },
        {
          "id": 322455,
          "text": "<p><span style=\"font-size:14.0pt;\">Rift Valley fever</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following infections listed by WHO as likely to cause future major epidemics shares the most epidemiological characteristics with Zika virus?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8527695",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Rift Valley fever</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Zika virus</strong> and <strong>Rift Valley Fever (RVF)</strong> both share important <strong>epidemiological features</strong>:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Vector-borne transmission:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Zika: Spread by Aedes aegypti and A. albopictus.</span></li><li><span style=\"font-size:14.0pt;\">RVF: Spread by Aedes and Culex mosquitoes.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Zoonotic potential:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Both viruses can infect animals and humans.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Vertical transmission and teratogenic potential:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Zika: Vertical transmission can lead to microcephaly and other congenital anomalies.</span></li><li><span style=\"font-size:14.0pt;\">RVF: Can cause miscarriage in livestock and humans.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Outbreak-prone behavior with climate-related triggers:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Both infections are influenced by seasonal patterns like rainfall (which increases mosquito breeding).</span></li></ul></li></ul></li><li><span style=\"font-size:14.0pt;\">These shared characteristics make <strong>Rift Valley fever</strong> the closest epidemiological match.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lassa fever:</strong> Transmitted via rodent excreta or direct contact with infected humans, <strong>not vector borne</strong>. It causes hemorrhagic fever and does not involve vertical mosquito-based transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Crimean-Congo hemorrhagic fever (CCHF):</strong> Transmitted via ticks or contact with infected blood/tissue; causes severe hemorrhagic fever. No perinatal effects like Zika.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Nipah virus:</strong> Transmitted via fruit bats and direct contact; causes encephalitis and respiratory symptoms, <strong>not mosquito-borne</strong>, and doesn’t show the same congenital effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Among WHO-listed high-risk emerging infections, Rift Valley fever shares the closest epidemiologic resemblance to Zika virus, particularly due to mosquito-borne transmission, zoonotic nature, and potential to cause vertical transmission and fetal abnormalities.</span></p>",
      "correct_choice_id": 322455,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80942/PSM_Mock_1_Q10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80942/PSM_Mock_1_Q10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81090,
      "choices": [
        {
          "id": 323040,
          "text": "<p><span style=\"font-size:14.0pt;\">Papillary thyroid carcinoma</span></p>"
        },
        {
          "id": 323041,
          "text": "<p><span style=\"font-size:14.0pt;\">Anaplastic thyroid carcinoma</span></p>"
        },
        {
          "id": 323042,
          "text": "<p><span style=\"font-size:14.0pt;\">Riedel fibrosing thyroiditis</span></p>"
        },
        {
          "id": 323043,
          "text": "<p><span style=\"font-size:14.0pt;\">Hashimoto thyroiditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 43-year-old woman presents with a slowly enlarging neck mass and symptoms of fatigue and cold intolerance. On physical examination, her thyroid is firm, immobile, and described as \"hard as wood.\" The gland is nontender, and there is evidence of mild tracheal deviation. Laboratory testing shows elevated TSH and low free T4. Imaging reveals fibrosis extending into surrounding neck structures. A biopsy demonstrates dense fibrosis and chronic inflammation without atypical cells. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4846609",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Riedel fibrosing thyroiditis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Riedel fibrosing thyroiditis is a rare form of chronic thyroiditis characterized by <strong>extensive fibrosis of the thyroid gland</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents in <strong>middle-aged adults (typically in their 40s)</strong> with a <strong>\"hard as wood\" thyroid</strong> that is <strong>painless and fixed</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The fibrosis can <strong>extend to local structures</strong>, leading to <strong>airway or esophageal compression</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Importantly, <strong>malignant cells are absent</strong> on biopsy, which distinguishes it from anaplastic carcinoma, a highly aggressive thyroid cancer.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The disease often leads to <strong>hypothyroidism</strong>, as seen in this patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Papillary thyroid carcinoma:</strong> Incorrect. This is the most common thyroid cancer and typically presents as a <strong>painless thyroid nodule</strong>, not as a diffusely hard gland with fibrosis. It shows characteristic nuclear features and often has psammoma bodies on histology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Anaplastic thyroid carcinoma:</strong> Incorrect. While this malignancy can present with a <strong>rapidly enlarging, hard thyroid mass that invades local structures</strong>, it is typically seen in <strong>older patients</strong> (&gt;60 years) and would show <strong>highly atypical malignant cells</strong> on biopsy. The fibrosis extends to the extra-thyroidal structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hashimoto thyroiditis:</strong> Incorrect. Hashimoto’s also leads to <strong>hypothyroidism</strong>, but the gland is typically <strong>painless, diffusely enlarged</strong>, and <strong>not rock-hard</strong>. Histology shows <strong>lymphoid aggregates with germinal centers</strong>, not extensive fibrosis into local tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Riedel fibrosing thyroiditis presents as a \"<strong>hard as wood</strong>\" nontender thyroid with fibrosis that may invade surrounding structures; it mimics anaplastic carcinoma but occurs in younger patients and lacks malignant cells.</span></p>",
      "correct_choice_id": 323042,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81090/NEET_PG_Mock_1_Q12_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81090/NEET_PG_Mock_1_Q12_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81136,
      "choices": [
        {
          "id": 323224,
          "text": "<p><span style=\"font-size:14.0pt;\">The body is small and wider from side to side than anteroposteriorly</span></p>"
        },
        {
          "id": 323225,
          "text": "<p><span style=\"font-size:14.0pt;\">The vertebral foramen is large and triangular</span></p>"
        },
        {
          "id": 323226,
          "text": "<p><span style=\"font-size:14.0pt;\">The transverse processes contain transverse foramina</span></p>"
        },
        {
          "id": 323227,
          "text": "<p><span style=\"font-size:14.0pt;\">The articular processes contain superior facets directed inferoanteriorly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not a distinctive characteristic of a typical cervical vertebra?&nbsp;</span></p>",
      "unique_key": "Q5416342",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) The articular processes contain superior facets directed inferoanteriorly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Typical <strong>cervical vertebrae</strong> (C3–C6) have the following features:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Doc34.jpg\" width=\"774\" height=\"988\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>superior articular facets</strong> of cervical vertebrae are actually directed <strong>superoposteriorly</strong>, not <strong>inferoanteriorly</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This orientation helps facilitate neck flexion, extension, and lateral flexion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>The body is small and wider from side to side than anteroposteriorly:&nbsp;</strong>Correct. Cervical vertebral bodies are <strong>small</strong> and <strong>wider transversely</strong> than anteroposteriorly, which helps support head movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>The vertebral foramen is large and triangular:&nbsp;</strong>Correct. The <strong>vertebral foramen is large and triangular</strong>, accommodating the cervical enlargement of the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>The transverse processes contain transverse foramina:&nbsp;</strong>Correct. Cervical transverse processes have <strong>foramina transversaria</strong>, which transmit the <strong>vertebral arteries and veins</strong> (except sometimes in C7).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Typical cervical vertebrae (C3–C6) are characterized by <strong>small bodies</strong>, <strong>bifid spinous processes</strong>, <strong>foramina transversaria</strong>, and <strong>large triangular vertebral foramina</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their <strong>superior articular facets</strong> are directed <strong>superoposteriorly</strong>, which is critical for their functional biomechanics.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Misidentifying the facet orientation can lead to confusion with thoracic or lumbar vertebrae.</span></li></ul>",
      "correct_choice_id": 323227,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81136/NEET_PG_Mock_1_Q1_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81136/NEET_PG_Mock_1_Q1_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81103,
      "choices": [
        {
          "id": 323092,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum amylase</span></p>"
        },
        {
          "id": 323093,
          "text": "<p><span style=\"font-size:14.0pt;\">Alkaline phosphatase</span></p>"
        },
        {
          "id": 323094,
          "text": "<p><span style=\"font-size:14.0pt;\">Creatine kinase</span></p>"
        },
        {
          "id": 323095,
          "text": "<p><span style=\"font-size:14.0pt;\">Uric acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-year-old child with developmental delay is brought in due to behavioral disturbances. On examination, he has multiple scars on lips and hands, consistent with self-mutilation. There is a positive family history of a similar condition in a male relative. Which of the following laboratory tests would be most valuable in guiding diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4259419",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Uric acid</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The child presents with classical features suggestive of <strong>Lesch-Nyhan syndrome</strong>, a rare <strong>X-linked recessive disorder</strong> caused by <strong>deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT)</strong>, an enzyme involved in the <strong>purine salvage pathway</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Key features include:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Self-mutilation</strong> (biting of lips and fingers)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Neurological abnormalities</strong> (dystonia, developmental delay)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Family history</strong> (X-linked inheritance)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hyperuricemia</strong> due to accumulation of uric acid</span></li><li><span style=\"font-size:14.0pt;\"><strong>Urate crystals in diaper</strong> or urate deposits in skin and joints</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Because of <strong>HGPRT deficiency</strong>, <strong>hypoxanthine and guanine</strong> are not salvaged, leading to increased <strong>purine degradation</strong>, which produces <strong>excess uric acid</strong>. Thus, measuring <strong>uric acid levels</strong> is the <strong>most valuable diagnostic tool</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Serum amylase:</strong> Serum amylase is elevated in <strong>pancreatic inflammation</strong> and is unrelated to <strong>neurologic or self-injurious symptoms</strong>. It offers <strong>no diagnostic value</strong> in the context of <strong>Lesch-Nyhan syndrome</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Alkaline phosphatase:</strong> This enzyme is elevated in <strong>bone or hepatobiliary disorders</strong>, but it is <strong>not elevated</strong> in Lesch-Nyhan syndrome and provides <strong>no diagnostic insight</strong> for this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Creatine kinase:</strong> While CK is used in the evaluation of <strong>muscular dystrophies</strong> and <strong>muscle injury</strong>, it is <strong>not useful</strong> in diagnosing <strong>purine metabolism disorders</strong> like Lesch-Nyhan syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lesch-Nyhan syndrome is an X-linked disorder of purine metabolism due to HGPRT deficiency, and is characterized by self-mutilation, neurological symptoms, and hyperuricemia. Measurement of uric acid is the most important diagnostic test.</span></p>",
      "correct_choice_id": 323095,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81103/NEET_PG_Mock_1_Q10_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81103/NEET_PG_Mock_1_Q10_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80932,
      "choices": [
        {
          "id": 322412,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform a pap smear&nbsp;</span></p>"
        },
        {
          "id": 322413,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform a cervical biopsy&nbsp;</span></p>"
        },
        {
          "id": 322414,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer to a gynecologic oncologist&nbsp;</span></p>"
        },
        {
          "id": 322415,
          "text": "<p><span style=\"font-size:14.0pt;\">Obtain a computed tomography (CT) scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old woman presents to the gynecology clinic for her routine annual examination. She is asymptomatic and has no significant medical history. She is not on any hormonal medications and has regular menstrual cycles. What is the most appropriate next step in management?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20104539.jpg\" width=\"525\" height=\"478\"></strong></span></p>",
      "unique_key": "Q6308692",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Perform a cervical biopsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps</span></li><li><span style=\"font-size:14.0pt;\">In this image, a growth is seen (cervical polyp), so a biopsy should be taken from the periphery of the lesion</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Perform a pap smear:&nbsp;</strong>A pap smear is done when there is no visible lesion on the cervix</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C and D.</strong> <strong>Refer to a gynecologic oncologist and obtain a computed tomography (CT) scan:&nbsp;</strong>Imaging studies and referral to a gynecologist&nbsp;have a role in cervical cancer once a diagnosis is made.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps</span></li><li><span style=\"font-size:14.0pt;\">In this image, a lesion is seen, so a biopsy should be taken from the periphery of the lesion</span></li></ul>",
      "correct_choice_id": 322413,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80932/OBG_Mock_1_Q3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80932/OBG_Mock_1_Q3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80930,
      "choices": [
        {
          "id": 322404,
          "text": "<p><span style=\"font-size:14.0pt;\">4.0</span></p>"
        },
        {
          "id": 322405,
          "text": "<p><span style=\"font-size:14.0pt;\">1.0</span></p>"
        },
        {
          "id": 322406,
          "text": "<p><span style=\"font-size:14.0pt;\">0.25</span></p>"
        },
        {
          "id": 322407,
          "text": "<p><span style=\"font-size:14.0pt;\">0.75</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a region with a total population of 10,000 individuals, serological surveys show that 7,500 individuals have antibodies to a particular infection. If the infection is in an endemic steady state, what is the basic reproduction number (R₀) for this infection?</span></p>",
      "unique_key": "Q1895847",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 4.0</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This is based on <strong>Hill’s criterion of temporality</strong> and <strong>endemic equilibrium</strong>, which follows the formula:</span><ul><li><span style=\"font-size:14.0pt;\">R<sub>0&nbsp;</sub>× S = 1&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Where:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>R₀</strong> = Basic Reproduction Number</span></li><li><span style=\"font-size:14.0pt;\"><strong>S</strong> = Proportion of the population that is <strong>susceptible</strong> to infection</span></li></ul></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Calculation:</strong></span><ul><li><span style=\"font-size:14.0pt;\"><strong>Total population</strong> = 10,000</span></li><li><span style=\"font-size:14.0pt;\"><strong>Individuals with antibodies (immune)</strong> = 7,500</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>Susceptibles (S)</strong> = 10,000 – 7,500 = <strong>2,500</strong></span></li><li><span style=\"font-size:14.0pt;\">Proportion susceptible = 2,500 / 10,000 = <strong>0.25</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">At endemic steady state:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tAokqYK.png\" width=\"597\" height=\"204\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To test the application of the <strong>endemic steady state formula</strong> R₀ × S = 1, reinforcing how immunity levels in the population (e.g., post-infection or vaccination) influence transmission dynamics of infections.</span></li><li><span style=\"font-size:14.0pt;\">In endemic conditions, the product of <strong>R₀</strong> and <strong>proportion susceptible</strong> (S) must equal <strong>1</strong>. Knowing the immunity status of the population allows you to <strong>back-calculate R₀</strong>, which is vital for forecasting and control of infectious diseases.</span></li></ul>",
      "correct_choice_id": 322404,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80930/PSM_Mock_1_Q8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80930/PSM_Mock_1_Q8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81118,
      "choices": [
        {
          "id": 323152,
          "text": "<p><span style=\"font-size:14.0pt;\">Entamoeba histolytica</span></p>"
        },
        {
          "id": 323153,
          "text": "<p><span style=\"font-size:14.0pt;\">Naegleria fowleri</span></p>"
        },
        {
          "id": 323154,
          "text": "<p><span style=\"font-size:14.0pt;\">Trypanosoma cruzi</span></p>"
        },
        {
          "id": 323155,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxoplasma gondii</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A previously healthy 30-year-old man presents to the emergency department with high-grade fever, headache, nausea, and neck stiffness. He rapidly develops altered mental status. Lumbar puncture is performed, and wet mount examination of the cerebrospinal fluid (CSF) reveals motile, unicellular organisms. What is the most likely causative organism in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2058686",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Naegleria fowleri</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The scenario describes <strong>acute meningoencephalitis</strong> in a previously healthy individual, with <strong>motile unicellular organisms on wet mount CSF microscopy</strong>. This is characteristic of <strong>Naegleria fowleri</strong>, a <strong>free-living amoeba</strong>, which causes <strong>Primary Amoebic Meningoencephalitis (PAM)</strong></span></li><li><span style=\"font-size:14.0pt;\">Infection occurs after <strong>nasal exposure to contaminated freshwater</strong>, especially during swimming. The amoebae <strong>invade through the cribriform plate</strong> to reach the brain</span></li><li><span style=\"font-size:14.0pt;\">CSF analysis may show <strong>motile trophozoites</strong> on <strong>wet mount</strong>, a diagnostic clue</span></li><li><span style=\"font-size:14.0pt;\">PAM progresses <strong>rapidly</strong> and is <strong>usually fatal</strong>, making early detection crucial.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Entamoeba histolytica:</strong> Causes <strong>intestinal amoebiasis</strong> and occasionally <strong>liver abscess</strong> but does <strong>not cause primary meningoencephalitis</strong>. It is <strong>non-motile</strong> in CSF and <strong>not found in CSF wet mounts</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Trypanosoma cruzi:</strong> Causes <strong>Chagas disease</strong>, which may lead to <strong>chronic cardiomyopathy and mega syndromes</strong>, and <strong>rarely CNS disease</strong>. It does <strong>not present acutely in CSF</strong> with <strong>motile trophozoites</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Toxoplasma gondii:</strong> Causes <strong>congenital defects in a child born to mother infected during first trimester of pregnancy,&nbsp;</strong>Unlike <strong>Naegleria</strong>, it does <strong>not show motile organisms in CSF</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Naegleria fowleri causes rapidly progressive primary amoebic meningoencephalitis (PAM), diagnosed by identifying motile trophozoites in CSF wet mount in an acutely ill patient.</span></p>",
      "correct_choice_id": 323153,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81118/Microbiology_NEET_PG_Mock_Q11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81118/Microbiology_NEET_PG_Mock_Q11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81141,
      "choices": [
        {
          "id": 323244,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior gluteal nerve</span></p>"
        },
        {
          "id": 323245,
          "text": "<p><span style=\"font-size:14.0pt;\">Obturator nerve</span></p>"
        },
        {
          "id": 323246,
          "text": "<p><span style=\"font-size:14.0pt;\">Superior gluteal nerve</span></p>"
        },
        {
          "id": 323247,
          "text": "<p><span style=\"font-size:14.0pt;\">Femoral nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which nerve supplies the muscle whose paralysis leads to this sign?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_kkPN1Qt.png\" width=\"737\" height=\"532\"></strong></span></p>",
      "unique_key": "Q9092816",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Superior gluteal nerve</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Trendelenburg sign</strong> is positive when the <strong>pelvis drops on the side opposite to the standing leg</strong>, indicating weakness or paralysis of the <strong>gluteus medius</strong> on the standing side.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>gluteus medius</strong> (along with gluteus minimus) is innervated by the <strong>superior gluteal nerve</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This nerve arises from the <strong>dorsal divisions of L4, L5, and S1</strong> spinal nerves.</span></li><li><span style=\"font-size:14.0pt;\">It plays a critical role in <strong>hip abduction</strong> and <strong>pelvic stabilization during gait</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inferior gluteal nerve:&nbsp;</strong>Supplies <strong>gluteus maximus</strong>, involved in hip extension, not abduction or pelvic stability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Obturator nerve:</strong> Supplies medial thigh adductors, not gluteal muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Femoral nerve:</strong> Supplies anterior thigh muscles (e.g., quadriceps), involved in hip flexion and knee extension, not hip abduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>positive Trendelenburg sign</strong> is caused by <strong>weakness/paralysis of gluteus medius</strong>, supplied by the <strong>superior gluteal nerve</strong>, which is responsible for <strong>hip abduction and pelvic stabilization</strong> during single-leg stance.</span></p>",
      "correct_choice_id": 323246,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81141/NEET_PG_Mock_1_Q6_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81141/NEET_PG_Mock_1_Q6_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80965,
      "choices": [
        {
          "id": 322544,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer 2 doses of Td—one now and one 1 month later</span></p>"
        },
        {
          "id": 322545,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer a single Td dose only</span></p>"
        },
        {
          "id": 322546,
          "text": "<p><span style=\"font-size:14.0pt;\">Defer Td until after delivery and administer 2 doses 1 month apart</span></p>"
        },
        {
          "id": 322547,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer one Td dose and 750 IU antitoxin post-delivery for neonatal protection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A primigravida woman reports to the health subcenter at 9 months of pregnancy (POG) with no prior antenatal visits or Td immunization. The ANM suggests giving one Td dose due to anticipated early labor. The medical officer (MO) intervenes. Which is the most appropriate public health action, assuming delivery is likely within 3 days?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1109412",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Administer 2 doses of Td—one now and one 1 month later</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">According to <strong>National Immunization Schedule (NIS)</strong> and <strong>MoHFW guidelines</strong>:</span><ul><li><span style=\"font-size:14.0pt;\">Pregnant women who report <strong>late in pregnancy</strong> (including <strong>9th month or just before delivery</strong>) and are <strong>unimmunized</strong>, <strong>must be given two Td doses</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>first Td dose</strong> is given <strong>immediately</strong>, and the <strong>second</strong> is scheduled <strong>1 month later</strong>, even <strong>if it is after delivery</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This ensures <strong>partial protection for the current pregnancy</strong> and <strong>full protection for the next 3 years</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The aim is <strong>not just maternal protection</strong> but also building immunity for <strong>future pregnancies</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Giving <strong>only one dose</strong> limits effectiveness and <strong>misses the opportunity to build sustained immunity</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Administer a single Td dose only:</strong> Incorrect<strong>.</strong> One dose may offer some protection, but two doses are <strong>mandatory</strong> for effective immunization and long-term protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Defer Td until after delivery and administer 2 doses 1 month apart:</strong> Incorrect<strong>.</strong> While two postnatal doses are valid if not given earlier, <strong>the first dose should not be delayed</strong>. Immediate initiation is crucial.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Administer one Td dose and 750 IU antitoxin post-delivery:</strong> Incorrect<strong>.</strong> Td vaccine is the <strong>preferred preventive measure</strong>. The <strong>antitoxin (heterologous serum)</strong> is used only <strong>for neonates</strong> born to unimmunized mothers <strong>within 6 hours of birth</strong> for passive protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Unimmunized pregnant women reporting late (even at 9 months or just before delivery) must receive 2 Td doses—first immediately and second 1 month later—to ensure both maternal and future pregnancy protection.</span></p>",
      "correct_choice_id": 322544,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80965/PSM_Mock_1_Q15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80965/PSM_Mock_1_Q15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81150,
      "choices": [
        {
          "id": 323280,
          "text": "<p><span style=\"font-size:14.0pt;\">Isosmotic fluid loss</span></p>"
        },
        {
          "id": 323281,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypoosmotic fluid loss</span></p>"
        },
        {
          "id": 323282,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperosmotic fluid loss</span></p>"
        },
        {
          "id": 323283,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypoosmotic fluid gain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old athlete undergoes intense physical exercise without proper hydration. During this period, significant sweating occurs. A graphical representation of his body fluid compartments and osmolarity is obtained. Which of the following best describes the type of body fluid disturbance in this scenario?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7687550",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hypoosmotic fluid loss</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Sweating results in the loss of <strong>hypoosmotic fluid</strong> relative to plasma because sweat contains less sodium and more water. When excessive sweating occurs:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Water is lost in greater proportion than solute (Na⁺)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">As a result, <strong>plasma osmolarity increases</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This causes water to shift <strong>from the intracellular to the extracellular compartment</strong>, leading to:</span><ul><li><span style=\"font-size:14.0pt;\">A <strong>decrease in intracellular fluid volume</strong></span></li><li><span style=\"font-size:14.0pt;\">A <strong>decrease in extracellular fluid volume</strong></span></li><li><span style=\"font-size:14.0pt;\">An <strong>increase in osmolarity</strong> of both compartments</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This pattern is classically referred to as <strong>hyperosmotic volume contraction</strong>, a subset of <strong>hyperosmotic fluid loss</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Isosmotic fluid loss</strong>: Seen in hemorrhage or diarrhea where fluid lost has osmolarity equal to plasma—no change in osmolarity occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hyperosmotic fluid loss</strong>: Incorrect terminology. <strong>Hyperosmotic&nbsp;</strong>fluids are not lost in sweating; rather, body fluid becomes hyperosmotic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hypoosmotic fluid gain</strong>: Seen in water intoxication or SIADH where free water is retained, leading to decreased osmolarity and increased volume.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sweating leads to a hyperosmotic volume contraction</strong> due to loss of hypoosmotic sweat.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This results in decreased ECF and ICF volumes with increased osmolarity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Such disturbances must be corrected by water intake with electrolyte replacement to restore fluid balance.</span></li></ul>",
      "correct_choice_id": 323281,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81150/Neet_Pg_Mock_1_Q1_Physiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81150/Neet_Pg_Mock_1_Q1_Physiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81114,
      "choices": [
        {
          "id": 323136,
          "text": "<p><span style=\"font-size:14.0pt;\">Detection of viral antigen NS1</span></p>"
        },
        {
          "id": 323137,
          "text": "<p><span style=\"font-size:14.0pt;\">Isolation of virus in Aedes albopictus C6/36 cell culture</span></p>"
        },
        {
          "id": 323138,
          "text": "<p><span style=\"font-size:14.0pt;\">Detection of viral RNA via RT-PCR</span></p>"
        },
        {
          "id": 323139,
          "text": "<p><span style=\"font-size:14.0pt;\">IgM antibody detection by ELISA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old male presents on the third day of high-grade fever, myalgia, retro-orbital pain, and a diffuse maculopapular rash. Dengue fever is suspected based on clinical grounds. Which of the following diagnostic methods is least appropriate for confirmation of dengue infection at this stage of illness?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7721845",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) IgM antibody detection by ELISA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At <strong>day 3</strong> of illness in suspected dengue cases, <strong>direct detection methods</strong> are preferred because <strong>viral replication is at its peak</strong> during the <strong>first 5 days</strong> of illness.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, <strong>NS1 antigen detection</strong>, <strong>RT-PCR</strong>, and <strong>viral culture in Aedes albopictus C6/36 cell line</strong> are useful during this early viremic phase.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IgM antibodies</strong>, detected by <strong>ELISA</strong>, are part of the <strong>host’s adaptive immune response</strong> and typically appear <strong>after day 5 of infection</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hence, antibody detection is <strong>not reliable on day 3</strong> and may yield <strong>false-negative results</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Detection of viral antigen NS1:</strong> True<strong>.</strong> Appropriate on <strong>day 3</strong>. NS1 is a <strong>non-structural protein</strong> secreted by infected cells and can be detected <strong>early (days 1–5)</strong>. Its presence correlates with <strong>active viral replication</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Isolation of virus in Aedes albopictus C6/36 cell culture:</strong> True<strong>.</strong> Though <strong>labor-intensive</strong>, viral culture using <strong>mosquito cell lines like C6/36</strong> is feasible in <strong>early dengue infection</strong>, especially during the viremic phase (first 5 days). Not routinely done due to technical challenges but still valid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Detection of viral RNA via RT-PCR:</strong> True<strong>.</strong> Highly sensitive and specific during the <strong>acute phase</strong> (days 1–5). It detects <strong>dengue viral RNA</strong> in serum and is ideal in the early stages of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">During the early phase of dengue infection (days 1–5), direct detection methods such as NS1 antigen, RT-PCR, and viral culture are appropriate; IgM ELISA is not useful this early, as antibodies typically appear after day 5.</span></p>",
      "correct_choice_id": 323139,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81114/Microbiology_NEET_PG_Mock_Q7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81114/Microbiology_NEET_PG_Mock_Q7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80955,
      "choices": [
        {
          "id": 322504,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-05-23%20at%2011.10.45.jpeg\" width=\"1000\" height=\"1000\"></p>"
        },
        {
          "id": 322505,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105539.jpg\" width=\"461\" height=\"327\"></p>"
        },
        {
          "id": 322506,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105549.jpg\" width=\"209\" height=\"400\"></p>"
        },
        {
          "id": 322507,
          "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105558.jpg\" width=\"335\" height=\"303\"></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old woman presents with intermenstrual bleeding. On speculum examination, a friable, cauliflower-like lesion is observed on the cervix. The lesion bleeds on touch. A biopsy is planned for histopathological confirmation. Which of the following instruments is most appropriate for obtaining a biopsy sample in this case?</span></p>",
      "unique_key": "Q5570195",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Punch biopsy forceps</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The lesion described is highly suggestive of cervical carcinoma.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In such cases, direct visualization followed by biopsy is the most appropriate step.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The instrument used to obtain a tissue biopsy from a visible lesion on the cervix is the <strong>Punch biopsy forceps</strong>, which allows for precise removal of a small tissue sample for histopathological analysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ayre's spatula:</strong> Incorrect. It is used for <strong>Pap smear</strong> collection, which involves surface cell scraping for cytology, not for biopsy of lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cervical brush (Cytobrush):</strong> Incorrect. Also used in <strong>Pap smears</strong>, especially for endocervical sampling; it does not collect adequate tissue for histopathological diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Endocervical curette:</strong> Incorrect. Used to sample <strong>endocervical canal</strong> tissue, not exophytic lesions on the ectocervix.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In patients with visible cervical lesions and abnormal bleeding, <strong>punch biopsy</strong> using <strong>biopsy forceps</strong> is the investigation of choice.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cytological tools like spatulas and brushes are used in screening but are inadequate for diagnosing invasive disease.</span></li></ul>",
      "correct_choice_id": 322504,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80955/OBG_Mock_1_Q14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80955/OBG_Mock_1_Q14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81111,
      "choices": [
        {
          "id": 323124,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 3 and 5</span></p>"
        },
        {
          "id": 323125,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1 and 2</span></p>"
        },
        {
          "id": 323126,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 2 and 4</span></p>"
        },
        {
          "id": 323127,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the biochemical properties of Shigella species are incorrect?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">All Shigella species are non-motile.</span></li><li><span style=\"font-size:14.0pt;\">Shigella sonnei is a non-lactose fermenter that may later ferment lactose on prolonged incubation.</span></li><li><span style=\"font-size:14.0pt;\">Shigella dysenteriae type 1 is catalase-positive, like all other Shigella species.</span></li><li><span style=\"font-size:14.0pt;\">Shigella dysenteriae does not ferment mannitol, unlike other Shigella species.</span></li><li><span style=\"font-size:14.0pt;\">Shigella flexneri is mannitol non-fermenting and catalase negative.</span></li></ol>",
      "unique_key": "Q3003744",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only 3 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Shigella dysenteriae type 1 is catalase-positive, like all other Shigella species:</strong> Incorrect. <strong>Shigella dysenteriae type 1</strong> is <strong>catalase-negative</strong>, unlike other Shigella species, which are <strong>catalase-positive</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>Shigella flexneri is mannitol non-fermenting and catalase negative: Incorrect.</strong> <strong>Shigella flexneri</strong> is <strong>mannitol-fermenting</strong> and <strong>catalase-positive</strong>, so this statement is false.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>All Shigella species are non-motile:</strong> Correct. All <strong>Shigella spp. are non-motile</strong>, which helps distinguish them from other Enterobacteriaceae.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Shigella sonnei is a non-lactose fermenter that may later ferment lactose on prolonged incubation:</strong> Correct. <strong>Shigella sonnei</strong> is a <strong>late lactose fermenter (LLF)</strong>. While initially non-lactose fermenting, it can appear to ferment lactose after <strong>prolonged incubation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Shigella dysenteriae does not ferment mannitol, unlike other Shigella species:&nbsp;</strong>Correct. <strong>Shigella dysenteriae</strong> is <strong>mannitol non-fermenting</strong>, while other Shigella species <strong>ferment mannitol</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Shigella spp. are non-motile; S. sonnei is a late lactose fermenter, while S. dysenteriae is distinctively catalase-negative and mannitol non-fermenting.</span></p>",
      "correct_choice_id": 323124,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81111/Microbiology_NEET_PG_Mock_Q4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81111/Microbiology_NEET_PG_Mock_Q4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81081,
      "choices": [
        {
          "id": 323004,
          "text": "<p><span style=\"font-size:14.0pt;\">IL-10</span></p>"
        },
        {
          "id": 323005,
          "text": "<p><span style=\"font-size:14.0pt;\">TNF-α</span></p>"
        },
        {
          "id": 323006,
          "text": "<p><span style=\"font-size:14.0pt;\">IL-4</span></p>"
        },
        {
          "id": 323007,
          "text": "<p><span style=\"font-size:14.0pt;\">Leukotriene B4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old woman is brought to the emergency department with sudden onset of confusion. Over the past week, she had increasing dysuria and left-sided flank pain. On examination, her blood pressure is 80/40 mm Hg, heart rate is 120/min, and respiratory rate is elevated with shallow breathing. Her extremities are warm to touch, and she appears acutely ill. Which of the following mediators is most likely responsible for this patient’s hypotension and systemic findings?</span></p>",
      "unique_key": "Q8189549",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) TNF-α</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This patient shows signs of <strong>septic shock</strong>, characterized by <strong>hypotension, fever, tachycardia, warm extremities (suggesting distributive shock), and confusion</strong>, in the setting of suspected urinary tract infection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These findings are most consistent with <strong>sepsis progressing to septic shock</strong>, commonly due to <strong>gram-negative bacteria</strong> such as E. coli.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tumor necrosis factor-alpha (TNF-α)</strong> is a <strong>proinflammatory cytokine</strong> produced primarily by <strong>activated macrophages</strong> in response to endotoxin (lipopolysaccharide, LPS) from gram-negative bacteria. TNF-α plays a <strong>central role in the pathogenesis of septic shock</strong> by:</span><ul><li><span style=\"font-size:14.0pt;\">Increasing vascular permeability</span></li><li><span style=\"font-size:14.0pt;\">Inducing nitric oxide production (causing vasodilation and hypotension)</span></li><li><span style=\"font-size:14.0pt;\">Promoting fever via hypothalamic stimulation</span></li><li><span style=\"font-size:14.0pt;\">Activating coagulation pathways (can lead to DIC)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">All the systemic findings in this patient (fever, hypotension, tachycardia, warm extremities, altered mental status) are classic effects of elevated <strong>TNF-α</strong> in sepsis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. IL-10:&nbsp;</strong>This is an <strong>anti-inflammatory cytokine</strong> that <strong>downregulates</strong> the immune response. It is produced by macrophages and T-cells to limit inflammation and prevent host damage. IL-10 <strong>does not cause</strong> fever, hypotension, or vasodilation. Hence, it is <strong>not responsible</strong> for the patient’s current systemic symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IL-4:&nbsp;</strong>IL-4 is a cytokine associated with the <strong>promotion of Th2 immune responses</strong>, <strong>class switching to IgE</strong>, and <strong>eosinophil recruitment</strong> in allergic reactions. It is required for mast cell activation. It plays no role in <strong>bacterial sepsis</strong> or in producing hypotension, fever, or altered mental status. It is <strong>not relevant</strong> in the pathogenesis of septic shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Leukotriene B4:&nbsp;</strong>This lipid mediator is derived from arachidonic acid and is a potent <strong>chemoattractant for neutrophils</strong>. While it contributes to <strong>local inflammation</strong> by recruiting leukocytes to the site of infection, it <strong>does not cause systemic hypotension or fever</strong>, making it an incorrect choice in this systemic presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">TNF-α is a key proinflammatory cytokine that mediates the systemic manifestations of septic shock, including hypotension, fever, and altered sensorium.</span></p>",
      "correct_choice_id": 323005,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81081/NEET_PG_Mock_1_Q3_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81081/NEET_PG_Mock_1_Q3_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80916,
      "choices": [
        {
          "id": 322348,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4 and 6 only</span></p>"
        },
        {
          "id": 322349,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 5 only</span></p>"
        },
        {
          "id": 322350,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4 and 6 only</span></p>"
        },
        {
          "id": 322351,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4 and 5 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements are true under the National Sickle Cell Anaemia Elimination Mission?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The mission aims to eliminate SCD by 2035</span></li><li><span style=\"font-size:14.0pt;\">Penicillin 125 mg/day is used after age 1 year</span></li><li><span style=\"font-size:14.0pt;\">Folic acid is started only above 2 years of age</span></li><li><span style=\"font-size:14.0pt;\">Cards are color-coded by gender, not by disease status</span></li><li><span style=\"font-size:14.0pt;\">Hydroxyurea is initiated in all patients at diagnosis</span></li><li><span style=\"font-size:14.0pt;\">The program is under National Health Mission</span></li></ol>",
      "unique_key": "Q6712334",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 2, 4 and 6 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-19%20170349.png\" width=\"519\" height=\"487\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Penicillin 125 mg/day is used after age 1 year:</strong> True. As per guidelines, penicillin prophylaxis starts with 62.5 mg BD for &lt;1 year, then increases to <strong>125 mg/day after age 1 year</strong>, and is escalated further to 250 mg/day till 5 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Cards are color-coded by gender, not by disease status:</strong> True. The color of the <strong>sickle cell cards</strong> indicates <strong>gender</strong> — <strong>blue for males</strong> and <strong>pink for females</strong> — while the <strong>text</strong> on the card indicates whether the individual is <strong>normal, carrier, or diseased</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 6. The program is under National Health Mission:</strong> True. The <strong>National Sickle Cell Anaemia Elimination Mission</strong> is a part of the larger <strong>National Health Mission (NHM)</strong> and operates under its umbrella.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. The mission aims to eliminate SCD by 2035:</strong> Incorrect. The actual goal is to eliminate sickle cell disease as a public health problem in India <strong>before 2047</strong>, not 2035.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Folic acid is started only above 2 years of age:</strong> Incorrect. Folic acid is started <strong>much earlier</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>2.5 mg daily</strong> for children <strong>below 1 year</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>5 mg daily</strong> for those <strong>above 1 year</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Hydroxyurea is initiated in all patients at diagnosis:</strong> Incorrect. Hydroxyurea is <strong>not universally started at diagnosis</strong>. It is initiated in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients with <strong>&gt;3 crises per year</strong>, or</span></li><li><span style=\"font-size:14.0pt;\">Those with <strong>repeated episodes of ACS (acute chest syndrome)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>National Sickle Cell Anaemia Elimination Mission</strong>, under the <strong>National Health Mission</strong>, uses <strong>gender-based color-coded cards</strong> (blue for males, pink for females) and provides prophylactic penicillin from infancy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hydroxyurea and folic acid therapy are started based on age and severity. The target year for elimination is <strong>2047</strong>.</span></li></ul>",
      "correct_choice_id": 322348,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80916/PSM_Mock_1_Q1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80916/PSM_Mock_1_Q1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81010,
      "choices": [
        {
          "id": 322724,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti–HMG-CoA reductase antibody</span></p>"
        },
        {
          "id": 322725,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-nuclear antibody</span></p>"
        },
        {
          "id": 322726,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-Jo-1 antibody</span></p>"
        },
        {
          "id": 322727,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti–signal recognition particle antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old man with prior MI presents with progressive proximal muscle weakness. He discontinued statins 3 weeks ago due to symptoms, but weakness has worsened. CK is elevated at 12× ULN. Which test best confirms the suspected diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6172018",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Anti–HMG-CoA reductase antibody</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Statin-induced immune-mediated necrotizing myopathy is confirmed by anti–HMG-CoA reductase antibodies.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Persistent symptoms despite stopping statins and markedly elevated CK suggest autoimmune etiology requiring immunosuppression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Anti-nuclear antibody:</strong> Nonspecific and not diagnostic for this condition.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anti-Jo-1 antibody:</strong> Associated with interstitial lung disease and dermatomyositis.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Anti–signal recognition particle antibody:</strong> Found in another subtype of necrotizing myopathy but less associated with statins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Anti–HMG-CoA reductase antibodies confirm statin-induced autoimmune necrotizing myopathy, especially when symptoms persist after statin discontinuation.</span></p>",
      "correct_choice_id": 322724,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81010/NEET_MOCK_-_1_Question_-_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81010/NEET_MOCK_-_1_Question_-_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81133,
      "choices": [
        {
          "id": 323212,
          "text": "<p><span style=\"font-size:14.0pt;\">Conjunctival hemorrhage</span></p>"
        },
        {
          "id": 323213,
          "text": "<p><span style=\"font-size:14.0pt;\">Episcleritis</span></p>"
        },
        {
          "id": 323214,
          "text": "<p><span style=\"font-size:14.0pt;\">Uveitis</span></p>"
        },
        {
          "id": 323215,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute angle-closure glaucoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old patient presents with redness in one eye that has developed gradually over a few days. There is no significant pain, and vision is unaffected. Instillation of 5% phenylephrine eye drops causes marked blanching of the redness. Based on this response, what is the most probable diagnosis?</span></p>",
      "unique_key": "Q4457629",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Episcleritis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Episcleritis</strong> is a benign, self-limiting inflammation of the <strong>episcleral tissue</strong> (a layer between the conjunctiva and sclera). It commonly presents with:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Mild redness</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Minimal discomfort or irritation</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>No visual impairment</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The hallmark diagnostic clue is the <strong>blanching of redness with topical vasoconstrictors</strong> such as <strong>5% phenylephrine</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-05-20%20at%2012.25.50%20PM.jpeg\" width=\"500\" height=\"164\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This occurs because <strong>episcleral vessels</strong> are <strong>superficial and responsive</strong> to vasoconstriction, distinguishing it from deeper conditions like scleritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Conjunctival hemorrhage:</strong> Appears as a <strong>bright red patch</strong> due to <strong>ruptured conjunctival vessels</strong> but <strong>does not blanch</strong> with phenylephrine drops. It is <strong>painless</strong> and resolves on its own.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-05-20%20at%2012.26.03%20PM.jpeg\" width=\"328\" height=\"228\"></span></p><p><span style=\"font-size:14.0pt;\">Subconjunctival hemorrhage</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Uveitis:</strong> Involves <strong>inflammation of the uveal tract</strong>, typically associated with <strong>photophobia</strong>, <strong>pain</strong>, and <strong>vision loss</strong>. Redness is <strong>ciliary</strong> and <strong>does not blanch</strong> with vasoconstrictors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acute angle-closure glaucoma:</strong> Presents with <strong>severe pain</strong>, <strong>headache</strong>, <strong>nausea</strong>, and <strong>blurred vision</strong>. The redness is <strong>diffuse and deeper</strong>, and it <strong>does not blanch</strong> with phenylephrine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Additional information:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zvqXcul.png\" width=\"1138\" height=\"886\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Episcleritis can be clinically distinguished by blanching of redness with 5% phenylephrine, due to its involvement of superficial episcleral vessels.</span></p>",
      "correct_choice_id": 323213,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81133/NEET_PG_Mock_1_Q3_Optha.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81133/NEET_PG_Mock_1_Q3_Optha.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80925,
      "choices": [
        {
          "id": 322384,
          "text": "<p><span style=\"font-size:14.0pt;\">Power was adequate; null hypothesis is definitively true</span></p>"
        },
        {
          "id": 322385,
          "text": "<p><span style=\"font-size:14.0pt;\">The result may represent a Type II error due to low power</span></p>"
        },
        {
          "id": 322386,
          "text": "<p><span style=\"font-size:14.0pt;\">Type I error occurred due to incorrect P-value threshold</span></p>"
        },
        {
          "id": 322387,
          "text": "<p><span style=\"font-size:14.0pt;\">The study needs to reduce its alpha to improve precision</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a study of a new chemotherapy regimen, the investigators set α = 0.05 and β = 0.20. During analysis, they find no statistically significant difference in overall survival. Which of the following is the most likely explanation for the negative finding?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7775317",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) The result may represent a Type II error due to low power</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A Type II error occurs when a real difference exists, but the study fails to detect it, often due to insufficient power.</span></li><li><span style=\"font-size:14.0pt;\">In this case, β = 0.20, which means the power = 1 - β = 0.80, i.e., 80%.</span></li><li><span style=\"font-size:14.0pt;\">Although 80% is conventionally acceptable, if no statistically significant difference was found, and if the true effect exists but went undetected, this raises the possibility of a Type II error.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Power was adequate; null hypothesis is definitively true:</strong> Incorrect. Even with 80% power, a non-significant result does not definitively prove the null hypothesis; it may still be a false negative.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Type I error occurred due to incorrect P-value threshold:</strong> Incorrect. Type I error (false positive) occurs when a difference is found but doesn't truly exist. In this case, no difference was found, so Type I error doesn't apply.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The study needs to reduce its alpha to improve precision:&nbsp;</strong>Incorrect. Reducing alpha (e.g., from 0.05 to 0.01) makes it harder to find significance, thus increasing the risk of Type II error, not improving precision.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When a study yields no statistically significant result, always consider the possibility of a Type II error, especially if the study may be underpowered to detect a meaningful difference.</span></p>",
      "correct_choice_id": 322385,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80925/PSM_Mock_1_Q6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80925/PSM_Mock_1_Q6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80996,
      "choices": [
        {
          "id": 322668,
          "text": "<p><span style=\"font-size:14.0pt;\">Children with Down syndrome are at higher risk of developing this condition</span></p>"
        },
        {
          "id": 322669,
          "text": "<p><span style=\"font-size:14.0pt;\">Azacitidine can improve cytopenias and prolong survival</span></p>"
        },
        {
          "id": 322670,
          "text": "<p><span style=\"font-size:14.0pt;\">Allogeneic hematopoietic stem cell transplantation is contraindicated</span></p>"
        },
        {
          "id": 322671,
          "text": "<p><span style=\"font-size:14.0pt;\">Higher blast percentages in bone marrow are associated with worse prognosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old man presents with fatigue, low-grade fever, weight loss, and exertional dyspnea. Labs show pancytopenia, macrocytic anemia, and 4% blasts on peripheral smear. A peripheral smear image is shown below. Which of the following statements regarding his likely diagnosis is incorrect?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4eYUdqh.png\" width=\"432\" height=\"325\"></strong></span></p>",
      "unique_key": "Q3368357",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Allogeneic hematopoietic stem cell transplantation is contraindicated</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Myelodysplastic syndrome (MDS) is a clonal bone marrow disorder with risk of AML transformation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Allogeneic HSCT is the only curative option.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Azacitidine improves survival in high-risk MDS.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Children with Down syndrome are at increased risk of MDS/AML.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Prognosis correlates with blast percentage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Children with Down syndrome are at higher risk of developing this condition:&nbsp;</strong>True. Down syndrome is a known risk factor.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Azacitidine can improve cytopenias and prolong survival:&nbsp;</strong>True. Azacitidine is a standard epigenetic therapy.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Higher blast percentages in bone marrow are associated with worse prognosis:&nbsp;</strong>True. Higher blasts predict progression to AML.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Stem cell transplantation remains the only curative therapy for eligible MDS patients; it is not contraindicated.</span></p>",
      "correct_choice_id": 322670,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80996/Neet_Mock_-_1_Question_-_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80996/Neet_Mock_-_1_Question_-_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80949,
      "choices": [
        {
          "id": 322480,
          "text": "<p><span style=\"font-size:14.0pt;\">Mineral oils in overhead tanks + Paris green in storm drains</span></p>"
        },
        {
          "id": 322481,
          "text": "<p><span style=\"font-size:14.0pt;\">Intermittent irrigation + poecilia fish stocking in sewage lines</span></p>"
        },
        {
          "id": 322482,
          "text": "<p><span style=\"font-size:14.0pt;\">Source reduction of artificial containers + removal of aquatic weeds + larvivorous fish in ponds</span></p>"
        },
        {
          "id": 322483,
          "text": "<p><span style=\"font-size:14.0pt;\">Abate + Malathion alternating weekly in all surface water sources</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">You are designing an urban vector control strategy for a Smart City project. Budget constraints prevent frequent chemical interventions. Which combination of cost-effective and sustainable anti-larval measures would best address multiple mosquito species without compromising water resource utility?</span></p>",
      "unique_key": "Q5627253",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Source reduction of artificial containers + removal of aquatic weeds + larvivorous fish in ponds</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This is a <strong>public health systems thinking</strong> question that integrates sustainability, cost-effectiveness, vector biology, and urban ecosystem management.</span></li><li><span style=\"font-size:14.0pt;\">It applies a <strong>multi-pronged biological and environmental control approach</strong> that is:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Sustainable</strong>: Does not require frequent chemical input.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Eco-friendly</strong>: Safe for aquatic ecosystems and potable water sources.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Species-specific</strong>:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Aedes</strong> (dengue, chikungunya): Controlled via <strong>source reduction of artificial containers</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mansonia</strong> (filariasis): Controlled via <strong>removal of aquatic vegetation</strong> (they lay eggs on aquatic plants).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Culex/Anopheles</strong>: Controlled via <strong>larvivorous fish</strong> like Gambusia, Lebistes, or Poecilia in water bodies.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mineral oils in overhead tanks + Paris green in storm drains:</strong> <strong>Not eco-friendly</strong>, mineral oils are <strong>toxic to fish</strong> and render water <strong>unfit for human consumption</strong>. Paris green is only effective if consumed by larvae and requires <strong>targeted application</strong>, which is difficult in storm drains.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Intermittent irrigation + poecilia in sewage lines:&nbsp;</strong>Poecilia and other larvivorous fish cannot survive in <strong>polluted sewage</strong>. Intermittent irrigation is suitable only for agricultural Anopheles breeding sites, not urban settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Abate + Malathion alternating weekly in all surface water sources:</strong> Highly <strong>chemical-intensive</strong>, not sustainable under <strong>budget constraints</strong>, and may <strong>harm aquatic ecosystems</strong> and generate resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Integrated Vector Management (IVM)</strong> relies on selecting the right mix of <strong>biological and environmental measures</strong>. In urban, resource-limited settings:</span><ul><li><span style=\"font-size:14.0pt;\">Use <strong>larvivorous fish</strong> for natural control.</span></li><li><span style=\"font-size:14.0pt;\">Prioritize <strong>source reduction</strong> for Aedes.</span></li><li><span style=\"font-size:14.0pt;\">Remove <strong>aquatic vegetation</strong> for Mansonia.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This multi-species approach is more <strong>economical, sustainable, and scalable</strong> than over-reliance on larvicides.</span></li></ul>",
      "correct_choice_id": 322482,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80949/PSM_Mock_1_Q13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80949/PSM_Mock_1_Q13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80913,
      "choices": [
        {
          "id": 322336,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true and R is the correct explanation of A</span></p>"
        },
        {
          "id": 322337,
          "text": "<p><span style=\"font-size:14.0pt;\">Both A and R are true but R is not the correct explanation of A</span></p>"
        },
        {
          "id": 322338,
          "text": "<p><span style=\"font-size:14.0pt;\">A is true, but R is false</span></p>"
        },
        {
          "id": 322339,
          "text": "<p><span style=\"font-size:14.0pt;\">A is false, but R is true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion (A): Zoledronic acid helps reduce bone breakdown and fracture risk in patients with osteoporosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Reason (R): Zoledronic acid is a bisphosphonate that binds to hydroxyapatite and stimulates osteoblast activity to promote bone formation.<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5490028",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A is true, but R is false</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Zoledronic acid</strong> is a potent bisphosphonate that <strong>binds to hydroxyapatite</strong> in bone and <strong>inhibits osteoclasts</strong>, thereby reducing <strong>bone resorption</strong> and lowering <strong>fracture risk</strong>—making the <strong>assertion true</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, it does <strong>not stimulate osteoblasts</strong> or directly promote <strong>bone formation</strong>, making the <strong>reason false</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Zoledronic acid reduces fracture risk in osteoporosis by inhibiting osteoclast-mediated bone resorption. It does not promote bone formation or stimulate osteoblasts.</span></p>",
      "correct_choice_id": 322338,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80913/Pharma_Mock_1_NEET_PG5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80913/Pharma_Mock_1_NEET_PG5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81018,
      "choices": [
        {
          "id": 322756,
          "text": "<p><span style=\"font-size:14.0pt;\">A–2, B–1, C–4, D–3</span></p>"
        },
        {
          "id": 322757,
          "text": "<p><span style=\"font-size:14.0pt;\">A–1, B–2, C–4, D–3</span></p>"
        },
        {
          "id": 322758,
          "text": "<p><span style=\"font-size:14.0pt;\">A–3, B–1, C–2, D–4</span></p>"
        },
        {
          "id": 322759,
          "text": "<p><span style=\"font-size:14.0pt;\">A–4, B–3, C–2, D–1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following (Muscles and Functions):</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7SZJcHE.png\" width=\"1067\" height=\"321\"></span></p>",
      "unique_key": "Q4865170",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A–2, B–1, C–4, D–3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iVrOZmr.png\" width=\"1400\" height=\"620\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VUAUAHq.png\" width=\"1221\" height=\"256\"></strong></span></p>",
      "correct_choice_id": 322756,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81018/Neet_Pg_Mock_1_Q2_Ent.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81018/Neet_Pg_Mock_1_Q2_Ent.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80941,
      "choices": [
        {
          "id": 322448,
          "text": "<p><span style=\"font-size:14.0pt;\">An anti-arrhythmic drug with a plasma half-life of 10 seconds used for acute treatment of PSVT</span></p>"
        },
        {
          "id": 322449,
          "text": "<p><span style=\"font-size:14.0pt;\">An anti-inflammatory drug with a plasma half-life of 24 hr</span></p>"
        },
        {
          "id": 322450,
          "text": "<p><span style=\"font-size:14.0pt;\">A hypnotic drug with a plasma half-life of 2 hours</span></p>"
        },
        {
          "id": 322451,
          "text": "<p><span style=\"font-size:14.0pt;\">An anti-hypertensive with a plasma half-life of 3 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following drugs should be given in sustained release oral dosage form?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3117428",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)&nbsp;An anti-hypertensive with a plasma half-life of 3 hours</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sustained release (SR) oral dosage forms are designed to release the drug over an extended period to maintain therapeutic drug concentrations in the blood for a longer duration.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the ideal candidates for making a sustained release formulation are:&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Drugs with a short plasma half-life</span></li><li><span style=\"font-size:14.0pt;\">The drug used for a condition where prolonged therapy is required</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong>&nbsp;<strong>An anti-arrhythmic drug with a plasma half-life of 10 seconds used for acute treatment of PSVT:&nbsp;</strong>Would not be suitable for a sustained release oral dosage form since it needs to act quickly in an acute situation. An anti-inflammatory drug with a plasma half-life of 24 hours will not require a SR formulation because the drug already has a long half-life.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. An anti-inflammatory drug with a plasma half-life of 24 hr:&nbsp;</strong>An anti-inflammatory drug with a plasma half-life of 24 hours will not require a SR formulation because the drug already has a long half-life.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>A hypnotic drug with a plasma half-life of 2 hours:</strong> Would not be suitable for a sustained release oral dosage form since hypontics are required to work for 5-6 hours only and an SR form may result in prolonged sleep.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Drugs with short to intermediate half-lives used for chronic conditions (e.g., antihypertensives) are ideal candidates for sustained release oral dosage forms to improve compliance and maintain steady therapeutic levels.</span></p>",
      "correct_choice_id": 322451,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80941/Pharma_Mock_1_NEET_PG17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80941/Pharma_Mock_1_NEET_PG17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81016,
      "choices": [
        {
          "id": 322748,
          "text": "<p><span style=\"font-size:14.0pt;\">7</span></p>"
        },
        {
          "id": 322749,
          "text": "<p><span style=\"font-size:14.0pt;\">6</span></p>"
        },
        {
          "id": 322750,
          "text": "<p><span style=\"font-size:14.0pt;\">8</span></p>"
        },
        {
          "id": 322751,
          "text": "<p><span style=\"font-size:14.0pt;\">5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Calculate the GCS-P score of a patient brought into the ER with a history of a fall from a motorcycle. He is just making incomprehensible sounds, has a completely flexed posture and only opens his eyes to knuckle pressure. On examination, right pupil is unreactive to light:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5910909",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;6</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To calculate the GCS-P (Glasgow Coma Scale-Pupils) score for the patient, we will assess the eye, verbal, and motor responses, and then adjust for pupil reactivity.</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Eye response:</strong> The patient opens eyes to knuckle pressure (pain), which scores a 2.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Verbal response:</strong> The patient is making incomprehensible sounds, which scores a 2.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Motor response:</strong> The patient has a completely flexed posture, which is consistent with decorticate posturing, which scores a 3.</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Adding these together:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Eye&nbsp;Response + Verbal&nbsp;Response + Motor&nbsp;Response=2+2+3=7</span></li><li><span style=\"font-size:14.0pt;\">Now, for the pupillary response:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">One pupil is unreactive to light, which subtracts 1 from the GCS score.</span></li><li><span style=\"font-size:14.0pt;\">GCS&nbsp;Score−Pupillary&nbsp;Score=7−1=6</span></li><li><span style=\"font-size:14.0pt;\">The final GCS-P score is 6.</span></li></ul></li></ul><p><span style=\"font-size:14.0pt;\">The correct answer is <strong>B. 6</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Glasgow Coma Scale-Pupils (GCS-P) is an extension of the GCS that includes the assessment of pupillary light response. It is used to evaluate the severity of brain injuries.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The GCS-P score is derived by subtracting the pupillary score from the GCS score, providing a more comprehensive assessment of the patient's neurological status.</span></li></ul>",
      "correct_choice_id": 322749,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81016/Surgery_NEET_PG_Mock_113.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81016/Surgery_NEET_PG_Mock_113.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81137,
      "choices": [
        {
          "id": 323228,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 4 only</span></p>"
        },
        {
          "id": 323229,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, and 4 only</span></p>"
        },
        {
          "id": 323230,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, and 5 only</span></p>"
        },
        {
          "id": 323231,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements (1–5) are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the brachial plexus are correct?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The brachial plexus is formed by the ventral rami of C5 to T1.</span></li><li><span style=\"font-size:14.0pt;\">The roots of the brachial plexus and the subclavian artery pass through the gap between the anterior and middle scalene muscles.</span></li><li><span style=\"font-size:14.0pt;\">Gray rami communicantes supply sympathetic fibers to each root of the brachial plexus.</span></li><li><span style=\"font-size:14.0pt;\">Each of the three trunks divides into anterior and posterior divisions.</span></li><li><span style=\"font-size:14.0pt;\">The cords of the brachial plexus surround the brachial artery.</span></li></ol>",
      "unique_key": "Q3295466",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2, 3, and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>The brachial plexus is formed by the ventral rami of C5 to T1:</strong> Correct. The brachial plexus is formed by <strong>ventral rami of C5–T1</strong>, known as the <strong>roots</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>The roots of the brachial plexus and the subclavian artery pass through the gap between the anterior and middle scalene muscles:&nbsp;</strong>Correct. These roots and the <strong>subclavian artery</strong> pass through the <strong>interscalene gap</strong> (between the anterior and middle scalene muscles).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Gray rami communicantes supply sympathetic fibers to each root of the brachial plexus:</strong> Correct. Each <strong>root</strong> receives <strong>sympathetic fibers</strong> via <strong>gray rami communicantes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Each of the three trunks divides into anterior and posterior divisions:</strong> Correct. The <strong>upper, middle, and lower trunks</strong> each divide into <strong>anterior and posterior divisions</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>The cords of the brachial plexus surround the brachial artery:</strong>&nbsp; Incorrect. The <strong>cords of the brachial plexus</strong> surround the <strong>axillary artery</strong>, <strong>not the brachial artery</strong>. The <strong>brachial artery</strong> is distal to the lower border of the teres major muscle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>brachial plexus</strong> has a precise and consistent anatomical organization. Understanding its formation, divisions, and spatial relationships—especially with major vessels like the <strong>axillary artery</strong>—is essential for clinical applications such as nerve blocks, surgical planning, and diagnosing nerve injuries.</span></p>",
      "correct_choice_id": 323229,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81137/NEET_PG_Mock_1_Q2_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81137/NEET_PG_Mock_1_Q2_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80910,
      "choices": [
        {
          "id": 322324,
          "text": "<p><span style=\"font-size:14.0pt;\">Disruption of microtubule polymerization</span></p>"
        },
        {
          "id": 322325,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of ergosterol synthesis</span></p>"
        },
        {
          "id": 322326,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of cell wall synthesis</span></p>"
        },
        {
          "id": 322327,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of cell membrane synthesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old immunocompromised man is hospitalized with invasive pulmonary aspergillosis confirmed by imaging and fungal biomarkers. He is started on caspofungin due to intolerance to azole therapy. Which of the following best describes the mechanism of action of the antifungal agent prescribed?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1249621",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Inhibition of cell wall synthesis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Caspofungin</strong>, an echinocandin antifungal, inhibits <strong>β-(1,3)-D-glucan synthase</strong>, thereby disrupting the <strong>synthesis of β-glucan</strong>, a critical structural component of the <strong>fungal cell wall</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This weakens the fungal cell wall and leads to cell death, especially in <strong>Candida</strong> and <strong>Aspergillus</strong> species.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is particularly useful for treating <strong>azole-resistant infections</strong> or when <strong>amphotericin B cannot be used</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Disruption of microtubule polymerization:</strong> This describes the action of <strong>griseofulvin</strong>, used for <strong>dermatophyte skin infections</strong>, not for systemic or invasive fungal infections like aspergillosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Inhibition of ergosterol synthesis:</strong> Azole antifungals like <strong>voriconazole</strong> and <strong>fluconazole</strong> work via this mechanism by inhibiting <strong>lanosterol 14-α-demethylase</strong>, which is crucial in the <strong>ergosterol biosynthesis pathway</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Inhibition of cell membrane synthesis:</strong> This is the mechanism of <strong>polyenes</strong> like <strong>amphotericin B</strong>, which bind ergosterol in the <strong>fungal cell membrane</strong>, causing increased permeability and cell death.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Caspofungin acts by inhibiting fungal cell wall synthesis through β-glucan synthase blockade, a unique mechanism among antifungal classes.</span></p>",
      "correct_choice_id": 322326,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80910/Pharma_Mock_1_NEET_PG4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80910/Pharma_Mock_1_NEET_PG4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80943,
      "choices": [
        {
          "id": 322456,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 322457,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 only</span></p>"
        },
        {
          "id": 322458,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 322459,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding GAPPD targets are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">GAPPD aims to reduce pneumonia deaths to fewer than 3 per 1,000 live births by 2025.</span></li><li><span style=\"font-size:14.0pt;\">The plan sets a target of at least 50% exclusive breastfeeding during the first six months of life.</span></li><li><span style=\"font-size:14.0pt;\">GAPPD recommends 90% coverage for vaccines against pertussis, measles, Hib, pneumococcus, and rotavirus.</span></li><li><span style=\"font-size:14.0pt;\">The goal is to reduce diarrhoea deaths to fewer than 2 per 1,000 live births by 2025.</span></li></ol>",
      "unique_key": "Q4153131",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) All statements are correct</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Integrated Global Action Plan for Prevention and Control of Pneumonia and Diarrhoea (GAPPD)</strong> by WHO and UNICEF aims to end preventable childhood deaths due to pneumonia and diarrhoea through integrated strategies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. GAPPD aims to reduce pneumonia deaths to fewer than 3 per 1,000 live births by 2025:&nbsp;</strong>Correct. GAPPD targets reducing pneumonia mortality to <strong>&lt;3 per 1000 live births by 2025</strong>, particularly in children under 5 years of age.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>The plan sets a target of at least 50% exclusive breastfeeding during the first six months of life:&nbsp;</strong>Correct. Promotion of <strong>exclusive breastfeeding for the first six months</strong> is a cornerstone of the GAPPD strategy. The target is to achieve <strong>at least 50% exclusive breastfeeding</strong> coverage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>GAPPD recommends 90% coverage for vaccines against pertussis, measles, Hib, pneumococcus, and rotavirus:&nbsp;</strong>Correct. The GAPPD recommends achieving <strong>at least 90% coverage</strong> of key childhood vaccines — including <strong>pertussis, measles, Haemophilus influenzae type b (Hib), pneumococcus, and rotavirus</strong> — as these directly prevent pneumonia and diarrhoea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>The goal is to reduce diarrhoea deaths to fewer than 2 per 1,000 live births by 2025:&nbsp;</strong>Correct. The diarrhoea mortality reduction goal is to <strong>bring it down to &lt;2 deaths per 1000 live births by 2025</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The GAPPD provides a unified framework aiming to <strong>reduce childhood deaths due to pneumonia and diarrhoea</strong> using a combination of <strong>preventive, protective, and treatment strategies</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It sets <strong>quantifiable global targets</strong> such as <strong>&lt;3/1000 live births for pneumonia</strong> and <strong>&lt;2/1000 for diarrhoea</strong>, supported by <strong>90% vaccine coverage</strong> and <strong>50% exclusive breastfeeding</strong>—all vital benchmarks in child survival programs.</span></li></ul>",
      "correct_choice_id": 322459,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80943/PSM_Mock_1_Q11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80943/PSM_Mock_1_Q11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81107,
      "choices": [
        {
          "id": 323108,
          "text": "<p><span style=\"font-size:14.0pt;\">It enhances growth of candida and staphylococcus species</span></p>"
        },
        {
          "id": 323109,
          "text": "<p><span style=\"font-size:14.0pt;\">It prevents swarming by proteus organisms</span></p>"
        },
        {
          "id": 323110,
          "text": "<p><span style=\"font-size:14.0pt;\">It assists in identification of pseudomonas by pigment production</span></p>"
        },
        {
          "id": 323111,
          "text": "<p><span style=\"font-size:14.0pt;\">It differentiates between lactose fermenters and non-lactose fermenters</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old woman presents with fever, dysuria, and urinary frequency. A midstream urine sample is sent for culture and sensitivity testing. The microbiology lab chooses Cystine Lactose Electrolyte Deficient (CLED) agar for primary culture instead of MacConkey agar. What is the primary reason for selecting CLED medium in this context?</span></p>",
      "unique_key": "Q3168799",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) It prevents swarming by Proteus organisms</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>CLED (Cystine Lactose Electrolyte Deficient) agar</strong> is a <strong>differential medium</strong> designed specifically for the <strong>culture of urinary pathogens</strong>. It is preferred over MacConkey agar when processing <strong>urine cultures</strong>, particularly for one crucial reason:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>It inhibits the swarming motility of Proteus species</strong>, which are <strong>highly motile uropathogens</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Proteus species, especially <strong>Proteus mirabilis</strong>, tend to <strong>overgrow</strong> on standard agar plates due to swarming, making it <strong>difficult to isolate other organisms</strong>.</span></li><li><span style=\"font-size:14.0pt;\">CLED medium contains <strong>electrolyte-deficient composition</strong>, which prevents this swarming behavior without inhibiting growth.</span></li><li><span style=\"font-size:14.0pt;\">Additionally, CLED also allows:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Differentiation of lactose fermenters (yellow colonies)</strong> and <strong>non-lactose fermenters (blue colonies)</strong>, although this is not its unique property.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It enhances growth of Candida and Staphylococcus species:</strong> While CLED supports the growth of various urinary pathogens, it is <strong>not specifically designed</strong> to promote Candida or Staphylococcus. Other enriched media are preferred for those organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It assists in identification of Pseudomonas by pigment production:</strong> Pseudomonas aeruginosa produces <strong>pigments</strong> (e.g., pyocyanin) more distinctly on <strong>nutrient agar or King’s A/B media</strong>, <strong>not on CLED</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It differentiates between lactose fermenters and non-lactose fermenters:</strong> While CLED <strong>can differentiate LF and NLF</strong>, this is also true for <strong>MacConkey agar</strong>. The <strong>unique advantage</strong> of CLED in urine cultures lies in its <strong>inhibition of Proteus swarming</strong>, which MacConkey agar does not prevent effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">CLED agar is preferred in urine cultures because it prevents swarming of Proteus species, which can otherwise obscure growth of other urinary pathogens.</span></p>",
      "correct_choice_id": 323109,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81107/Microbiology_NEET_PG_Mock_Q1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81107/Microbiology_NEET_PG_Mock_Q1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81034,
      "choices": [
        {
          "id": 322820,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        },
        {
          "id": 322821,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 322822,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 322823,
          "text": "<p><span style=\"font-size:14.0pt;\">All are incorrect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Concerning the pathophysiology and toxic mechanisms of the poisoning caused by the seeds shown in the image below, which of the following statements are incorrect?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qiGDTNN.png\" width=\"568\" height=\"550\"></strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">This causes direct irritant injury to gastrointestinal mucosa.</span></li><li><span style=\"font-size:14.0pt;\">Toxin inhibits cellular ribosomal protein synthesis.</span></li><li><span style=\"font-size:14.0pt;\">Death results primarily from cardiotoxicity.</span></li><li><span style=\"font-size:14.0pt;\">Fluid and electrolyte loss contributes to circulatory collapse.</span></li></ol>",
      "unique_key": "Q6933795",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The seeds in the image are <strong>Croton tiglium</strong> (Jamalgota).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Toxin inhibits cellular ribosomal protein synthesis:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Crotin inhibits cellular ribosomal protein synthesis.&nbsp;</strong>Incorrect.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Although crotin is a toxalbumin like ricin and abrin, <strong>its primary clinical action in Croton tiglium poisoning is mucosal irritation</strong>, not systemic ribosomal inhibition leading to widespread cytotoxicity.</span></li><li><span style=\"font-size:14.0pt;\">Ribosomal inhibition is the hallmark of poisons like ricin (castor beans) and abrin (rosary peas), <strong>not croton poisoning</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Death results primarily from cardiotoxicity:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Death results primarily from cardiotoxicity.&nbsp;</strong>Incorrect.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Death results from hypovolemic shock</strong> due to massive gastrointestinal fluid losses, <strong>not from direct cardiac toxicity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Cardiotoxic deaths are typically associated with aconitine, oleander, cerbera (suicide tree), and not Croton tiglium.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>This causes direct irritant injury to gastrointestinal mucosa:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This causes direct irritant injury to gastrointestinal mucosa. Correct.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Crotonoside, a glycoside found in Croton tiglium, acts as a <strong>direct mucosal irritant</strong>, leading to burning, vomiting, bloody diarrhea, and hemorrhagic enteritis.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Fluid and electrolyte loss contributes to circulatory collapse:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fluid and electrolyte loss contributes to circulatory collapse. Correct.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Hypovolemia from <strong>persistent vomiting and bloody diarrhea</strong> leads to dehydration, electrolyte imbalance, prostration, and circulatory failure.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Croton tiglium poisoning causes death by direct mucosal irritation leading to fluid loss and circulatory collapse, it does not act primarily via ribosomal inhibition or cardiotoxicity.</span></p>",
      "correct_choice_id": 322821,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81034/NEET_PG_Mock_1_Q4_FMT.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81034/NEET_PG_Mock_1_Q4_FMT.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80920,
      "choices": [
        {
          "id": 322364,
          "text": "<p><span style=\"font-size:14.0pt;\">Abacavir</span></p>"
        },
        {
          "id": 322365,
          "text": "<p><span style=\"font-size:14.0pt;\">Efavirenz</span></p>"
        },
        {
          "id": 322366,
          "text": "<p><span style=\"font-size:14.0pt;\">Emtricitabine</span></p>"
        },
        {
          "id": 322367,
          "text": "<p><span style=\"font-size:14.0pt;\">Ritonavir</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man recently diagnosed with HIV infection and a CD4 count of 180 cells/mm³ begins antiretroviral therapy (ART). Two weeks later, he returns with complaints of intense vivid dreams, nightmares, dizziness, and difficulty concentrating, especially during the night. His symptoms are interfering with sleep and daytime function. Which of the following medications in his ART regimen is most likely responsible for these neuropsychiatric side effects?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8611792",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Efavirenz</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Efavirenz</strong> is a <strong>non-nucleoside reverse transcriptase inhibitor (NNRTI)</strong> that is well known for causing <strong>neuropsychiatric side effects</strong>, particularly during the first few weeks of treatment. Common symptoms include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Vivid dreams</strong> or <strong>nightmares</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Dizziness</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Confusion or poor concentration</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Insomnia</strong></span></li><li><span style=\"font-size:14.0pt;\">Occasionally <strong>hallucinations or mood disturbances</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">These effects are usually <strong>worse at night</strong> and may improve with time, though some patients may require a change in therapy.</span></li><li><span style=\"font-size:14.0pt;\">Efavirenz has <strong>good central nervous system penetration</strong>, which contributes to both its efficacy and its CNS-related adverse effects.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Abacavir:</strong> Can cause myocardial infarction and <strong>hypersensitivity reactions</strong>, particularly in patients with the <strong>HLA-B*5701 allele</strong>, but is <strong>not associated with neuropsychiatric side effects</strong> like vivid dreams or dizziness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Emtricitabine:</strong> A well-tolerated <strong>nucleoside reverse transcriptase inhibitor (NRTI)</strong>, often used in combination therapies. It rarely causes <strong>CNS effects</strong>. It causes tree like pigmentation on hand and feet.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ritonavir:&nbsp;</strong>A <strong>protease inhibitor</strong> mainly used to <strong>boost other PIs</strong> via CYP3A4 inhibition. Common side effects include <strong>GI upset, lipid abnormalities</strong>, <strong>hepatotoxicity</strong> and Lipodystrophy syndromes, but not typically&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Efavirenz is associated with neuropsychiatric side effects such as vivid dreams, insomnia, dizziness, and impaired concentration, especially early in treatment. These effects are dose-related and usually occur within the first few weeks of initiation.</span></p>",
      "correct_choice_id": 322365,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80920/Pharma_Mock_1_NEET_PG10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80920/Pharma_Mock_1_NEET_PG10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81145,
      "choices": [
        {
          "id": 323260,
          "text": "<p><span style=\"font-size:14.0pt;\">Non articular hyaline cartilage</span></p>"
        },
        {
          "id": 323261,
          "text": "<p><span style=\"font-size:14.0pt;\">Articular hyaline cartilage</span></p>"
        },
        {
          "id": 323262,
          "text": "<p><span style=\"font-size:14.0pt;\">Yellow cartilage</span></p>"
        },
        {
          "id": 323263,
          "text": "<p><span style=\"font-size:14.0pt;\">White fibrocartilage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the cartilage given below:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_rF6hJs4.png\" width=\"486\" height=\"364\"></strong></span></p>",
      "unique_key": "Q5190076",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) White fibrocartilage&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The given image shows a <strong>dense arrangement of collagen fibers</strong> in bundles with rows of <strong>round chondrocytes</strong> embedded between them. These histological features are characteristic of <strong>white fibrocartilage</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Fibrocartilage displays:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Type I collagen fibers</strong> in abundance, giving it a highly fibrous, eosinophilic appearance.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chondrocytes arranged in rows</strong> between the collagen bundles.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Absence of perichondrium</strong>, which differentiates it from hyaline and elastic cartilage.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Non-articular hyaline cartilage</strong>: Contains Type II collagen, appears glassy and lacks the thick collagen bundles seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Articular hyaline cartilage</strong>: Although also lacks perichondrium, it does not show the fibrous texture with distinct bundles of collagen seen in fibrocartilage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Yellow cartilage (Elastic cartilage)</strong>: Contains elastic fibers and appears more loosely arranged with a yellowish tinge, typically found in ear pinna and epiglottis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>White fibrocartilage</strong> is a tough, durable cartilage designed to withstand pressure and shearing forces.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is found in <strong>intervertebral discs, pubic symphysis, articular discs, and tendon insertions</strong>, and is <strong>rich in Type I collagen</strong> but lacks a perichondrium, which distinguishes it microscopically from hyaline and elastic cartilage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_AdR1oOp.png\" width=\"1128\" height=\"953\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_MLQxaUN.png\" width=\"1116\" height=\"714\"></span></p>",
      "correct_choice_id": 323263,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81145/NEET_PG_Mock_1_Q10_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81145/NEET_PG_Mock_1_Q10_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81025,
      "choices": [
        {
          "id": 322784,
          "text": "<p><span style=\"font-size:14.0pt;\">Lumbar radiculopathy</span></p>"
        },
        {
          "id": 322785,
          "text": "<p><span style=\"font-size:14.0pt;\">Sciatica due to herniated disc</span></p>"
        },
        {
          "id": 322786,
          "text": "<p><span style=\"font-size:14.0pt;\">Piriformis syndrome</span></p>"
        },
        {
          "id": 322787,
          "text": "<p><span style=\"font-size:14.0pt;\">Trochanteric bursitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman presents to the clinic with a 6-month history of deep, aching pain in her left buttock that radiates down the posterior thigh. The pain is exacerbated by prolonged sitting, climbing stairs, and running, but it is relieved by walking. The patient denies any history of trauma or direct injury to the hip. On physical examination, there is tenderness to palpation in the region of the left buttock, overlying the piriformis muscle. The Straight Leg Raise test is negative, but a Patrick’s test (FABER test) is positive for pain reproduction. There is no weakness or sensory loss in the lower limb, and neurological examination is otherwise normal. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "Q1529400",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;Piriformis syndrome</strong></span><br><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Buttock pain radiating down the posterior thigh, worsened by sitting, stair climbing, and running, with tenderness over the piriformis and a negative Straight Leg Raise (SLR) but positive FABER test — is classic for piriformis syndrome.</span></li><li><span style=\"font-size:14.0pt;\">Piriformis syndrome Caused by irritation or compression of the sciatic nerve by the piriformis muscle in the buttock.</span></li><li><span style=\"font-size:14.0pt;\">Classic features include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Deep buttock pain that may radiate down the posterior thigh (sciatic nerve distribution).</span></li><li><span style=\"font-size:14.0pt;\">Worsened by sitting, running, or climbing stairs.</span></li><li><span style=\"font-size:14.0pt;\">Tenderness over the piriformis muscle.</span></li><li><span style=\"font-size:14.0pt;\">Normal neurological exam (no true radiculopathy).</span></li><li><span style=\"font-size:14.0pt;\">Negative SLR, but positive FABER or FAIR test can reproduce the pain.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lumbar radiculopathy:</strong></span></p><ul><li><span style=\"font-size:14.0pt;\">Caused by nerve root compression in the lumbar spine (e.g., due to degenerative disc disease or disc herniation).</span></li><li><span style=\"font-size:14.0pt;\">Symptoms often include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Radiating pain, numbness, tingling, or weakness in a dermatomal distribution.</span></li><li><span style=\"font-size:14.0pt;\">Positive Straight Leg Raise test.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In this case:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Neurological exam is normal.</span></li><li><span style=\"font-size:14.0pt;\">SLR is negative, which makes lumbar radiculopathy unlikely.</span></li><li><span style=\"font-size:14.0pt;\">Pain is localized to the buttock, not the lower back.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Sciatica due to herniated disc:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While this can cause pain radiating down the posterior leg (sciatica), it typically originates from lumbar disc herniation.</span></li><li><span style=\"font-size:14.0pt;\">Features would include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Low back pain, neurological deficits, positive SLR, and possibly motor weakness.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This patient has no back pain, no sensory loss, no weakness, and normal SLR — which argues against disc herniation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Trochanteric bursitis:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Involves inflammation of the bursa over the greater trochanter (outer hip).</span></li><li><span style=\"font-size:14.0pt;\">Presents with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Lateral hip pain (not buttock pain).</span></li><li><span style=\"font-size:14.0pt;\">Pain with lying on the affected side, walking, or climbing stairs.</span></li><li><span style=\"font-size:14.0pt;\">Tenderness over the lateral aspect of the hip.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This patient has medial buttock pain, not lateral hip pain, making this diagnosis unlikely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The combination of buttock pain, radiation down the thigh, pain with sitting and activity, localized tenderness over the piriformis, and normal neurological findings strongly supports piriformis syndrome.</span></p>",
      "correct_choice_id": 322786,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81025/NEET_MOCK_-_1_Question_-_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81025/NEET_MOCK_-_1_Question_-_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81127,
      "choices": [
        {
          "id": 323188,
          "text": "<p><span style=\"font-size:14.0pt;\">Lung abscess</span></p>"
        },
        {
          "id": 323189,
          "text": "<p><span style=\"font-size:14.0pt;\">Invasive pulmonary aspergillosis</span></p>"
        },
        {
          "id": 323190,
          "text": "<p><span style=\"font-size:14.0pt;\">Miliary tuberculosis</span></p>"
        },
        {
          "id": 323191,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary embolism with infarction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old man undergoing induction chemotherapy for acute myeloid leukemia presents with fever and cough for 4 days. He is profoundly neutropenic. CT chest findings is shown in the image. Which of the following is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_YgfZtJO.png\" width=\"387\" height=\"376\"></span></p>",
      "unique_key": "Q3675451",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Invasive pulmonary aspergillosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The CT image demonstrates a <strong>\"halo sign\"</strong> — a central nodular opacity surrounded by ground-glass attenuation — a classic early radiographic finding in <strong>angioinvasive aspergillosis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The clinical setting of neutropenia further supports the diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9dCf3UL.png\" width=\"405\" height=\"403\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Lung abscess:&nbsp;</strong>Lung abscess typically shows air-fluid levels and thick-walled cavitation, usually in alcoholics or aspirators.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Miliary tuberculosis:&nbsp;</strong>Miliary TB presents with <strong>diffuse, millet-sized nodules</strong>, not a single halo lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Pulmonary embolism with infarction:&nbsp;</strong>Pulmonary infarcts appear as <strong>wedge-shaped peripheral opacities</strong>, not as nodules with ground-glass halo.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In neutropenic patients, a nodular lung lesion with surrounding ground-glass opacity on CT (halo sign) strongly suggests <strong>angioinvasive aspergillosis</strong>.</span></p>",
      "correct_choice_id": 323189,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81127/NEET_PG_Mock_1_Q1_Radiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81127/NEET_PG_Mock_1_Q1_Radiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80987,
      "choices": [
        {
          "id": 322632,
          "text": "<p><span style=\"font-size:14.0pt;\">T3N3M0</span></p>"
        },
        {
          "id": 322633,
          "text": "<p><span style=\"font-size:14.0pt;\">T4N3M0</span></p>"
        },
        {
          "id": 322634,
          "text": "<p><span style=\"font-size:14.0pt;\">T3N0M1</span></p>"
        },
        {
          "id": 322635,
          "text": "<p><span style=\"font-size:14.0pt;\">T4N3M1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old female presents with a 6 x 4 cm right breast lump in the upper medial quadrant. The lump is fixed to the pectoralis major. Examination reveals no axillary nodes but a left-sided supraclavicular node. Investigation confirms it to be an invasive ductal carcinoma. Her TNM stage is:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5897244",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) T3N0M1</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A 6 cm tumor implies T3. Fixity to P. Major doesn’t affect the T stage</span></li><li><span style=\"font-size:14.0pt;\">Absence of ipsilateral nodal metastasis is seen- N0.</span></li><li><span style=\"font-size:14.0pt;\">Any contralateral nodal involvement is M1 disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105836.jpg\" width=\"1533\" height=\"630\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105902.jpg\" width=\"1593\" height=\"719\"></strong></span></p>",
      "correct_choice_id": 322634,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80987/Surgery_NEET_PG_Mock_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80987/Surgery_NEET_PG_Mock_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80928,
      "choices": [
        {
          "id": 322396,
          "text": "<p><span style=\"font-size:14.0pt;\">Symmetric</span></p>"
        },
        {
          "id": 322397,
          "text": "<p><span style=\"font-size:14.0pt;\">Right-skewed</span></p>"
        },
        {
          "id": 322398,
          "text": "<p><span style=\"font-size:14.0pt;\">Left-skewed</span></p>"
        },
        {
          "id": 322399,
          "text": "<p><span style=\"font-size:14.0pt;\">U-shaped distribution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A clinical laboratory reports serum thyroid-stimulating hormone (TSH) levels from a sample of 100 ambulatory adult patients undergoing routine thyroid function testing. The following summary statistics are observed:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mean = 3.1 mIU/L,</span></li><li><span style=\"font-size:14.0pt;\">Median = 2.5 mIU/L,&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Mode = 1.8 mIU/L.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Based on this data, which of the following best describes the shape of the distribution of serum TSH levels in this sample?</span></p>",
      "unique_key": "Q9049622",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Right-skewed</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Skewness describes the <strong>asymmetry</strong> of a distribution:</span><ul><li><span style=\"font-size:14.0pt;\">In a <strong>right-skewed distribution</strong> (positively skewed), the <strong>mean &gt; median &gt; mode</strong> because extreme <strong>high values</strong> pull the mean to the right.</span></li><li><span style=\"font-size:14.0pt;\">In a <strong>left-skewed distribution</strong> (negatively skewed), the <strong>mean &lt; median &lt; mode</strong> due to extreme <strong>low values</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In a <strong>symmetric distribution</strong>, the mean ≈ median ≈ mode.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In this case:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Mean (3.1) &gt; Median (2.5) &gt; Mode (1.8).</strong> This pattern reflects a <strong>right-skewed</strong> (positively skewed) distribution, meaning that <strong>most values are clustered on the lower end</strong>, but a <strong>few higher values</strong> are pulling the mean upward.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Symmetric:</strong> Incorrect. In a symmetric distribution, the mean, median, and mode are approximately equal, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Left-skewed:</strong> Incorrect. A left-skewed distribution would show mean &lt; median &lt; mode. Here, the opposite is true.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. U-shaped distribution:</strong> Incorrect. A U-shaped distribution has two peaks (bimodal) with fewer values in the center, and this cannot be determined from summary statistics alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Skewness can be inferred from the relative positions of the mean, median, and mode:</span><ul><li><span style=\"font-size:14.0pt;\">Mean &gt; Median &gt; Mode → Right (positive) skew</span></li><li><span style=\"font-size:14.0pt;\">Mean &lt; Median &lt; Mode → Left (negative) skew</span></li><li><span style=\"font-size:14.0pt;\">Mean ≈ Median ≈ Mode → Symmetric distribution</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20134921.jpg\" width=\"1018\" height=\"417\"></span></p>",
      "correct_choice_id": 322397,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80928/PSM_Mock_1_Q7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80928/PSM_Mock_1_Q7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80929,
      "choices": [
        {
          "id": 322400,
          "text": "<p><span style=\"font-size:14.0pt;\">This includes all pregnancies born after 280 days of pregnancy</span></p>"
        },
        {
          "id": 322401,
          "text": "<p><span style=\"font-size:14.0pt;\">Recognized post term complications include oligohydramnios and fetal macrosomia</span></p>"
        },
        {
          "id": 322402,
          "text": "<p><span style=\"font-size:14.0pt;\">Amniocentesis should be routinely done to confirm fetal lung maturity prior to induction of labor</span></p>"
        },
        {
          "id": 322403,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiation of fetal surveillance is recommended after 41 weeks of gestation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 29-year-old woman presents at 41 weeks and 3 days of gestation for a routine antenatal check-up. She has no complications during pregnancy thus far, and fetal growth parameters have been within normal limits. She expresses concern about the risks associated with continuing the pregnancy beyond her due date and inquires whether additional testing or interventions are needed. Which amongst the following is a true statement regarding post term pregnancy?&nbsp;</span></p>",
      "unique_key": "Q3969024",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Recognized post term complications include oligohydramnios and fetal macrosomia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Recognized post term complications include oligohydramnios and fetal macrosomia</strong> - True<strong>.</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Post-term pregnancy (defined as ≥42 weeks of gestation) is associated with increased risks of:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Oligohydramnios</strong>: Decreased amniotic fluid due to placental aging and reduced fetal urine output.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fetal macrosomia</strong>: Excessive fetal growth, increasing the risk of shoulder dystocia, labor complications, and cesarean section.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These are <strong>well-established and clinically significant complications</strong> of prolonged pregnancy.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-20%20121146.jpg\" width=\"1154\" height=\"449\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. This includes all pregnancies born after 280 days of pregnancy: </strong>Incorrect<strong>.&nbsp;</strong>280 days corresponds to <strong>40 weeks</strong>, which is the <strong>estimated due date</strong> (EDD). However, <strong>post-term pregnancy is defined as lasting 42 weeks (294 days) or more</strong>. Therefore, this statement misrepresents the actual definition of post-term pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Amniocentesis should be routinely done to confirm fetal lung maturity prior to induction of labor:&nbsp;</strong>Incorrect<strong>.&nbsp;</strong>Routine <strong>amniocentesis for fetal lung maturity is not indicated</strong> in pregnancies beyond term. At or after 39 weeks, <strong>fetal lungs are presumed to be mature</strong>, and decisions about induction rely on <strong>gestational age and fetal surveillance</strong>, not on lung maturity testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Initiation of fetal surveillance is recommended after 41 weeks of gestation:&nbsp;</strong>Incorrect<strong>.&nbsp;</strong>While fetal surveillance (e.g., nonstress test and amniotic fluid assessment) <strong>may be initiated at or after 41 weeks</strong>, it is <strong>not universally recommended across all guidelines</strong>. Surveillance becomes <strong>standard</strong> and <strong>strongly advised after 42 weeks</strong>, i.e., when the pregnancy becomes truly post-term. Therefore, the blanket statement that it is <i>recommended</i> after 41 weeks is too strong and not universally accurate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Complications of a post term pregnancy (&gt; 42 weeks) include:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20104520.jpg\" width=\"1032\" height=\"728\"></span></p>",
      "correct_choice_id": 322401,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80929/OBG_Mock_1_Q1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80929/OBG_Mock_1_Q1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81085,
      "choices": [
        {
          "id": 323020,
          "text": "<p><span style=\"font-size:14.0pt;\">A and E</span></p>"
        },
        {
          "id": 323021,
          "text": "<p><span style=\"font-size:14.0pt;\">B only&nbsp;</span></p>"
        },
        {
          "id": 323022,
          "text": "<p><span style=\"font-size:14.0pt;\">A, B and C</span></p>"
        },
        {
          "id": 323023,
          "text": "<p><span style=\"font-size:14.0pt;\">D only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old man presents with progressive shortness of breath and decreased exercise tolerance. He has never smoked. Physical examination reveals decreased breath sounds and hyperresonance to percussion. Pulmonary function tests show an obstructive pattern. A liver biopsy shows pink, PAS-positive globules in hepatocytes. Which of the following best explains the underlying cause of this patient's disease?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Excess elastase activity causes centriacinar emphysema predominantly in the upper lobes.</span></li><li><span style=\"font-size:14.0pt;\">Mutated antiprotease accumulates in the endoplasmic reticulum of hepatocytes, resulting in liver damage and panacinar emphysema.</span></li><li><span style=\"font-size:14.0pt;\">Chronic tobacco smoke exposure increases goblet cell hyperplasia and submucosal gland hypertrophy.</span></li><li><span style=\"font-size:14.0pt;\">Autoimmune destruction of alveolar walls leads to honeycombing of the lung bases.</span></li><li><span style=\"font-size:14.0pt;\">Bronchial obstruction leads to air trapping and recurrent infections with mucus plugging.</span></li></ol>",
      "unique_key": "Q3849578",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) B only&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has <strong>Alpha-1 Antitrypsin (A1AT) deficiency</strong>, a <strong>rare cause of emphysema</strong>. A1AT is an <strong>antiprotease</strong> that protects alveolar walls from <strong>protease-mediated damage</strong>, particularly <strong>elastase</strong> released by neutrophils. In its absence, <strong>unopposed protease activity</strong> damages the <strong>air sacs</strong>, resulting in <strong>panacinar emphysema</strong>, which is <strong>most severe in the lower lobes</strong> of the lung.</span></li><li><span style=\"font-size:14.0pt;\">In addition to lung disease, <strong>liver cirrhosis may also be present</strong>. This occurs because <strong>A1AT deficiency is due to misfolding of the mutated protein</strong>, which causes the <strong>mutant A1AT to accumulate in the endoplasmic reticulum of hepatocytes</strong>, leading to <strong>hepatocellular injury</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">On liver <strong>biopsy</strong>, these accumulations appear as <strong>pink, PAS-positive globules</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2Br3H7W.png\" width=\"466\" height=\"407\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A. Excess elastase activity causes centriacinar emphysema predominantly in the upper lobes:</strong> Incorrect. This describes <strong>smoking-related emphysema</strong>, not <strong>A1AT deficiency</strong>. In A1AT deficiency, emphysema is <strong>panacinar</strong> and affects the <strong>lower lobes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C. Chronic tobacco smoke exposure increases goblet cell hyperplasia and submucosal gland hypertrophy:</strong> Incorrect. This is the mechanism of <strong>chronic bronchitis</strong>, not A1AT deficiency. Also, this patient has <strong>never smoked</strong>, and the biopsy findings point to <strong>A1AT accumulation</strong>, not mucus overproduction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D. Autoimmune destruction of alveolar walls leads to honeycombing of the lung bases:</strong> Incorrect. This describes <strong>idiopathic pulmonary fibrosis</strong>, not A1AT deficiency. There’s no mention of autoimmune features, fibrosis, or honeycombing in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>E. Bronchial obstruction leads to air trapping and recurrent infections with mucus plugging:</strong> Incorrect. This is characteristic of <strong>bronchiectasis</strong> or <strong>obstructive airway disease</strong> due to infections or tumors, not A1AT deficiency. There's no mention of mucus plugging, and the pathology described points to <strong>protein accumulation in hepatocytes</strong>, not airway blockage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Alpha-1 antitrypsin (A1AT) deficiency causes panacinar emphysema (most severe in the lower lobes) and liver cirrhosis due to misfolded A1AT protein accumulating in the endoplasmic reticulum of hepatocytes, seen as pink, PAS-positive globules on biopsy.</span></p>",
      "correct_choice_id": 323021,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81085/NEET_PG_Mock_1_Q7_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81085/NEET_PG_Mock_1_Q7_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80940,
      "choices": [
        {
          "id": 322444,
          "text": "<p><span style=\"font-size:14.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 322445,
          "text": "<p><span style=\"font-size:14.0pt;\">Clonidine</span></p>"
        },
        {
          "id": 322446,
          "text": "<p><span style=\"font-size:14.0pt;\">Enalapril</span></p>"
        },
        {
          "id": 322447,
          "text": "<p><span style=\"font-size:14.0pt;\">Prazosin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56-year-old man with a history of hypertension is being considered for a new antihypertensive medication. His physician is weighing various options, taking into consideration their potential impact on plasma renin activity, which could have downstream effects on blood pressure control. All of the following drugs increase plasma renin activity except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3235496",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Clonidine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">All antihypertensive drugs result in compensatory increase in sympathetic activity.</span></li><li><span style=\"font-size:14.0pt;\">This tends to increase plasma renin levels and plasma renin activity due to stimulation of beta 1 receptors in JG cells of kidney.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, those antihypertensive drugs will decrease plasma renin levels that work by stopping sympathetic activity like beta blockers and alpha 2 agonists.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clonidine is a centrally acting alpha-2 adrenergic agonist similar to clonidine.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It decreases sympathetic nervous system activity, which generally results in a decrease in renin release from the juxtaglomerular cells of the kidney.</span></li><li><span style=\"font-size:14.0pt;\">This leads to lower plasma renin activity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Amlodipine:</strong> This calcium channel blocker reduces arterial pressure and typically triggers a compensatory increase in renin release to restore blood pressure, thereby increasing plasma renin activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Enalapril:</strong> This angiotensin-converting enzyme (ACE) inhibitor reduces levels of angiotensin II, reflux increase in renin activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Prazosin:</strong> This alpha-1 adrenergic antagonist reduces vascular tone, leading to a compensatory increase in renin release to restore blood pressure, thereby increasing plasma renin activity.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clonidine decreases plasma renin activity by reducing central sympathetic outflow, distinguishing it from other antihypertensive agents that increase plasma renin activity.</span></p>",
      "correct_choice_id": 322445,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80940/Pharma_Mock_1_NEET_PG16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80940/Pharma_Mock_1_NEET_PG16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81131,
      "choices": [
        {
          "id": 323204,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute anterior uveitis</span></p>"
        },
        {
          "id": 323205,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior scleritis</span></p>"
        },
        {
          "id": 323206,
          "text": "<p><span style=\"font-size:14.0pt;\">Scleromalacia perforans</span></p>"
        },
        {
          "id": 323207,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute angle-closure glaucoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old woman presents with severe, deep, boring pain and redness in the left eye. The pain is persistent and intense enough to disturb sleep. Ocular ultrasonography (B-scan) reveals a ‘T-sign’ involving the outer coats of the eyeball. What is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q5767127",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Posterior scleritis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Posterior scleritis</strong> is an <strong>inflammatory disease of the posterior sclera</strong> that classically presents with:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Severe deep, boring ocular pain</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Redness</strong></span></li><li><span style=\"font-size:14.0pt;\">Pain may be <strong>severe enough to disturb sleep</strong></span></li><li><span style=\"font-size:14.0pt;\">In the mild form, there is thickening.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In the severe form, there is increased inflammation and separation of layers, resulting in characteristic T-sign on B-scan ultrasonography.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">On imaging, <strong>ultrasound B-scan</strong> often reveals a <strong>‘T-sign’</strong>, due to fluid in <strong>Tenon’s space</strong> separating the sclera from the choroid and optic nerve shadow.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-05-20%20at%2012.08.17%20PM.jpeg\" width=\"215\" height=\"283\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This diagnosis must be considered in <strong>elderly patients with deep eye pain and no clear anterior pathology</strong>, especially when imaging findings are supportive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute anterior uveitis:</strong> Presents with <strong>photophobia</strong>, <strong>ciliary injection</strong>, and <strong>pain</strong>, but typically involves the <strong>anterior segment</strong>. It does <strong>not produce a ‘T-sign’</strong> on B-scan and lacks the deep, boring quality of pain typical in posterior scleritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Scleromalacia perforans:</strong> A <strong>painless, necrotizing form of scleritis</strong>, often associated with <strong>rheumatoid arthritis</strong>. There is <strong>no redness</strong>, <strong>no pain</strong>, and <strong>no T-sign</strong>, making it inconsistent with this presentation. There is thinning of the sclera with the underlying uvea shining through.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-05-20%20at%2012.08.57%20PM.jpeg\" width=\"319\" height=\"195\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acute angle-closure glaucoma:</strong> Presents with <strong>sudden onset of severe ocular pain</strong>, <strong>mid-dilated pupil</strong>, <strong>corneal edema</strong>, and <strong>increased intraocular pressure</strong>. It is not associated with a <strong>‘T-sign’</strong>, and while pain is severe, the <strong>imaging findings and history differ significantly</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Posterior scleritis is characterized by deep, boring ocular pain and the presence of a T-sign on B-scan ultrasonography, indicating inflammation and fluid in Tenon’s space.</span></p>",
      "correct_choice_id": 323205,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81131/NEET_PG_Mock_1_Q1_Optha.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81131/NEET_PG_Mock_1_Q1_Optha.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81121,
      "choices": [
        {
          "id": 323164,
          "text": "<p><span style=\"font-size:14.0pt;\">Ancylostoma caninum</span></p>"
        },
        {
          "id": 323165,
          "text": "<p><span style=\"font-size:14.0pt;\">Ancylostoma ceylanicum</span></p>"
        },
        {
          "id": 323166,
          "text": "<p><span style=\"font-size:14.0pt;\">Ancylostoma braziliense</span></p>"
        },
        {
          "id": 323167,
          "text": "<p><span style=\"font-size:14.0pt;\">Ancylostoma duodenale</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 33-year-old traveler returns from a beach vacation in Southeast Asia and presents with intensely itchy, serpiginous, erythematous tracks on the soles of his feet. The lesions appear to be slowly migrating. Based on clinical suspicion, cutaneous larva migrans is diagnosed. Which of the following hookworm species is not typically associated with this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9447049",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Ancylostoma duodenale</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Cutaneous larva migrans (CLM)</strong> is a <strong>zoonotic parasitic skin disease</strong> caused by the <strong>intraepidermal migration of nematode larvae</strong>, most commonly <strong>dog and cat hookworms</strong>. Key points include:</span><ul><li><span style=\"font-size:14.0pt;\">It presents with <strong>itchy, creeping, serpiginous skin lesions</strong>, often on feet, buttocks, or thighs.</span></li><li><span style=\"font-size:14.0pt;\">The most common causative organisms are:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Ancylostoma braziliense</strong> (most common)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ancylostoma caninum</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Ancylostoma ceylanicum</strong></span></li></ul></li></ul></li><li><span style=\"font-size:14.0pt;\">These <strong>animal hookworms</strong> <strong>cannot penetrate deeply into human tissue</strong>, so they remain <strong>trapped in the epidermis</strong>, causing the classic <strong>cutaneous pattern</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ancylostoma duodenale&nbsp;</strong>is a <strong>human hookworm</strong> that penetrates the skin, enters the bloodstream, and causes <strong>systemic infection</strong>, including <strong>iron-deficiency anemia</strong>, not <strong>cutaneous larva migrans</strong>. It does not get trapped in the skin to cause the serpiginous tracks. It causes gastroenteritic symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ancylostoma caninum:</strong> This is a <strong>dog hookworm</strong> that can occasionally infect humans. It is primarily known to cause <strong>cutaneous larva migrans (CLM)</strong>, a skin condition resulting from the migration of larvae through the epidermis, leading to serpiginous, itchy lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ancylostoma ceylanicum:</strong> Can infect both animals and humans; known to cause <strong>cutaneous larva migrans</strong> and occasionally enteric symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ancylostoma braziliense:</strong> The <strong>most common cause</strong> of <strong>cutaneous larva migrans</strong> in tropical and subtropical regions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cutaneous larva migrans is caused by animal hookworms such as Ancylostoma braziliense, caninum, and ceylanicum, but not by Ancylostoma duodenale, which is a human hookworm that causes systemic disease.</span></p>",
      "correct_choice_id": 323167,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81121/Microbiology_NEET_PG_Mock_Q14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81121/Microbiology_NEET_PG_Mock_Q14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80986,
      "choices": [
        {
          "id": 322628,
          "text": "<p><span style=\"font-size:14.0pt;\">Fat-free diet</span></p>"
        },
        {
          "id": 322629,
          "text": "<p><span style=\"font-size:14.0pt;\">Lactose-free diet</span></p>"
        },
        {
          "id": 322630,
          "text": "<p><span style=\"font-size:14.0pt;\">Low carbohydrate diet</span></p>"
        },
        {
          "id": 322631,
          "text": "<p><span style=\"font-size:14.0pt;\">Gluten-free diet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old child presents with chronic diarrhea and weight loss. On physical examination, the child’s height and weight are below the expected growth percentile. Laboratory investigations show a positive result for class II HLA-DQ2. Which of the following dietary modifications would be most appropriate for this child?</span></p>",
      "unique_key": "Q1517828",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Gluten-free diet</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This child's presentation, including chronic diarrhea, weight loss, and growth retardation, is consistent with <strong>Celiac Disease</strong>, an autoimmune disorder triggered by the ingestion of gluten in genetically predisposed individuals.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of <strong>HLA-DQ2</strong> class II antigen further supports this diagnosis, as it is commonly associated with Celiac Disease.</span></li><li><span style=\"font-size:14.0pt;\">The primary treatment for Celiac Disease is a <strong>strict gluten-free diet</strong>, which leads to improvement in symptoms and prevention of long-term complications such as nutritional deficiencies and growth impairment.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The gluten-free diet helps manage inflammation and damage in the small intestine caused by gluten exposure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fat-free diet:</strong> This is not the recommended diet for Celiac Disease. A fat-free diet is typically used for managing conditions related to <strong>fat malabsorption</strong>, such as <strong>pancreatic insufficiency</strong> or <strong>gallbladder disease</strong>. It would not address the underlying cause of the child’s symptoms related to gluten intolerance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Lactose-free diet:</strong> While <strong>lactose intolerance</strong> is common in individuals with Celiac Disease, it is not the primary concern in this case. A lactose-free diet might help alleviate some gastrointestinal symptoms temporarily, but it will not address the root cause, which is <strong>gluten sensitivity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Low carbohydrate diet:</strong> A low carbohydrate diet is not indicated for Celiac Disease. This type of diet is more relevant in managing conditions like <strong>obesity</strong> or <strong>type 2 diabetes</strong>, not for gluten-induced autoimmune disorders like Celiac Disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>Celiac Disease</strong>, the definitive treatment is a <strong>gluten-free diet</strong>, which helps alleviate symptoms and prevent long-term complications.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Positive findings for <strong>HLA-DQ2</strong> are a strong indicator of genetic susceptibility to the disease.</span></li></ul>",
      "correct_choice_id": 322631,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80986/Pediatrics__NEET_MOCK_-_1_Question_-_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80986/Pediatrics__NEET_MOCK_-_1_Question_-_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81011,
      "choices": [
        {
          "id": 322728,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti Histone &amp; Anti-Sm</span></p>"
        },
        {
          "id": 322729,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-Histone &amp; Anti-dsDNA</span></p>"
        },
        {
          "id": 322730,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti Histone &amp; Anti-Ro</span></p>"
        },
        {
          "id": 322731,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti Histone &amp; Anti TPO</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old woman with psoriasis develops new joint pain and a rash as shown in the image below. She was on infliximab for the past 3 months. ANA is positive at 1:320. Which autoantibody is most likely to be positive?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_BzUxmpr.png\" width=\"637\" height=\"337\"></strong></span></p>",
      "unique_key": "Q5583566",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Anti-Histone &amp; Anti-dsDNA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient likely has drug-induced lupus erythematosus (DILE), triggered by <strong>infliximab</strong>, a TNF-α inhibitor known to cause lupus-like syndrome.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The most commonly positive antibody in DILE is <strong>anti-histone</strong>, seen in &gt;90% of cases.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, <strong>TNF-inhibitor-induced lupus</strong> is somewhat unique—it may <strong>also present with anti-dsDNA positivity</strong>, which is more typical of idiopathic SLE.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ANA is usually positive in high titers in both forms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Anti-Histone &amp; Anti-Sm:&nbsp;</strong>Anti-Sm is specific for idiopathic SLE, not drug-induced lupus. It is not typically seen in TNF-inhibitor-induced lupus.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anti-Histone &amp; Anti-Ro:</strong> Anti-Ro (SSA) is more commonly seen in <strong>subacute cutaneous lupus</strong> and <strong>Sjogren’s syndrome</strong>, not in drug-induced lupus.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Anti-Histone &amp; Anti-TPO:</strong> Anti-TPO is a marker of autoimmune thyroid disease (like Hashimoto’s thyroiditis), unrelated to lupus or drug-induced lupus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Infliximab and other TNF-α inhibitors can cause a unique form of drug-induced lupus characterized by high-titer ANA, anti-histone, and occasionally anti-dsDNA positivity—distinguishing it from classic DILE.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Always monitor patients on biologics for lupus-like symptoms.</span></li></ul>",
      "correct_choice_id": 322729,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81011/NEET_MOCK_-_1_Question_-_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81011/NEET_MOCK_-_1_Question_-_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81110,
      "choices": [
        {
          "id": 323120,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 3</span></p>"
        },
        {
          "id": 323121,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 4</span></p>"
        },
        {
          "id": 323122,
          "text": "<p><span style=\"font-size:14.0pt;\">Both 3 and 4</span></p>"
        },
        {
          "id": 323123,
          "text": "<p><span style=\"font-size:14.0pt;\">Both 1 and 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about Staphylococcus aureus-specific enzymes are incorrect?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The coagulase test is used to differentiate S. aureus from coagulase-negative staphylococci (CoNS).</span></li><li><span style=\"font-size:14.0pt;\">Thermonuclease produced by S. aureus is heat-stable and can digest DNA.</span></li><li><span style=\"font-size:14.0pt;\">The DNase test is positive in both S. aureus and CoNS species.</span></li><li><span style=\"font-size:14.0pt;\">Phosphatase activity is absent in S. aureus, which differentiates it from other Gram-positive cocci.</span></li><li><span style=\"font-size:14.0pt;\">All listed enzyme activities are typically absent in CoNS.</span></li></ol>",
      "unique_key": "Q7299495",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Both 3 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. The DNase test is positive in both S. aureus and CoNS species:</strong> Incorrect. The <strong>DNase test</strong> is <strong>positive for S. aureus</strong>, but <strong>negative in most CoNS</strong>, making this a key <strong>differentiating test</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Phosphatase activity is absent in S. aureus, which differentiates it from other Gram-positive cocci: </strong>Incorrect. <strong>S. aureus is phosphatase -positive</strong>, not negative. The <strong>phosphatase test</strong> helps distinguish S. aureus from CoNS, where CoNS are typically <strong>phosphatase negative</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>The coagulase test is used to differentiate S. aureus from coagulase-negative staphylococci (CoNS):</strong> Correct. The <strong>coagulase test</strong> (both slide and tube method) is <strong>classically used</strong> to differentiate <strong>S. aureus (coagulase-positive)</strong> from <strong>CoNS (coagulase-negative staphylococci)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Thermonuclease produced by S. aureus is heat-stable and can digest DNA: </strong>Correct. <strong>Thermonuclease</strong> is a <strong>heat-stable enzyme</strong> produced by <strong>S. aureus</strong> that can degrade DNA and remains active even after boiling, which helps in diagnostic testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>All listed enzyme activities are typically absent in CoNS: </strong>Correct. <strong>CoNS generally lack</strong> all the listed enzyme activities, including <strong>coagulase, thermonuclease, DNase, and phosphatase</strong>, making these features <strong>specific for S. aureus</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">S. aureus is uniquely positive for coagulase, heat-stable thermonuclease, DNase, and phosphatase; these enzyme activities are typically absent in coagulase-negative staphylococci (CoNS), making them useful for laboratory differentiation.</span></p>",
      "correct_choice_id": 323122,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81110/Microbiology_NEET_PG_Mock_Q3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81110/Microbiology_NEET_PG_Mock_Q3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80952,
      "choices": [
        {
          "id": 322492,
          "text": "<p><span style=\"font-size:14.0pt;\">A–2, B–5, C–3, D–1, E–4</span></p>"
        },
        {
          "id": 322493,
          "text": "<p><span style=\"font-size:14.0pt;\">A–2, B–3, C–5, D–4, E–1</span></p>"
        },
        {
          "id": 322494,
          "text": "<p><span style=\"font-size:14.0pt;\">A–4, B–2, C–5, D–3, E–1</span></p>"
        },
        {
          "id": 322495,
          "text": "<p><span style=\"font-size:14.0pt;\">A–3, B–2, C–1, D–5, E–4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following: Maneuvers for Shoulder Dystocia and Their Descriptions:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A (Maneuver)</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">McRoberts maneuver</span></li><li><span style=\"font-size:14.0pt;\">Suprapubic pressure</span></li><li><span style=\"font-size:14.0pt;\">Rubin II maneuver</span></li><li><span style=\"font-size:14.0pt;\">Woods’ screw maneuver</span></li><li><span style=\"font-size:14.0pt;\">Gaskin maneuver</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B (Description)</span></p><ol><li><span style=\"font-size:14.0pt;\">Rotation of the anterior shoulder to posterior to dislodge impacted shoulder</span></li><li><span style=\"font-size:14.0pt;\">Maternal hip hyperflexion to flatten the lumbar spine and widen pelvic outlet</span></li><li><span style=\"font-size:14.0pt;\">Posterior-directed pressure on the anterior shoulder to move fetus into oblique angle</span></li><li><span style=\"font-size:14.0pt;\">Changing maternal position to hands-and-knees to increase pelvic dimensions</span></li><li><span style=\"font-size:14.0pt;\">Pressure applied over pubic area toward the posterior aspect of fetal anterior shoulder</span></li></ol>",
      "unique_key": "Q3238951",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A–2, B–5, C–3, D–1, E–4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A–2. McRoberts maneuver:</strong> Involves hyperflexion of the maternal hips onto the abdomen to flatten the lumbar spine and widen the pelvic outlet.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B–5. Suprapubic pressure:</strong> Pressure is directed posteriorly and laterally over the pubic area to assist in dislodging the anterior fetal shoulder.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C–3. Rubin II maneuver:</strong> Posterior-directed pressure on the anterior fetal shoulder to rotate it into an oblique plane.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D–1. Woods’ screw maneuver:</strong> Simultaneous pressure on the posterior shoulder to rotate the fetus, effectively turning the anterior shoulder to the posterior.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>E–4. Gaskin maneuver:</strong> Positioning the mother on all fours (hands and knees), increasing pelvic dimensions and facilitating delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Shoulder dystocia is an obstetric emergency that requires prompt maneuvering to release the impacted fetal shoulder.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A systematic approach using well-established maneuvers—such as McRoberts, suprapubic pressure, Rubin II, Woods' screw, and Gaskin—is essential to safely resolve the obstruction and minimize fetal and maternal morbidity.</span></li></ul>",
      "correct_choice_id": 322492,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80952/OBG_Mock_1_Q13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80952/OBG_Mock_1_Q13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80984,
      "choices": [
        {
          "id": 322620,
          "text": "<p><span style=\"font-size:14.0pt;\">Child’s score</span></p>"
        },
        {
          "id": 322621,
          "text": "<p><span style=\"font-size:14.0pt;\">LIRADS score</span></p>"
        },
        {
          "id": 322622,
          "text": "<p><span style=\"font-size:14.0pt;\">Milan criteria</span></p>"
        },
        {
          "id": 322623,
          "text": "<p><span style=\"font-size:14.0pt;\">King’s college criteria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old male, known case of cirrhosis of the liver, presents with an abdominal lump. Imaging reveals a solitary 3 x 4 cm nodule with rapid washout of contrast in the venous phase. Serum AFP levels are elevated. Which clinical criteria would decide suitability for liver transplant in this patient?</span></p>",
      "unique_key": "Q2274928",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Milan criteria</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Milan criteria are utilised to ascertain suitability for liver transplant in patients with cirrhosis and hepatoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Child’s score:</strong> Severity of chronic liver disease</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>LIRADS score:&nbsp;</strong>LI-RADS stands for <strong>Liver Imaging Reporting and Data System</strong>, a standardized system used in radiology to evaluate liver lesions in patients with risk factors for hepatocellular carcinoma (HCC).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. King’s College criteria:</strong> For liver transplant in acute liver failure</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Transplantation for HCC, first described by Mazzaferro in 1996 for patients with tumours ≤5&nbsp;cm or up to three nodules ≤3&nbsp;cm, achieved 4-year overall survivals of 75% and recurrence-free survivals of 83%.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These inclusion criteria were adopted as the “Milan criteria”, with angioinvasion and extrahepatic involvement as additional exclusion criteria, and are now universally accepted.</span></li></ul>",
      "correct_choice_id": 322622,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80984/Surgery_NEET_PG_Mock_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80984/Surgery_NEET_PG_Mock_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81117,
      "choices": [
        {
          "id": 323148,
          "text": "<p><span style=\"font-size:14.0pt;\">Trichophyton violaceum</span></p>"
        },
        {
          "id": 323149,
          "text": "<p><span style=\"font-size:14.0pt;\">Trichophyton rubrum</span></p>"
        },
        {
          "id": 323150,
          "text": "<p><span style=\"font-size:14.0pt;\">Trichophyton tonsurans</span></p>"
        },
        {
          "id": 323151,
          "text": "<p><span style=\"font-size:14.0pt;\">Trichophyton schoenleinii</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with itching in the axillary region. Skin scrapings were collected and inoculated on Sabaroud’s Dextrose agar. After incubation, the organism shows the characteristic appearance as seen in the image provided. Which of the following is the most likely organism responsible for this presentation?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_619gx3p.png\" width=\"450\" height=\"495\"></strong></span></p>",
      "unique_key": "Q3561893",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Trichophyton rubrum</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Trichophyton rubrum</strong> is a <strong>dermatophyte fungus</strong> and the <strong>most common cause</strong> of <strong>tinea infections</strong> (dermatophytoses). Key identifying features include:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Red pigment production</strong> on culture (on Sabouraud’s dextrose agar or cornmeal agar)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pencil-shaped (elongated, smooth-walled) macroconidia</strong>, as seen in the image</span></li><li><span style=\"font-size:14.0pt;\">Commonly infects <strong>skin, hair, and nails</strong></span></li><li><span style=\"font-size:14.0pt;\">Causes <strong>tinea corporis</strong>, <strong>tinea cruris</strong>, and <strong>tinea pedis</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The combination of <strong>red pigmentation</strong> and <strong>microscopic morphology</strong> is <strong>classic for T. rubrum</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Trichophyton violaceum:</strong> Produces <strong>violaceous (purple)</strong> colonies; lacks <strong>distinctive macroconidia</strong>. More common in <strong>tinea capitis</strong>, especially in endemic regions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Trichophyton tonsurans:</strong> A common cause of <strong>tinea capitis</strong>, especially in children. Characterized by <strong>chlamydoconidia</strong> and <strong>rare macroconidia</strong>. It does <strong>not produce red pigment,&nbsp;</strong>rather it produces whitish colonies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Trichophyton schoenleinii:</strong> Associated with <strong>favus</strong>, a chronic form of tinea capitis. Shows <strong>antler-shaped hyphae (favic chandeliers)</strong> rather than macroconidia. The colonies are typically <strong>whitish</strong> in appearance and do <strong>not</strong> produce red pigmentation. &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Trichophyton rubrum is identified by red pigment production in culture and pencil-shaped macroconidia; it is the most common dermatophyte causing tinea infections<strong>.</strong></span></p>",
      "correct_choice_id": 323149,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81117/Microbiology_NEET_PG_Mock_Q10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81117/Microbiology_NEET_PG_Mock_Q10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81083,
      "choices": [
        {
          "id": 323012,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 are correct</span></p>"
        },
        {
          "id": 323013,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 4 are correct</span></p>"
        },
        {
          "id": 323014,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 5 are correct</span></p>"
        },
        {
          "id": 323015,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding amyloidosis is/are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Amyloidosis is characterized by the extracellular deposition of abnormal protein fibrils that interfere with normal tissue function.</span></li><li><span style=\"font-size:14.0pt;\">Congo red staining under polarized light reveals a characteristic apple-green birefringence, which is considered diagnostic for amyloid deposits.</span></li><li><span style=\"font-size:14.0pt;\">X-ray crystallography can detect the presence of beta-pleated sheet conformations, which are a hallmark of amyloid fibrils.</span></li><li><span style=\"font-size:14.0pt;\">The primary form of amyloidosis, known as AL amyloidosis, occurs due to an accumulation of amyloid deposits secondary to chronic inflammation.</span></li><li><span style=\"font-size:14.0pt;\">The extracellular amyloid deposits primarily consist of misfolded proteins that accumulate within cells, leading to organ dysfunction.</span></li></ol>",
      "unique_key": "Q9321901",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2 and 3 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Amyloidosis is characterized by the extracellular deposition of abnormal protein fibrils that interfere with normal tissue function:</strong> Correct. Amyloidosis is the deposition of abnormal protein fibrils in tissues, primarily in the extracellular space.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Congo red staining under polarized light reveals a characteristic apple-green birefringence, which is considered diagnostic for amyloid deposits:</strong> Correct. The apple-green birefringence seen with Congo red staining is a classic feature of amyloid deposits under polarized light.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>X-ray crystallography can detect the presence of beta-pleated sheet conformations, which are a hallmark of amyloid fibrils:</strong> Correct. The amyloid fibrils show beta-pleated sheet structures, detectable by X-ray crystallography.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>The primary form of amyloidosis, known as AL amyloidosis, occurs due to an accumulation of amyloid deposits secondary to chronic inflammation:</strong> Incorrect. AL amyloidosis is a primary form, not secondary. Secondary amyloidosis is linked with chronic inflammatory conditions and is usually associated with AA amyloidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>The extracellular amyloid deposits primarily consist of misfolded proteins that accumulate within cells, leading to organ dysfunction:</strong> Incorrect. Amyloid deposits are extracellular, not intracellular, and cause organ dysfunction through deposition in tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Amyloidosis involves extracellular deposition of misfolded protein fibrils with beta-pleated sheet structure, best identified by Congo red staining (showing apple-green birefringence) and confirmed structurally by X-ray crystallography</span></p>",
      "correct_choice_id": 323012,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81083/NEET_PG_Mock_1_Q5_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81083/NEET_PG_Mock_1_Q5_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80964,
      "choices": [
        {
          "id": 322540,
          "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-3, C-2</span></p>"
        },
        {
          "id": 322541,
          "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-1, C-3</span></p>"
        },
        {
          "id": 322542,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-2, C-1</span></p>"
        },
        {
          "id": 322543,
          "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-2, C-3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A:</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">First trimester parameter</span></li><li><span style=\"font-size:14.0pt;\">Second trimester parameter</span></li><li><span style=\"font-size:14.0pt;\">Third trimester parameter</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B: (Parameter for assessing gestational age)</span></p><ol><li><span style=\"font-size:14.0pt;\">Femur length (FL)</span></li><li><span style=\"font-size:14.0pt;\">Biparietal diameter (BPD)</span></li><li><span style=\"font-size:14.0pt;\">Crown-rump length (CRL)</span></li></ol>",
      "unique_key": "Q1003903",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A-3, B-2, C-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A-3. First trimester parameter — Crown-rump length:</strong> CRL is the most accurate parameter for assessing gestational age in the first trimester. It measures the distance from the crown to the rump of the fetus and is highly reliable during this period.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B-2. Second trimester parameter — Biparietal diameter:</strong> BPD is the most accurate parameter in the second trimester. It is measured in the transthalamic view, from the outer edge of the skull in the near field to the inner edge in the far field.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C-1. Third trimester parameter — Femur length:</strong> FL is used in the third trimester to estimate gestational age, especially when other parameters become less reliable due to fetal growth variations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The accuracy of fetal parameters for gestational age estimation changes across trimesters:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>First trimester</strong>: CRL is most accurate.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Second trimester</strong>: BPD provides the best estimate.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Third trimester</strong>: FL is useful when other measurements are less reliable.</span></li></ul></li></ul>",
      "correct_choice_id": 322542,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80964/OBG_Mock_1_Q17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80964/OBG_Mock_1_Q17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80992,
      "choices": [
        {
          "id": 322652,
          "text": "<p><span style=\"font-size:14.0pt;\">Internal sphincter injury doesn’t lead to fecal incontinence if the external sphincter is intact</span></p>"
        },
        {
          "id": 322653,
          "text": "<p><span style=\"font-size:14.0pt;\">The external sphincter is a continuation of the outer longitudinal muscle coat of the rectum</span></p>"
        },
        {
          "id": 322654,
          "text": "<p><span style=\"font-size:14.0pt;\">Anal canal is derived entirely from proctodaeum</span></p>"
        },
        {
          "id": 322655,
          "text": "<p><span style=\"font-size:14.0pt;\">Part of the anus above the dentate line lacks sensations</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the incorrect statement about anal anatomy:</span></p>",
      "unique_key": "Q7898771",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Anal canal is derived entirely from proctodaeum</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Anal canal is derived from <strong>cloaca (above dentate line) and proctodaeum (below dentate line).</strong></span></li><li><span style=\"font-size:14.0pt;\">The anal canal has dual embryonic origins; the portion above the dentate line is derived from the endoderm (cloaca), while the area below is from the ectoderm (proctodeum).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Internal sphincter injury doesn’t lead to fecal incontinence if the external sphincter is intact:&nbsp;</strong>Correct<strong>.</strong> The internal sphincter, made up of smooth muscle, contributes to some amount continence at rest. Injury to this sphincter doesn’t indeed lead to fecal incontinence, if external sphincter is intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>The external sphincter is a continuation of the outer longitudinal muscle coat of the rectum:&nbsp;</strong>Correct. The external sphincter is made up of skeletal muscle, which is under voluntary control and is a continuation of the outer longitudinal muscle of the rectum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Part of the anus above the dentate line lacks sensations:&nbsp;</strong>Correct<strong>.</strong> The part of the anus above the dentate line lacks sensations such as pain and temperature because it is innervated by visceral sensory fibers, unlike the area below the dentate line, which has somatic innervation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The anal canal has dual embryological origins: the upper part from the hindgut (endoderm) and the lower part from the proctodaeum (ectoderm); it is incorrect to that it is derived entirely from the proctodaeum.</span></p>",
      "correct_choice_id": 322654,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80992/Surgery_NEET_PG_Mock_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80992/Surgery_NEET_PG_Mock_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81013,
      "choices": [
        {
          "id": 322736,
          "text": "<p><span style=\"font-size:14.0pt;\">Lichen Planus</span></p>"
        },
        {
          "id": 322737,
          "text": "<p><span style=\"font-size:14.0pt;\">Darier Disease</span></p>"
        },
        {
          "id": 322738,
          "text": "<p><span style=\"font-size:14.0pt;\">Gianotti-Crosti Syndrome</span></p>"
        },
        {
          "id": 322739,
          "text": "<p><span style=\"font-size:14.0pt;\">Porokeratosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-month-old infant is brought to the pediatric clinic with a 1-week history of a skin rash. The rash started on the face and limbs and progressively spread to the buttocks, forming multiple dusky red papules that later coalesced into plaques. The child is otherwise afebrile and active. On examination, the rash is symmetrically distributed, sparing the trunk and mucosal membranes. There is also mild hepatomegaly and generalized lymphadenopathy. The mother reports that the child received routine vaccinations 10 days ago, and his hepatitis B surface antigen (HBsAg) is positive. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20161521.jpg\" width=\"762\" height=\"542\"></p>",
      "unique_key": "Q4344052",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Gianotti-Crosti Syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The classic findings here — <strong>symmetrically distributed dusky red papules</strong>, <strong>involvement of face, limbs, and buttocks</strong>, <strong>sparing of trunk</strong>, associated <strong>lymphadenopathy</strong>, <strong>hepatomegaly</strong>, and recent <strong>viral trigger (HBV)</strong> — are hallmark features of <strong>Gianotti-Crosti Syndrome</strong> (also called <strong>papular acrodermatitis</strong>).</span></li><li><span style=\"font-size:14.0pt;\">These patients will have some vaccines and acrodermatitis.</span></li><li><span style=\"font-size:14.0pt;\">It often follows a <strong>viral illness or vaccination</strong> and is linked to viruses such as:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Hepatitis B virus</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Epstein-Barr virus</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Coxsackievirus A16</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Parainfluenza virus</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The condition is <strong>self-limiting</strong>, and treatment is typically <strong>supportive</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lichen Planus:</strong> Rare in infants, often affects mucosa and has violaceous flat-topped papules, not seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Darier Disease:</strong> Genetic disorder with greasy, warty papules in seborrheic areas; not associated with HBV or symmetric rash.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Porokeratosis:</strong> Characterized by annular plaques with a keratotic ridge, often chronic and not associated with viral triggers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Gianotti-Crosti syndrome is a <strong>self-limited papular acrodermatitis</strong> seen in young children following <strong>viral infections</strong> (especially <strong>HBV</strong>) or <strong>vaccinations</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Key features include:</span><ul><li><span style=\"font-size:14.0pt;\">Symmetrical dusky papular rash on <strong>face, limbs, and buttocks</strong></span></li><li><span style=\"font-size:14.0pt;\">Sparing of <strong>trunk and mucosa</strong></span></li><li><span style=\"font-size:14.0pt;\">Associated <strong>lymphadenopathy</strong> and <strong>hepatomegaly</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Spontaneous resolution</strong> without treatment in most cases.</span></li></ul></li></ul>",
      "correct_choice_id": 322738,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81013/Pediatrics_NEET_MOCK_-_1_Question_-_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81013/Pediatrics_NEET_MOCK_-_1_Question_-_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81128,
      "choices": [
        {
          "id": 323192,
          "text": "<p><span style=\"font-size:14.0pt;\">Gaucher disease</span></p>"
        },
        {
          "id": 323193,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteopetrosis&nbsp;</span></p>"
        },
        {
          "id": 323194,
          "text": "<p><span style=\"font-size:14.0pt;\">Infantile cortical hyperostosis&nbsp;</span></p>"
        },
        {
          "id": 323195,
          "text": "<p><span style=\"font-size:14.0pt;\">X-linked hypophosphatemic rickets&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-month-old infant presents with failure to thrive, pallor, and hepatosplenomegaly. Laboratory studies show anemia, thrombocytopenia, and leukopenia. Genetic analysis identifies a mutation in the TCIRG1 gene. Skeletal survey reveals the following. Which of the following is the likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zqsryOj.png\" width=\"300\" height=\"510\"></span></p>",
      "unique_key": "Q1680382",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Osteopetrosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical presentation and radiographic findings are classic for <strong>infantile malignant osteopetrosis</strong>, which is caused by <strong>mutations in the TCIRG1 gene</strong>. This gene encodes a subunit of the osteoclast proton pump necessary for bone resorption.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>autosomal recessive osteopetrosis</strong>, defective osteoclasts fail to remodel bone properly, leading to:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Diffuse bony sclerosis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Marrow cavity obliteration → pancytopenia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Extramedullary hematopoiesis → hepatosplenomegaly</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Cranial nerve compression → visual/hearing loss</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The autosomal recessive form presents in infancy and is <strong>severe</strong>, often requiring <strong>hematopoietic stem cell transplantation</strong> for survival.</span></li><li><span style=\"font-size:14.0pt;\">The x-ray given in the question shows diffusely increased bone density and Erlenmeyer flask deformity (which is non-specific).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gaucher disease:</strong> Also presents with hepatosplenomegaly and cytopenias, but radiologically shows <strong>Erlenmeyer flask deformities</strong>, not generalized sclerosis or “bone-in-bone” appearance. The bone density in Gaucher disease is decreased (osteopenia due to bone marrow infiltration by Gaucher cells).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Infantile cortical hyperostosis (Caffey disease):</strong> Presents with <strong>fever, irritability, and cortical thickening</strong>, particularly of the <strong>mandible and long bones</strong>, but <strong>does not cause marrow failure</strong> or “bone-in-bone” X-ray features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. X-linked hypophosphatemic rickets:</strong> Causes <strong>bowing of legs</strong>, <strong>growth delay</strong>, and <strong>hypophosphatemia</strong>, but X-rays show <strong>metaphyseal cupping and fraying</strong>, not sclerosis. There will be decreased bone density.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Infantile malignant osteopetrosis</strong> is an autosomal recessive disorder caused by <strong>osteoclast dysfunction</strong>, leading to <strong>bony sclerosis</strong>, <strong>pancytopenia</strong>, and <strong>extramedullary hematopoiesis</strong>, often presenting in early infancy.</span></p>",
      "correct_choice_id": 323193,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81128/NEET_PG_Mock_1_Q2_Radiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81128/NEET_PG_Mock_1_Q2_Radiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81009,
      "choices": [
        {
          "id": 322720,
          "text": "<p><span style=\"font-size:14.0pt;\">A–1, B–3, C–2, D–5, E–4</span></p>"
        },
        {
          "id": 322721,
          "text": "<p><span style=\"font-size:14.0pt;\">A–3, B–1, C–2, D–4, E–5</span></p>"
        },
        {
          "id": 322722,
          "text": "<p><span style=\"font-size:14.0pt;\">A–2, B–1, C–4, D–3, E–5</span></p>"
        },
        {
          "id": 322723,
          "text": "<p><span style=\"font-size:14.0pt;\">A–1, B–2, C–3, D–4, E–5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following: Developmental Milestones and Usual Age:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A<strong>&nbsp;</strong>(Milestone)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Holding of objects with both hands</span></li><li><span style=\"font-size:14.0pt;\">Transfer of objects</span></li><li><span style=\"font-size:14.0pt;\">Tripod sitting</span></li><li><span style=\"font-size:14.0pt;\">Pulls to standing</span></li><li><span style=\"font-size:14.0pt;\">Pincer grasp</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B<strong>&nbsp;</strong>(Usual Age)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">4 months</span></li><li><span style=\"font-size:14.0pt;\">7 months</span></li><li><span style=\"font-size:14.0pt;\">6 months</span></li><li><span style=\"font-size:14.0pt;\">9 months – child begins to stand holding onto furniture</span></li><li><span style=\"font-size:14.0pt;\">9 months – fine grasp using thumb and index finger</span></li></ol>",
      "unique_key": "Q7916369",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) A–1, B–2, C–3, D–4, E–5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_q0yIcfZ.png\" width=\"1533\" height=\"461\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_VQ7DW7I.png\" width=\"1641\" height=\"478\"></strong></span></p>",
      "correct_choice_id": 322723,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81009/Pediatrics_NEET_MOCK_-_1_Question_-_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81009/Pediatrics_NEET_MOCK_-_1_Question_-_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80935,
      "choices": [
        {
          "id": 322424,
          "text": "<p><span style=\"font-size:14.0pt;\">1–A, 2–D, 3–B, 4–C</span></p>"
        },
        {
          "id": 322425,
          "text": "<p><span style=\"font-size:14.0pt;\">1–D, 2–C, 3–B, 4–A</span></p>"
        },
        {
          "id": 322426,
          "text": "<p><span style=\"font-size:14.0pt;\">1–D, 2–C, 3–A, 4–B</span></p>"
        },
        {
          "id": 322427,
          "text": "<p><span style=\"font-size:14.0pt;\">1–C, 2–D, 3–A, 4–B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match each pelvic floor defect with its most appropriate corrective surgical procedure:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A – Deformity</span></p><ol><li><span style=\"font-size:14.0pt;\">Cystocele</span></li><li><span style=\"font-size:14.0pt;\">Vault prolapse</span></li><li><span style=\"font-size:14.0pt;\">Enterocele</span></li><li><span style=\"font-size:14.0pt;\">Utero-vaginal prolapse</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B – Corrective Surgery</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">McCall’s repair</span></li><li><span style=\"font-size:14.0pt;\">Ward Mayo repair</span></li><li><span style=\"font-size:14.0pt;\">Sacrocolpopexy</span></li><li><span style=\"font-size:14.0pt;\">Anterior colporrhaphy</span></li></ol>",
      "unique_key": "Q8253998",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1–D, 2–C, 3–A, 4–B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1-D. Cystocele</strong> (herniation of bladder into vaginal wall) → <strong>Anterior colporrhaphy</strong> is the standard repair technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2-C. Vault prolapse</strong> (post-hysterectomy prolapse of vaginal apex) → <strong>Sacrocolpopexy</strong> is preferred to restore pelvic support using mesh.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3-A. Enterocele</strong> (herniation of pouch of Douglas) → <strong>McCall's repair</strong> is commonly used at the time of vaginal hysterectomy to prevent or treat it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4-B. Utero-vaginal prolapse:</strong> → <strong>Ward Mayo repair</strong>, a type of vaginal hysterectomy with pelvic floor repair, is the classic procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20104810.jpg\" width=\"1221\" height=\"622\"></strong></span></p>",
      "correct_choice_id": 322426,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80935/OBG_Mock_1_Q4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80935/OBG_Mock_1_Q4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81080,
      "choices": [
        {
          "id": 323000,
          "text": "<p><span style=\"font-size:14.0pt;\">BRCA1</span></p>"
        },
        {
          "id": 323001,
          "text": "<p><span style=\"font-size:14.0pt;\">MSH2</span></p>"
        },
        {
          "id": 323002,
          "text": "<p><span style=\"font-size:14.0pt;\">WT-1</span></p>"
        },
        {
          "id": 323003,
          "text": "<p><span style=\"font-size:14.0pt;\">APC</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old woman is undergoing evaluation following a hysterectomy that revealed endometrial carcinoma. Her family history is notable for her mother dying from endometrial cancer at age 50 and her 42-year-old brother recently diagnosed with colorectal carcinoma. Further investigation is pursued to determine if a genetic predisposition is responsible for the pattern of malignancies observed across generations. Which of the following genes is most likely mutated in this family?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6275675",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) MSH2</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This clinical presentation suggests a <strong>hereditary cancer syndrome</strong>, specifically <strong>Lynch syndrome</strong> (hereditary nonpolyposis colorectal cancer, HNPCC).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Lynch syndrome is associated with germline mutations in <strong>DNA mismatch repair (MMR) genes</strong>, most commonly <strong>MSH2</strong> (<strong>mutS homolog 2</strong>) and <strong>MLH1</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This syndrome significantly increases the risk for <strong>colorectal cancer</strong>, <strong>endometrial carcinoma</strong>, and other malignancies.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The woman’s <strong>early-onset endometrial cancer</strong>, in conjunction with her <strong>mother’s history of endometrial cancer at age 50</strong> and her <strong>brother’s diagnosis of colon cancer at age 42</strong>, fits the pattern of autosomal dominant inheritance seen in Lynch syndrome.</span></li><li><span style=\"font-size:14.0pt;\"><strong>MSH2</strong>, a critical component of the MMR pathway, is among the most frequently mutated genes in Lynch syndrome families.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Mutations impair DNA repair, increasing the risk of microsatellite instability and cancer development.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. BRCA1:</strong> This gene is associated with <strong>hereditary breast and ovarian cancer syndrome</strong>, not with colon or endometrial cancer. BRCA1 mutations increase the risk for <strong>breast, ovarian, pancreatic, and prostate cancers</strong>, but are not linked to the familial pattern of <strong>endometrial and colorectal cancer</strong> seen in this question.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. WT-1:&nbsp;</strong>The <strong>Wilms tumor 1</strong> gene is a tumor suppressor associated with <strong>Wilms tumor</strong>, a pediatric kidney cancer. It is not involved in the pathogenesis of <strong>endometrial</strong> or <strong>colorectal cancers</strong>, nor is it relevant in adults or familial cancer syndromes with the described pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. APC:&nbsp;</strong>Mutations in the <strong>APC</strong> gene are characteristic of <strong>familial adenomatous polyposis (FAP)</strong>, which leads to hundreds of colonic adenomas and a nearly 100% lifetime risk of colorectal cancer if untreated. However, <strong>FAP is not associated with endometrial carcinoma</strong>, which is a key part of the clinical picture in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">MSH2 is a DNA mismatch repair gene commonly mutated in Lynch syndrome, a familial cancer syndrome characterized by early-onset colorectal and endometrial cancers.</span></p>",
      "correct_choice_id": 323001,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81080/NEET_PG_Mock_1_Q2_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81080/NEET_PG_Mock_1_Q2_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81100,
      "choices": [
        {
          "id": 323080,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 2 and 5</span></p>"
        },
        {
          "id": 323081,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1 and 3</span></p>"
        },
        {
          "id": 323082,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 3 and 4</span></p>"
        },
        {
          "id": 323083,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 2 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Serine Hydroxy Methyl Transferase (SHMT) are incorrect?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Serine Hydroxy Methyl Transferase belongs to the class II group of enzymes.</span></li><li><span style=\"font-size:14.0pt;\">The enzyme catalyzes an irreversible reaction converting serine to glycine.</span></li><li><span style=\"font-size:14.0pt;\">Pyridoxal phosphate (PLP) and folic acid derivatives are essential cofactors for this enzyme’s activity.</span></li><li><span style=\"font-size:14.0pt;\">The conversion of serine to glycine involves the donation of the β-carbon of serine to tetrahydrofolate (THFA).</span></li><li><span style=\"font-size:14.0pt;\">The α-carbon of serine is donated to THFA during the reaction.</span></li></ol>",
      "unique_key": "Q9154084",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only 2 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>The enzyme catalyzes an irreversible reaction converting serine to glycine:&nbsp;</strong>Incorrect. The reaction is stated as <strong>freely reversible</strong>, so saying it is <strong>irreversible</strong> is false.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>The α-carbon of serine is donated to THFA during the reaction:&nbsp;</strong>Incorrect. The <strong>α-carbon</strong> is not donated; it remains part of the <strong>glycine</strong> molecule. The <strong>β-carbon</strong> is the one transferred to THFA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Serine Hydroxy Methyl Transferase belongs to the class II group of enzymes:&nbsp;</strong>Correct. SHMT belongs to <strong>class II enzymes</strong>, as explicitly stated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Pyridoxal phosphate (PLP) and folic acid derivatives are essential cofactors for this enzyme’s activity:&nbsp;</strong>Correct. <strong>PLP (pyridoxal phosphate)</strong> and <strong>folic acid</strong> are indeed the required <strong>vitamin cofactors</strong> for SHMT.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>The conversion of serine to glycine involves the donation of the β-carbon of serine to tetrahydrofolate (THFA):&nbsp;</strong>Correct. The <strong>β-carbon</strong> of serine is donated to <strong>THFA</strong>, forming a one-carbon unit.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Serine Hydroxy Methyl Transferase (SHMT)</strong> catalyzes a <strong>reversible</strong> reaction that converts <strong>serine to glycine</strong>, involving the <strong>donation of the β-carbon</strong> of serine to <strong>THFA</strong>, and requires <strong>PLP and folic acid</strong> as cofactors.</span></p>",
      "correct_choice_id": 323080,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81100/NEET_PG_Mock_1_Q7_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81100/NEET_PG_Mock_1_Q7_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81101,
      "choices": [
        {
          "id": 323084,
          "text": "<p><span style=\"font-size:14.0pt;\">Lipoprotein lipase</span></p>"
        },
        {
          "id": 323085,
          "text": "<p><span style=\"font-size:14.0pt;\">LDL receptors</span></p>"
        },
        {
          "id": 323086,
          "text": "<p><span style=\"font-size:14.0pt;\">HMG-CoA reductase</span></p>"
        },
        {
          "id": 323087,
          "text": "<p><span style=\"font-size:14.0pt;\">ApoB-48</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man presents with a history of recurrent pancreatitis, eruptive xanthomas, normal cholesterol levels, and markedly elevated plasma triglycerides (~1500 mg/dL). Laboratory analysis reveals the presence of chylomicrons in fasting plasma. Which of the following deficiencies is the most likely cause of this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2866955",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Lipoprotein lipase</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The clinical presentation is classic for <strong>Type I hyperlipoproteinemia</strong> (also called <strong>familial chylomicronemia syndrome</strong>), a <strong>rare autosomal recessive disorder</strong> characterized by:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Very high plasma triglyceride levels</strong> (&gt;1000 mg/dL),</span></li><li><span style=\"font-size:14.0pt;\"><strong>Eruptive xanthomas</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lipemia retinalis,</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Milky white plasma,</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Recurrent episodes of pancreatitis</strong>, and</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chylomicron accumulation</strong> in <strong>fasting plasma</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The condition is caused by <strong>deficiency of lipoprotein lipase (LPL)</strong> or its cofactor <strong>ApoC-II</strong>, which is required for the hydrolysis of <strong>triglycerides</strong> in chylomicrons and VLDL.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Without functional LPL:</strong></span><ul><li><span style=\"font-size:14.0pt;\"><strong>Triglyceride-rich chylomicrons cannot be broken down</strong>, leading to <strong>accumulation of chylomicrons</strong>, and subsequent <strong>hypertriglyceridemia</strong>, increasing the risk of <strong>pancreatitis</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. LDL receptors:</strong> Deficiency leads to <strong>familial hypercholesterolemia (Type IIa)</strong>, characterized by <strong>elevated LDL cholesterol</strong>, <strong>not triglycerides</strong>, and <strong>does not involve chylomicrons</strong>. The patient presents with chest pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. HMG-CoA reductase:</strong> This is the <strong>rate-limiting enzyme of cholesterol synthesis</strong> and is the <strong>target of statin therapy</strong>. Its deficiency does not cause <strong>hypertriglyceridemia or chylomicronemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. ApoB-48:</strong> ApoB-48 is essential for <strong>chylomicron formation</strong>. Its <strong>deficiency would result in low or absent chylomicrons</strong>, not accumulation. Hence, it does <strong>not explain chylomicronemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lipoprotein lipase deficiency leads to Type I hyperlipoproteinemia, causing severe hypertriglyceridemia, chylomicronemia, recurrent pancreatitis, and eruptive xanthomas, despite normal cholesterol levels.</span></p>",
      "correct_choice_id": 323084,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81101/NEET_PG_Mock_1_Q8_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81101/NEET_PG_Mock_1_Q8_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80993,
      "choices": [
        {
          "id": 322656,
          "text": "<p><span style=\"font-size:14.0pt;\">It can control bleeding from fundic varices</span></p>"
        },
        {
          "id": 322657,
          "text": "<p><span style=\"font-size:14.0pt;\">It is inserted orally</span></p>"
        },
        {
          "id": 322658,
          "text": "<p><span style=\"font-size:14.0pt;\">It can be used for 1-2 weeks</span></p>"
        },
        {
          "id": 322659,
          "text": "<p><span style=\"font-size:14.0pt;\">It lacks an esophageal aspiration port</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the incorrect feature of the tube shown in the image below.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20110014.jpg\" width=\"805\" height=\"418\"></strong></span></p>",
      "unique_key": "Q2472645",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) It can be used for 1-2 weeks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The given image shows the Sengstaken-Blakemore tube, used for balloon tamponade in variceal bleeding. It is used for 24-48 hours</span></li><li><span style=\"font-size:14.0pt;\"><strong>It can be used for 1-2 weeks</strong> This statement is incorrect<strong>.</strong>&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The Blakemore tube is typically used for short-term management, usually for <strong>no more than 24-36 hours</strong>, due to the risk of complications such as pressure necrosis and perforation if used for extended durations</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It can control bleeding from fundic varices: </strong>This statement is correct<strong>.</strong> A Blakemore tube has a gastric balloon that can compress bleeding fundic varices by applying pressure, thereby controlling the hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It is inserted orally:</strong> This statement is correct<strong>.</strong> The Blakemore tube is inserted through the mouth (orogastrically) to reach the stomach and esophagus for effective tamponade.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It lacks an esophageal aspiration port:</strong> This statement is correct<strong>.</strong> The Blakemore tube lacks an esophageal aspiration port, which differentiates it from the Minnesota tube that includes an esophageal suction port for draining secretions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The triple lumen Sengstaken-Blakemore tube is used as a temporary measure to control acute bleeding from esophageal or gastric varices, typically caused by portal hypertension in cirrhotic patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It achieves hemostasis by mechanical compression of the bleeding vessels</span></li></ul>",
      "correct_choice_id": 322658,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80993/Surgery_NEET_PG_Mock_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80993/Surgery_NEET_PG_Mock_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80972,
      "choices": [
        {
          "id": 322572,
          "text": "<p><span style=\"font-size:14.0pt;\">Mild COPD</span></p>"
        },
        {
          "id": 322573,
          "text": "<p><span style=\"font-size:14.0pt;\">Eczema</span></p>"
        },
        {
          "id": 322574,
          "text": "<p><span style=\"font-size:14.0pt;\">Early-stage cancer</span></p>"
        },
        {
          "id": 322575,
          "text": "<p><span style=\"font-size:14.0pt;\">Peripheral artery disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old woman with mild COPD and a history of childhood eczema is advised workplace smallpox vaccination. She is otherwise healthy and not on immunosuppressants. Which of the following conditions is a contraindication to smallpox vaccination in the absence of exposure?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1202967",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Eczema</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The smallpox vaccine contains live vaccinia virus and is contraindicated in individuals with current or past eczema due to the risk of eczema vaccinatum, a severe complication.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This remains true even if the eczema is currently inactive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mild COPD:</strong> Not a contraindication unless on systemic steroids.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Early-stage cancer:</strong> Only a concern if there’s immunosuppression.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Peripheral artery disease (PAD):</strong> Has no impact on immune function or skin reactivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Live vaccinia vaccination is contraindicated in people with current or past eczema due to risk of life-threatening skin reactions.</span></p>",
      "correct_choice_id": 322573,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80972/NEET_MOCK_-_1_Question_-_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80972/NEET_MOCK_-_1_Question_-_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80915,
      "choices": [
        {
          "id": 322344,
          "text": "<p><span style=\"font-size:14.0pt;\">Clopidogrel</span></p>"
        },
        {
          "id": 322345,
          "text": "<p><span style=\"font-size:14.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 322346,
          "text": "<p><span style=\"font-size:14.0pt;\">Isosorbide dinitrate</span></p>"
        },
        {
          "id": 322347,
          "text": "<p><span style=\"font-size:14.0pt;\">Metoprolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 67-year-old man is brought to the emergency department with dizziness, fainting, and extremely low blood pressure after taking an erectile dysfunction medication the night before. His past medical history includes coronary artery disease, for which he is on multiple medications. On arrival, his blood pressure is 70/40 mmHg. Which of the following medications is most likely to have interacted with his erectile dysfunction drug to cause this episode of severe hypotension?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5452436",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Isosorbide dinitrate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Isosorbide dinitrate</strong> is a <strong>long-acting nitrate</strong> used to manage <strong>angina pectoris</strong>. It acts by releasing <strong>nitric oxide</strong>, leading to <strong>vasodilation and reduced preload</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">When taken in combination with <strong>phosphodiesterase-5 (PDE-5) inhibitors</strong> such as sildenafil (commonly used for erectile dysfunction), there is a <strong>synergistic vasodilatory effect</strong>, leading to <strong>profound hypotension</strong> and <strong>risk of circulatory collapse</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This combination is <strong>absolutely contraindicated</strong>, and patients must be advised to <strong>avoid nitrates within 24–48 hours of taking a PDE-5 inhibitor</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Clopidogrel:</strong> An <strong>antiplatelet agent</strong> that does <strong>not affect blood pressure</strong> or interact with erectile dysfunction medications. No hypotensive effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amlodipine:</strong> A <strong>calcium channel blocker</strong> that can cause <strong>mild hypotension</strong>, but it does <strong>not have a synergistic vasodilatory interaction</strong> with PDE-5 inhibitors like nitrates do. Still safer than nitrate combinations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metoprolol:</strong> A <strong>beta-blocker</strong> that may lower blood pressure and heart rate, but it does <strong>not directly interact with PDE-5 inhibitors</strong> to cause severe hypotension like nitrates do.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Combining nitrates such as isosorbide dinitrate with phosphodiesterase-5 inhibitors is contraindicated due to the risk of life-threatening hypotension from synergistic vasodilation.</span></p>",
      "correct_choice_id": 322346,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80915/Pharma_Mock_1_NEET_PG7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80915/Pharma_Mock_1_NEET_PG7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80983,
      "choices": [
        {
          "id": 322616,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 322617,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 322618,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 3</span></p>"
        },
        {
          "id": 322619,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the incorrect statements about pediatric surgical principles in contrast to adults:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Wider abdomen with reduced vertical distance</span></li><li><span style=\"font-size:14.0pt;\">The urinary bladder is mainly intraperitoneal</span></li><li><span style=\"font-size:14.0pt;\">Ribs are more horizontal and rigid</span></li><li><span style=\"font-size:14.0pt;\">The umbilicus is lower than that of an adult</span></li></ol>",
      "unique_key": "Q4978512",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Only 3&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Ribs are more horizontal and rigid:</strong> Flexible ribs in children, which don’t easily fracture-&gt; If fractures-&gt; Sign of child abuse</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Wider abdomen with reduced vertical distance:</strong> Wider abdomen with shallow pelvis- horizontal incisions are preferred in children-&gt; EXPOSURE is better</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. The urinary bladder is mainly intraperitoneal:</strong> Urinary bladder is intra-peritoneal, liver extends sub-costally-&gt; Easily traumatized in children following blunt trauma</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>The umbilicus is lower than that of an adult:</strong> Lower umbilicus-&gt; Difficulty in stoma position in the lower abdomen</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In pediatric patients:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Wider abdomen and shallower pelvis</strong> = better exposure via transverse incisions</span></li><li><span style=\"font-size:14.0pt;\"><strong>Intraperitoneal bladder</strong> = increased risk in blunt trauma</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lower umbilicus</strong> = complicates stoma placement</span></li><li><span style=\"font-size:14.0pt;\"><strong>Flexible, horizontal ribs</strong> = rib fracture may indicate child abuse</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recognizing these anatomic and physiological differences is crucial for safe and effective pediatric surgical planning.</span></p>",
      "correct_choice_id": 322618,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80983/Surgery_NEET_PG_Mock_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80983/Surgery_NEET_PG_Mock_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81032,
      "choices": [
        {
          "id": 322812,
          "text": "<p><span style=\"font-size:14.0pt;\">Bruise</span></p>"
        },
        {
          "id": 322813,
          "text": "<p><span style=\"font-size:14.0pt;\">Postmortem staining</span></p>"
        },
        {
          "id": 322814,
          "text": "<p><span style=\"font-size:14.0pt;\">Congestion</span></p>"
        },
        {
          "id": 322815,
          "text": "<p><span style=\"font-size:14.0pt;\">Decomposition changes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A dead body shows the following findings:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Discoloration over dependent parts</span></li><li><span style=\"font-size:14.0pt;\">Sharply defined margins</span></li><li><span style=\"font-size:14.0pt;\">Color does not change with time</span></li><li><span style=\"font-size:14.0pt;\">Oozing blood easily washed off on incision</span></li><li><span style=\"font-size:14.0pt;\">No surface elevation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which condition can you most confidently exclude?</span></p>",
      "unique_key": "Q3995448",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Bruise</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Discoloration over dependent parts</strong>: Typical of <strong>postmortem staining</strong>, where blood pools due to gravity after death.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sharply defined margins</strong>: Characteristic of <strong>postmortem staining</strong>, not bruises. Bruises usually have <strong>diffuse and irregular margins</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Color does not change with time</strong>: Again, matches <strong>postmortem staining</strong> — bruises <strong>change color</strong> (red → blue → green → yellow) as hemoglobin breaks down.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Oozing blood easily washed off on incision</strong>: In <strong>postmortem staining</strong>, blood is still in vessels (capillo-venous distension) and can <strong>ooze out and be washed away</strong> easily.</span><br><span style=\"font-size:14.0pt;\">In <strong>bruises</strong>, blood is infiltrated into tissues and cannot be easily washed.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No surface elevation</strong>: Postmortem staining is <strong>flat</strong>; bruises may cause <strong>slight swelling</strong> due to blood extravasation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, <strong>bruise</strong> can be <strong>confidently excluded</strong> because:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Bruises have <strong>diffuse margins</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Color changes with time</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Blood infiltrates tissues</strong> (cannot be washed away),</span></li><li><span style=\"font-size:14.0pt;\"><strong>May be slightly elevated</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">All the findings here fit <strong>postmortem staining</strong>, not bruising.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Postmortem staining:</strong> Matches perfectly with all findings, so cannot be excluded.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Congestion:</strong> Congestion involves <strong>internal organs</strong> (lungs, liver, stomach) and would not typically show sharply defined discoloration of external skin, but it's less confidently excluded than a bruise.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Decomposition changes:</strong> Decomposition shows <strong>greenish discoloration</strong>, <strong>marbling</strong>, <strong>gas formation</strong>, and <strong>skin slippage</strong>, none of which are described here — but based only on given findings, decomposition cannot be fully ruled out <strong>without additional signs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Postmortem staining is characterized by dependent bluish discoloration, sharp margins, blanching early after death, no surface elevation, and blood that can be washed off on incision — whereas bruises involve diffuse margins, color change over time, subcutaneous infiltration, and cannot be washed away.</span></p>",
      "correct_choice_id": 322812,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81032/NEET_PG_Mock_1_Q2_FMT.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81032/NEET_PG_Mock_1_Q2_FMT.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81031,
      "choices": [
        {
          "id": 322808,
          "text": "<p><span style=\"font-size:14.0pt;\">Atrophic non-union</span></p>"
        },
        {
          "id": 322809,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypertrophic non-union</span></p>"
        },
        {
          "id": 322810,
          "text": "<p><span style=\"font-size:14.0pt;\">Delayed union</span></p>"
        },
        {
          "id": 322811,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudarthrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old male presents to the orthopaedic clinic with persistent pain and difficulty moving his left leg following a tibia fracture that occurred 6 months ago. The fracture was initially treated with casting, but the patient reports that he has not regained full function of his leg. There is no significant displacement of the bone fragments. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20110350.jpg\" width=\"334\" height=\"482\"></span></p>",
      "unique_key": "Q2024531",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;Delayed union</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A delayed union refers to a fracture that is taking longer than expected to heal, but healing is still ongoing.</span></li><li><span style=\"font-size:14.0pt;\">Generally suspected if healing is not evident by 3–6 months, depending on the fracture and location.</span></li><li><span style=\"font-size:14.0pt;\">Key Features:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Persistent pain</span></li><li><span style=\"font-size:14.0pt;\">Impaired function</span></li><li><span style=\"font-size:14.0pt;\">No or minimal fracture displacement</span></li><li><span style=\"font-size:14.0pt;\">Healing process visible on imaging, just slower than usual</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In this case the patient had a fracture 6 months ago, still has pain and functional limitation, and no major displacement—this fits delayed union.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Atrophic Non-union:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A type of non-healing fracture where there is no biological activity at the fracture site, leading to bone resorption and narrowed fracture ends.</span></li><li><span style=\"font-size:14.0pt;\">The x-ray appearance is Tapered or rounded bone ends with no callus formation.</span></li><li><span style=\"font-size:14.0pt;\">Clinical Clues:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Usually occurs in older patients or with poor blood supply</span></li><li><span style=\"font-size:14.0pt;\">Often associated with infection, severe trauma, or improper immobilization</span></li><li><span style=\"font-size:14.0pt;\">Bone ends may appear \"dead\" on imaging</span></li></ul></li><li><span style=\"font-size:14.0pt;\">As there is no mention of bony resorption, dead bone, or failed healing—only delayed progress.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hypertrophic Non-union:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A non-healing fracture characterized by excess callus formation, suggesting the bone is biologically active but mechanically unstable (e.g., poor fixation or movement at the site).</span></li><li><span style=\"font-size:14.0pt;\">The x-ray appearance is large callus formation with visible fracture line.</span></li><li><span style=\"font-size:14.0pt;\">Clinical Clues:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Typically associated with inadequate immobilization (e.g., loose cast or hardware failure)</span></li><li><span style=\"font-size:14.0pt;\">\"Elephant foot\" appearance on radiographs</span></li></ul></li><li><span style=\"font-size:14.0pt;\">There is no evidence of excess callus or mechanical instability described.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pseudarthrosis:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Literally means “false joint”—a chronic non-union where the fracture ends develop a capsule and synovial-like fluid, mimicking a joint.</span></li><li><span style=\"font-size:14.0pt;\">It occurs after long-standing non-union (often &gt;9 months to 1 year).</span></li><li><span style=\"font-size:14.0pt;\">The x-ray appearance consists of fracture line with sclerosis and sometimes motion at the site.</span></li><li><span style=\"font-size:14.0pt;\">Clinical Clues:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Instability, often with a palpable movement at the fracture site</span></li><li><span style=\"font-size:14.0pt;\">Visible \"false joint\" on imaging</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The fracture is only 6 months old, and there’s no mention of movement or joint-like features.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient's symptoms of persistent pain and difficulty moving at 6 months post-fracture, without significant displacement, suggest that the bone is taking longer than usual to heal but hasn't necessarily reached a state of complete non-union or pseudarthrosis.</span></p>",
      "correct_choice_id": 322810,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81031/NEET_MOCK_-_1_Question_-_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81031/NEET_MOCK_-_1_Question_-_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81094,
      "choices": [
        {
          "id": 323056,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of alpha-glycosidic linkages</span></p>"
        },
        {
          "id": 323057,
          "text": "<p><span style=\"font-size:14.0pt;\">Beta configuration of anomeric C2</span></p>"
        },
        {
          "id": 323058,
          "text": "<p><span style=\"font-size:14.0pt;\">Low pH of the stomach</span></p>"
        },
        {
          "id": 323059,
          "text": "<p><span style=\"font-size:14.0pt;\">Beta configuration of anomeric C1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a patient undergoing dietary modification to improve gut health, inulin-type fructans are introduced as prebiotics. These compounds are resistant to digestion in the upper gastrointestinal tract and reach the colon intact. Which of the following best explains this resistance to enzymatic digestion?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3187797",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Beta configuration of anomeric C2</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Inulin-like fructans</strong> are a type of <strong>prebiotic fiber</strong> composed primarily of <strong>fructose units</strong> linked together by <strong>β(2→1) glycosidic bonds</strong>, starting from an initial glucose unit.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The key reason they are <strong>not digested in the upper gastrointestinal (GI) tract</strong> is due to the <strong>β-configuration of the anomeric carbon at C2</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Human digestive enzymes (e.g., <strong>amylases, sucrase, maltase</strong>) are <strong>specific to α-linkages</strong>, such as those found in starch and glycogen.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>β(2→1) bonds</strong> in inulin are <strong>not recognized or broken down</strong> by these enzymes, making them <strong>resistant to digestion</strong> until they reach the colon.</span></li><li><span style=\"font-size:14.0pt;\">Once in the colon, they are fermented by <strong>commensal gut microbiota</strong>, leading to beneficial effects such as production of <strong>short-chain fatty acids (SCFAs)</strong> and promotion of <strong>healthy bacterial growth</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Presence of alpha-glycosidic linkages:</strong> This is incorrect because inulin-like fructans do <strong>not contain α-osidic linkages</strong>. In fact, <strong>α-linkages are digestible</strong> by human enzymes. It is the <strong>β-linkage</strong> that confers resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Low pH of the stomach:</strong> While the <strong>stomach acid</strong> (low pH) can denature some proteins and partially digest certain nutrients, it does <strong>not significantly affect the β(2→1) glycosidic bonds</strong> in inulin. Therefore, <strong>acid environment is not the reason</strong> for inulin's resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Beta configuration of anomeric C1:</strong>&nbsp;Cellulose is digested due to beta configuration at anomeric C1 not inulin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>β-configuration at the anomeric C2</strong> in inulin-type fructans makes them <strong>resistant to digestion by human enzymes</strong>, allowing them to act as <strong>prebiotics</strong> that reach the colon intact and support <strong>gut microbiota fermentation</strong>.</span></p>",
      "correct_choice_id": 323057,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81094/NEET_PG_Mock_1_Q1_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81094/NEET_PG_Mock_1_Q1_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81023,
      "choices": [
        {
          "id": 322776,
          "text": "<p><span style=\"font-size:14.0pt;\">Start furosemide 40 mg daily</span></p>"
        },
        {
          "id": 322777,
          "text": "<p><span style=\"font-size:14.0pt;\">Restrict fluid intake to &lt;2 L/day</span></p>"
        },
        {
          "id": 322778,
          "text": "<p><span style=\"font-size:14.0pt;\">Begin sodium restriction to &lt;2 g/day</span></p>"
        },
        {
          "id": 322779,
          "text": "<p><span style=\"font-size:14.0pt;\">Start spironolactone 100 mg daily</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with decompensated cirrhosis and recurrent large-volume paracenteses has normal kidney function and sodium. He is not on diuretics. Which intervention is not appropriate in initial management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2292947",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Restrict fluid intake to &lt;2 L/day</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fluid restriction is not needed unless serum sodium is &lt;125–128 mmol/L.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Sodium restriction and diuretics (spironolactone ± furosemide) are first line. Furosemide is used with spironolactone to prevent hyperkalemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br><br><span style=\"font-size:14.0pt;\"><strong>Option A. Start furosemide 40 mg daily:</strong> Appropriate diuretic add-on.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong> <strong>Begin sodium restriction to &lt;2 g/day</strong>: Essential dietary intervention.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Start spironolactone 100 mg daily:</strong> First-line diuretic for ascites.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Fluid restriction in cirrhotic ascites is only required in significant hyponatremia, sodium restriction and spironolactone form the treatment backbone.</span></p>",
      "correct_choice_id": 322777,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81023/Neet_Mock_-_1_Question_-_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81023/Neet_Mock_-_1_Question_-_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81015,
      "choices": [
        {
          "id": 322744,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage IIA</span></p>"
        },
        {
          "id": 322745,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage IIB</span></p>"
        },
        {
          "id": 322746,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage IIC</span></p>"
        },
        {
          "id": 322747,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage IIIA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old boy presents to the ENT outpatient department with complaints of progressively worsening nasal obstruction and frequent episodes of epistaxis for the past 3 months. He also reports a recent change in facial contour with mild right cheek swelling. On anterior rhinoscopy, a reddish mass is seen in the nasal cavity. Contrast-enhanced CT reveals a large enhancing mass extending from the nasopharynx into the right maxillary sinus, with further involvement of the infratemporal fossa and cheek. There is clear evidence of posterior extension through the pterygomaxillary fissure into the temporal fossa. What is the stage of Juvenile Nasopharyngeal Angiofibroma in this patient based on the Radkowski classification?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3433304",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Stage IIC</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to the <strong>Radkowski classification</strong> of JNA:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Stage IIC</strong> indicates <strong>extension into the cheek, temporal fossa, or posterior to pterygoids through the pterygomaxillary fissure</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In this case, the mass extends into the cheek and temporal fossa through the pterygomaxillary fissure—<strong>fulfilling criteria for Stage IIC</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stage IIA</strong>: Involves <strong>minimal extension into the sphenopalatine foramen</strong> with minor involvement of the <strong>pterygopalatine fossa</strong> — less extensive than the findings in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Stage IIB</strong>: Includes <strong>full occupation of the pterygopalatine fossa</strong> with the <strong>Holman-Miller sign</strong> and may have <strong>erosion of orbital bones</strong>, but no mention of extension into the cheek or temporal fossa.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Stage IIIA</strong>: Characterized by <strong>erosion of skull base with minimal intracranial extension</strong>. This is more advanced than current findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Radkowski Staging of Juvenile Nasopharyngeal Angiofibroma</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XGvAMur.png\" width=\"1359\" height=\"713\"></span></p>",
      "correct_choice_id": 322746,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81015/Neet_Pg_Mock_1_Q1_Ent.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81015/Neet_Pg_Mock_1_Q1_Ent.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80933,
      "choices": [
        {
          "id": 322416,
          "text": "<p><span style=\"font-size:14.0pt;\">Amphotericin B</span></p>"
        },
        {
          "id": 322417,
          "text": "<p><span style=\"font-size:14.0pt;\">Spiramycin</span></p>"
        },
        {
          "id": 322418,
          "text": "<p><span style=\"font-size:14.0pt;\">Paromomycin</span></p>"
        },
        {
          "id": 322419,
          "text": "<p><span style=\"font-size:14.0pt;\">Sodium stibogluconate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man who recently returned from an endemic region of Bihar, India, presents with fever, significant weight loss, massive splenomegaly, and pancytopenia. A diagnosis of visceral leishmaniasis (kala-azar) is confirmed by bone marrow aspirate showing amastigotes. As part of his management, the attending physician reviews pharmacologic options for treating this parasitic infection. Which of the following drugs is not effective in the treatment of visceral leishmaniasis?</span></p>",
      "unique_key": "Q9531586",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Spiramycin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Spiramycin</strong> is a <strong>macrolide antibiotic</strong> primarily used in the treatment of <strong>toxoplasmosis</strong>, especially in <strong>pregnant women</strong>, and <strong>has no role</strong> in the treatment of <strong>visceral leishmaniasis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does <strong>not act against Leishmania donovani</strong>, the causative organism of kala-azar, and is therefore <strong>not included in the therapeutic arsenal</strong> for this condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Amphotericin B:</strong> A potent <strong>antifungal</strong> with broad-spectrum activity, <strong>liposomal amphotericin B</strong> is highly effective against visceral leishmaniasis and is often used in <strong>refractory or severe cases</strong>, particularly in <strong>HIV co-infected</strong> individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Paromomycin:</strong> An <strong>aminoglycoside</strong> antibiotic that also has <strong>antileishmanial activity</strong>, particularly used in <strong>resource-limited settings</strong> due to its affordability. It is effective in <strong>combination therapy</strong> for visceral leishmaniasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sodium stibogluconate:</strong> This drug, belonging to the class of <strong>pentavalent antimonials</strong>, has historically served as the <strong>first-line therapy for leishmaniasis</strong> in many regions. However, the emergence of <strong>drug resistance</strong>, particularly in areas such as <strong>Bihar, India</strong>, has significantly reduced its effectiveness and utility.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Spiramycin is not used in the treatment of visceral leishmaniasis, whereas amphotericin B, paromomycin, and pentavalent antimonials are established therapeutic agents for this parasitic infection.</span></p>",
      "correct_choice_id": 322417,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80933/Pharma_Mock_1_NEET_PG14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80933/Pharma_Mock_1_NEET_PG14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81162,
      "choices": [
        {
          "id": 323328,
          "text": "<p><span style=\"font-size:14.0pt;\">Acceptance</span></p>"
        },
        {
          "id": 323329,
          "text": "<p><span style=\"font-size:14.0pt;\">Depression</span></p>"
        },
        {
          "id": 323330,
          "text": "<p><span style=\"font-size:14.0pt;\">Denial</span></p>"
        },
        {
          "id": 323331,
          "text": "<p><span style=\"font-size:14.0pt;\">Bargaining</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman who lost her husband 1 month ago says, “This can't be real; he was just here yesterday. I keep thinking he will walk through that door.” Which stage of grief is she most likely experiencing according to the Kübler-Ross model?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2266379",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;Denial</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The woman’s statement reflects <strong>difficulty accepting the reality</strong> of her husband's death.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Believing “he will walk through that door” and saying “this can’t be real” are classic features of the <strong>denial stage</strong> of grief.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Denial</strong> is often the <strong>first reaction</strong> in the <strong>Kübler-Ross model</strong>, serving as a <strong>psychological defense mechanism</strong> that buffers the immediate shock.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Acceptance:</strong> Characterized by <strong>coming to terms with the loss</strong> and moving forward — not evident in her words.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Depression:</strong> Marked by <strong>overwhelming sadness, hopelessness</strong>, and withdrawal — she is still struggling with accepting the loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Bargaining:</strong> Involves <strong>thinking in “what if” or “if only” terms</strong> (e.g., “If I had taken him to the doctor sooner...”) not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Kübler-Ross model</strong> outlines five stages of grief: <strong>Denial, Anger, Bargaining, Depression, and Acceptance (Mnemonic: DABDA)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Denial</strong> is an initial coping mechanism that helps individuals <strong>gradually process emotional trauma</strong>.</span></li></ul>",
      "correct_choice_id": 323330,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81162/Psychiatry_Mock_1_Q4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81162/Psychiatry_Mock_1_Q4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81158,
      "choices": [
        {
          "id": 323312,
          "text": "<p><span style=\"font-size:14.0pt;\">Thrombocytopenia</span></p>"
        },
        {
          "id": 323313,
          "text": "<p><span style=\"font-size:14.0pt;\">Relative polycythemia</span></p>"
        },
        {
          "id": 323314,
          "text": "<p><span style=\"font-size:14.0pt;\">Secondary polycythemia</span></p>"
        },
        {
          "id": 323315,
          "text": "<p><span style=\"font-size:14.0pt;\">Polycythemia vera</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old female arrives for her annual physical examination. She complains of itching in her hands<strong>,&nbsp;</strong>headache<strong>&nbsp;</strong>and vertigo. A routine complete blood count (CBC) reveals:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">RBCs: 8.2 million/μl,</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">WBCs: 37,000/μl,&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Platelets: 640,000/μl,&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Erythropoietin (EPO) levels: Lower than normal</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4448914",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Polycythemia vera</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This patient presents with <strong>symptoms</strong> (pruritus, headache, vertigo) and <strong>lab findings</strong> consistent with <strong>polycythemia vera</strong>, a <strong>myeloproliferative neoplasm</strong> characterized by:</span><ul><li><span style=\"font-size:14.0pt;\">Elevated <strong>RBC</strong>, <strong>WBC</strong>, and <strong>platelets</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Low erythropoietin</strong> (EPO) due to negative feedback from excessive RBCs</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pruritus after hot showers</strong> due to histamine release from basophils.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Thrombocytopenia:</strong> Platelets are elevated, not low.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Relative polycythemia:</strong> Due to hemoconcentration (e.g., dehydration) but no actual increase in cell lines and <strong>EPO is normal</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Secondary polycythemia:</strong> Caused by hypoxia (e.g., lung disease, high altitude) or tumors → <strong>EPO would be elevated</strong>, not low.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Polycythemia vera</strong> is a clonal proliferation of <strong>hematopoietic stem cells</strong> leading to increased production of <strong>all three cell lines</strong> (RBCs, WBCs, platelets), often driven by a <strong>JAK2 mutation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is distinguished from secondary causes by <strong>low EPO</strong> and the presence of <strong>symptoms</strong> like pruritus, thrombosis, and hyperviscosity-related headaches or dizziness.</span></li></ul>",
      "correct_choice_id": 323315,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81158/Neet_Pg_Mock_1_Q9_Physiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81158/Neet_Pg_Mock_1_Q9_Physiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81149,
      "choices": [
        {
          "id": 323276,
          "text": "<p><span style=\"font-size:14.0pt;\">Interscalene block</span></p>"
        },
        {
          "id": 323277,
          "text": "<p><span style=\"font-size:14.0pt;\">Supraclavicular block</span></p>"
        },
        {
          "id": 323278,
          "text": "<p><span style=\"font-size:14.0pt;\">Infraclavicular block</span></p>"
        },
        {
          "id": 323279,
          "text": "<p><span style=\"font-size:14.0pt;\">Axillary block</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The image given below is characteristic of which of the following nerve blocks?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3YT1H5E.png\" width=\"787\" height=\"413\"></span></p>",
      "unique_key": "Q2520315",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Supraclavicular block</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>brachial plexus (BP)</strong> is seen <strong>lateral and superior to the subclavian artery (SA)</strong>, resting on the <strong>first rib</strong>, just <strong>above the pleura</strong>—this sonographic landmark is <strong>classic for the supraclavicular approach (</strong>giving a “<strong>bunch of grapes” appearance)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It provides <strong>dense anesthesia</strong> for the <strong>upper limb (especially below the shoulder)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Interscalene block:</strong> Performed at the root/trunk level between anterior and middle scalene muscles—nerves are more cephalad and dispersed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8ipMHD6.png\" width=\"791\" height=\"446\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Infraclavicular block:&nbsp;</strong>Plexus cords surround the axillary artery <strong>below the clavicle</strong>, much deeper and medial.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4OQS7hP.png\" width=\"788\" height=\"585\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Axillary block:</strong> Done at terminal branches in the axilla; nerves surround the axillary artery in a circular pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nDCsCAo.png\" width=\"789\" height=\"482\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>supraclavicular block</strong> is referred to as the <strong>\"spinal of the arm\"</strong> due to its rapid onset and complete anesthesia for the upper extremity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It requires careful needle placement to avoid pneumothorax due to proximity to the pleura.</span></li></ul>",
      "correct_choice_id": 323277,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81149/NEET_PG_Mock_1_Q4_Anesthesia.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81149/NEET_PG_Mock_1_Q4_Anesthesia.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81004,
      "choices": [
        {
          "id": 322700,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrocortisone</span></p>"
        },
        {
          "id": 322701,
          "text": "<p><span style=\"font-size:14.0pt;\">Thyroxine</span></p>"
        },
        {
          "id": 322702,
          "text": "<p><span style=\"font-size:14.0pt;\">Piperacillin-tazobactam</span></p>"
        },
        {
          "id": 322703,
          "text": "<p><span style=\"font-size:14.0pt;\">Packed red blood cell transfusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 23-year-old postpartum woman develops visual disturbances, headache, and then unresponsiveness. BP is 70/30 mmHg, HR 140/min. Labs show glucose 48 mg/dL, hematocrit is normal. Which of the following is the most appropriate immediate therapy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6150739",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Hydrocortisone</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sheehan syndrome is postpartum pituitary infarction which can sometimes cause secondary adrenal insufficiency (but very rare).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Glucocorticoid replacement (IV hydrocortisone) is lifesaving.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thyroxine may be required but should only be initiated after cortisol levels are stabilized to avoid adrenal crisis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br><br><span style=\"font-size:14.0pt;\"><strong>Option B. Thyroxine:</strong> Not first-line in acute adrenal insufficiency.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Piperacillin-tazobactam:</strong> No evidence of sepsis.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Packed red</strong> <strong>Blood transfusion:</strong> Hematocrit is normal; shock is not due to hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">In postpartum pituitary failure, IV steroids should be administered urgently to treat life-threatening cortisol deficiency.</span></p>",
      "correct_choice_id": 322700,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81004/NEET_MOCK_-_1_Question_-_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81004/NEET_MOCK_-_1_Question_-_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81093,
      "choices": [
        {
          "id": 323052,
          "text": "<p><span style=\"font-size:14.0pt;\">The immune response targets the streptococcal toxins, leading to a systemic inflammatory response</span></p>"
        },
        {
          "id": 323053,
          "text": "<p><span style=\"font-size:14.0pt;\">The M protein of Group A Streptococcus (GAS) induces the production of antibodies that cross-react with human tissues, leading to inflammation and tissue damage</span></p>"
        },
        {
          "id": 323054,
          "text": "<p><span style=\"font-size:14.0pt;\">The body mounts a T-cell-mediated response against the streptococcal capsule, causing tissue necrosis</span></p>"
        },
        {
          "id": 323055,
          "text": "<p><span style=\"font-size:14.0pt;\">The bacteria directly invade the heart and joints, leading to acute inflammation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy presents with a recent history of sore throat and fever. Two weeks after the infection resolves, he develops painful swollen joints, a migratory rash, and painless nodules on his skin. The child is diagnosed with acute rheumatic fever (ARF). Which of the following best explains the pathogenesis of the disease?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6597812",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) The M protein of Group A Streptococcus (GAS) induces the production of antibodies that cross-react with human tissues, leading to inflammation and tissue damage</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acute Rheumatic Fever (ARF)</strong> is a complication of <strong>Group A Streptococcus (GAS)</strong> throat infection that occurs <strong>2-4 weeks</strong> after the infection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is caused by an <strong>immune-mediated reaction</strong>, where <strong>antibodies</strong> produced against the <strong>M protein</strong> of GAS cross-react with similar <strong>molecular structures</strong>(glycoproteins) in human tissues, particularly in the <strong>heart valves</strong>, <strong>joints</strong>, and <strong>skin</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This cross-reaction triggers an <strong>inflammatory response</strong>, which results in the symptoms of ARF such as <strong>migratory polyarthritis</strong>, <strong>pancarditis</strong>, and <strong>erythema marginatum</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This process is a classic example of a <strong>type II hypersensitivity reaction</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The immune response targets the streptococcal toxins, leading to a systemic inflammatory response:&nbsp;</strong>Incorrect. Although the immune system reacts to the <strong>M protein</strong> of the bacteria, ARF is not primarily caused by a response to <strong>streptococcal toxins</strong>. It is the <strong>antibody cross-reactivity</strong> with human tissues that leads to inflammation, not the toxins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The body mounts a T-cell-mediated response against the streptococcal capsule, causing tissue necrosis:&nbsp;</strong>Incorrect. The <strong>immune response</strong> in ARF is primarily <strong>antibody-mediated</strong> (type II hypersensitivity), not <strong>T-cell-mediated</strong>. It is not related to <strong>capsular antigens</strong>, and necrosis is not the primary mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The bacteria directly invade the heart and joints, leading to acute inflammation:&nbsp;</strong>Incorrect. The pathology of <strong>ARF</strong> is not due to <strong>direct bacterial invasion</strong> of tissues. The inflammation is due to the <strong>immune response</strong> to the bacterial antigens, not the presence of the bacteria themselves.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The pathogenesis of acute rheumatic fever is characterized by an immune response against the M protein of Group A Streptococcus, leading to the production of antibodies that cross-react with human tissues and cause inflammation.</span></p>",
      "correct_choice_id": 323053,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81093/NEET_PG_Mock_1_Q15_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81093/NEET_PG_Mock_1_Q15_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80934,
      "choices": [
        {
          "id": 322420,
          "text": "<p><span style=\"font-size:14.0pt;\">Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks&nbsp;</span></p>"
        },
        {
          "id": 322421,
          "text": "<p><span style=\"font-size:14.0pt;\">Pembrolizumab – Immune check point inhibitor used for endometrial carcinoma&nbsp;</span></p>"
        },
        {
          "id": 322422,
          "text": "<p><span style=\"font-size:14.0pt;\">Ertugliflozin – SGLT2 inhibitor for treatment of diabetes mellitus&nbsp;</span></p>"
        },
        {
          "id": 322423,
          "text": "<p><span style=\"font-size:14.0pt;\">Ivabradine – Funny current blocker for treatment of decreased visual acuity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not a correct match with respect to the mechanism of action and clinical use of the given drugs?</span></p>",
      "unique_key": "Q5621105",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Ivabradine – Funny current blocker for treatment of decreased visual acuity.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ivabradine is indeed a \"funny\" current (If) blocker, but it is a bradycardiac agent, used for the treatment of certain types of chronic heart failure and angina pectoris (chest pain), but it causes decrease in visual acuity, so cannot used for the patient with vision problem.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, option D is not a correct match concerning the mechanism of action and clinical use of the given drug.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Zavegepant - CGRP receptor antagonist used for the treatment of acute migraine attacks:</strong> This is a correct match. Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. It is used for the treatment of acute migraine attacks. CGRP is a neuropeptide that plays a role in the pathophysiology of migraines, and antagonists like Zavegepant block its activity, thereby alleviating symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pembrolizumab – Immune check point inhibitor used for endometrial carcinoma:</strong> This is also a correct match. Pembrolizumab is an immune checkpoint inhibitor that targets the PD-1 receptor. It is used for a variety of cancers, including endometrial carcinoma, especially in cases that are MSI-H or dMMR (microsatellite instability-high or mismatch repair deficient).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ertugliflozin – SGLT2 inhibitor for treatment of diabetes mellitus:</strong> This is another correct match. Ertugliflozin is a Sodium-Glucose Cotransporter-2 (SGLT2) inhibitor, which is used to manage blood sugar levels in type 2 diabetes mellitus. It works by inhibiting the reabsorption of glucose in the kidneys, thereby leading to the excretion of glucose in the urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ivabradine is a funny current (If) blocker used for chronic heart failure and angina, not for treating visual disorders like decreased visual acuity.</span></p>",
      "correct_choice_id": 322423,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80934/Pharma_Mock_1_NEET_PG15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80934/Pharma_Mock_1_NEET_PG15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81142,
      "choices": [
        {
          "id": 323248,
          "text": "<p><span style=\"font-size:14.0pt;\">Loss of sensation on lower lateral aspect of arm</span></p>"
        },
        {
          "id": 323249,
          "text": "<p><span style=\"font-size:14.0pt;\">Inability to abduct the shoulder</span></p>"
        },
        {
          "id": 323250,
          "text": "<p><span style=\"font-size:14.0pt;\">Weakness of flexion at the shoulder joint</span></p>"
        },
        {
          "id": 323251,
          "text": "<p><span style=\"font-size:14.0pt;\">Inability to extend the arm at shoulder joint</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old man presents with acute onset pain and swelling in the right shoulder for the past 3 days. The pain is continuous, moderate to severe in intensity, and worsens with movement. He also complains of difficulty abducting the right arm. On examination, there is swelling and tenderness in the deltoid region with marked limitation in shoulder abduction. MRI reveals pyomyositis of the posterior belly of the right deltoid muscle with abscess formation. The patient also gives a history of intramuscular injection of iron in the right deltoid region two weeks earlier. Which of the following is not a likely complication in this case if left untreated?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8702973",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Loss of sensation on lower lateral aspect of arm</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>deltoid muscle</strong> is innervated by the <strong>axillary nerve</strong>, which also gives off the <strong>upper lateral cutaneous nerve of arm</strong> responsible for sensory supply to the <strong>upper lateral</strong> aspect of the arm. Therefore:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Inability to abduct</strong> the arm (deltoid function) is a valid complication.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Weakness in flexion or extension</strong> (due to anterior and posterior fibers of deltoid) are possible.</span></li><li><span style=\"font-size:14.0pt;\">However, <strong>loss of sensation in the lower lateral aspect</strong> of the arm is <strong>not</strong> expected, as that area is <strong>not innervated</strong> by the axillary nerve.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>axillary nerve</strong> supplies the <strong>deltoid muscle</strong> (abduction, flexion, extension of shoulder) and provides <strong>sensation to the upper lateral arm</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Injury to this nerve causes <strong>motor deficits and sensory loss over upper lateral arm</strong>, but <strong>not the lower lateral aspect</strong>.</span></li></ul>",
      "correct_choice_id": 323248,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81142/NEET_PG_Mock_1_Q7_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81142/NEET_PG_Mock_1_Q7_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81014,
      "choices": [
        {
          "id": 322740,
          "text": "<p><span style=\"font-size:14.0pt;\">Signature of the doctor</span></p>"
        },
        {
          "id": 322741,
          "text": "<p><span style=\"font-size:14.0pt;\">Consent</span></p>"
        },
        {
          "id": 322742,
          "text": "<p><span style=\"font-size:14.0pt;\">Functioning pulse oximeter</span></p>"
        },
        {
          "id": 322743,
          "text": "<p><span style=\"font-size:14.0pt;\">Sterility of instruments</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a Preoperative surgical safety Checklist, which of the following is not a component?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6252410",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;Signature of the doctor&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a preoperative patient surgical safety checklist, a doctor's signature is not needed.</span></li><li><span style=\"font-size:14.0pt;\">The signature of the doctor is not typically a component of the surgical safety checklist. Instead, the checklist focuses on verifying critical safety elements like patient consent, equipment functionality, and instrument sterility.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Consent:</strong> Ensuring that informed consent has been obtained from the patient is a crucial component of preoperative safety checklists. It confirms that the patient has been informed about the procedure, risks, and alternatives and has given their consent for the surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Functioning pulse oximeter:</strong> Checking the functioning of medical equipment like a pulse oximeter is an important step in preoperative safety. It ensures that necessary monitoring devices are in working order to monitor the patient's vital signs during surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sterility of instruments:</strong> Verifying the sterility of surgical instruments is essential to prevent infections during surgery. It ensures that all instruments that will come into contact with the patient are properly sterilized and safe for use.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20110149.jpg\" width=\"1559\" height=\"681\"></strong></span></p>",
      "correct_choice_id": 322740,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81014/Surgery_NEET_PG_Mock_112.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81014/Surgery_NEET_PG_Mock_112.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81020,
      "choices": [
        {
          "id": 322764,
          "text": "<p><span style=\"font-size:14.0pt;\">Adenocarcinoma of the stomach</span></p>"
        },
        {
          "id": 322765,
          "text": "<p><span style=\"font-size:14.0pt;\">GIST of the stomach</span></p>"
        },
        {
          "id": 322766,
          "text": "<p><span style=\"font-size:14.0pt;\">Intractable peptic ulcer disease</span></p>"
        },
        {
          "id": 322767,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The procedure shown in the image is performed for which of these indications?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20110219.jpg\" width=\"439\" height=\"595\"></strong></span></p>",
      "unique_key": "Q8560421",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Adenocarcinoma of the stomach</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Radical gastrectomy</strong> is primarily performed as a curative treatment for <strong>gastric adenocarcinoma</strong>, aiming for complete tumor resection with lymph node dissection.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adenocarcinoma of the stomach:</strong>&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Radical gastrectomy is the <strong>standard treatment</strong> for <strong>localized gastric adenocarcinoma</strong>, especially in advanced cases requiring extensive lymph node removal.</span></li><li><span style=\"font-size:14.0pt;\">The procedure involves <strong>subtotal or total gastrectomy</strong>, along with lymphadenectomy to improve survival rates.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. GIST of the stomach:</strong> Incorrect<strong>.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Gastrointestinal stromal tumors (GISTs)</strong> are typically managed with <strong>segmental resection</strong> rather than radical gastrectomy.</span></li><li><span style=\"font-size:14.0pt;\">Radical gastrectomy is <strong>not necessary</strong> unless the GIST is very large or infiltrating extensively.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Intractable peptic ulcer disease:</strong> Incorrect<strong>.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Peptic ulcer disease is usually treated with <strong>medical therapy (PPIs, eradication of H. pylori)</strong> or <strong>limited surgical procedures</strong> like vagotomy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Radical gastrectomy is not performed for ulcers</strong>, unless complicated by <strong>malignancy or non-healing perforation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Radical gastrectomy</strong> is primarily performed for <strong>gastric adenocarcinoma</strong> to achieve tumor resection and improve survival by removing the stomach and nearby lymph nodes. It is not typically indicated for <strong>GISTs</strong> or <strong>peptic ulcer disease</strong>, unless there are complications like malignancy or extensive infiltration.</span></p>",
      "correct_choice_id": 322764,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81020/Surgery_NEET_PG_Mock_115.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81020/Surgery_NEET_PG_Mock_115.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81148,
      "choices": [
        {
          "id": 323272,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-B, 3-A, 4-D</span></p>"
        },
        {
          "id": 323273,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-A, 3-B, 4-D</span></p>"
        },
        {
          "id": 323274,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-A, 3-D, 4-B</span></p>"
        },
        {
          "id": 323275,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-A, 4-B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the position with its use:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WaNDMrJ.png\" width=\"785\" height=\"493\"></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Laparoscopic cholecystectomy&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Shoulder surgery</span></li><li><span style=\"font-size:14.0pt;\">Shifting unconscious patients&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Robotic prostatectomy</span></li></ol>",
      "unique_key": "Q8565303",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;1-C, 2-A, 3-D, 4-B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>&nbsp;1→ C. Recovery Position → Shifting unconscious patients:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This <strong>lateral recumbent</strong> position is used for <strong>unconscious patients</strong> to maintain a <strong>clear airway</strong> and reduce the risk of <strong>aspiration</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It’s commonly used during <strong>first aid or postictal recovery</strong> (after seizures).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2 → A. Reverse Trendelenburg Position → Laparoscopic cholecystectomy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In this position, the <strong>head is elevated</strong> higher than the feet.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It helps <strong>displace abdominal contents caudally</strong>, providing better visualization of <strong>upper abdominal organs</strong> such as the <strong>gallbladder</strong>. Commonly used in <strong>laparoscopic upper GI surgeries</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3→ D. Steep Trendelenburg Position → Robotic prostatectomy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Here, the <strong>patient’s head is lower than the pelvis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This improves <strong>pelvic organ exposure</strong> and is essential in <strong>robotic pelvic surgeries</strong> such as <strong>prostatectomy</strong> and <strong>gynecologic procedures</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4→ B. Beach Chair Position → Shoulder surgery:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The patient is positioned in a <strong>semi-upright seated position</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This allows easy access to the <strong>shoulder joint</strong> and is frequently used in <strong>arthroscopic and open shoulder surgeries</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is also used in <strong>neurosurgery.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Recovery position:</strong> Recovery position is used for <strong>unconscious patients</strong> to prevent aspiration and maintain airway.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reverse Trendelenburg:</strong> Reverse Trendelenburg helps in <strong>laparoscopic cholecystectomy</strong> by improving view of upper abdomen.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Steep Trendelenburg:</strong> Steep Trendelenburg is ideal for <strong>robotic pelvic surgeries</strong> like prostatectomy due to better pelvic access.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Beach chair position:</strong> Beach chair position is commonly used for <strong>shoulder surgeries</strong> as it provides optimal joint exposure.</span></li></ol>",
      "correct_choice_id": 323274,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81148/NEET_PG_Mock_1_Q3_Anesthesia.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81148/NEET_PG_Mock_1_Q3_Anesthesia.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81160,
      "choices": [
        {
          "id": 323320,
          "text": "<p><span style=\"font-size:14.0pt;\">Capgras syndrome&nbsp;</span></p>"
        },
        {
          "id": 323321,
          "text": "<p><span style=\"font-size:14.0pt;\">Frégoli syndrome&nbsp;</span></p>"
        },
        {
          "id": 323322,
          "text": "<p><span style=\"font-size:14.0pt;\">Cotard syndrome&nbsp;</span></p>"
        },
        {
          "id": 323323,
          "text": "<p><span style=\"font-size:14.0pt;\">De Clerambault syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old female with a 10-year history of schizophrenia is brought to the emergency department by police after creating a disturbance at a shopping mall. She was agitated and screaming at several different shoppers, accusing them all of being her ex-husband who was \"disguising himself\" to follow her. She insists that although these people look completely different from one another, they are all the same person (her ex-husband) who keeps changing his appearance to spy on her. Her medical records show she has been non-compliant with risperidone for the past 3 months. Which syndrome best describes this patient's presentation?&nbsp;</span></p>",
      "unique_key": "Q4083619",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;Frégoli syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient is exhibiting <strong>Frégoli syndrome</strong>, a rare delusional misidentification syndrome in which the person believes that <strong>different people are actually a single person who changes appearances</strong> or is in disguise.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In this case, the patient believes that multiple different-looking individuals at the mall are all actually her ex-husband in disguise.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This syndrome is named after the Italian actor Leopoldo Frégoli who was known for his ability to make quick changes of appearance during his performances.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Capgras syndrome:</strong> Capgras syndrome is incorrect. In Capgras syndrome, patients believe that <strong>familiar persons have been replaced by identical-looking impostors</strong>. The mnemonic for Capgras is \"Close Person Got Replaced by a Stranger.\" This patient instead believes different-looking strangers are the same person (her ex-husband).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Cotard syndrome:&nbsp;</strong>Cotard syndrome is incorrect. Cotard syndrome involves <strong>nihilistic delusions</strong> about oneself or parts of oneself, like believing one is dead or that parts of one's body are missing or rotting. The patient shows no such beliefs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;De Clerambault syndrome:&nbsp;</strong>De Clerambault syndrome is incorrect. De Clerambault syndrome, also known as <strong>erotomania</strong>, is a delusional disorder in which a person believes that <strong>another person, usually of higher social status, is in love with them</strong>. This patient shows no erotomanic delusions but rather persecutory delusions involving her ex-husband.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Frégoli syndrome is characterized by the delusion</strong> that a persecutor (often associated with paranoid schizophrenia) is disguising themselves as different people, representing the opposite phenomenon to Capgras syndrome.</span></p>",
      "correct_choice_id": 323321,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81160/Psychiatry_Mock_1_Q2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81160/Psychiatry_Mock_1_Q2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80985,
      "choices": [
        {
          "id": 322624,
          "text": "<p><span style=\"font-size:14.0pt;\">Juvenile Idiopathic Arthritis</span></p>"
        },
        {
          "id": 322625,
          "text": "<p><span style=\"font-size:14.0pt;\">Systemic Lupus Erythematosus</span></p>"
        },
        {
          "id": 322626,
          "text": "<p><span style=\"font-size:14.0pt;\">Blau Syndrome</span></p>"
        },
        {
          "id": 322627,
          "text": "<p><span style=\"font-size:14.0pt;\">Kawasaki Disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 7-year-old child presents with recurrent episodes of joint pain, swelling, and rash. The rash appears as erythematous, scaly plaques over the cheeks and buttocks. Parents report that symptoms flare up periodically and are often associated with fever. On physical examination, there is synovitis in multiple joints and uveitis on eye exam. Genetic testing reveals a mutation in the NOD2 gene. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9472048",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Blau Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The classic triad in this child—<strong>arthritis, skin rash, and uveitis</strong>—along with the <strong>NOD2 gene mutation</strong> strongly suggests <strong>Blau Syndrome</strong>, a rare <strong>autoinflammatory disorder</strong> with <strong>granulomatous inflammation</strong> of the skin, joints, and eyes.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mnemonic: \"BLAU = Bones, Lids, Autoimmune, Unusual gene\"</span><ul><li><span style=\"font-size:14.0pt;\">B-Bones → Arthritis (boggy, symmetric)</span></li><li><span style=\"font-size:14.0pt;\">L-Lids → Uveitis (can lead to blindness)</span></li><li><span style=\"font-size:14.0pt;\">A-Autoimmune granulomas → Skin rash, systemic features</span></li><li><span style=\"font-size:14.0pt;\">U-Uncommon gene → NOD2/ CARD15</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Juvenile Idiopathic Arthritis (JIA):</strong> &nbsp;Incorrect. While JIA can present with arthritis and occasionally uveitis, the scaly rash and genetic NOD2 mutation do not support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Systemic Lupus Erythematosus (SLE):&nbsp;</strong>Incorrect. SLE may present with joint pain, rash, and systemic symptoms, but it usually affects older children/adolescents, and NOD2 mutation is not associated. Uveitis is also not characteristic. These patients will have butterfly malar rash on cheeks and not on buttocks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Kawasaki Disease:&nbsp;</strong>Incorrect<strong>.</strong> Kawasaki presents with fever, conjunctival injection, rash, and mucosal involvement, but not chronic arthritis or uveitis, and is not linked to NOD2 mutation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Z5Il2D6.png\" width=\"912\" height=\"356\"></strong></span></p>",
      "correct_choice_id": 322626,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80985/Pediatrics__NEET_MOCK_-_1_Question_-_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80985/Pediatrics__NEET_MOCK_-_1_Question_-_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80970,
      "choices": [
        {
          "id": 322564,
          "text": "<p><span style=\"font-size:14.0pt;\">Constrictive pericarditis</span></p>"
        },
        {
          "id": 322565,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary embolism</span></p>"
        },
        {
          "id": 322566,
          "text": "<p><span style=\"font-size:14.0pt;\">Cardiac tamponade</span></p>"
        },
        {
          "id": 322567,
          "text": "<p><span style=\"font-size:14.0pt;\">Severe left ventricular dysfunction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 75-year-old man is brought with altered mental status and fatigue. His pulse is regular, but alternate Korotkoff sounds are heard during BP measurement, unrelated to respiration. His arterial pressure tracings are shown below. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-19%20155210-Picsart-AiImageEnhancer.jpg\" width=\"1688\" height=\"740\"></p>",
      "unique_key": "Q3211499",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Severe left ventricular dysfunction</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pulsus alternans is defined as alternating strong and weak pulses in a regular rhythm, commonly due to advanced left ventricular systolic dysfunction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is not dependent on respiration and reflects impaired calcium handling and contractility.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Constrictive pericarditis</strong>: Associated with Kussmaul sign, not pulsus alternans.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pulmonary embolism</strong>: Associated with pulsus paradoxus, may cause shock or RV strain but not this pulse pattern.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cardiac tamponade</strong>: Associated with electrical alternans in the ECG, not pulsus alternans.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Pulsus alternans is a bedside clue to advanced LV dysfunction and should prompt urgent heart failure evaluation.</span></p>",
      "correct_choice_id": 322567,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80970/Neet_Mock_-_1_Question_-_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80970/Neet_Mock_-_1_Question_-_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80967,
      "choices": [
        {
          "id": 322552,
          "text": "<p><span style=\"font-size:14.0pt;\">Semaglutide</span></p>"
        },
        {
          "id": 322553,
          "text": "<p><span style=\"font-size:14.0pt;\">Tirzepatide</span></p>"
        },
        {
          "id": 322554,
          "text": "<p><span style=\"font-size:14.0pt;\">Orlistat</span></p>"
        },
        {
          "id": 322555,
          "text": "<p><span style=\"font-size:14.0pt;\">Liraglutide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman with a BMI of 37 kg/m² and no history of diabetes is being evaluated for pharmacologic therapy for obesity. Despite structured dietary changes and physical activity for the past 6 months, she has only achieved 2% weight loss. She now seeks medical treatment to maximize further reduction. Among the FDA-approved options, which of the following medications has demonstrated the greatest average weight loss in clinical trials?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9366222",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Tirzepatide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tirzepatide</strong> is a <strong>dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In clinical trials, it has shown <strong>superior weight reduction</strong> compared to other anti-obesity agents.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Average weight loss with tirzepatide has reached <strong>over 20% of baseline body weight</strong>, depending on the dose and trial duration, making it the <strong>most effective currently approved anti-obesity medication</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Its <strong>dual mechanism</strong> enhances insulin secretion, suppresses appetite, delays gastric emptying, and promotes significant satiety — all of which contribute to <strong>maximum weight loss</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Semaglutide:</strong> A <strong>GLP-1 receptor agonist</strong>, semaglutide is highly effective, inducing <strong>~15% weight loss</strong> at the approved obesity dose (2.4 mg weekly). However, it is <strong>less effective than tirzepatide</strong>, which combines GLP-1 and GIP effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Orlistat:&nbsp;</strong>A <strong>gastrointestinal lipase inhibitor</strong>, orlistat <strong>prevents dietary fat absorption</strong>. It leads to <strong>modest weight loss (~5–7%)</strong> and is associated with <strong>GI side effects</strong> like oily stools, which limit its tolerability. It is <strong>far less effective</strong> than GLP-1 or dual agonists.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Liraglutide:</strong> Also, a <strong>GLP-1 receptor agonist</strong>, approved for weight loss at 3.0 mg daily, liraglutide achieves around <strong>8–10% weight loss</strong> on average — <strong>less than semaglutide and tirzepatide</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Tirzepatide, a <strong>dual GIP and GLP-1 receptor agonist,</strong> produces the greatest average weight loss among currently approved anti-obesity drugs.</span></p>",
      "correct_choice_id": 322553,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80967/Pharma_Mock_1_NEET_PG20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80967/Pharma_Mock_1_NEET_PG20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80922,
      "choices": [
        {
          "id": 322372,
          "text": "<p><span style=\"font-size:14.0pt;\">Item 7 enhances the scale's internal consistency and should be retained</span></p>"
        },
        {
          "id": 322373,
          "text": "<p><span style=\"font-size:14.0pt;\">Item 7 may not align well with the overall construct and could be considered for removal</span></p>"
        },
        {
          "id": 322374,
          "text": "<p><span style=\"font-size:14.0pt;\">The increase in alpha is negligible; no action is needed regarding item 7</span></p>"
        },
        {
          "id": 322375,
          "text": "<p><span style=\"font-size:14.0pt;\">Item 7 is essential for maintaining the scale's validity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher is evaluating the reliability of a newly developed 10-item self-report scale intended to measure depressive symptoms in a college population. Upon running an internal consistency analysis, she finds that the Cronbach’s alpha for the entire scale is 0.78. However, when item 7 is removed, the Cronbach’s alpha increases to 0.82. What is the most appropriate interpretation of this finding regarding item 7?</span></p>",
      "unique_key": "Q9884236",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Item 7 may not align well with the overall construct and could be considered for removal.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cronbach’s alpha</strong> is a measure of <strong>internal consistency</strong>, or how well the items in a scale correlate with each other to measure the same underlying construct (e.g., depression). A <strong>higher alpha</strong> suggests that the scale items are more homogeneous and consistently reflect the target trait.</span></li><li><span style=\"font-size:14.0pt;\">If the <strong>removal of an item</strong> results in a <strong>notable increase in Cronbach’s alpha</strong>, it suggests that the item was <strong>not contributing positively</strong> to the overall consistency of the scale. It may be measuring a <strong>different concept</strong>, be <strong>ambiguous</strong>, or <strong>poorly worded</strong>, and thus <strong>diluting</strong> the reliability of the scale.</span></li><li><span style=\"font-size:14.0pt;\">In this scenario, removing item 7 raises alpha from 0.78 to 0.82—a meaningful improvement—indicating that item 7 likely <strong>does not align well with the intended construct of depression</strong>. The researcher should <strong>review or consider removing</strong> the item to improve the scale’s overall internal consistency.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-19%20180408.png\" width=\"1152\" height=\"325\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Item 7 enhances the scale's internal consistency and should be retained:&nbsp;</strong>Incorrect. If item 7 truly enhanced internal consistency, <strong>removing</strong> it would cause a <strong>drop</strong> in alpha—not an increase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The increase in alpha is negligible; no action is needed regarding item 7:&nbsp;</strong>Incorrect. An increase from <strong>0.78 to 0.82</strong> is <strong>meaningful</strong>, especially when the original alpha was borderline. This justifies further evaluation of item 7.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Item 7 is essential for maintaining the scale's validity:&nbsp;</strong>Incorrect. While <strong>validity</strong> is important, this finding speaks to <strong>reliability (internal consistency)</strong>, not whether the item is essential for validity. Moreover, poor internal consistency could actually harm the scale's validity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">If <strong>removing an item increases Cronbach’s alpha</strong>, it suggests the item is <strong>not internally consistent</strong> with the other items and may be <strong>misaligned with the overall construct</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Such items should be carefully reviewed or revised to improve scale reliability.</span></li></ul>",
      "correct_choice_id": 322373,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80922/PSM_Mock_1_Q4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80922/PSM_Mock_1_Q4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81116,
      "choices": [
        {
          "id": 323144,
          "text": "<p><span style=\"font-size:14.0pt;\">To determine the virus strain or serotype</span></p>"
        },
        {
          "id": 323145,
          "text": "<p><span style=\"font-size:14.0pt;\">To qualitatively assess cytopathic effect of virus</span></p>"
        },
        {
          "id": 323146,
          "text": "<p><span style=\"font-size:14.0pt;\">To confirm the presence of the virus in a clinical sample</span></p>"
        },
        {
          "id": 323147,
          "text": "<p><span style=\"font-size:14.0pt;\">To quantify the number of infectious viral particles</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a virology research lab, a scientist is working on measuring the infectivity of a newly isolated virus. A plaque assay is performed using a monolayer of host cells. Each clear zone that appears corresponds to viral lysis of host cells. What is the primary purpose of performing this plaque assay?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4758740",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) To quantify the number of infectious viral particles</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>plaque assay</strong> is a <strong>quantitative virological technique</strong> used to measure the <strong>infectivity titer</strong> of a virus (i.e., how many <strong>infectious virions</strong> are present in a given volume)</span></li><li><span style=\"font-size:14.0pt;\">Results are expressed in <strong>plaque-forming units (PFU)/mL</strong></span></li><li><span style=\"font-size:14.0pt;\">Each <strong>plaque</strong> corresponds to one <strong>infectious virus particle</strong> that has infected a cell, replicated, and caused <strong>cytolysis</strong>, leading to a <strong>clear zone</strong></span></li><li><span style=\"font-size:14.0pt;\">This assay helps determine the <strong>exact concentration of infectious virus</strong>, making it a <strong>quantitative assay</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. To determine the virus strain or serotype:</strong> Incorrect<strong>.</strong> Strain or serotype determination requires <strong>genotyping or serologic assays</strong>, not plaque assays.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. To qualitatively assess cytopathic effect of virus:</strong> Incorrect<strong>.</strong> Although plaques <strong>result from cytopathic effects</strong>, the assay’s <strong>primary use is quantitative</strong>, not merely qualitative.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. To confirm the presence of the virus in a clinical sample:</strong> Incorrect<strong>.</strong> Other assays such as <strong>PCR or antigen detection</strong> are better suited for diagnosis. Plaque assay is typically used in <strong>research and vaccine development</strong> settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Plaque assays are used to quantify the number of infectious virus particles in a sample, expressed as plaque-forming units per milliliter (PFU/mL).</span></p>",
      "correct_choice_id": 323147,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81116/Microbiology_NEET_PG_Mock_Q9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81116/Microbiology_NEET_PG_Mock_Q9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81109,
      "choices": [
        {
          "id": 323116,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and the Reason is the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 323117,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but the Reason is not the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 323118,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true, but Reason is false</span></p>"
        },
        {
          "id": 323119,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is false, but Reason is true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Assertion and Reason Question:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Assertion (A):</strong> The Paul-Bunnell test is used in the diagnosis of infectious mononucleosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason (R):</strong> This test detects heterophile antibodies in the patient’s serum that agglutinate sheep red blood cells.</span></p>",
      "unique_key": "Q7829673",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Both Assertion and Reason are true, and the Reason is the correct explanation of the Assertion.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>Paul-Bunnell test</strong> is a <strong>heterophile agglutination test</strong> used in the <strong>diagnosis of infectious mononucleosis</strong>, a disease caused by the <strong>Epstein-Barr virus (EBV)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It detects <strong>heterophile antibodies</strong> in the patient’s serum, which are <strong>IgM antibodies</strong> that <strong>cross-react with antigens on sheep red blood cells</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>agglutination</strong> of sheep RBCs indicates the presence of these <strong>cross-reactive antibodies</strong>, confirming recent <strong>EBV infection</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the <strong>reason correctly explains</strong> the <strong>assertion</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Paul-Bunnell test detects heterophile IgM antibodies</strong> in infectious mononucleosis using sheep RBCs, making it a diagnostic tool for EBV infection.</span></p>",
      "correct_choice_id": 323116,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81109/Microbiology_NEET_PG_Mock_Q2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81109/Microbiology_NEET_PG_Mock_Q2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80946,
      "choices": [
        {
          "id": 322468,
          "text": "<p><span style=\"font-size:14.0pt;\">Secondary arrest after progression of labor</span></p>"
        },
        {
          "id": 322469,
          "text": "<p><span style=\"font-size:14.0pt;\">Prolonged active phase of labor</span></p>"
        },
        {
          "id": 322470,
          "text": "<p><span style=\"font-size:14.0pt;\">Prolonged latent phase/primary arrest of labor</span></p>"
        },
        {
          "id": 322471,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal labor in a primigravida</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old primigravida in active labor is being monitored for cervical dilatation over time. The progression is as depicted in the graph provided. Based on this pattern, which of the following diagnoses is most accurate?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105346.jpg\" width=\"788\" height=\"460\"></span></p>",
      "unique_key": "Q1075801",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Secondary arrest after progression of labor</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Secondary arrest refers to a cessation of cervical dilation after a previously normal progression during the active phase of labor.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The partograph demonstrates an initial normal labor progression followed by a plateau, indicative of secondary arrest.&nbsp;&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This may occur due to cephalopelvic disproportion, inadequate uterine contractions, or fetal malposition. Prompt identification and management are essential to prevent maternal and fetal complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Prolonged active phase of labor</strong>: Characterized by a slower-than-expected rate of cervical dilation during the active phase. However, in this case, there is a clear cessation rather than just a slowing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Prolonged latent phase/primary arrest of labor</strong>: Involves a failure to progress from the latent phase to the active phase of labor. This condition occurs before reaching 6 cm of dilation, which is inconsistent with the given case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Normal labor in a primigravida</strong>: Normal labor typically progresses without a prolonged plateau in cervical dilation, as seen in the mean labor curve. The observed plateau clearly deviates from normal progression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Secondary arrest of labor is defined as a cessation of cervical dilation after initially normal progression during the active phase.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Accurate diagnosis and timely intervention are critical to optimize maternal and fetal outcomes.</span></li></ul>",
      "correct_choice_id": 322468,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80946/OBG_Mock_1_Q9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80946/OBG_Mock_1_Q9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81005,
      "choices": [
        {
          "id": 322704,
          "text": "<p><span style=\"font-size:14.0pt;\">21-hydroxylase</span></p>"
        },
        {
          "id": 322705,
          "text": "<p><span style=\"font-size:14.0pt;\">17,20-lyase</span></p>"
        },
        {
          "id": 322706,
          "text": "<p><span style=\"font-size:14.0pt;\">11β-hydroxylase</span></p>"
        },
        {
          "id": 322707,
          "text": "<p><span style=\"font-size:14.0pt;\">3β-hydroxysteroid dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A phenotypically female child presents with ambiguous genitalia and clitoromegaly. On examination, she is found to have hypertension. What is the most likely enzyme deficiency?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RfXnzrs.png\" width=\"786\" height=\"721\"></strong></span></p>",
      "unique_key": "Q8763418",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 11β-hydroxylase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The child is <strong>phenotypically female</strong> but presents with <strong>ambiguous genitalia and clitoromegaly</strong>, suggesting <strong>excess androgen exposure in utero</strong>. This is a clue toward a form of <strong>congenital adrenal hyperplasia (CAH)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The additional clue is the presence of <strong>hypertension</strong>, which is critical for identifying the correct enzyme deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>11β-hydroxylase deficiency</strong>, there is impaired conversion of <strong>11-deoxycortisol to cortisol</strong> and <strong>11-deoxycorticosterone (DOC) to corticosterone</strong> in the adrenal cortex. This leads to:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Excess DOC</strong>, a potent <strong>mineralocorticoid</strong>, resulting in <strong>hypertension</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Excess androgen production</strong>, causing <strong>virilization</strong> in <strong>genotypic females</strong> (leading to ambiguous genitalia and clitoromegaly)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, this is the most likely cause of the phenotype described.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 21-hydroxylase:&nbsp;</strong>This is the most common form of CAH and also causes <strong>virilization</strong> in females due to excess androgens. However, it leads to <strong>salt-wasting (hypotension)</strong> because of <strong>aldosterone deficiency</strong>, not hypertension. This directly contradicts the clue of <strong>hypertension</strong> in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 17,20-lyase:&nbsp;</strong>Deficiency here would <strong>impair sex steroid synthesis</strong>, leading to <strong>undervirilization</strong>, not virilization. So, it would not cause <strong>clitoromegaly or ambiguous genitalia</strong> in a female. Hypertension is also not a feature of this defect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 3β-hydroxysteroid dehydrogenase:&nbsp;</strong>Deficiency would impair the synthesis of all steroids (glucocorticoids, mineralocorticoids, and androgens), leading to <strong>hypotension</strong> and <strong>lack of androgen effects</strong>, not clitoromegaly. This contradicts both main findings in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a phenotypic female presenting with ambiguous genitalia, clitoromegaly, and hypertension, suspect 11β-hydroxylase deficiency.”</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note: HTN in CAH is due to – 11β hydroxylase and 17α hydroxylase deficiency</strong></span></p>",
      "correct_choice_id": 322706,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81005/Pediatrics_NEET_MOCK_-_1_Question_-_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81005/Pediatrics_NEET_MOCK_-_1_Question_-_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81124,
      "choices": [
        {
          "id": 323176,
          "text": "<p><span style=\"font-size:14.0pt;\">Only A, B and E are true</span></p>"
        },
        {
          "id": 323177,
          "text": "<p><span style=\"font-size:14.0pt;\">Only A, B and D are true</span></p>"
        },
        {
          "id": 323178,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are true</span></p>"
        },
        {
          "id": 323179,
          "text": "<p><span style=\"font-size:14.0pt;\">Only B, C and E are true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding pemphigus vulgaris are true?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Pemphigus vulgaris is an autoimmune disorder caused by IgG autoantibodies against desmoglein 1 and desmoglein 3, leading to acantholysis.</span></li><li><span style=\"font-size:14.0pt;\">The characteristic clinical features include flaccid blisters and painful erosions.</span></li><li><span style=\"font-size:14.0pt;\">Rituximab, an anti-CD20 monoclonal antibody, is considered first-line treatment for mild disease.</span></li><li><span style=\"font-size:14.0pt;\">Systemic corticosteroids combined with steroid-sparing agents like azathioprine or mycophenolate mofetil are standard first-line therapy.</span></li><li><span style=\"font-size:14.0pt;\">Methotrexate is preferred in severe refractory cases.</span></li></ol>",
      "unique_key": "Q8364458",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Only A, B, and D are true</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement A.</strong> <strong>Pemphigus vulgaris is an autoimmune disorder caused by IgG autoantibodies against desmoglein 1 and desmoglein 3, leading to acantholysis:&nbsp;</strong>True. Pemphigus vulgaris is an autoimmune blistering disease caused by <strong>IgG autoantibodies against desmoglein 1 and desmoglein 3</strong>, which are important components of desmosomes involved in cell-to-cell adhesion. The loss of adhesion between keratinocytes is known as <strong>acantholysis</strong>, and it is a hallmark histopathological finding in this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement B.</strong> <strong>The characteristic clinical features include flaccid blisters and painful erosions:&nbsp;</strong>True. The clinical presentation of pemphigus vulgaris typically includes <strong>flaccid intraepidermal blisters</strong> that rupture easily, leaving behind <strong>painful erosions</strong> on the skin and mucous membranes. These erosions are a key clinical clue, especially when oral mucosal involvement is present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement D. Systemic corticosteroids combined with steroid-sparing agents like azathioprine or mycophenolate mofetil are standard first-line therapy:&nbsp;</strong>True. The <strong>first-line treatment</strong> for pemphigus vulgaris consists of <strong>systemic corticosteroids</strong> in combination with <strong>steroid-sparing immunosuppressive agents</strong> such as <strong>azathioprine</strong> or <strong>mycophenolate mofetil</strong>. This approach helps control disease activity while minimizing long-term corticosteroid side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement C.</strong> <strong>Rituximab, an anti-CD20 monoclonal antibody, is considered first-line treatment for mild disease:&nbsp;</strong>False. While <strong>rituximab</strong>, an anti-CD20 monoclonal antibody, is highly effective and often used in moderate to severe or refractory cases, it is <strong>not the first-line treatment</strong> for mild disease. Instead, it is reserved for more severe or steroid-resistant cases due to its immunosuppressive profile and cost.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement E. Methotrexate is preferred in severe refractory cases:</strong> False. Methotrexate is a <strong>steroid-sparing</strong> agent sometimes used in pemphigus vulgaris. It is generally <strong>not preferred in severe refractory cases</strong>. More potent immunosuppressants like rituximab or cyclophosphamide are typically considered in such situations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pemphigus vulgaris is an autoimmune disorder characterized by IgG-mediated acantholysis, leading to flaccid blisters and erosions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">First-line treatment includes <strong>systemic corticosteroids with immunosuppressive agents</strong>, while <strong>rituximab</strong> is reserved for <strong>severe or refractory cases</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Methotrexate is generally used in patients of psoriasis. In pemphigus vulgaris, it may be used sometimes, but generally not preferred.</span></li></ul>",
      "correct_choice_id": 323177,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81124/Dermatology_Mock_1_Q2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81124/Dermatology_Mock_1_Q2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80948,
      "choices": [
        {
          "id": 322476,
          "text": "<p><span style=\"font-size:14.0pt;\">A, B, C, E</span></p>"
        },
        {
          "id": 322477,
          "text": "<p><span style=\"font-size:14.0pt;\">A, C, D, E</span></p>"
        },
        {
          "id": 322478,
          "text": "<p><span style=\"font-size:14.0pt;\">A, B, D, E</span></p>"
        },
        {
          "id": 322479,
          "text": "<p><span style=\"font-size:14.0pt;\">B, C, D, E</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old G2P1 woman presents at 17 weeks gestation and is being counseled for a diagnostic prenatal procedure as part of her genetic screening. The image below represents the procedure. Which of the following statements regarding this procedure are true?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105501.jpg\" width=\"632\" height=\"507\"></span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">It is most appropriately performed between 15–20 weeks of gestation for prenatal genetic diagnosis</span></li><li><span style=\"font-size:14.0pt;\">It can be used to diagnose fetal infections and assess Rh alloimmunization severity</span></li><li><span style=\"font-size:14.0pt;\">Lecithin/sphingomyelin ratio and phosphatidylglycerol in fluid assess fetal lung maturity</span></li><li><span style=\"font-size:14.0pt;\">The risk of procedure-related fetal loss is approximately 5%</span></li><li><span style=\"font-size:14.0pt;\">Vaginal spotting and amniotic fluid leakage are potential complications</span></li></ol>",
      "unique_key": "Q4320661",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A, B, C, E</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>The test depicted is amniocentesis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement A.</strong> <strong>It is most appropriately performed between 15–20 weeks of gestation for prenatal genetic diagnosis:&nbsp;</strong>True. Amniocentesis is typically performed between <strong>15–20 weeks</strong> for prenatal diagnosis of chromosomal abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement B.</strong> <strong>It can be used to diagnose fetal infections and assess Rh alloimmunization severity: True</strong>. It helps detect <strong>congenital infections</strong> and assess <strong>bilirubin levels</strong> in Rh isoimmunization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement C.</strong> <strong>Lecithin/sphingomyelin ratio and phosphatidylglycerol in fluid assess fetal lung maturity:&nbsp;</strong>True. Later in pregnancy, it is used to assess <strong>fetal lung maturity</strong> via <strong>L/S ratio</strong> and <strong>phosphatidylglycerol</strong> presence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement E.</strong> <strong>Vaginal spotting and amniotic fluid leakage are potential complications: True</strong>. <strong>Vaginal spotting</strong> and <strong>amniotic fluid leakage</strong> are recognized complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement D.</strong> <strong>The risk of procedure-related fetal loss is approximately 5%:&nbsp;</strong>False. The actual <strong>procedure-related loss rate is very low (~0.1–0.3%)</strong>, not 5%.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Amniocentesis is the most commonly used prenatal diagnostic procedure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is safe when done between 15–20 weeks for detecting fetal chromosomal abnormalities and congenital infections.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It also serves as a tool for assessing Rh isoimmunization and fetal lung maturity. While generally safe, risks include minimal fetal loss, fluid leakage, and spotting.</span></li></ul>",
      "correct_choice_id": 322476,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80948/OBG_Mock_1_Q11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80948/OBG_Mock_1_Q11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80971,
      "choices": [
        {
          "id": 322568,
          "text": "<p><span style=\"font-size:14.0pt;\">Adenosine 6 mg</span></p>"
        },
        {
          "id": 322569,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct current cardioversion</span></p>"
        },
        {
          "id": 322570,
          "text": "<p><span style=\"font-size:14.0pt;\">Metoprolol 5 mg IV</span></p>"
        },
        {
          "id": 322571,
          "text": "<p><span style=\"font-size:14.0pt;\">Pain control and IV hydration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 79-year-old woman with COPD and diabetes is admitted after a fall. She is found to be dehydrated, in pain, and has an irregularly irregular pulse. ECG tracing is shown below. What is the most appropriate next step in management?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_COIkRFz.png\" width=\"1222\" height=\"225\"></strong></span></p>",
      "unique_key": "Q4512104",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Pain control and IV hydration</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Multifocal atrial tachycardia (MAT) is commonly seen in elderly patients with pulmonary disease, especially when hypoxia, pain, or dehydration is present.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Treating underlying triggers or symptomatic treatment usually resolves the arrhythmia without the need for antiarrhythmics or cardioversion.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Adenosine 6 mg:</strong> Only effective for PSVT; not indicated for MAT.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Direct current</strong> <strong>Cardioversion:</strong> Ineffective in MAT, which lacks a reentrant circuit.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Metoprolol 5 mg IV:</strong> May worsen bronchospasm in COPD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Initial MAT management focuses on correcting precipitating factor.</span></p>",
      "correct_choice_id": 322571,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80971/NEET_MOCK_-_1_Question_-_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80971/NEET_MOCK_-_1_Question_-_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81120,
      "choices": [
        {
          "id": 323160,
          "text": "<p><span style=\"font-size:14.0pt;\">Hymenolepis nana</span></p>"
        },
        {
          "id": 323161,
          "text": "<p><span style=\"font-size:14.0pt;\">Taenia solium</span></p>"
        },
        {
          "id": 323162,
          "text": "<p><span style=\"font-size:14.0pt;\">Diphyllobothrium latum</span></p>"
        },
        {
          "id": 323163,
          "text": "<p><span style=\"font-size:14.0pt;\">Ascaris lumbricoides</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old fisherman from Scandinavia presents with fatigue, glossitis, and paresthesias. Laboratory workup reveals macrocytic anemia, and serum levels show a marked deficiency of vitamin B12. Stool examination reveals ova consistent with a fish tapeworm infection. Which of the following helminths is most likely responsible for his condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2007622",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Diphyllobothrium latum</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Diphyllobothrium latum</strong>, also known as the <strong>fish tapeworm</strong>, is the <strong>largest human tapeworm</strong> and is acquired by consuming <strong>raw or undercooked freshwater fish</strong>. It is most commonly found in regions like <strong>Scandinavia, Russia, and North America</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key clinical feature: </strong>This parasite <strong>competes with the host for vitamin B12</strong> in the ileum, leading to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Vitamin B12 deficiency</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Megaloblastic (pernicious-like) anemia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Neurologic symptoms</strong> including paresthesia, ataxia, and glossitis</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hymenolepis nana:</strong> Also known as the <strong>dwarf tapeworm</strong>, it causes <strong>mild gastrointestinal symptoms</strong>, especially in children. It does <strong>not cause vitamin B12 deficiency</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Taenia solium:</strong> The <strong>pork tapeworm</strong> causes <strong>intestinal taeniasis</strong> or <strong>neurocysticercosis</strong> when its larvae invade the CNS. It is <strong>not associated</strong> with megaloblastic anemia or B12 deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ascaris lumbricoides:</strong> A <strong>roundworm</strong> causing <strong>intestinal obstruction</strong>, <strong>eosinophilia</strong>, and <strong>pulmonary symptoms (Löffler’s syndrome)</strong> during migration, but has <strong>no role in vitamin B12 metabolism or deficiency</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diphyllobothrium latum causes vitamin B12 deficiency and megaloblastic anemia by competing for B12 absorption in the ileum, distinguishing it from other helminths.</span></p>",
      "correct_choice_id": 323162,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81120/Microbiology_NEET_PG_Mock_Q13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81120/Microbiology_NEET_PG_Mock_Q13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80927,
      "choices": [
        {
          "id": 322392,
          "text": "<p><span style=\"font-size:14.0pt;\">Patients with type 2 diabetes mellitus</span></p>"
        },
        {
          "id": 322393,
          "text": "<p><span style=\"font-size:14.0pt;\">Obese individuals with type 2 diabetes</span></p>"
        },
        {
          "id": 322394,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-diabetic individuals</span></p>"
        },
        {
          "id": 322395,
          "text": "<p><span style=\"font-size:14.0pt;\">Patients who are resistant to sulfonylureas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In which of the following groups of patients is metformin least likely to reduce blood glucose levels?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2714137",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Non-diabetic individuals</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Metformin</strong> is a <strong>biguanide</strong> and first-line agent for the management of <strong>type 2 diabetes mellitus</strong>, particularly in <strong>overweight or obese individuals</strong>. It reduces blood glucose by:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Inhibiting hepatic gluconeogenesis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Improving insulin sensitivity</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Enhancing peripheral glucose uptake</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">However, in <strong>non-diabetic individuals</strong>, metformin <strong>does not lower blood glucose significantly</strong> because their baseline glucose levels and insulin sensitivity are within normal range.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, its glucose-lowering effect is <strong>minimal to negligible</strong> in those without insulin resistance or elevated hepatic glucose production.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Patients with type 2 diabetes mellitus:</strong> These patients typically benefit the most from metformin, which reduces both fasting and postprandial glucose levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Obese individuals with type 2 diabetes:</strong> Metformin is especially effective in <strong>obese diabetics</strong> due to its weight-neutral or mild weight-reducing effect and improvement in insulin sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Patients who are resistant to sulfonylureas:</strong> Metformin acts via a <strong>different mechanism</strong> than sulfonylureas (which stimulate insulin secretion), so it may still work in patients who do <strong>not respond to sulfonylureas</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Metformin does not significantly lower blood glucose in non-diabetic individuals, as its primary effects depend on the presence of insulin resistance and elevated hepatic glucose production.</span></p>",
      "correct_choice_id": 322394,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80927/Pharma_Mock_1_NEET_PG13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80927/Pharma_Mock_1_NEET_PG13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81012,
      "choices": [
        {
          "id": 322732,
          "text": "<p><span style=\"font-size:14.0pt;\">1-2%</span></p>"
        },
        {
          "id": 322733,
          "text": "<p><span style=\"font-size:14.0pt;\">3%</span></p>"
        },
        {
          "id": 322734,
          "text": "<p><span style=\"font-size:14.0pt;\">8-10%</span></p>"
        },
        {
          "id": 322735,
          "text": "<p><span style=\"font-size:14.0pt;\">10-20%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old female patient undergoes elective laparoscopic cholecystectomy after receiving prophylactic antibiotics. What is the expected rate of surgical site infection in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8052550",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 3%&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">After the administration of prophylactic antibiotics, the anticipated rate of surgical site infection in a patient with a clean-contaminated wound, such as lap. cholecystectomy is 3%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20110124.jpg\" width=\"1125\" height=\"625\"></strong></span></p>",
      "correct_choice_id": 322733,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81012/Surgery_NEET_PG_Mock_111.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81012/Surgery_NEET_PG_Mock_111.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81087,
      "choices": [
        {
          "id": 323028,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 323029,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4 and 5</span></p>"
        },
        {
          "id": 323030,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 323031,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4 and 5&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding esophageal varices is/are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Esophageal varices are dilated submucosal veins that most commonly occur in the upper third of the esophagus.</span></li><li><span style=\"font-size:14.0pt;\">They are a consequence of portal hypertension, typically due to cirrhosis.</span></li><li><span style=\"font-size:14.0pt;\">The distal esophageal vein normally drains into the portal circulation via the left gastric vein.</span></li><li><span style=\"font-size:14.0pt;\">In portal hypertension, backflow through the left gastric vein leads to dilation of submucosal veins in the esophagus.</span></li><li><span style=\"font-size:14.0pt;\">Esophageal varices may remain asymptomatic but carry a risk of life-threatening rupture.</span></li></ol>",
      "unique_key": "Q2122325",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 2, 3, 4 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. They are a consequence of portal hypertension, typically due to cirrhosis:</strong> This statement is correct. <strong>Esophageal varices</strong> are most often a result of <strong>portal hypertension</strong>, which typically occurs due to <strong>cirrhosis</strong>. Cirrhosis leads to <strong>increased pressure in the portal vein</strong>, and blood is rerouted to smaller veins, including those in the esophagus, causing them to dilate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. The distal esophageal vein normally drains into the portal circulation via the left gastric vein:</strong> This statement is correct. The <strong>distal esophageal vein</strong> drains into the <strong>left gastric vein</strong>, which is a branch of the portal vein. This connection is critical in the pathophysiology of <strong>portal hypertension</strong> leading to varices.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. In portal hypertension, backflow through the left gastric vein leads to dilation of submucosal veins in the esophagus:</strong> This statement is correct. In <strong>portal hypertension</strong>, increased pressure in the portal system causes <strong>backflow</strong> into the <strong>left gastric vein</strong>, which then leads to the dilation of <strong>submucosal veins in the esophagus</strong>, resulting in varices.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5. Esophageal varices may remain asymptomatic but carry a risk of life-threatening rupture:</strong> This statement is correct. Esophageal varices often remain <strong>asymptomatic</strong> unless they rupture. When rupture occurs, it can lead to <strong>massive gastrointestinal bleeding</strong>, which can be <strong>life-threatening</strong>. This is a key feature of esophageal varices.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Esophageal varices are dilated submucosal veins that most commonly occur in the upper third of the esophagus:</strong> This statement is incorrect. Esophageal varices most commonly occur in the <strong>lower third</strong> of the esophagus, not the upper third. this is because the lower esophagus is primarily <strong>drained by the left gastric vein</strong>, which is part of the portal venous system. In contrast, the upper esophagus is drained by veins that do not participate in the portal venous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Esophageal varices are dilated submucosal veins primarily in the lower esophagus, caused by portal hypertension, typically due to cirrhosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They result from backflow through the left gastric vein and carry a risk of life-threatening rupture.</span></li></ul>",
      "correct_choice_id": 323031,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81087/NEET_PG_Mock_1_Q9_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81087/NEET_PG_Mock_1_Q9_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81140,
      "choices": [
        {
          "id": 323240,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior vena cava (IVC)</span></p>"
        },
        {
          "id": 323241,
          "text": "<p><span style=\"font-size:14.0pt;\">T12 vertebra</span></p>"
        },
        {
          "id": 323242,
          "text": "<p><span style=\"font-size:14.0pt;\">Suprarenal gland</span></p>"
        },
        {
          "id": 323243,
          "text": "<p><span style=\"font-size:14.0pt;\">First part of the duodenum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not a posterior boundary of the epiploic foramen?</span></p>",
      "unique_key": "Q5103241",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) First part of the duodenum</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>epiploic (omental) foramen</strong> is an anatomical passage that connects the <strong>greater and lesser sacs</strong> of the peritoneal cavity. It is clinically significant due to its proximity to major vascular structures and its involvement in internal hernias.</span></li><li><span style=\"font-size:14.0pt;\">Posterior boundary includes:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Suprarenal gland</strong> (right)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Inferior vena cava (IVC)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>T12 vertebra</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Anterior boundary:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Lesser omentum</strong> containing the <strong>portal triad</strong> (hepatic artery, portal vein, bile duct)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Superior boundary:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Caudate process of liver</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Inferior boundary:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>First part of the duodenum</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Horizontal part of hepatic artery</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, while the <strong>first part of the duodenum</strong> is an <strong>inferior boundary</strong>, it is <strong>not part of the posterior boundary</strong>, making <strong>Option D</strong> the correct answer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><h1><span style=\"font-size:14.0pt;\"><strong>Epiploic (Omental) Foramen – Boundaries</strong></span></h1><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-17%20172444.png\" width=\"1283\" height=\"497\"></p><p>&nbsp;</p><p><span style=\"color:windowtext;font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_p07Niki.png\" width=\"855\" height=\"608\"></strong></span></p>",
      "correct_choice_id": 323243,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81140/NEET_PG_Mock_1_Q5_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81140/NEET_PG_Mock_1_Q5_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81021,
      "choices": [
        {
          "id": 322768,
          "text": "<p><span style=\"font-size:14.0pt;\">ALT is abundant in cardiac muscle and red cells</span></p>"
        },
        {
          "id": 322769,
          "text": "<p><span style=\"font-size:14.0pt;\">AST elevation is more specific for liver damage than ALT</span></p>"
        },
        {
          "id": 322770,
          "text": "<p><span style=\"font-size:14.0pt;\">AST and ALT &gt;1000 IU/L occur in ischemic or toxin-induced injury</span></p>"
        },
        {
          "id": 322771,
          "text": "<p><span style=\"font-size:14.0pt;\">AST: ALT &gt;3 is typical of acute viral hepatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about liver transaminase patterns is most accurate?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6313391",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) AST and ALT &gt;1000 IU/L occur in ischemic or toxin-induced injury</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Very high aminotransferase levels (&gt;1000 IU/L) suggest severe hepatocellular injury, such as ischemic hepatitis or drug/toxin-induced injury.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ALT is more liver-specific than AST. AST: ALT &gt;2 is typical of alcoholic hepatitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>ALT is abundant in cardiac muscle and red cells:&nbsp;</strong>ALT is primarily liver specific not cardiac muscle or red cells.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>AST elevation is more specific for liver damage than ALT:&nbsp;</strong>AST is less specific due to presence in other tissues.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>AST: ALT &gt;3 is typical of acute viral hepatitis:&nbsp;</strong>AST: ALT &gt;3 is not a feature of viral hepatitis.</span><span style=\"font-size:11.0pt;\">&nbsp;</span><span style=\"font-size:14.0pt;\">It should be &lt;1</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Markedly elevated AST and ALT suggest ischemic or toxic liver injury; ALT is more specific for liver than AST.</span></p>",
      "correct_choice_id": 322770,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81021/NEET_MOCK_-_1_Question_-_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81021/NEET_MOCK_-_1_Question_-_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81030,
      "choices": [
        {
          "id": 322804,
          "text": "<p><span style=\"font-size:14.0pt;\">The patient's family&nbsp;(plaintiffs), because they are accusing the doctor of negligence</span></p>"
        },
        {
          "id": 322805,
          "text": "<p><span style=\"font-size:14.0pt;\">Dr. Singh, because he must prove that his clinical decision was based on standard medical practice</span></p>"
        },
        {
          "id": 322806,
          "text": "<p><span style=\"font-size:14.0pt;\">The hospital, because it is the employer and responsible for the actions of its staff under vicarious liability</span></p>"
        },
        {
          "id": 322807,
          "text": "<p><span style=\"font-size:14.0pt;\">Shared between the patient's family and the hospital, as both need to provide evidence to support or refute the claim</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old male, Mr. Sharma without any relevant past medical history, visits Dr Singh in a hospital with abdominal discomfort. Dr. Singh makes a diagnosis of gastritis and prescribes antacids. Hours later, he suffers a heart attack and is hospitalized. His family sues Dr. Singh and the hospital for medical negligence, alleging failure to order cardiac tests. Who bears the onus of proof in this civil negligence case?&nbsp;</span></p>",
      "unique_key": "Q1542911",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) The patient's family&nbsp;(plaintiffs), because they are accusing the doctor of negligence.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In&nbsp;<strong>civil medical negligence cases</strong>, the&nbsp;<strong>burden (onus) of proof</strong>&nbsp;lies with the&nbsp;<strong>plaintiff</strong>—in this case,&nbsp;<strong>Mr. Sharma’s family</strong>—because they are the ones alleging negligence.</span></li><li><span style=\"font-size:14.0pt;\">They must prove&nbsp;<strong>all three essential elements</strong>&nbsp;of medical negligence:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Duty of care</strong>&nbsp;existed (doctor-patient relationship),</span></li><li><span style=\"font-size:14.0pt;\">There was a&nbsp;<strong>breach of that duty</strong>&nbsp;(i.e., standard care not followed),</span></li><li><span style=\"font-size:14.0pt;\">That breach&nbsp;<strong>directly caused harm</strong>&nbsp;to the patient (causation and damage).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The doctor (defendant)&nbsp;<strong>does not need to prove innocence</strong>. Rather, once the plaintiff has presented evidence of negligence, the doctor may then present&nbsp;<strong>justifications</strong>&nbsp;or&nbsp;<strong>explain clinical reasoning</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dr. Singh, because he must prove that his clinical decision was based on standard medical practice:&nbsp;</strong>The doctor may defend his actions, but the&nbsp;<strong>initial burden</strong>&nbsp;lies on the complainant.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>The hospital, because it is the employer and responsible for the actions of its staff under vicarious liability:&nbsp;</strong>While the hospital may be&nbsp;<strong>vicariously liable</strong>&nbsp;if negligence is proven, it&nbsp;<strong>does not bear the initial onus</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Shared between the patient's family and the hospital, as both need to provide evidence to support or refute the claim: </strong>The burden is&nbsp;<strong>not shared</strong>&nbsp;initially; it is solely on the plaintiff to prove negligence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In civil medical negligence cases, the <strong>burden of proof lies with the plaintiff</strong>, who must establish that:&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">A duty of care existed,&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">There was a breach of that duty,&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The breach caused the harm. The defendant (doctor or hospital) is not required to prove innocence unless rebutting the presented claim.</span></li></ul>",
      "correct_choice_id": 322804,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81030/NEET_PG_Mock_1_Q1_FMT.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81030/NEET_PG_Mock_1_Q1_FMT.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80919,
      "choices": [
        {
          "id": 322360,
          "text": "<p><span style=\"font-size:14.0pt;\">Child stunting</span></p>"
        },
        {
          "id": 322361,
          "text": "<p><span style=\"font-size:14.0pt;\">Literacy rate</span></p>"
        },
        {
          "id": 322362,
          "text": "<p><span style=\"font-size:14.0pt;\">Sanitation</span></p>"
        },
        {
          "id": 322363,
          "text": "<p><span style=\"font-size:14.0pt;\">Life expectancy at birth</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A health economist is analyzing various global indices that measure development and deprivation. She notes that one specific indicator appears in both the Global Hunger Index (GHI) and the Multidimensional Poverty Index (MDPI). Which of the following indicators is common to both the Global Hunger Index (GHI) and the Multidimensional Poverty Index (MDPI)?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4959184",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Child stunting</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>Global Hunger Index (GHI)</strong> is a composite indicator that reflects <strong>undernourishment and child undernutrition</strong>, particularly through:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Undernourishment (population-level food access)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Child stunting</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Child wasting</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Child mortality</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>Multidimensional Poverty Index (MDPI)</strong> captures deprivations across three broad dimensions: <strong>Health, Education, and Standard of Living</strong>. Under the <strong>Health</strong> dimension, it includes:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Nutrition</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Child mortality</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Although the MDPI does not list “stunting” by name, the <strong>nutrition indicator</strong> often operationalizes <strong>child stunting</strong> (height-for-age) and/or underweight as proxies in household surveys to reflect chronic malnutrition.</span></li><li><span style=\"font-size:14.0pt;\">Hence, <strong>child stunting is a shared indicator</strong> (direct in GHI, indirect in MDPI through “nutrition”).</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-05-20%20at%2011.41.28%20AM.jpeg\" width=\"1251\" height=\"1384\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Literacy rate:</strong> Included in <strong>PQLI</strong> and indirectly in <strong>HDI</strong> but <strong>not</strong> used in <strong>GHI</strong> or <strong>MDPI</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sanitation:</strong> Included under the <strong>standard of living</strong> domain of <strong>MDPI</strong>, but <strong>not part of GHI</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Life expectancy at birth:</strong> This is a key component of <strong>HDI</strong>, not GHI or MDPI.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Indices:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zgeeJnk.png\" width=\"1101\" height=\"733\"></strong></span></p>",
      "correct_choice_id": 322360,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80919/PSM_Mock_1_Q2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80919/PSM_Mock_1_Q2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81084,
      "choices": [
        {
          "id": 323016,
          "text": "<p><span style=\"font-size:14.0pt;\">Immune complex deposition causes necrotizing vasculitis and crescentic glomerulonephritis</span></p>"
        },
        {
          "id": 323017,
          "text": "<p><span style=\"font-size:14.0pt;\">Fragmentation of internal elastic lamina leads to aneurysm formation in medium-sized arteries</span></p>"
        },
        {
          "id": 323018,
          "text": "<p><span style=\"font-size:14.0pt;\">Lipid-laden macrophages accumulate in the vessel wall, leading to plaque formation and thrombosis</span></p>"
        },
        {
          "id": 323019,
          "text": "<p><span style=\"font-size:14.0pt;\">Proliferation of smooth muscle cells causes \"onion-skin\" appearance of arterioles, leading to end-organ ischemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with a history of poorly controlled hypertension presents to the emergency department with sudden-onset headache and blurred vision. His blood pressure is recorded at 240/130 mmHg. Laboratory studies show elevated serum creatinine. A renal biopsy is shown below. Which of the following best describes the pathological process and its potential consequences?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20172208.jpg\" width=\"603\" height=\"432\"></p>",
      "unique_key": "Q4213975",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Proliferation of smooth muscle cells causes \"onion-skin\" appearance of arterioles, leading to end-organ ischemia.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with features of <strong>malignant hypertension</strong> (BP &gt; 180/120 mmHg) including <strong>headache</strong>, <strong>blurred vision</strong>, and <strong>acute renal impairment</strong> (elevated serum creatinine).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The renal biopsy shows <strong>hyperplasia of smooth muscle</strong> in arterioles, creating a <strong>concentric, laminated \"onion-skin\" appearance</strong>, which is the hallmark of <strong>hyperplastic arteriolosclerosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This vascular change is a <strong>consequence of malignant hypertension</strong> and results in <strong>thickening of the vessel wall</strong>, leading to <strong>reduced vessel caliber</strong>. As a result, <strong>end-organ ischemia</strong> develops — especially in the kidneys, where this can lead to <strong>fibrinoid necrosis</strong> and <strong>hemorrhage</strong>. When this occurs, the kidneys may develop a characteristic <strong>'flea-bitten' appearance</strong>, and <strong>acute renal failure</strong> can result.</span></li><li><span style=\"font-size:14.0pt;\">Thus, this option fully captures the process: <strong>smooth muscle hyperplasia</strong> → <strong>onion-skin appearance</strong> → <strong>vessel narrowing</strong> → <strong>end-organ ischemia</strong>, which may progress to <strong>fibrinoid necrosis</strong> and <strong>renal hemorrhage</strong> in malignant hypertension.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Immune complex deposition causes necrotizing vasculitis and crescentic glomerulonephritis:</strong> This describes a different pathological process, such as <strong>immune complex-mediated glomerulonephritis</strong>, seen in conditions like <strong>lupus nephritis</strong> or <strong>post-infectious GN</strong>. These involve immune complex deposition, <strong>necrotizing inflammation</strong>, and formation of <strong>crescents</strong> in glomeruli — not <strong>smooth muscle hyperplasia</strong>, not <strong>onion-skinning</strong>, and not associated with <strong>malignant hypertension</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Fragmentation of internal elastic lamina leads to aneurysm formation in medium-sized arteries:</strong> This option describes the pathogenesis of aneurysms, especially in <strong>vasculitides</strong> like <strong>polyarteritis nodosa</strong> or <strong>connective tissue disorders</strong> like <strong>Marfan syndrome</strong>, not hyperplastic arteriolosclerosis. There is no mention of <strong>smooth muscle proliferation</strong>, <strong>onion-skinning</strong>, or <strong>flea-bitten kidneys</strong> in such settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lipid-laden macrophages accumulate in the vessel wall, leading to plaque formation and thrombosis:</strong> This option refers to <strong>atherosclerosis</strong>, which involves <strong>intimal lipid accumulation</strong>, <strong>macrophages (foam cells)</strong>, and <strong>plaque formation</strong> in large and medium arteries — not arterioles. It is not related to <strong>malignant hypertension</strong>, <strong>onion-skin lesions</strong>, or <strong>acute renal failure</strong> with a <strong>flea-bitten kidney appearance</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hyperplastic arteriolosclerosis is a consequence of malignant hypertension, characterized by concentric smooth muscle hyperplasia in arterioles (\"onion-skin\" appearance), which leads to reduced vessel caliber, end-organ ischemia, and may result in acute renal failure with a characteristic flea-bitten appearance of the kidney.</span></p>",
      "correct_choice_id": 323019,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81084/NEET_PG_Mock_1_Q6_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81084/NEET_PG_Mock_1_Q6_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81002,
      "choices": [
        {
          "id": 322692,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum lipase</span></p>"
        },
        {
          "id": 322693,
          "text": "<p><span style=\"font-size:14.0pt;\">CECT abdomen immediately</span></p>"
        },
        {
          "id": 322694,
          "text": "<p><span style=\"font-size:14.0pt;\">Exploratory laparotomy</span></p>"
        },
        {
          "id": 322695,
          "text": "<p><span style=\"font-size:14.0pt;\">CECT abdomen after 72 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old male with a history of occasional alcohol consumption presented to the casualty with acute colicky abdominal pain, distention of the abdomen, and vomiting. On x-ray, the following was noticed. What is the next step?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20110039.jpg\" width=\"447\" height=\"520\"></span></p>",
      "unique_key": "Q8288472",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) CECT abdomen immediately</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The given scenario is suggestive of acute mechanical small bowel obstruction. The dilated air fluid levels in step-ladder pattern suggest a mechanical block.</span></li><li><span style=\"font-size:14.0pt;\">Thus, CECT needs to be done immediately to identify the site and the status of the bowel ischemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Serum lipase:&nbsp;</strong>Serum lipase is done when suspecting acute pancreatitis, which is unlikely here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Exploratory laparotomy:&nbsp;</strong>Exploratory laparotomy may be done depending on etiology of acute obstruction, which would require CECT to confirm prior.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CECT abdomen after 72 hours:</strong> It is done for assessing extent of necrosis in acute pancreatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In case of acute mechanical small bowel obstruction, CECT is required to assess site of obstruction and presence of ischemia.</span></p>",
      "correct_choice_id": 322693,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81002/Surgery_NEET_PG_Mock_110.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81002/Surgery_NEET_PG_Mock_110.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80926,
      "choices": [
        {
          "id": 322388,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of dihydroorotate dehydrogenase</span></p>"
        },
        {
          "id": 322389,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of AICAR transformylase</span></p>"
        },
        {
          "id": 322390,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of dihydrofolate reductase enzyme</span></p>"
        },
        {
          "id": 322391,
          "text": "<p><span style=\"font-size:14.0pt;\">Activation of TNF-alpha</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old woman diagnosed with rheumatoid arthritis (RA) is started on methotrexate as a first-line disease-modifying antirheumatic drug (DMARD). Which of the following best describes the most important mechanism of methotrexate when used in rheumatoid arthritis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9534936",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Inhibition of AICAR transformylase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Although <strong>methotrexate</strong> is widely known for <strong>inhibiting dihydrofolate reductase</strong> (DHFR) in high doses (e.g., in cancer therapy), its <strong>anti-inflammatory effect</strong> in <strong>rheumatoid arthritis</strong> is primarily mediated through a <strong>different mechanism</strong>.</span></li><li><span style=\"font-size:14.0pt;\">At low doses used for RA, methotrexate <strong>inhibits the enzyme AICAR transformylase</strong> (aminoimidazole carboxamide ribonucleotide transformylase), leading to <strong>accumulation of AICAR</strong>. AICAR then inhibits <strong>adenosine deaminase</strong>, resulting in <strong>increased extracellular adenosine</strong>, a <strong>potent anti-inflammatory molecule</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This mechanism <strong>modulates immune response</strong> and reduces <strong>inflammation</strong> in joints.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inhibition of dihydroorotate dehydrogenase:</strong> This is the mechanism of <strong>leflunomide</strong>, another DMARD. It inhibits <strong>pyrimidine synthesis</strong>, which is distinct from methotrexate’s action in RA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Inhibition of dihydrofolate reductase enzyme:</strong> This is the <strong>primary mechanism in oncology</strong>, were methotrexate blocks folate metabolism and DNA synthesis. While this occurs at higher doses, it is <strong>not the dominant anti-inflammatory mechanism</strong> in RA therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Activation of TNF-alpha:</strong> TNF-alpha is a <strong>pro-inflammatory cytokine</strong>. Methotrexate and other DMARDs aim to <strong>suppress</strong>, not activate, TNF-alpha. This choice is the <strong>opposite</strong> of the drug’s intended immune modulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Methotrexate exerts its anti-inflammatory effects in rheumatoid arthritis primarily through inhibition of AICAR transformylase, leading to increased adenosine levels and immune suppression.</span></p>",
      "correct_choice_id": 322389,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80926/Pharma_Mock_1_NEET_PG12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80926/Pharma_Mock_1_NEET_PG12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81143,
      "choices": [
        {
          "id": 323252,
          "text": "<p><span style=\"font-size:14.0pt;\">They are separated from adjacent segments by connective tissue septa</span></p>"
        },
        {
          "id": 323253,
          "text": "<p><span style=\"font-size:14.0pt;\">They are the largest subdivisions of a lobe</span></p>"
        },
        {
          "id": 323254,
          "text": "<p><span style=\"font-size:14.0pt;\">They are not resectable</span></p>"
        },
        {
          "id": 323255,
          "text": "<p><span style=\"font-size:14.0pt;\">They are named according to the segmental bronchus supplying them</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements about bronchopulmonary segments<strong>&nbsp;</strong>is<strong>&nbsp;</strong>not<strong>&nbsp;</strong>correct?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3479963",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) They are not resectable</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Bronchopulmonary segments are functionally and anatomically discrete units of the lung. Each segment is:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Supplied by its own segmental (tertiary) bronchus and artery</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Drained by intersegmental pulmonary veins</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Surrounded by connective tissue septa</strong>, which separate it from adjacent segments</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pyramid-shaped</strong>, with the <strong>apex directed toward the lung root</strong> and the <strong>base facing the pleural surface</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Named based on the supplying segmental bronchus</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Most importantly, they are <strong>independently resectable</strong>, meaning a surgeon can remove a diseased segment without affecting others.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This makes them clinically important in segmental lung resections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>bronchopulmonary segment</strong> is the <strong>largest resectable unit</strong> of the lung, each supplied by its own <strong>segmental bronchus and artery</strong>, separated by connective tissue, and shaped like a pyramid.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Because of these features, individual segments can be surgically removed in localized disease.</span></li></ul>",
      "correct_choice_id": 323254,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81143/NEET_PG_Mock_1_Q8_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81143/NEET_PG_Mock_1_Q8_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81113,
      "choices": [
        {
          "id": 323132,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and the Reason is the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 323133,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but the Reason is not the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 323134,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true, but Reason is false</span></p>"
        },
        {
          "id": 323135,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is false, but Reason is true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\"><strong>Assertion (A):</strong> Human herpesvirus-8 (HHV-8) is associated with Kaposi sarcoma, primary effusion lymphoma, and Castleman disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason (R):</strong> T-cell leukemia is caused by Human T-cell leukemia virus type 1 (HTLV-1).</span></p>",
      "unique_key": "Q3995589",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Both Assertion and Reason are true, but the Reason is not the correct explanation of the Assertion.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Assertion is true:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>HHV-8 (Human herpesvirus-8)</strong> is a <strong>gamma herpesvirus</strong> linked to the development of:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Kaposi sarcoma</strong>, particularly in <strong>HIV/AIDS patients</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Primary effusion lymphoma</strong>, a rare type of <strong>non-Hodgkin lymphoma</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Multicentric Castleman disease</strong>, a lymphoproliferative disorder</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason is also true:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>HTLV-1 (Human T-cell leukemia/lymphoma virus type 1)</strong> is a <strong>retrovirus</strong> that causes <strong>adult T-cell leukemia/lymphoma (ATLL)</strong>, an aggressive malignancy of CD4+ T cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">However, the <strong>Reason does not explain the Assertion</strong>, as <strong>HTLV-1 and HHV-8 are unrelated viruses</strong> affecting <strong>different cell types and diseases</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">HHV-8 is associated with Kaposi sarcoma, primary effusion lymphoma, and Castleman disease, while HTLV-1 causes adult T-cell leukemia/lymphoma, but they are distinct viruses with unrelated disease mechanisms.</span></p>",
      "correct_choice_id": 323133,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81113/Microbiology_NEET_PG_Mock_Q6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81113/Microbiology_NEET_PG_Mock_Q6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81151,
      "choices": [
        {
          "id": 323284,
          "text": "<p><span style=\"font-size:14.0pt;\">Exocytosis is a Ca²⁺-dependent process</span></p>"
        },
        {
          "id": 323285,
          "text": "<p><span style=\"font-size:14.0pt;\">Phagocytosis is an example of endocytosis</span></p>"
        },
        {
          "id": 323286,
          "text": "<p><span style=\"font-size:14.0pt;\">Facilitated diffusion is when carrier proteins move substances against their chemical gradient</span></p>"
        },
        {
          "id": 323287,
          "text": "<p><span style=\"font-size:14.0pt;\">Aquaporins are ion channels selective for transporting water molecules</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding transport across cell membranes is incorrect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1748344",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Facilitated diffusion is when carrier proteins move substances against their chemical gradient</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Facilitated diffusion</strong> is a <strong>passive transport</strong> process where substances move <strong>along</strong> (not against) their chemical or concentration gradient with the help of specific carrier or channel proteins.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>No ATP is required</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Exocytosis is a Ca²⁺-dependent process:&nbsp;</strong>Correct. Exocytosis, such as neurotransmitter release, is a <strong>Ca²⁺-dependent process</strong>, where an increase in intracellular calcium triggers vesicle fusion with the plasma membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Phagocytosis is an example of endocytosis: </strong>Correct. <strong>Phagocytosis</strong> is a type of <strong>endocytosis</strong> involving engulfment of large particles or microbes by the plasma membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Aquaporins are ion channels selective for transporting water molecules:&nbsp;</strong>Correct. <strong>Aquaporins</strong> are specialized <strong>water channels</strong>, not ion channels, that selectively allow <strong>water molecules</strong> to pass through the membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Facilitated diffusion</strong> involves the passive movement of molecules down their concentration gradient with the help of membrane proteins.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is distinct from <strong>active transport</strong>, which requires energy (e.g., ATP) to move substances <strong>against</strong> their gradient.</span></li></ul>",
      "correct_choice_id": 323286,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81151/Neet_Pg_Mock_1_Q2_Physiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81151/Neet_Pg_Mock_1_Q2_Physiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80914,
      "choices": [
        {
          "id": 322340,
          "text": "<p><span style=\"font-size:14.0pt;\">Cefepime</span></p>"
        },
        {
          "id": 322341,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceftobiprole</span></p>"
        },
        {
          "id": 322342,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceftazidime</span></p>"
        },
        {
          "id": 322343,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceftriaxone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man is admitted to the hospital with fever, productive cough, and shortness of breath. Chest X-ray shows bilateral infiltrates. Blood cultures are pending, and sputum Gram stain reveals gram-positive cocci in clusters. Given the high suspicion of methicillin-resistant Staphylococcus aureus (MRSA) pneumonia, the attending physician considers starting a broad-spectrum beta-lactam antibiotic with activity against MRSA. Which of the following agents would be the most appropriate choice?</span></p>",
      "unique_key": "Q1502380",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ceftobiprole</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ceftobiprole</strong> is a <strong>fifth-generation cephalosporin</strong> with <strong>broad-spectrum activity</strong>, including <strong>methicillin-resistant Staphylococcus aureus (MRSA)</strong> and <strong>penicillin-resistant Streptococcus pneumoniae</strong>, along with <strong>gram-negative coverage</strong>, including Pseudomonas aeruginosa.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is approved in some regions (e.g., Europe) for <strong>hospital-acquired pneumonia (HAP)</strong> and <strong>community-acquired pneumonia (CAP)</strong>, excluding ventilator-associated pneumonia.</span></li><li><span style=\"font-size:14.0pt;\">Unlike earlier-generation cephalosporins, <strong>ceftobiprole binds to PBP2a</strong>, the penicillin-binding protein responsible for methicillin resistance in MRSA, making it one of the few beta-lactams effective against this organism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cefepime:&nbsp;</strong>A fourth-generation cephalosporin with excellent gram-negative coverage including Pseudomonas but <strong>lacks activity against MRSA</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ceftazidime:</strong> A third-generation cephalosporin with <strong>strong antipseudomonal activity</strong> but <strong>limited gram-positive activity</strong> and <strong>no MRSA coverage</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ceftriaxone:</strong> A widely used third-generation cephalosporin effective against many gram-positive and gram-negative bacteria, but <strong>ineffective against MRSA</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ceftobiprole is a fifth-generation cephalosporin with broad-spectrum activity including MRSA and should be considered when beta-lactam therapy is desired in suspected MRSA infections.</span></p>",
      "correct_choice_id": 322341,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80914/Pharma_Mock_1_NEET_PG6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80914/Pharma_Mock_1_NEET_PG6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81125,
      "choices": [
        {
          "id": 323180,
          "text": "<p><span style=\"font-size:14.0pt;\">The prescribed Clofazimine dose is appropriate, but both Dapsone and Rifampicin doses are higher than recommended for a child</span></p>"
        },
        {
          "id": 323181,
          "text": "<p><span style=\"font-size:14.0pt;\">The patient is receiving a correct regimen as per the revised pediatric MB guidelines</span></p>"
        },
        {
          "id": 323182,
          "text": "<p><span style=\"font-size:14.0pt;\">The Rifampicin and Clofazimine doses are excessive for a child, but Dapsone is appropriately dosed</span></p>"
        },
        {
          "id": 323183,
          "text": "<p><span style=\"font-size:14.0pt;\">All three drugs are overdosed compared to the pediatric MB leprosy regimen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy is diagnosed with multibacillary (MB) leprosy. He is initiated on WHO-recommended multidrug therapy. After 6 months of regular treatment, his family moves to a different state where he is seen by another physician unfamiliar with the revised pediatric dosing schedule. The physician prescribes Clofazimine 150 mg once a month and 50 mg on alternate day, and Rifampicin 600 mg monthly, along with Dapsone 100 mg daily. Which of the following statements is most accurate regarding this modified regimen?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9219180",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) The prescribed Clofazimine dose is appropriate, but both Dapsone and Rifampicin doses are higher than recommended for a child.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">According to the <strong>Revised National Leprosy Eradication Programme (NLEP) guidelines</strong>, for a <strong>child aged 9–14 years</strong> with <strong>multibacillary (MB) leprosy</strong>, the <strong>correct monthly and daily doses</strong> are:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Dapsone</strong>: <strong>50 mg daily</strong> (not 100 mg as in the adult dose)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clofazimine</strong>: <strong>150 mg once a month</strong> &amp; <strong>50 mg on alternate days</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Rifampicin</strong>: <strong>450 mg once a month</strong> (not 600 mg as in adults)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In the given scenario:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Dapsone 100 mg daily</strong> and <strong>Rifampicin 600 mg monthly</strong> clearly reflect <strong>adult dosing</strong>, which <strong>exceeds the recommended pediatric dosing</strong> and may increase risk of adverse effects like anemia and hepatotoxicity.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In pediatric patients (aged 9–14 years) with <strong>multibacillary leprosy</strong>, appropriate drug dosages must be used to avoid toxicity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adult doses of Dapsone and Rifampicin should not be used in children</strong>, while <strong>Clofazimine requires adjusted monthly and alternate-day dosing</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uzMvqOj.png\" width=\"1230\" height=\"708\"></span></p>",
      "correct_choice_id": 323180,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81125/Dermatology_Mock_1_Q3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81125/Dermatology_Mock_1_Q3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81008,
      "choices": [
        {
          "id": 322716,
          "text": "<p><span style=\"font-size:14.0pt;\">Campylobacter jejuni</span></p>"
        },
        {
          "id": 322717,
          "text": "<p><span style=\"font-size:14.0pt;\">Clostridium difficile</span></p>"
        },
        {
          "id": 322718,
          "text": "<p><span style=\"font-size:14.0pt;\">Escherichia coli</span></p>"
        },
        {
          "id": 322719,
          "text": "<p><span style=\"font-size:14.0pt;\">Shigella flexneri</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man presents with right knee swelling and dactylitis three weeks after a diarrheal illness. He also reports dysuria. Several children at his workplace had similar GI symptoms. What is the most likely causative pathogen?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3464819",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Shigella flexneri</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Reactive arthritis commonly follows infections with Shigella, Yersinia, Chlamydia, or Salmonella.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Dactylitis, arthritis, and post-GI symptoms support the diagnosis. Shigella is a common trigger in post-enteric cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Campylobacter jejuni:</strong> Can cause reactive arthritis, but less frequently.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Clostridium difficile:&nbsp;</strong>Not a common trigger.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Escherichia coli</strong>: Rare cause of reactive arthritis. It produce classic HUS (Hemolytic uremic syndrome).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Reactive arthritis classically follows enteric infections like Shigella flexneri and features arthritis, dactylitis, and mucocutaneous involvement.</span></p>",
      "correct_choice_id": 322719,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81008/NEET_MOCK_-_1_Question_-_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81008/NEET_MOCK_-_1_Question_-_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80950,
      "choices": [
        {
          "id": 322484,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaccination with the 9-valent HPV vaccine offers protection against high-risk oncogenic types including 16, 18, 31, 33, 45, 52, and 58.</span></p>"
        },
        {
          "id": 322485,
          "text": "<p><span style=\"font-size:14.0pt;\">If previously infected with one HPV type, vaccination can still offer protection against other vaccine-included types.</span></p>"
        },
        {
          "id": 322486,
          "text": "<p><span style=\"font-size:14.0pt;\">HPV vaccination eliminates the need for routine cervical cancer screening in vaccinated individuals.</span></p>"
        },
        {
          "id": 322487,
          "text": "<p><span style=\"font-size:14.0pt;\">The recommended schedule for HPV vaccination in adults aged 15 years and older is three doses at 0, 1–2, and 6 months.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 23-year-old woman attends a gynecology clinic requesting HPV vaccination. She is sexually active, has had three lifetime partners, and recently tested negative for HPV on a cervical screening test. Regarding the use of HPV vaccines in her case and the broader public health implications, which of the following statements is incorrect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6503515",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) HPV vaccination eliminates the need for routine cervical cancer screening in vaccinated individuals.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Vaccination does not eliminate the need for screening</strong>, as the vaccine does not cover all oncogenic types and is not therapeutic.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Routine cervical cancer screening (e.g., Pap smear or HPV DNA testing) must still be followed per guidelines.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Vaccination with the 9-valent HPV vaccine offers protection against high-risk oncogenic types including 16, 18, 31, 33, 45, 52, and 58:</strong> True. The 9-valent HPV vaccine (Gardasil 9) covers HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. Of these, types 16, 18, 31, 33, 45, 52, and 58 are oncogenic (high-risk).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>If previously infected with one HPV type, vaccination can still offer protection against other vaccine-included types:&nbsp;</strong>True. Even if a person has been infected with one type of HPV, the vaccine can still prevent infection with other types included in the vaccine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>The recommended schedule for HPV vaccination in adults aged 15 years and older is three doses at 0, 1–2, and 6 months:&nbsp;</strong>True. For individuals ≥15 years old at the time of first dose, <strong>three doses</strong> (at 0, 1–2, and 6 months) are recommended for full protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">HPV vaccination is a key preventive strategy against cervical and other anogenital cancers caused by oncogenic HPV types.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While highly effective, it does <strong>not negate the need for cervical screening</strong>, as it does not offer complete protection against all oncogenic strains, and some individuals may already be exposed before vaccination.</span></li></ul>",
      "correct_choice_id": 322486,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80950/OBG_Mock_1_Q12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80950/OBG_Mock_1_Q12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81092,
      "choices": [
        {
          "id": 323048,
          "text": "<p><span style=\"font-size:14.0pt;\">CA-125</span></p>"
        },
        {
          "id": 323049,
          "text": "<p><span style=\"font-size:14.0pt;\">Carcinoembryonic antigen (CEA)</span></p>"
        },
        {
          "id": 323050,
          "text": "<p><span style=\"font-size:14.0pt;\">CA 19-9</span></p>"
        },
        {
          "id": 323051,
          "text": "<p><span style=\"font-size:14.0pt;\">Alpha-fetoprotein (AFP)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old man is evaluated for progressive yellowing of the skin, unintended weight loss, and dull epigastric discomfort that has persisted for several weeks. On examination, he is found to have scleral icterus and a palpable, non-tender gallbladder. Laboratory studies reveal elevated total bilirubin and alkaline phosphatase. Cross-sectional abdominal imaging demonstrates a mass at the head of the pancreas causing obstruction of the common bile duct. A tumor marker assay is obtained to support the suspected diagnosis. Which of the following markers is most likely to be elevated in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4773252",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) CA 19-9</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient presents with classic features of <strong>pancreatic head adenocarcinoma</strong>, which include <strong>weight loss</strong>, <strong>painless jaundice</strong>, <strong>elevated bilirubin</strong>, and a <strong>palpable gallbladder</strong> (Courvoisier’s sign).</span></li><li><span style=\"font-size:14.0pt;\"><strong>CA 19-9 (carbohydrate antigen 19-9)</strong> is the most frequently elevated <strong>tumor marker</strong> associated with <strong>pancreatic adenocarcinoma</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is especially elevated in tumors of the <strong>head of the pancreas</strong>, where it is often used not just for diagnosis but also to monitor <strong>treatment response</strong> and <strong>recurrence</strong>.</span></li><li><span style=\"font-size:14.0pt;\">While not diagnostic on its own, its elevated levels in the appropriate clinical setting strongly support the diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. CA-125: </strong>Incorrect. CA-125 is primarily a tumor marker used in <strong>epithelial ovarian cancer</strong>. It has no specific relevance to <strong>pancreatic cancer</strong>, and it is not typically elevated in tumors of the pancreas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Carcinoembryonic antigen (CEA):&nbsp;</strong>Incorrect. Although CEA can be mildly elevated in <strong>pancreatic, colorectal</strong>, and other <strong>gastrointestinal malignancies</strong>, it is <strong>less specific and sensitive</strong> than CA 19-9 for pancreatic cancer and is not the preferred marker in this setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Alpha-fetoprotein (AFP):</strong> Incorrect. AFP is a tumor marker associated with <strong>hepatocellular carcinoma</strong> and <strong>nonseminomatous germ cell tumors</strong>, particularly <strong>yolk sac tumors</strong>. It does <strong>not</strong> play a diagnostic role in <strong>pancreatic malignancy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">CA 19-9 is the most relevant and commonly elevated tumor marker in pancreatic adenocarcinoma, especially when the tumor arises in the head of the pancreas and causes obstructive jaundice.</span></p>",
      "correct_choice_id": 323050,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81092/NEET_PG_Mock_1_Q14_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81092/NEET_PG_Mock_1_Q14_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80966,
      "choices": [
        {
          "id": 322548,
          "text": "<p><span style=\"font-size:14.0pt;\">Metformin-associated lactic acidosis</span></p>"
        },
        {
          "id": 322549,
          "text": "<p><span style=\"font-size:14.0pt;\">Euglycemic diabetic ketoacidosis due to SGLT2 inhibitor</span></p>"
        },
        {
          "id": 322550,
          "text": "<p><span style=\"font-size:14.0pt;\">Starvation ketosis</span></p>"
        },
        {
          "id": 322551,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperosmolar hyperglycemic state</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old woman with type 2 diabetes mellitus presents with nausea, abdominal discomfort, and malaise for the past two days. She has no fever, and her blood glucose level is 160 mg/dL. Her medications include metformin and empagliflozin, which she started 3 weeks ago. Laboratory results show:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Serum bicarbonate: 14 mEq/L&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Arterial pH: 7.28&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Serum ketones: positive&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Anion gap: elevated&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Blood glucose: 162 mg/dL&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is the most likely explanation for her metabolic disturbance?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3895595",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Euglycemic diabetic ketoacidosis due to SGLT2 inhibitor</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">SGLT2 inhibitors (like&nbsp;<strong>empagliflozin</strong>) promote urinary glucose loss, leading to&nbsp;<strong>normal or only mildly elevated blood glucose</strong>&nbsp;levels.</span></li><li><span style=\"font-size:14.0pt;\">They also reduce insulin levels and increase glucagon, promoting&nbsp;<strong>lipolysis and ketogenesis</strong>, increasing risk for&nbsp;<strong>euglycemic DKA</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Classically presents with&nbsp;<strong>nausea, vomiting, abdominal pain</strong>,&nbsp;<strong>mild hyperglycemia</strong>,&nbsp;<strong>ketosis</strong>, and&nbsp;<strong>high anion gap metabolic acidosis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Metformin-associated lactic acidosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Typically presents with&nbsp;<strong>high anion gap metabolic acidosis</strong>, but&nbsp;<strong>lactate</strong>&nbsp;is elevated, and&nbsp;<strong>ketones are absent</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Glucose levels are not usually elevated, and GI symptoms may mimic this case.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Not correct here</strong>&nbsp;due to&nbsp;<strong>presence of ketones</strong>, making DKA more likely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Starvation ketosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">May present with ketonemia but&nbsp;<strong>rarely causes significant acidosis (pH usually &gt;7.3)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Bicarbonate is only mildly low, and anion gap is not as significantly elevated.</span></li><li><span style=\"font-size:14.0pt;\">Less likely in a type 2 diabetic on medications with normal caloric intake.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hyperosmolar hyperglycemic state (HHS):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Presents with&nbsp;<strong>very high glucose (&gt;600 mg/dL)</strong>,&nbsp;<strong>altered mental status</strong>, and&nbsp;<strong>dehydration</strong>, but&nbsp;<strong>no significant ketosis or acidosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Not consistent</strong>&nbsp;with this patient's normal glucose and presence of acidosis with ketones.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>SGLT2 inhibitors</strong>&nbsp;(e.g., canagliflozin, dapagliflozin, empagliflozin) are associated with&nbsp;<strong>euglycemic DKA</strong>, especially in settings of&nbsp;<strong>illness, fasting, surgery, or low insulin states</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Always consider this diagnosis when a patient on these agents presents with&nbsp;<strong>acidosis and ketones despite normal glucose levels</strong>.</span></li></ul>",
      "correct_choice_id": 322549,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80966/Pharma_Mock_1_NEET_PG19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80966/Pharma_Mock_1_NEET_PG19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80969,
      "choices": [
        {
          "id": 322560,
          "text": "<p><span style=\"font-size:14.0pt;\">Angiotensin receptor blockers</span></p>"
        },
        {
          "id": 322561,
          "text": "<p><span style=\"font-size:14.0pt;\">Phosphodiesterase-5 inhibitors</span></p>"
        },
        {
          "id": 322562,
          "text": "<p><span style=\"font-size:14.0pt;\">Sodium-potassium-ATPase inhibitors</span></p>"
        },
        {
          "id": 322563,
          "text": "<p><span style=\"font-size:14.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old man with uncontrolled hypertension and type 2 diabetes presents with increasing breathlessness, orthopnea, and bilateral leg swelling. Examination reveals elevated JVP and a fourth heart sound. Echocardiogram shows an ejection fraction of 55% and left atrial enlargement. Which of the following treatments has shown mortality benefit in such patients?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5602460",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) None of the above</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">There is no evidence of mortality benefit from any pharmacologic agent in heart failure with preserved ejection fraction (HFpEF).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Management centers on symptom control and treatment of comorbidities such as hypertension, diabetes, and atrial fibrillation.</span></li><li><span style=\"font-size:14.0pt;\">Drugs which reduce heart failure in patients with HfpEF</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">SGLT2 inhibitors&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Mineralocorticoid receptor antagonist (Spironolactone)</span></li><li><span style=\"font-size:14.0pt;\">GLP1 receptor agonists (Semaglutide) and Dual GIP and GLP-1 receptor agonist (Tirzepatide)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Angiotensin receptor blockers (ARBs):&nbsp;</strong>Studied in CHARM-Preserved trial, no mortality benefit.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Phosphodiesterase-5 inhibitors (PDE-5 inhibitors)</strong>: Limited data may reduce filling pressures but no outcome benefit.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C. Sodium-potassium-ATPase inhibitors:&nbsp;</strong>Na⁺/K⁺ ATPase inhibitors (e.g., digoxin) – Failed to reduce mortality in HFpEF.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Management of HFpEF focuses on volume and blood pressure control, no drug has been shown to improve survival.</span></p>",
      "correct_choice_id": 322563,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80969/Neet_Mock_-_1_Question_-_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80969/Neet_Mock_-_1_Question_-_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80908,
      "choices": [
        {
          "id": 322316,
          "text": "<p><span style=\"font-size:14.0pt;\">Peramivir</span></p>"
        },
        {
          "id": 322317,
          "text": "<p><span style=\"font-size:14.0pt;\">Oseltamivir</span></p>"
        },
        {
          "id": 322318,
          "text": "<p><span style=\"font-size:14.0pt;\">Zanamivir</span></p>"
        },
        {
          "id": 322319,
          "text": "<p><span style=\"font-size:14.0pt;\">Amantadine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old man with a longstanding history of moderate persistent asthma is being considered for antiviral prophylaxis after a recent exposure to a confirmed case of influenza A. He has been stable on inhaled corticosteroids and long-acting beta-agonists, but he has a history of bronchospasm triggered by inhaled medications. Which of the following antivirals should be avoided in this patient due to its delivery method and potential adverse effect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7491011",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Zanamivir</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Zanamivir</strong> is an <strong>inhaled neuraminidase inhibitor</strong> used in the <strong>treatment and prevention of influenza A and B</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is administered via a <strong>dry powder inhaler</strong>. In patients with <strong>asthma or chronic obstructive pulmonary disease (COPD)</strong>, inhaled zanamivir can <strong>trigger bronchospasm</strong>, a potentially life-threatening condition in individuals with reactive airways.</span></li><li><span style=\"font-size:14.0pt;\">Due to this <strong>bronchospasm risk</strong>, <strong>zanamivir is contraindicated in patients with underlying asthma</strong> or should be used with extreme caution only when the potential benefits outweigh the risk.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This route of administration is especially critical in a patient who is predisposed to airway reactivity, such as the asthmatic individual described in the scenario.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Peramivir:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Peramivir is administered intravenously and is generally reserved for the treatment (not prophylaxis) of influenza.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Since it is not inhaled and does not carry a risk of inducing bronchospasm, it is considered safe for use in patients with asthma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Oseltamivir:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Oseltamivir&nbsp;is taken orally and is approved for both the treatment and prophylaxis of influenza A and B.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does not have any significant risk of causing bronchospasm and is widely used in patients with asthma without concern for respiratory side effects.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Amantadine:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Amantadine is an oral antiviral that was historically used for influenza A, though its use has declined significantly due to widespread resistance.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It does not cause bronchospasm and is not contraindicated in asthma, though it is no longer a first-line antiviral option.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Zanamivir is an inhaled neuraminidase inhibitor that can induce bronchospasm and must be avoided in patients with asthma or chronic obstructive pulmonary disease.</span></p>",
      "correct_choice_id": 322318,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80908/Pharma_Mock_1_NEET_PG3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80908/Pharma_Mock_1_NEET_PG3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80978,
      "choices": [
        {
          "id": 322596,
          "text": "<p><span style=\"font-size:14.0pt;\">Emphasizing religious undertones in health care delivery</span></p>"
        },
        {
          "id": 322597,
          "text": "<p><span style=\"font-size:14.0pt;\">Shifting focus from curative to purely preventive health services</span></p>"
        },
        {
          "id": 322598,
          "text": "<p><span style=\"font-size:14.0pt;\">Making the centers more culturally relatable and accessible at the community level</span></p>"
        },
        {
          "id": 322599,
          "text": "<p><span style=\"font-size:14.0pt;\">Redirecting funding away from primary healthcare to spiritual healing centers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old medical officer is briefing new community health workers during the rollout of revised Ayushman Bharat services in a rural block. He explains that all existing Health and Wellness Centres (HWCs) are now renamed as \"Ayushman Arogya Mandir\". What is the most likely policy-driven outcome of changing the name from “Health and Wellness Centre” to “Arogya Mandir”?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2781589",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Making the centers more culturally relatable and accessible at the community level</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The renaming of <strong>Ayushman Bharat Health and Wellness Centres (AB-HWCs)</strong> to <strong>“Ayushman Arogya Mandir”</strong> with the tagline <strong>“Arogyam Paramam Dhanam”</strong> (Health is the Supreme Wealth) is a <strong>strategic move</strong> aimed at <strong>deepening cultural resonance</strong> with the Indian population, especially in rural and underserved areas.</span></li><li><span style=\"font-size:14.0pt;\">The use of the word <strong>“Mandir”</strong>, which translates to <strong>“temple”</strong>, invokes a sense of trust, familiarity, reverence, and accessibility—terms that often do not accompany clinical, bureaucratic labels like “centre” or “facility.” The change aligns with the public health goal of:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Promoting healthcare-seeking behavior</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Strengthening community ownership</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Reinforcing primary care as a sacred, reliable, and compassionate space</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This initiative also supports <strong>public health communication</strong>, making the health facility a symbolic center for <strong>well-being</strong>, not just disease treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Emphasizing religious undertones in health care delivery:</strong> Incorrect. The name “Arogya Mandir” does <strong>not aim to religiously brand</strong> health services. The term “Mandir” is used <strong>culturally</strong>, not theologically, to create emotional trust and enhance <strong>community connect</strong>, particularly in areas with high traditional beliefs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Shifting focus from curative to purely preventive health services:</strong> Incorrect. The AB-HWC model and Arogya Mandir continue to offer <strong>both preventive and curative care</strong>. There is no policy to exclude treatment services; instead, there's an integration of <strong>health promotion, disease prevention, diagnosis, and treatment</strong> under one roof.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Redirecting funding away from primary healthcare to spiritual healing centers:</strong> Incorrect. The renaming <strong>does not imply any shift in funding</strong> towards spiritual or non-allopathic practices. The initiative remains grounded in <strong>evidence-based, allopathic primary healthcare</strong> within the public health system.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The renaming of AB-HWCs to <strong>Ayushman Arogya Mandirs</strong> is a <strong>policy-level communication strategy</strong> designed to improve <strong>community acceptance, emotional connection</strong>, and <strong>utilization of primary healthcare services</strong>, particularly in culturally rooted rural populations.</span></p>",
      "correct_choice_id": 322598,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80978/PSM_Mock_1_Q18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80978/PSM_Mock_1_Q18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80918,
      "choices": [
        {
          "id": 322356,
          "text": "<p><span style=\"font-size:14.0pt;\">Area under the curve (AUC)</span></p>"
        },
        {
          "id": 322357,
          "text": "<p><span style=\"font-size:14.0pt;\">Maximum plasma concentration (C-max)</span></p>"
        },
        {
          "id": 322358,
          "text": "<p><span style=\"font-size:14.0pt;\">Time to reach peak plasma concentration (T-max)</span></p>"
        },
        {
          "id": 322359,
          "text": "<p><span style=\"font-size:14.0pt;\">Bioavailability index</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old patient is being started on a new oral antihypertensive agent. As part of pharmacokinetic profiling, a plasma concentration vs. time graph is reviewed to understand the medication’s absorption characteristics. Which of the following parameters on the graph best represents the rate of absorption of this drug?</span></p>",
      "unique_key": "Q1650959",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Time to reach peak plasma concentration (T-max)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>T-max</strong>, or <strong>Time to reach maximum plasma concentration</strong>, is a key parameter derived from the <strong>concentration-time graph</strong> and serves as a <strong>marker for the rate of drug absorption</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>shorter T-max</strong> implies <strong>faster absorption</strong>, while a <strong>longer T-max</strong> suggests slower absorption.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Although it does not provide the exact numeric value of the rate, it reflects how quickly a drug reaches systemic circulation at its peak concentration, hence correlating with absorption rate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Area under the curve (AUC)</strong>: AUC represents the <strong>overall exposure of the drug</strong> over time and is primarily used to calculate <strong>bioavailability</strong> and <strong>clearance</strong>, not the rate of absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Maximum plasma concentration (C-max)</strong>: C-max shows the <strong>peak level of drug in plasma</strong> but does <strong>not represent the rate of absorption</strong> directly. A high C-max may indicate greater extent of absorption but not how fast it occurred.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bioavailability index:</strong> This is a <strong>comparative measure</strong> of the extent of absorption when compared to a reference (usually IV), but it does not provide information regarding <strong>absorption rate</strong> or timing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">T-max is the pharmacokinetic parameter that best reflects the rate at which a drug is absorbed from the site of administration into the systemic circulation.</span></p>",
      "correct_choice_id": 322358,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80918/Pharma_Mock_1_NEET_PG9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80918/Pharma_Mock_1_NEET_PG9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80974,
      "choices": [
        {
          "id": 322580,
          "text": "<p><span style=\"font-size:14.0pt;\">Thickening of the retroplacental myometrium</span></p>"
        },
        {
          "id": 322581,
          "text": "<p><span style=\"font-size:14.0pt;\">Disruption of the bladder-uterine serosal interface</span></p>"
        },
        {
          "id": 322582,
          "text": "<p><span style=\"font-size:14.0pt;\">Placental lacunae</span></p>"
        },
        {
          "id": 322583,
          "text": "<p><span style=\"font-size:14.0pt;\">Bridging vessels from the placenta to the bladder-serosal interface</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old G2P1 woman with a history of previous lower segment cesarean section presents at 30 weeks of gestation with painless vaginal bleeding. Transabdominal and transvaginal ultrasound with color Doppler is performed and shows the findings in the image. Which of the following findings is not typically seen in placenta accreta?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105658.jpg\" width=\"601\" height=\"480\"></span></p>",
      "unique_key": "Q3832871",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Thickening of the retroplacental myometrium</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Placenta accreta spectrum (PAS) refers to abnormal adherence of the placenta to the myometrium due to defective decidua basalis. It is commonly associated with previous uterine surgery (e.g., LSCS, curettage) and placenta previa. Ultrasound with color Doppler is the primary modality for antenatal diagnosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ultrasound Features Suggestive of Placenta Accreta:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Placental lacunae</strong> – Irregular vascular spaces within the placenta giving a “Swiss cheese” appearance; highly specific.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Thinning or absence of the retroplacental myometrium</strong> – Typically &lt;1 mm, indicating invasion into the myometrium.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Disruption of the bladder-uterine serosal interface</strong> – Suggests deep invasion into the bladder wall (especially in percreta).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bridging vessels</strong> – Vessels seen traversing from the placenta across the myometrium into adjacent structures, particularly the bladder.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Placental bulge</strong> – Focal outward contour bulge of the placenta or uterus due to invasive growth.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In contrast, <strong>thickening</strong> of the retroplacental myometrium is not characteristic of PAS and would rather suggest normal or non-invasive placentation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Disruption of the bladder-uterine serosal interface:&nbsp;</strong>Disruption of the bladder-uterine serosa is a sign of placental percreta (the most severe form of PAS) with invasion into adjacent organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Placental lacunae:&nbsp;</strong>Presence of placental lacunae is a classic hallmark and among the earliest sonographic signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Bridging vessels from the placenta to the bladder-serosal interface:&nbsp;</strong>Bridging vessels are seen on color Doppler and are highly specific for PAS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Placenta accreta spectrum disorders are characterized by abnormal placental adherence or invasion into the myometrium.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Ultrasound findings such as placental lacunae, thinning of the retroplacental zone, bridging vessels, and disruption of the bladder-uterine interface are diagnostic clues.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thickening of the retroplacental myometrium is not a feature of PAS. Early identification is crucial for peripartum planning and reducing maternal morbidity.</span></li></ul>",
      "correct_choice_id": 322580,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80974/OBG_Mock_1_Q18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80974/OBG_Mock_1_Q18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80938,
      "choices": [
        {
          "id": 322436,
          "text": "<p><span style=\"font-size:14.0pt;\">March 17th</span></p>"
        },
        {
          "id": 322437,
          "text": "<p><span style=\"font-size:14.0pt;\">March 22nd</span></p>"
        },
        {
          "id": 322438,
          "text": "<p><span style=\"font-size:14.0pt;\">March 13th</span></p>"
        },
        {
          "id": 322439,
          "text": "<p><span style=\"font-size:14.0pt;\">March 21st</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-week primigravida had her LMP on June 10th and had regular 32-day cycles prior to that. What would her EDD be?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7935741",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) March 21st</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The Expected Date of Delivery (EDD) is calculated using <strong>Naegele’s Rule</strong>, which assumes a 28-day cycle. Adjustments are made for cycle lengths that differ from 28 days:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Naegele’s Formula for 28-day cycles</strong>: LMP + 9 months + 7 days</span><br><span style=\"font-size:14.0pt;\">For an LMP of June 10th:</span><br><span style=\"font-size:14.0pt;\">June 10 + 9 months = March 10</span><br><span style=\"font-size:14.0pt;\">March 10 + 7 days = March 17</span></li><li><span style=\"font-size:14.0pt;\"><strong>Adjustment for a 32-day cycle</strong>:</span><br><span style=\"font-size:14.0pt;\">Since the cycle is 4 days longer than 28 days, we add 4 days to the EDD calculated above.</span><br><span style=\"font-size:14.0pt;\">March 17 + 4 days = <strong>March 21st</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, the corrected EDD for this patient is <strong>March 21st</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Use <strong>Naegele’s Rule</strong> to calculate EDD for a standard 28-day cycle, and adjust for longer or shorter cycles by adding or subtracting the difference in cycle days.</span></p>",
      "correct_choice_id": 322439,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80938/OBG_Mock_1_Q7_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80938/OBG_Mock_1_Q7_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80975,
      "choices": [
        {
          "id": 322584,
          "text": "<p><span style=\"font-size:14.0pt;\">The dose is sufficient; maximum requirement is 20 IU/kg</span></p>"
        },
        {
          "id": 322585,
          "text": "<p><span style=\"font-size:14.0pt;\">This is a suboptimal dose; patient needs 3000 IU of eRIG</span></p>"
        },
        {
          "id": 322586,
          "text": "<p><span style=\"font-size:14.0pt;\">No RIG is required if the bite is on the foot</span></p>"
        },
        {
          "id": 322587,
          "text": "<p><span style=\"font-size:14.0pt;\">A partial dose can be used only if vaccine is withheld</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-kg adult male presents to the emergency department with a Category III dog bite, characterized by multiple deep bites to the thigh. The hospital has access only to equine rabies immunoglobulin (eRIG), and 1500 IU is currently available for administration. Which of the following is the most appropriate interpretation of this case?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4111962",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) This is a suboptimal dose; patient needs 3000 IU of eRIG</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The recommended dose of <strong>eRIG</strong> is <strong>40 IU/kg body weight </strong>and HRIG is 20 IU/Kg</span></li><li><span style=\"font-size:14.0pt;\">For a 60-kg adult:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>60 kg × 40 IU = 2400 IU (minimum requirement) up to 3000 IU may be used</strong>, especially when wound size or infiltration volume is large.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Since only <strong>1500 IU</strong> is available, the dose is clearly <strong>insufficient</strong> for optimal infiltration.</span></li><li><span style=\"font-size:14.0pt;\">In such cases, <strong>limited RIG should be infiltrated into and around the wound</strong>, and <strong>rabies vaccination must still be given immediately</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>The dose is sufficient; maximum requirement is 20 IU/kg:&nbsp;</strong>Incorrect. <strong>20 IU/kg</strong> is the dose for <strong>human RIG (hRIG)</strong>, not eRIG. eRIG requires <strong>40 IU/kg</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. No RIG is required if the bite is on the foot:&nbsp;</strong>Incorrect. RIG is required regardless of <strong>wound site</strong> in Category III exposure; foot bites are still significant.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. A partial dose can be used only if vaccine is withheld:</strong> Incorrect. RIG is <strong>never withheld due to dose constraints</strong>, and <strong>vaccine should never be delayed or withheld</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For <strong>Category III rabies exposures</strong>, administer <strong>RIG at 40 IU/kg for eRIG</strong>. If limited RIG is available, infiltrate as much as possible into the wound and initiate the <strong>rabies vaccine series without delay</strong>.</span></p>",
      "correct_choice_id": 322585,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80975/PSM_Mock_1_Q17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80975/PSM_Mock_1_Q17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81152,
      "choices": [
        {
          "id": 323288,
          "text": "<p><span style=\"font-size:14.0pt;\">10 millivolts hyperpolarization</span></p>"
        },
        {
          "id": 323289,
          "text": "<p><span style=\"font-size:14.0pt;\">122 millivolts depolarization</span></p>"
        },
        {
          "id": 323290,
          "text": "<p><span style=\"font-size:14.0pt;\">61 millivolts depolarization</span></p>"
        },
        {
          "id": 323291,
          "text": "<p><span style=\"font-size:14.0pt;\">61 millivolts hyperpolarization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A cell is permeable only to potassium ions. The intracellular K⁺ concentration is 140 mEq/L, and the extracellular K⁺ concentration is initially 14 mEq/L. What change in membrane potential would be expected if the extracellular K⁺ concentration is reduced from 14 to 1.4 mEq/L?</span></p>",
      "unique_key": "Q1832043",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) 61 millivolts hyperpolarization</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To solve this, we apply the <strong>Nernst equation</strong>, which describes the equilibrium (Nernst) potential for a particular ion:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Doc35.jpg\" width=\"1133\" height=\"1170\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">When extracellular potassium concentration decreases, potassium moves out of the cell, making the inside more negative.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This results in hyperpolarization. A 10-fold decrease in [K⁺]<sub>outside&nbsp;</sub>causes a 61mV hyperpolarization according to the Nernst equation</span></li></ul>",
      "correct_choice_id": 323291,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81152/Neet_Pg_Mock_1_Q3_Physiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81152/Neet_Pg_Mock_1_Q3_Physiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81156,
      "choices": [
        {
          "id": 323304,
          "text": "<p><span style=\"font-size:14.0pt;\">300 ml/min</span></p>"
        },
        {
          "id": 323305,
          "text": "<p><span style=\"font-size:14.0pt;\">1600 ml/min</span></p>"
        },
        {
          "id": 323306,
          "text": "<p><span style=\"font-size:14.0pt;\">25,600 ml/min</span></p>"
        },
        {
          "id": 323307,
          "text": "<p><span style=\"font-size:14.0pt;\">16,000 ml/min</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Under control conditions, flow through a blood vessel is 100 ml/min under a pressure gradient of 50 mm Hg. What would be the approximate flow through the vessel after increasing the vessel diameter to four times normal, assuming that the pressure gradient remains constant at 50 mm Hg?&nbsp;</span></p>",
      "unique_key": "Q5178995",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 25,600 ml/min</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>To solve this, we apply&nbsp;</strong>Poiseuille’s Law<strong>, which describes laminar flow of fluid through a cylindrical vessel:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_p6uLWOF.png\" width=\"295\" height=\"126\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Where:</span><ul><li><span style=\"font-size:14.0pt;\">Q = flow</span></li><li><span style=\"font-size:14.0pt;\">ΔP = pressure gradient</span></li><li><span style=\"font-size:14.0pt;\">r = radius of the vessel</span></li><li><span style=\"font-size:14.0pt;\">η = viscosity of the fluid</span></li><li><span style=\"font-size:14.0pt;\">L = length of the vessel</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Key point:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Flow is directly proportional to the <strong>fourth power of the radius</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Step-by-Step Calculation:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Initial flow: 100 ml/min</span></li><li><span style=\"font-size:14.0pt;\">New radius = 4 × original</span></li><li><span style=\"font-size:14.0pt;\">Flow increases by a factor of&nbsp;</span></li></ul></li></ul><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fPKKWxq.png\" width=\"179\" height=\"69\"></span></p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tS7z1Ug.png\" width=\"683\" height=\"91\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to <strong>Poiseuille’s law</strong>, blood flow through a vessel is <strong>proportional to the fourth power of the radius</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A <strong>4-fold increase in vessel radius</strong> results in a <strong>256-fold increase in flow</strong>, assuming pressure and other factors remain constant.</span></li></ul>",
      "correct_choice_id": 323306,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81156/Neet_Pg_Mock_1_Q7_Physiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81156/Neet_Pg_Mock_1_Q7_Physiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81029,
      "choices": [
        {
          "id": 322800,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteomyelitis</span></p>"
        },
        {
          "id": 322801,
          "text": "<p><span style=\"font-size:14.0pt;\">Growth disturbance</span></p>"
        },
        {
          "id": 322802,
          "text": "<p><span style=\"font-size:14.0pt;\">Ligament tear</span></p>"
        },
        {
          "id": 322803,
          "text": "<p><span style=\"font-size:14.0pt;\">Joint instability</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy presents to the emergency department with pain, swelling, and limited range of motion in his left knee after a fall during a soccer game. X-rays reveal an epiphyseal injury at the distal femur. Which of the following is the most common complication associated with this type of injury in paediatric patients?&nbsp;</span></p>",
      "unique_key": "Q9078234",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;Growth disturbance</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The growth plate (physis) is responsible for longitudinal bone growth.</span></li><li><span style=\"font-size:14.0pt;\">Distal femoral physis contributes significantly (~35%) to leg length — so injuries here are high-risk.</span></li><li><span style=\"font-size:14.0pt;\">Damage can lead to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Premature closure of the growth plate</span></li><li><span style=\"font-size:14.0pt;\">Limb length discrepancy</span></li><li><span style=\"font-size:14.0pt;\">Angular deformities</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This is the most common and significant complication of epiphyseal injuries in children.</span></li><li><span style=\"font-size:14.0pt;\">Growth disturbances are more likely with Salter-Harris type III–V fractures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Osteomyelitis:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Osteomyelitis (bone infection) is more commonly seen in:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Open fractures</span></li><li><span style=\"font-size:14.0pt;\">Hematogenous spread (in younger children)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">It is not a common complication of closed epiphyseal injuries.</span></li><li><span style=\"font-size:14.0pt;\">While possible, especially in the setting of infection or open injury, it is not the most likely complication here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ligament tear:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ligament injuries are more common in adults due to stronger bones and weaker ligaments.</span></li><li><span style=\"font-size:14.0pt;\">In children, growth plates are weaker than ligaments, so trauma often causes physeal fractures instead of ligament tears.</span></li><li><span style=\"font-size:14.0pt;\">A ligament tear is not the most likely consequence of this injury pattern.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Joint instability:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Joint instability could occur if ligaments or joint capsules are damaged, or if the fracture extends into the joint with poor alignment.</span></li><li><span style=\"font-size:14.0pt;\">However, in isolated epiphyseal injuries, especially if properly treated, this is not the most common complication.</span></li><li><span style=\"font-size:14.0pt;\">Again, growth disturbance remains the more frequent and serious long-term risk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In paediatric patients with epiphyseal (growth plate) fractures, especially around the distal femur, the most common and clinically significant complication is growth disturbance.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This is due to potential damage to the physis leading to limb length discrepancy or angular deformities.</span></li></ul>",
      "correct_choice_id": 322801,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81029/NEET_MOCK_-_1_Question_-_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81029/NEET_MOCK_-_1_Question_-_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80945,
      "choices": [
        {
          "id": 322464,
          "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-3, C-2, D-4</span></p>"
        },
        {
          "id": 322465,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-2, C-4, D-1</span></p>"
        },
        {
          "id": 322466,
          "text": "<p><span style=\"font-size:14.0pt;\">A-4, B-2, C-3, D-1</span></p>"
        },
        {
          "id": 322467,
          "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-4, C-1, D-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A (Color of Amniotic Fluid):</span></p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">Green-yellow with flakes</span></li><li><span style=\"font-size:14.0pt;\">Golden color</span></li><li><span style=\"font-size:14.0pt;\">Straw colored</span></li><li><span style=\"font-size:14.0pt;\">Dark brown (tobacco juice)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B (Fetal Condition):</span></p><ol><li><span style=\"font-size:14.0pt;\">Intrauterine demise</span></li><li><span style=\"font-size:14.0pt;\">Rh incompatibility</span></li><li><span style=\"font-size:14.0pt;\">Fetal distress</span></li><li><span style=\"font-size:14.0pt;\">Term Pregnancy&nbsp;</span></li></ol>",
      "unique_key": "Q4806945",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) A-3, B-2, C-4, D-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A-3. Green, yellow with flakes:</strong> Indicates meconium-stained amniotic fluid, a sign of <strong>fetal distress</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B-2. Golden color:</strong> Associated with <strong>Rh incompatibility</strong> due to bilirubin in the fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C-4. Straw colored:</strong> Suggestive of <strong>normal amniotic fluid colour (term pregnancy)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D-1. Dark brown:</strong> Indicates <strong>intrauterine demise</strong> due to breakdown of blood and tissue in prolonged fetal death.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105231.jpg\" width=\"1172\" height=\"567\"></strong></span></p>",
      "correct_choice_id": 322465,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80945/OBG_Mock_1_Q8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80945/OBG_Mock_1_Q8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81134,
      "choices": [
        {
          "id": 323216,
          "text": "<p><span style=\"font-size:14.0pt;\">Retinal detachment</span></p>"
        },
        {
          "id": 323217,
          "text": "<p><span style=\"font-size:14.0pt;\">Macular degeneration</span></p>"
        },
        {
          "id": 323218,
          "text": "<p><span style=\"font-size:14.0pt;\">Optic atrophy</span></p>"
        },
        {
          "id": 323219,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitreous hemorrhage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 31-year-old male presents with a 3-week history of sudden painless vision loss in one eye. The patient denies any trauma or injury. On examination, the anterior segment is normal, but there is no fundal glow visible upon fundoscopy. Which of the following is the most likely cause of his symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8497222",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Vitreous hemorrhage</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient's sudden, painless vision loss with normal anterior segment findings and <strong>no fundal glow</strong> is most likely due to <strong>vitreous hemorrhage</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition involves bleeding into the vitreous cavity, obscuring the view of the retina and leading to the absence of the fundal glow.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The most common causes of vitreous hemorrhage include <strong>diabetic retinopathy</strong>, <strong>retinal tears</strong>, and <strong>trauma</strong>, although in some cases, the cause may not be immediately identifiable.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The blood in the vitreous prevents light from reaching the retina, thus blocking the typical reflection seen during ophthalmoscopy.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gqh2BVz.png\" width=\"1181\" height=\"428\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Retinal detachment:</strong> Retinal detachment typically presents with a sudden onset of visual changes, such as flashes of light or floaters, and can cause loss of vision in the affected part of the retina. However, retinal detachment does not typically cause the <strong>absence of fundal glow,&nbsp;</strong>rather it presents with a <strong>dull, whitish glow.</strong> The retina is still visible in cases of detachment, though it may appear detached or folded.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Macular degeneration:</strong> Macular degeneration, especially age-related macular degeneration, leads to central vision loss due to degeneration of the macula. However, it usually causes a gradual, not sudden, loss of vision. It does not cause the absence of fundal glow, as the retina is still visible on examination. Moreover, macular degeneration often presents with distorted vision or a dark spot in the central vision, rather than complete vision loss in one eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Optic atrophy:</strong> Optic atrophy involves the degeneration of the optic nerve, leading to vision loss, but it does not cause sudden, painless vision loss or absence of fundal glow. The condition typically results in <strong>gradual vision loss</strong>, often with visible changes in the optic disc. The retina itself would still be visible in cases of optic atrophy, unlike in vitreous hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Vitreous hemorrhage</strong> causes sudden, painless vision loss with normal anterior segment findings and no fundal glow due to the obscuring effect of blood in the vitreous cavity, preventing light from reaching the retina.</span></p>",
      "correct_choice_id": 323219,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81134/NEET_PG_Mock_1_Q4_Optha.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81134/NEET_PG_Mock_1_Q4_Optha.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81022,
      "choices": [
        {
          "id": 322772,
          "text": "<p><span style=\"font-size:14.0pt;\">Microphone → Transmitter → Speech processor → Receiver/stimulator → Electrodes</span></p>"
        },
        {
          "id": 322773,
          "text": "<p><span style=\"font-size:14.0pt;\">Speech processor → Microphone → Transmitter → Electrodes → Receiver/stimulator</span></p>"
        },
        {
          "id": 322774,
          "text": "<p><span style=\"font-size:14.0pt;\">Microphone → Speech processor → Transmitter → Receiver/stimulator → Electrodes</span></p>"
        },
        {
          "id": 322775,
          "text": "<p><span style=\"font-size:14.0pt;\">Microphone → Speech processor → Receiver/stimulator → Transmitter → Electrodes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old child with congenital bilateral sensorineural hearing loss undergoes cochlear implantation. Postoperatively, the audiologist explains the working mechanism of the implant to the parents. Which of the following is the correct sequence in which sound is transmitted using a cochlear implant?</span></p>",
      "unique_key": "Q2823118",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Microphone → Speech processor → Transmitter → Receiver/stimulator → Electrodes</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The correct <strong>order of sound transmission</strong> in a cochlear implant is:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Microphone</strong>: Picks up sound from the environment.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Speech Processor</strong>: Converts sound into digital signals.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Transmitter (External)</strong>: Sends digital signals across the skin.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Receiver/Stimulator (Internal)</strong>: Receives, decodes signals, and transmits to electrodes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Electrode array (in cochlea)</strong>: Stimulates the <strong>spiral ganglion cells</strong> in the <strong>scala tympani</strong>, bypassing damaged hair cells.</span></li></ol></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_eJeR0tZ.png\" width=\"1044\" height=\"536\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The stepwise mechanism of <strong>sound signal transmission</strong> in a <strong>cochlear implant</strong> includes the transition from <strong>external components</strong> (sound reception and digital conversion) to <strong>internal components</strong> (electrical stimulation of cochlear nerve).</span></p>",
      "correct_choice_id": 322774,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81022/Neet_Pg_Mock_1_Q3_Ent.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81022/Neet_Pg_Mock_1_Q3_Ent.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81132,
      "choices": [
        {
          "id": 323208,
          "text": "<p><span style=\"font-size:14.0pt;\">Balloon catheter dilation</span></p>"
        },
        {
          "id": 323209,
          "text": "<p><span style=\"font-size:14.0pt;\">Massage over lacrimal sac</span></p>"
        },
        {
          "id": 323210,
          "text": "<p><span style=\"font-size:14.0pt;\">Dacryocystorhinostomy</span></p>"
        },
        {
          "id": 323211,
          "text": "<p><span style=\"font-size:14.0pt;\">Syringing and probing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4-month-old infant is brought to the clinic with a complaint of persistent watering and mucopurulent discharge from one eye. Ocular examination reveals a normal anterior chamber and fundus, and there are no signs of systemic infection. Based on the clinical findings, what is the initial treatment of choice for this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7767017",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Massage over lacrimal sac</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture is typical of <strong>congenital nasolacrimal duct obstruction (CNLDO)</strong>, also known as <strong>dacryostenosis</strong>, which commonly presents in the <strong>first few months of life</strong> with:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Epiphora (watering of the eyes)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Mucopurulent discharge</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Normal anterior and posterior segment findings</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The <strong>first-line treatment</strong> in infants under 6 months is <strong>Crigler's massage</strong>, which involves <strong>downward pressure over the medial canthal&nbsp;</strong>area to create a hydrostatic pressure.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dhyCmyj.png\" width=\"623\" height=\"327\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This maneuver helps to <strong>open up the nasolacrimal duct</strong>, especially if the obstruction is at the <strong>valve of Hasner</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Spontaneous resolution is common with this method.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No surgical intervention</strong> is typically required initially.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Balloon catheter dilation:</strong> This is a <strong>second-line or adjunctive intervention</strong>, often reserved for <strong>older children</strong> or those in whom <strong>probing has failed</strong>. Not the first-line treatment in a 3-month-old.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dacryocystorhinostomy (DCR):</strong> A <strong>surgical procedure</strong> to create a new drainage pathway. This is typically indicated only in <strong>older children or adults</strong> with <strong>failed conservative and probing treatments</strong>. It is considered beyond 18 months of age, while the preferred age being <strong>4 years.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Syringing and probing:</strong> While <strong>probing is effective</strong>, it is not the <strong>first line</strong> in infants under 6 months. It is considered after 6 months of age if <strong>massage fails</strong>, up to 18 months of age. The probe is first inserted vertically, then turn horizontally, and finally turned vertically down.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1kCxFsi.png\" width=\"584\" height=\"599\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In infants with congenital nasolacrimal duct obstruction, massage over the lacrimal sac is the initial treatment of choice, as it promotes spontaneous opening of the obstructed duct.</span></p>",
      "correct_choice_id": 323209,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81132/NEET_PG_Mock_1_Q2_Optha.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81132/NEET_PG_Mock_1_Q2_Optha.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80998,
      "choices": [
        {
          "id": 322676,
          "text": "<p><span style=\"font-size:14.0pt;\">Annual chest X-ray</span></p>"
        },
        {
          "id": 322677,
          "text": "<p><span style=\"font-size:14.0pt;\">Annual low-dose CT scan</span></p>"
        },
        {
          "id": 322678,
          "text": "<p><span style=\"font-size:14.0pt;\">Genetic screening for lung cancer</span></p>"
        },
        {
          "id": 322679,
          "text": "<p><span style=\"font-size:14.0pt;\">Daily vitamin E supplementation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 61-year-old man with a 30-pack-year smoking history (quit 7 years ago) is asymptomatic and presents for preventive care. Which of the following is the most appropriate screening test for lung cancer?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6830297",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Annual low-dose CT scan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Low-dose CT (LDCT) screening reduces lung cancer mortality in high-risk patients aged 50–80 years with ≥20 pack-years of smoking.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Chest X-ray has no mortality benefit. Genetic testing and vitamins are not recommended for screening.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Annual Chest X-ray</strong>: Ineffective for screening; lacks sensitivity.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Genetic screening</strong> <strong>for lung cancer:&nbsp;</strong>No proven utility in lung cancer prevention.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Daily vitamin E supplementation:</strong> Not beneficial; may even increase risk in smokers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">LDCT is the only validated screening tool to reduce lung cancer mortality in patients with significant smoking history.</span></p>",
      "correct_choice_id": 322677,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80998/NEET_MOCK_-_1_Question_-_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80998/NEET_MOCK_-_1_Question_-_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80979,
      "choices": [
        {
          "id": 322600,
          "text": "<p><span style=\"font-size:14.0pt;\">Chest X-ray</span></p>"
        },
        {
          "id": 322601,
          "text": "<p><span style=\"font-size:14.0pt;\">High-resolution CT scan</span></p>"
        },
        {
          "id": 322602,
          "text": "<p><span style=\"font-size:14.0pt;\">Bronchoscopy</span></p>"
        },
        {
          "id": 322603,
          "text": "<p><span style=\"font-size:14.0pt;\">Sweat chloride testing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 53-year-old woman reports 6 years of daily green sputum, frequent sinus infections, and occasional hemoptysis. Lung auscultation reveals coarse crackles. Spirometry shows FEV₁/FVC = 54%. Sputum grows Pseudomonas aeruginosa. What is the most appropriate next investigation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7341651",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) High-resolution CT scan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">HRCT is the gold standard for diagnosing bronchiectasis, which is suspected in patients with chronic productive cough and Pseudomonas colonization.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It detects bronchial dilation, lack of tapering, and signet ring sign, unlike chest X-ray.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chest X-ray:</strong> May miss early or subtle bronchiectasis.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Bronchoscopy:</strong> Reserved for localized or unclear etiologies.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sweat chloride testing:</strong> Done post-diagnosis to evaluate for CF in young or atypical cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">HRCT is the preferred diagnostic test for bronchiectasis in patients with recurrent infections and chronic sputum production.</span></p>",
      "correct_choice_id": 322601,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80979/NEET_MOCK_-_1_Question_-_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80979/NEET_MOCK_-_1_Question_-_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80989,
      "choices": [
        {
          "id": 322640,
          "text": "<p><span style=\"font-size:14.0pt;\">Agenesis of the corpus callosum</span></p>"
        },
        {
          "id": 322641,
          "text": "<p><span style=\"font-size:14.0pt;\">Infantile spasms</span></p>"
        },
        {
          "id": 322642,
          "text": "<p><span style=\"font-size:14.0pt;\">46, XY karyotype</span></p>"
        },
        {
          "id": 322643,
          "text": "<p><span style=\"font-size:14.0pt;\">Chorioretinal lacunae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-month-old female infant is brought for evaluation of refractory infantile spasms and delayed milestones. The child was born at term with no perinatal complications. MRI brain is as shown below. Which of the following findings, if present, would most strongly argue against the diagnosis of Aicardi Syndrome?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_y0G1fDw.png\" width=\"434\" height=\"486\"></strong></span></p>",
      "unique_key": "Q4126662",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 46, XY karyotype</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Aicardi syndrome</strong> is a rare, classically <strong>X-linked dominant</strong> disorder that <strong>almost exclusively affects females</strong>. It presents with a <strong>triad</strong> of:</span><ol><li><span style=\"font-size:14.0pt;\"><strong>Agenesis of the corpus callosum</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Chorioretinal lacunae</strong> (pathognomonic)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Infantile spasms</strong> (refractory seizures)</span></li></ol></li><li><span style=\"font-size:14.0pt;\">Additional features may include:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Intellectual disability</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Vertebral anomalies</strong> (e.g., hemivertebrae, scoliosis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Optic nerve colobomas</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Polymicrogyria or cortical dysplasia</strong> on imaging</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Agenesis of corpus callosum:</strong> Seen in &gt;90% of Aicardi syndrome patients. Strongly supportive of diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Infantile spasms:</strong> Part of the classic triad. Refractory epilepsy is often the presenting feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chorioretinal lacunae: Pathognomonic finding</strong> on fundoscopy in Aicardi syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PFoYn5R.png\" width=\"1321\" height=\"352\"></p>",
      "correct_choice_id": 322642,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80989/Pediatrics__NEET_MOCK_-_1_Question_-_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80989/Pediatrics__NEET_MOCK_-_1_Question_-_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81007,
      "choices": [
        {
          "id": 322712,
          "text": "<p><span style=\"font-size:14.0pt;\">AST:ALT ratio &gt;2</span></p>"
        },
        {
          "id": 322713,
          "text": "<p><span style=\"font-size:14.0pt;\">Carbohydrate Deficient Transferrin &gt;2.6% and elevated GGT</span></p>"
        },
        {
          "id": 322714,
          "text": "<p><span style=\"font-size:14.0pt;\">MCV &gt;91&nbsp;μm³</span></p>"
        },
        {
          "id": 322715,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum uric acid &gt;7 mg/dL</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old man drinks daily and reports hangovers and one blackout. He denies social or legal issues. Which lab markers best detect chronic heavy alcohol use?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1219714",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Carbohydrate Deficient Transferrin &gt;2.6% and elevated GGT</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Carbohydrate-deficient transferrin (CDT) and gamma-glutamyl transferase (GGT) are the most specific markers for chronic heavy alcohol use.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Used together, they improve diagnostic accuracy over individual markers like MCV or AST:ALT ratio.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. AST:ALT ratio &gt;2:</strong> Suggestive of alcoholic hepatitis, not screening.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. MCV &gt;91 μm³:</strong> Can be elevated for many reasons; lacks specificity.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Serum uric acid &gt;7 mg/dL</strong>:&nbsp;Non-specific; elevated in many conditions like CKD, metabolic syndrome, etc.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">For detecting covert alcohol use, CDT and GGT together offer optimal sensitivity and specificity among lab tests.</span></p>",
      "correct_choice_id": 322713,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81007/NEET_MOCK_-_1_Question_-_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81007/NEET_MOCK_-_1_Question_-_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80905,
      "choices": [
        {
          "id": 322304,
          "text": "<p><span style=\"font-size:14.0pt;\">Acetazolamide</span></p>"
        },
        {
          "id": 322305,
          "text": "<p><span style=\"font-size:14.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 322306,
          "text": "<p><span style=\"font-size:14.0pt;\">Spironolactone</span></p>"
        },
        {
          "id": 322307,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrochlorothiazide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 57-year-old man with a history of chronic kidney disease stage 3 and long-standing hypertension is found to have recurrent episodes of hyperkalemia during routine lab monitoring. He is currently taking an angiotensin-converting enzyme inhibitor as part of his antihypertensive regimen. Which of the following diuretics is the most suitable choice to address his blood pressure and electrolyte imbalance?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9782996",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Furosemide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The presence of <strong>recurrent hyperkalemia</strong> in a patient with <strong>chronic kidney disease (CKD) stage 3</strong> who is also on an <strong>ACE inhibitor</strong> (which reduces aldosterone and impairs potassium excretion) raises the need for a <strong>potassium-wasting</strong> agent.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Furosemide</strong> is a <strong>loop diuretic</strong> that increases urinary excretion of sodium, chloride, and <strong>potassium</strong>, making it highly beneficial for patients with <strong>hyperkalemia</strong> and <strong>moderate-to-severe CKD</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is more effective than thiazides in patients with <strong>reduced glomerular filtration rate (GFR)</strong>, particularly in <strong>CKD stage 3 or worse</strong>. Thus, <strong>furosemide</strong> addresses both:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hypertension</strong> control</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reduction of serum potassium</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Acetazolamide:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a <strong>carbonic anhydrase inhibitor</strong>, leading to <strong>bicarbonate loss</strong> and mild diuresis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>not effective</strong> in controlling blood pressure or in managing <strong>hyperkalemia</strong>, making it unsuitable for this scenario.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Spironolactone:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>potassium-sparing diuretic</strong> and <strong>aldosterone antagonist</strong>, which would <strong>worsen hyperkalemia</strong>, especially when combined with <strong>ACE inhibitors</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This combination can lead to <strong>life-threatening elevations in serum potassium</strong>, particularly in <strong>CKD</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hydrochlorothiazide</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Although it can cause <strong>hypokalemia</strong>, its effectiveness decreases in patients with <strong>moderate to advanced CKD</strong> due to <strong>poor efficacy at lower GFR</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, it is <strong>not as effective</strong> as furosemide in <strong>stage 3 CKD</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Furosemide is the preferred diuretic in patients with stage 3 chronic kidney disease and recurrent hyperkalemia, particularly when they are receiving an ACE inhibitor<strong>.</strong></span></p>",
      "correct_choice_id": 322305,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80905/Pharma_Mock_1_NEET_PG1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80905/Pharma_Mock_1_NEET_PG1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80936,
      "choices": [
        {
          "id": 322428,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency lower segment cesarean section (LSCS)</span></p>"
        },
        {
          "id": 322429,
          "text": "<p><span style=\"font-size:14.0pt;\">Induction of labor</span></p>"
        },
        {
          "id": 322430,
          "text": "<p><span style=\"font-size:14.0pt;\">Corticosteroids followed by induction of labor</span></p>"
        },
        {
          "id": 322431,
          "text": "<p><span style=\"font-size:14.0pt;\">Weekly Doppler of umbilical artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 21-year-old woman, gravida 2 para 1, presents for a routine antenatal visit at 32 weeks of gestation. Her previous pregnancy was uneventful. On examination, her symphysis-fundal height is found to be lagging by 4 weeks. An obstetric ultrasound confirms fetal growth restriction (FGR) with an estimated fetal weight below the 10th percentile for gestational age. Umbilical artery Doppler is as follows. Fetal heart rate is 146 bpm. She is otherwise asymptomatic and has no signs of preeclampsia. What is the next best step in the management of this patient?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20104901.jpg\" width=\"810\" height=\"542\"></span></p>",
      "unique_key": "Q7405767",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Weekly Doppler of umbilical artery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is the <strong>standard recommendation</strong> in early-onset FGR with <strong>normal umbilical artery Doppler</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Surveillance</strong> with <strong>weekly</strong> Doppler velocimetry is done to detect early signs of placental insufficiency.</span></li><li><span style=\"font-size:14.0pt;\">If flow becomes <strong>absent or reversed</strong>, or other signs of compromise appear, <strong>delivery may be considered</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This strategy balances the risks of prematurity with those of intrauterine hypoxia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Emergency lower segment cesarean section (LSCS):&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Emergency LSCS is indicated in cases of <strong>fetal distress</strong>, such as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Reversed or absent end-diastolic flow in the umbilical artery</span></li><li><span style=\"font-size:14.0pt;\">Non-reassuring fetal heart rate patterns</span></li><li><span style=\"font-size:14.0pt;\">Severe oligohydramnios or worsening maternal condition (e.g., preeclampsia, eclampsia)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In this patient, Doppler is <strong>normal</strong>, and there's <strong>no fetal or maternal instability</strong>, so emergency LSCS is not justified.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Induction of labor:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Induction of labor at <strong>32 weeks</strong> is generally avoided unless:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">There is <strong>non-reassuring fetal status</strong>, or</span></li><li><span style=\"font-size:14.0pt;\">Fetal/maternal complications mandate early delivery.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Spontaneous labor is not favorable at this gestational age without lung maturity. Also, FGR with normal Doppler should be monitored, not delivered prematurely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Corticosteroids followed by induction of labor:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While corticosteroids are given between <strong>24 and 34 weeks</strong> to accelerate fetal lung maturity in anticipation of preterm birth, <strong>induction of labor is not needed immediately</strong> unless fetal monitoring deteriorates.</span></li><li><span style=\"font-size:14.0pt;\">Here, fetal Doppler is normal, and no immediate threat exists. Hence, the approach is <strong>close monitoring</strong>, not planned early delivery yet.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>early-onset FGR</strong> with <strong>normal Doppler flow</strong>, the best approach is <strong>weekly umbilical artery Doppler monitoring</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early intervention is considered only if Doppler findings worsen or other complications develop.</span></li></ul>",
      "correct_choice_id": 322431,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80936/OBG_Mock_1_Q5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80936/OBG_Mock_1_Q5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81112,
      "choices": [
        {
          "id": 323128,
          "text": "<p><span style=\"font-size:14.0pt;\">Antibody to early antigen (EA)</span></p>"
        },
        {
          "id": 323129,
          "text": "<p><span style=\"font-size:14.0pt;\">Antibody to viral capsid antigen (VCA) IgM</span></p>"
        },
        {
          "id": 323130,
          "text": "<p><span style=\"font-size:14.0pt;\">Antibody to EBV nuclear antigen (EBNA)</span></p>"
        },
        {
          "id": 323131,
          "text": "<p><span style=\"font-size:14.0pt;\">Antibody to capsular antigen&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old college student presents with fever, sore throat, generalized lymphadenopathy, and fatigue. Monospot test is negative, but Epstein-Barr virus (EBV) serology is sent to confirm the diagnosis. Which of the following antibodies, if present, would indicate a past EBV infection rather than an acute one?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9182786",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Antibody to EBV nuclear antigen (EBNA)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">EBV-specific antibody detection involves serologic evaluation of responses to three key antigens:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Viral capsid antigen (VCA):</strong></span><ul><li><span style=\"font-size:14.0pt;\"><strong>IgM</strong> → Indicates <strong>acute or recent infection</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>IgG</strong> → Appears in both <strong>acute and past infection</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Early antigen (EA):</strong></span><ul><li><span style=\"font-size:14.0pt;\">Appears <strong>transiently during acute infection</strong>, then fades</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>EBV nuclear antigen (EBNA):</strong></span><ul><li><span style=\"font-size:14.0pt;\">Appears <strong>late</strong>, typically <strong>6–8 weeks</strong> after infection</span></li><li><span style=\"font-size:14.0pt;\"><strong>Remains positive for life</strong>, thus <strong>marker of past infection</strong></span></li></ul></li></ul></li><li><span style=\"font-size:14.0pt;\">So, detection of <strong>anti-EBNA antibodies</strong> confirms that the patient has had <strong>past EBV exposure</strong> and is <strong>not in the acute phase</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Antibody to early antigen (EA):</strong> Suggests <strong>acute or active</strong> infection; it disappears in recovery phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Antibody to viral capsid antigen (VCA) IgM:</strong> A marker of <strong>early/acute</strong> infection, not past infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Antibody to capsular antigen:</strong> No such thing as capsular antigen in EBV&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Antibodies to EBV nuclear antigen (EBNA) are detected only after the acute phase and persist lifelong, serving as a marker of past EBV infection.</span></p>",
      "correct_choice_id": 323130,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81112/Microbiology_NEET_PG_Mock_Q5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81112/Microbiology_NEET_PG_Mock_Q5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81024,
      "choices": [
        {
          "id": 322780,
          "text": "<p><span style=\"font-size:14.0pt;\">Closed reduction and internal fixation</span></p>"
        },
        {
          "id": 322781,
          "text": "<p><span style=\"font-size:14.0pt;\">Hip replacement surgery</span></p>"
        },
        {
          "id": 322782,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-weight bearing with follow-up X-ray in 6 weeks</span></p>"
        },
        {
          "id": 322783,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiate weight-bearing with analgesics and physical therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old female presents to the emergency department after a fall from standing height. She is unable to bear weight on her right leg and reports severe hip pain. On examination, the right leg appears shortened and externally rotated. The patient has a history of osteoporosis and is currently on long-term corticosteroid therapy for rheumatoid arthritis. What is the most appropriate next step in the management of this patient?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20110233.jpg\" width=\"686\" height=\"439\"></span></p>",
      "unique_key": "Q7471537",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;Hip replacement surgery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>It is indicated in</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Elderly patients (≥65 years old) with displaced femoral neck fractures or intra-capsular fractures</span></li><li><span style=\"font-size:14.0pt;\">Poor bone healing potential (e.g., due to osteoporosis or steroid use)</span></li><li><span style=\"font-size:14.0pt;\">To restore mobility and reduce the risk of complications from immobility</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Types</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Hemiarthroplasty: Replaces only the femoral head and neck</span></li><li><span style=\"font-size:14.0pt;\">Total hip replacement: Replaces both acetabulum and femoral head (may be used in active, mobile elderly patients); preferred choice for the arthritis patient of any age.&nbsp;</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Closed Reduction and Internal Fixation (CRIF):</strong></span></p><ul><li><span style=\"font-size:14.0pt;\">Indicated in:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Younger patients or those with non-displaced or minimally displaced fractures</span></li><li><span style=\"font-size:14.0pt;\">Better bone healing potential</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Not ideal here:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The patient is elderly and likely has a displaced femoral neck fracture</span></li><li><span style=\"font-size:14.0pt;\">Osteoporotic bone may not hold fixation well</span></li><li><span style=\"font-size:14.0pt;\">Higher risk of non-union or avascular necrosis (AVN)</span></li></ul></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Non-weight bearing with follow-up X-ray in 6 weeks:</strong></span></p><ul><li><span style=\"font-size:14.0pt;\">Indicated in:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Stable fractures, particularly pelvic or acetabular fractures that don’t require surgery</span></li><li><span style=\"font-size:14.0pt;\">Occasionally for nondisplaced fractures in non-surgical candidates</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Not appropriate:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">This is an unstable fracture with classic signs of a displaced hip fracture</span></li><li><span style=\"font-size:14.0pt;\">Delaying intervention increases risk of complications: thromboembolism, pneumonia, pressure sores</span></li></ul></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Initiate weight-bearing with analgesics and physical therapy:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Indicated in:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Minor injuries or non-fracture pain</span></li><li><span style=\"font-size:14.0pt;\">Stable orthopedic conditions (e.g., osteoarthritis)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Not appropriate:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The patient has a fracture — weight-bearing would worsen the injury</span></li><li><span style=\"font-size:14.0pt;\">Surgery is needed before any weight-bearing</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-20%20162218.jpg\" width=\"1110\" height=\"461\"></p>",
      "correct_choice_id": 322781,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81024/NEET_MOCK_-_1_Question_-_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81024/NEET_MOCK_-_1_Question_-_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80991,
      "choices": [
        {
          "id": 322648,
          "text": "<p><span style=\"font-size:14.0pt;\">Febrile seizures are seizures that occur between the ages of 5 and 60 months (peak 12–18 months) with a temperature of 38°C (100.4°F) or higher, that are not the result of CNS infection</span></p>"
        },
        {
          "id": 322649,
          "text": "<p><span style=\"font-size:14.0pt;\">Febrile seizures are seizures that occur between the ages of 6 and 70 months (peak 12–18 months) with a temperature of 38°C (100.4°F) or higher, that are not the result of CNS infection</span></p>"
        },
        {
          "id": 322650,
          "text": "<p><span style=\"font-size:14.0pt;\">Febrile seizures are seizures that occur between the ages of 6 and 60 months (peak 18–36 months) with a temperature of 38°C (100.4°F) or higher, that are not the result of CNS infection</span></p>"
        },
        {
          "id": 322651,
          "text": "<p><span style=\"font-size:14.0pt;\">Febrile seizures are seizures that occur between the ages of 6 and 60 months (peak 12–18 months) with a temperature of 38°C (100.4°F) or higher, that are not the result of CNS infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the statements given below is correct regarding febrile seizures?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1187110",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Febrile seizures are seizures that occur between the ages of 6 and 60 months (peak 12–18 months) with a temperature of 38°C (100.4°F) or higher, that are not the result of CNS infection</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Febrile seizures</strong> are the <strong>most common type of seizure in children</strong>. They are defined by the following criteria:</span><ul><li><span style=\"font-size:14.0pt;\">Occur between <strong>6 months and 60 months</strong> (5 years) of age</span></li><li><span style=\"font-size:14.0pt;\">Occur in association with <strong>fever ≥38°C (100.4°F)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>No evidence of CNS infection</strong>, prior afebrile seizures, or acute metabolic abnormality</span></li><li><span style=\"font-size:14.0pt;\">Most common between <strong>12 and 18 months</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EWwkfmd.png\" width=\"1360\" height=\"302\"></strong></span></p>",
      "correct_choice_id": 322651,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80991/Pediatrics__NEET_MOCK_-_1_Question_-_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80991/Pediatrics__NEET_MOCK_-_1_Question_-_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81019,
      "choices": [
        {
          "id": 322760,
          "text": "<p><span style=\"font-size:14.0pt;\">Omeprazole + Bismuth + Metronidazole + Tetracycline</span></p>"
        },
        {
          "id": 322761,
          "text": "<p><span style=\"font-size:14.0pt;\">Vonoprazan-Amoxicillin</span></p>"
        },
        {
          "id": 322762,
          "text": "<p><span style=\"font-size:14.0pt;\">Low-dose Rifabutin Triple</span></p>"
        },
        {
          "id": 322763,
          "text": "<p><span style=\"font-size:14.0pt;\">Pantoprazole and Clarithromycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old woman presents with upper abdominal discomfort, dark stools, and relief with antacids. Endoscopy reveals a 2.2 cm duodenal ulcer and positive H. pylori biopsy. Which of the following is not an appropriate treatment?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3311327",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Pantoprazole and Clarithromycin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Monotherapy with clarithromycin and PPI (without a third agent) is inadequate.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clarithromycin triple therapy requires amoxicillin or metronidazole. Bismuth quadruple, vonoprazan-based dual therapy, and rifabutin-based regimens are all validated alternatives.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Omeprazole + Bismuth + Metronidazole + Tetracycline:&nbsp;</strong>Effective bismuth quadruple regimen. This is the first line treatment as per the most of the guidelines. But, In India we still use triple therapy.&nbsp;</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vonoprazan-Amoxicillin:&nbsp;</strong>Vonoprazan dual therapy is approved. This is long acting, can be taken irrespective of meal time, and can be used as double therapy.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Low-dose Rifabutin Triple:&nbsp;</strong>Rifabutin triple is used in refractory cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Effective H. pylori treatment requires at least two antibiotics and a PPI; dual regimens without this are inadequate.&nbsp;</span></p>",
      "correct_choice_id": 322763,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81019/Neet_Mock_-_1_Question_-_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81019/Neet_Mock_-_1_Question_-_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81126,
      "choices": [
        {
          "id": 323184,
          "text": "<p><span style=\"font-size:14.0pt;\">Alopecia areata</span></p>"
        },
        {
          "id": 323185,
          "text": "<p><span style=\"font-size:14.0pt;\">Discoid lupus erythematosus</span></p>"
        },
        {
          "id": 323186,
          "text": "<p><span style=\"font-size:14.0pt;\">Dermatomyositis</span></p>"
        },
        {
          "id": 323187,
          "text": "<p><span style=\"font-size:14.0pt;\">Lupus vulgaris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman presents with gradually progressive patchy hair loss over the scalp for the past 4 months. On examination, the scalp shows well-demarcated erythematous plaques with adherent scales. When one of the scales is gently lifted, multiple horny projections are seen on its underside that had been lodged within the follicular openings. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8970247",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Discoid lupus erythematosus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Discoid lupus erythematosus (DLE) is a chronic, scarring form of cutaneous lupus that commonly affects the scalp, face, and ears.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents as erythematous plaques with adherent scales and follicular plugging.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A characteristic clinical sign is the <strong>“carpet tack” sign</strong> (also known as the cat's tongue or tin tack sign), where removal of the scale reveals horny plugs on its undersurface that were lodged in dilated follicles.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">DLE is a leading cause of <strong>scarring alopecia</strong> and requires prompt diagnosis to prevent permanent hair loss.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_6rdYzbD.png\" width=\"727\" height=\"416\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Alopecia areata:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This autoimmune disorder presents with sudden-onset, <strong>non-scarring hair loss</strong> in well-circumscribed patches.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The hallmark findings are <strong>“exclamation mark” hairs</strong> (short broken hairs that are narrower at the base) seen at the periphery of lesions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">There is <strong>no erythema or scaling</strong>, and the carpet tack sign is not observed. Follicular structures are preserved, allowing for regrowth if the disease is controlled.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dermatomyositis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Though dermatomyositis may involve the scalp, it typically presents with <strong>heliotrope rash</strong>, <strong>Gottron’s papules</strong>, and <strong>photosensitive poikilodermatous eruptions</strong>, not scarring alopecia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hair loss, when present, is usually diffuse and non-scarring, and there is no follicular plugging or carpet tack sign.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The associated muscle weakness and elevated muscle enzymes are key diagnostic features.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lupus vulgaris:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a form of <strong>cutaneous tuberculosis</strong>, characterized by slowly progressive <strong>reddish-brown plaques</strong> that may ulcerate.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Commonly seen on the face or extremities, lupus vulgaris is not associated with alopecia or follicular plugging.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The carpet tack sign is not a feature, and diagnosis is confirmed via histopathology, PCR, or culture for Mycobacterium tuberculosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>carpet tack sign</strong>—seen when scales from DLE lesions are removed—is a clinical clue to follicular plugging and chronic scarring alopecia.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Recognizing this sign is important in distinguishing DLE from other causes of hair loss.</span></li></ul>",
      "correct_choice_id": 323185,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81126/Dermatology_Mock_1_Q4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81126/Dermatology_Mock_1_Q4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81154,
      "choices": [
        {
          "id": 323296,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of the Na⁺, K⁺-ATPase</span></p>"
        },
        {
          "id": 323297,
          "text": "<p><span style=\"font-size:14.0pt;\">Movement of K⁺ into the cell</span></p>"
        },
        {
          "id": 323298,
          "text": "<p><span style=\"font-size:14.0pt;\">Movement of K⁺ out of the cell</span></p>"
        },
        {
          "id": 323299,
          "text": "<p><span style=\"font-size:14.0pt;\">Movement of Na⁺ into the cell</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is primarily responsible for the change in membrane potential between points B and D?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_arTxW8Y.png\" width=\"582\" height=\"429\"></strong></span></p>",
      "unique_key": "Q5429200",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Movement of Na⁺ into the cell</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The change in membrane potential between points <strong>B and D</strong> represents the <strong>depolarization phase</strong> of the action potential:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>At point B</strong>, the membrane has reached the <strong>threshold potential</strong>, which leads to the <strong>opening of voltage-gated Na⁺ channels</strong>.</span></li><li><span style=\"font-size:14.0pt;\">As a result, <strong>Na⁺ ions rapidly flow into the cell</strong> down their electrochemical gradient.</span></li><li><span style=\"font-size:14.0pt;\">This <strong>influx of Na⁺</strong> causes the <strong>interior of the cell to become more positive</strong>, producing the sharp <strong>rise in membrane potential</strong> that characterizes depolarization.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Point D</strong> marks the peak of depolarization, just before the Na⁺ channels inactivate and K⁺ channels open.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inhibition of the Na⁺, K⁺-ATPase:</strong> This pump maintains resting membrane potential over the long term but is not responsible for rapid voltage changes during an action potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Movement of K⁺ into the cell:</strong> K⁺ usually moves <strong>out</strong> of the cell during <strong>repolarization</strong>, not during the depolarization phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Movement of K⁺ out of the cell:</strong> This occurs during the <strong>falling phase</strong> (after point D), contributing to <strong>repolarization</strong>, not the rising phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During the depolarization phase of an action potential, <strong>voltage-gated Na⁺ channels open</strong>, allowing <strong>Na⁺ to flow into the cell</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This <strong>inward current</strong> causes the membrane potential to rapidly become more positive, a hallmark of the <strong>rising phase</strong> of the action potential.</span></li></ul>",
      "correct_choice_id": 323299,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81154/Neet_Pg_Mock_1_Q5_Physiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81154/Neet_Pg_Mock_1_Q5_Physiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81079,
      "choices": [
        {
          "id": 322996,
          "text": "<p><span style=\"font-size:14.0pt;\">Follicular lymphoma</span></p>"
        },
        {
          "id": 322997,
          "text": "<p><span style=\"font-size:14.0pt;\">Diffuse large B-cell lymphoma</span></p>"
        },
        {
          "id": 322998,
          "text": "<p><span style=\"font-size:14.0pt;\">Hairy cell leukemia</span></p>"
        },
        {
          "id": 322999,
          "text": "<p><span style=\"font-size:14.0pt;\">Mantle cell lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man presents with fatigue, weight loss, and mild abdominal fullness. Examination reveals splenomegaly. Laboratory tests show lymphocytosis. Lymph node biopsy reveals a population of CD5-positive B cells with overexpression of cyclin D1. Genetic analysis identifies a t(11;14) translocation involving the immunoglobulin heavy chain (IgH) locus and the CCND1 gene. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3490075",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Mantle cell lymphoma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This patient's clinical presentation with fatigue, splenomegaly, and lymphocytosis, along with histologic and molecular findings, is characteristic of <strong>mantle cell lymphoma (MCL)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">MCL is a mature B-cell neoplasm that typically affects older men and presents with generalized lymphadenopathy, bone marrow involvement, and sometimes gastrointestinal tract polyps (lymphomatous polyposis).</span></li><li><span style=\"font-size:14.0pt;\">The key diagnostic hallmark is the <strong>t(11;14)(q13;q32) translocation</strong>, which brings the <strong>CCND1 (cyclin D1)</strong> gene under the control of the <strong>IgH enhancer</strong> on chromosome 14, resulting in <strong>cyclin D1 overexpression</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cyclin D1 is a <strong>cell cycle regulator (cyclin)</strong> that promotes the G1-to-S phase transition, leading to unregulated proliferation of neoplastic B cells.</span></li><li><span style=\"font-size:14.0pt;\">The question includes:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>CCND1 (cyclin D1)</strong> – the gene affected</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cyclin</strong> – the class of protein overexpressed</span></li><li><span style=\"font-size:14.0pt;\"><strong>t(11;14)</strong> – the translocation</span></li><li><span style=\"font-size:14.0pt;\"><strong>IgH</strong> – the gene locus involved</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mantle cell lymphoma</strong> – the disease diagnosis</span></li></ul></li><li><span style=\"font-size:14.0pt;\">All elements are directly integrated into this clinical question and answer.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Follicular lymphoma:</strong> This lymphoma is associated with <strong>t(14;18)</strong> translocation, leading to overexpression of <strong>BCL2</strong>, which inhibits apoptosis. It typically presents with painless lymphadenopathy and lacks <strong>cyclin D1</strong> overexpression or <strong>t(11;14)</strong> translocation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Diffuse large B-cell lymphoma (DLBCL):</strong> This is the most common type of non-Hodgkin lymphoma and usually presents aggressively with rapidly enlarging masses. It does not feature <strong>cyclin D1</strong> overexpression or <strong>t(11;14)</strong>. Genetic changes are variable and may include <strong>BCL6</strong>, <strong>BCL2</strong>, or <strong>MYC</strong> rearrangements.</span> <span style=\"font-size:14.0pt;\">A patient with DLBCL may present with a history of pre-existing lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hairy cell leukemia:</strong> A rare chronic B-cell leukemia characterized by splenomegaly and pancytopenia, and involvement of bone marrow. The patients may present with fine hairy projections. It is associated with <strong>BRAF V600E</strong> mutations, not translocations. It does not involve <strong>CCND1</strong>, <strong>cyclin</strong>, <strong>t(11;14)</strong>, or <strong>IgH</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mantle cell lymphoma is defined by a t(11;14) translocation involving the CCND1 gene and the immunoglobulin heavy chain (IgH) locus, resulting in cyclin D1 overexpression and dysregulated cell cycle progression.</span></p>",
      "correct_choice_id": 322999,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81079/NEET_PG_Mock_1_Q1_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81079/NEET_PG_Mock_1_Q1_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81098,
      "choices": [
        {
          "id": 323072,
          "text": "<p><span style=\"font-size:14.0pt;\">DNA gyrase</span></p>"
        },
        {
          "id": 323073,
          "text": "<p><span style=\"font-size:14.0pt;\">DNA helicase</span></p>"
        },
        {
          "id": 323074,
          "text": "<p><span style=\"font-size:14.0pt;\">DNA ligase</span></p>"
        },
        {
          "id": 323075,
          "text": "<p><span style=\"font-size:14.0pt;\">DNA polymerase I</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A lethal mutation in a bacterium results in the inability to properly replicate its chromosome. DNA synthesis is initiated, but the process yields numerous short DNA fragments, each containing an RNA segment at their 5′ ends. This mutation is most likely affecting a gene encoding which of the following enzymes?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3378128",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) DNA polymerase I</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>The key clues in this scenario are:</strong></span><ul><li><span style=\"font-size:14.0pt;\"><strong>Numerous short DNA fragments</strong>: These are <strong>Okazaki fragments</strong>, formed on the <strong>lagging strand</strong> during DNA replication.</span></li><li><span style=\"font-size:14.0pt;\"><strong>RNA sequences at the 5′ ends</strong>: This indicates that <strong>RNA primers</strong> were laid down to initiate synthesis.</span></li><li><span style=\"font-size:14.0pt;\">The fragments are <strong>not being processed properly</strong>, i.e., <strong>RNA primers are not being removed</strong> and replaced with DNA.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">In bacteria, <strong>DNA polymerase I</strong> is responsible for:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Removing RNA primers</strong> (via its 5′→3′ exonuclease activity), and</span></li><li><span style=\"font-size:14.0pt;\"><strong>Replacing them with DNA</strong> (via its 5′→3′ polymerase activity).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">A mutation in the gene encoding <strong>DNA polymerase I</strong> would prevent removal of RNA primers from Okazaki fragments, leaving <strong>RNA at the 5′ ends</strong>, and disrupting formation of continuous DNA strands—ultimately impairing <strong>chromosomal replication</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. DNA gyrase:</strong> This enzyme relieves <strong>supercoiling tension</strong> ahead of the replication fork. A defect here could slow or stall replication but would <strong>not cause persistence of RNA primers</strong> on DNA fragments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. DNA helicase:</strong> Responsible for <strong>unwinding DNA</strong> at the replication fork. Its loss would prevent <strong>strand separation</strong>, leading to a <strong>halt in replication initiation</strong>, not accumulation of <strong>RNA-tagged fragments</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. DNA ligase:</strong> DNA ligase joins <strong>DNA-DNA nicks</strong> between Okazaki fragments after RNA primers are removed and replaced. It cannot act if <strong>RNA primers remain</strong> and is <strong>not involved in removing RNA</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>DNA polymerase I</strong> in prokaryotes removes <strong>RNA primers</strong> from Okazaki fragments and replaces them with <strong>DNA</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A mutation impairing this function leads to the accumulation of <strong>short DNA fragments with RNA at their 5′ ends</strong>, disrupting chromosome replication.</span></li></ul>",
      "correct_choice_id": 323075,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81098/NEET_PG_Mock_1_Q5_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81098/NEET_PG_Mock_1_Q5_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80931,
      "choices": [
        {
          "id": 322408,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate cesarean followed by bilateral internal iliac artery ligation</span></p>"
        },
        {
          "id": 322409,
          "text": "<p><span style=\"font-size:14.0pt;\">Administration of corticosteroids, transfuse blood, followed by a planned cesarean at 37 weeks.&nbsp;</span></p>"
        },
        {
          "id": 322410,
          "text": "<p><span style=\"font-size:14.0pt;\">Serial ultrasound monitoring with plans of delivery if evidence of increasing vascularity in the placenta</span></p>"
        },
        {
          "id": 322411,
          "text": "<p><span style=\"font-size:14.0pt;\">Admit, transfuse blood, give steroids and plan an elective cesarean delivery with hysterectomy at 36 weeks of pregnancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old pregnant woman, G4P3 at 28 weeks of gestation, presents with recurrent episodes of painless vaginal bleeding over the past 1 week. Her medical history is significant for 1 previous cesarean delivery and 1 dilatation and curettage of a previous incomplete abortion. On examination, her vital signs are stable, and the fetal heart rate is reassuring. Abdominal ultrasound reveals a placenta located near the cervix with multiple hypoechoic areas and irregular vascular spaces within the placenta. Laboratory results show an Hb of 8g%. Which of the following is the most appropriate management option?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5094806",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Admit, transfuse blood, give steroids and plan an elective cesarean delivery with hysterectomy at 36 weeks of pregnancy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is a clinical scenario of placenta accreta syndromes as the history of previous cesarean and D &amp; C with the current ultrasound findings support this diagnosis</span></li><li><span style=\"font-size:14.0pt;\">Treatment of placenta accreta syndromes includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Stabilization of the patient</span></li><li><span style=\"font-size:14.0pt;\">Planning an elective cesarean delivery (preferably a classical cesarean) at 34-37 weeks, leaving the placenta in situ followed by a hysterectomy as any attempts to remove an adherent placenta result in severe hemorrhage&nbsp;</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Immediate cesarean followed by bilateral internal iliac artery ligation:&nbsp;</strong>As the patient is stable currently, immediate cesarean is not warranted as she is only 29 weeks</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Administration of corticosteroids, transfuse blood, followed by a planned cesarean at 37 weeks:&nbsp;</strong>This would have been correct, but option D is a better option in the scenario of accreta. If only placenta previa, this would have been the preferred option</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Serial ultrasound monitoring with plans of delivery if evidence of increasing vascularity in the placenta:&nbsp;</strong>There is no role of looking at increasing vascularity on ultrasound and it will not change the management.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Treatment of placenta accreta syndromes includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Stabilization of the patient</span></li><li><span style=\"font-size:14.0pt;\">Planning an elective cesarean delivery (preferably a classical cesarean) at 34-37 weeks, leaving the placenta in situ followed by a hysterectomy as any attempts to remove an adherent placenta result in severe hemorrhage.</span></li></ul></li></ul>",
      "correct_choice_id": 322411,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80931/OBG_Mock_1_Q2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80931/OBG_Mock_1_Q2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81033,
      "choices": [
        {
          "id": 322816,
          "text": "<p><span style=\"font-size:14.0pt;\">Brain fingerprinting measures heart rate variability</span></p>"
        },
        {
          "id": 322817,
          "text": "<p><span style=\"font-size:14.0pt;\">Brain fingerprinting evaluates emotional arousal</span></p>"
        },
        {
          "id": 322818,
          "text": "<p><span style=\"font-size:14.0pt;\">Brain fingerprinting detects cognitive memory-based responses</span></p>"
        },
        {
          "id": 322819,
          "text": "<p><span style=\"font-size:14.0pt;\">Brain fingerprinting determines truthfulness through galvanic skin response</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old intelligence officer is undergoing screening to ensure loyalty and integrity before receiving a high-security clearance. Investigators decide to use a method based on measuring brain recognition signals, which is unaffected by emotional reactions. Which of the following best differentiates brain fingerprinting from polygraph testing?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9221399",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Brain fingerprinting detects cognitive memory-based responses</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Brain fingerprinting is a <strong>neuroscientific technique</strong> designed to detect whether specific information is stored in a person’s brain, without relying on emotional or physical reactions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It primarily uses <strong>event-related potentials (ERPs)</strong>, especially the <strong>P300 wave</strong> and <strong>MERMER</strong> (Memory and Encoding Related Multifaceted Electroencephalographic Response), to detect whether a subject recognizes crime-related or relevant information.</span></li><li><span style=\"font-size:14.0pt;\">The method is <strong>independent of emotional responses</strong> and physiological changes (such as sweating, heart rate changes), making it fundamentally different from a polygraph.</span></li><li><span style=\"font-size:14.0pt;\">In contrast, <strong>polygraph testing</strong> is based on <strong>physiological measures</strong> like <strong>heart rate, blood pressure, respiratory rate, and galvanic skin response</strong>, which are indirectly affected by emotional arousal (fear, stress, anxiety) during interrogation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, polygraph results can be unreliable if the subject is nervous even when innocent.</span></li><li><span style=\"font-size:14.0pt;\">Brain fingerprinting <strong>focuses purely on recognition memory signals</strong> — if a subject has prior knowledge of a specific crime-related stimulus, the brain’s electrical activity will show a specific pattern, regardless of their emotional state.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Brain fingerprinting measures heart rate variability:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect. Heart rate variability is a <strong>physiological measure</strong> used in polygraph testing, not in brain fingerprinting.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Brain fingerprinting strictly records <strong>brainwave patterns</strong> through EEG.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Brain fingerprinting evaluates emotional arousal:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect. Evaluating emotional arousal (e.g., anxiety, fear) is the primary principle behind <strong>polygraph testing</strong>, not brain fingerprinting.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Brain fingerprinting assesses <strong>recognition memory</strong>, not emotional states.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Brain fingerprinting determines truthfulness through galvanic skin response:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect. <strong>Galvanic skin response (GSR)</strong>, or skin conductance, is another <strong>emotion-based physiological measure</strong> used in polygraphs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Brain fingerprinting <strong>does not measure</strong> GSR; it purely analyzes <strong>EEG brain signals</strong> linked to memory recognition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Unlike polygraphy, which depends on emotional and autonomic responses (e.g., heart rate, sweating), brain fingerprinting directly measures brain recognition responses (P300 and MERMER) to known information, offering a more objective tool for detecting concealed knowledge<strong>.</strong></span></p>",
      "correct_choice_id": 322818,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81033/NEET_PG_Mock_1_Q3_FMT.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81033/NEET_PG_Mock_1_Q3_FMT.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80924,
      "choices": [
        {
          "id": 322380,
          "text": "<p><span style=\"font-size:14.0pt;\">Timolol</span></p>"
        },
        {
          "id": 322381,
          "text": "<p><span style=\"font-size:14.0pt;\">Brimonidine</span></p>"
        },
        {
          "id": 322382,
          "text": "<p><span style=\"font-size:14.0pt;\">Latanoprost</span></p>"
        },
        {
          "id": 322383,
          "text": "<p><span style=\"font-size:14.0pt;\">Dorzolamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-month-old infant is diagnosed with congenital glaucoma and is initiated on medical therapy while awaiting surgical intervention. The ophthalmology team considers several topical antiglaucoma agents. Which of the following medications is contraindicated or unsafe in infants due to the risk of serious central nervous system side effects?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2117538",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Brimonidine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Brimonidine</strong> is an <strong>alpha-2 adrenergic agonist</strong> used as an antiglaucoma agent to <strong>reduce aqueous humor production</strong> and increase <strong>uveoscleral outflow</strong>. It causes brain suppression. However, it is <strong>contraindicated in infants and young children</strong>, especially <strong>under the age of 2 years</strong>, due to the <strong>risk of systemic absorption</strong> and serious <strong>central nervous system (CNS) depression</strong>. Documented side effects include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Apnea</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Bradycardia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypotension</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypothermia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Coma</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">These potentially life-threatening complications make brimonidine <strong>unsafe in pediatric populations</strong>, particularly infants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Timolol:</strong> A <strong>beta-blocker</strong> that is generally considered <strong>safe for use in infants</strong> with proper monitoring. Though systemic absorption may cause <strong>bradycardia or bronchospasm</strong>, these effects are usually manageable and less severe compared to brimonidine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Latanoprost:</strong> A <strong>prostaglandin analog</strong> that increases <strong>uveoscleral outflow</strong>. It is <strong>generally safe</strong> in pediatric patients and is used off-label in congenital glaucoma when needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dorzolamide:</strong> A <strong>carbonic anhydrase inhibitor</strong> that reduces aqueous humor production. It is considered <strong>safe in pediatric patients</strong>, although some local irritation may occur.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Brimonidine is contraindicated in infants due to its potential to cause serious CNS depression, including apnea, hypotension, and coma.</span></p>",
      "correct_choice_id": 322381,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80924/Pharma_Mock_1_NEET_PG11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80924/Pharma_Mock_1_NEET_PG11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80973,
      "choices": [
        {
          "id": 322576,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased TLC, reduced VC, low FEV₁/FVC ratio</span></p>"
        },
        {
          "id": 322577,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced TLC, RV, and VC; high FEV₁/FVC; normal MIP</span></p>"
        },
        {
          "id": 322578,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced TLC, increased RV, normal FEV₁/FVC ratio, low MIP</span></p>"
        },
        {
          "id": 322579,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal TLC, RV, FEV₁/FVC, and MIP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old man with progressive muscle weakness undergoes pulmonary function testing. She has tested positive for AchRAb and repetitive nerve stimulation shows a decremental response. Which pattern in pulmonary function testing best corresponds to the suspected diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1471126",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Reduced TLC, increased RV, normal FEV₁/FVC ratio, low MIP</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient likely has <strong>myasthenia gravis</strong>, a neuromuscular junction disorder characterized by fatigable weakness and positive AchR antibodies. Pulmonary involvement arises due to <strong>respiratory muscle weakness</strong>, including the diaphragm. In neuromuscular weakness:</span><br><br>&nbsp;<ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>TLC is reduced</strong> due to inability to expand the lungs fully.</span></li><li><span style=\"font-size:14.0pt;\"><strong>RV is increased</strong> due to impaired expiratory muscle function.</span></li><li><span style=\"font-size:14.0pt;\"><strong>FEV₁/FVC ratio is normal or slightly increased</strong>, since both FEV₁ and FVC are proportionally reduced.</span></li><li><span style=\"font-size:14.0pt;\"><strong>MIP (maximum inspiratory pressure)</strong> is <strong>low</strong>, indicating weakened inspiratory muscles.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Increased TLC, reduced VC, low FEV₁/FVC ratio:</strong> Suggests <strong>obstructive lung disease</strong> (e.g., emphysema), not neuromuscular weakness.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Reduced TLC, RV, and VC; high FEV₁/FVC; normal MIP:</strong> Reduced RV and <strong>normal MIP</strong> are inconsistent with neuromuscular disease.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Normal TLC, RV, FEV₁/FVC, and MIP:</strong> Findings would be normal in a healthy individual, not in someone with myasthenia gravis and muscle weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Neuromuscular diseases like myasthenia gravis show a restrictive pattern on PFTs with low TLC, increased RV, normal FEV₁/FVC, and low MIP—reflecting inspiratory muscle weakness and ineffective expiration.</span></p>",
      "correct_choice_id": 322578,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80973/Neet_Mock_-_1_Question_-_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80973/Neet_Mock_-_1_Question_-_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81159,
      "choices": [
        {
          "id": 323316,
          "text": "<p><span style=\"font-size:14.0pt;\">Dopamine D2 receptors</span></p>"
        },
        {
          "id": 323317,
          "text": "<p><span style=\"font-size:14.0pt;\">Histamine H1 receptors</span></p>"
        },
        {
          "id": 323318,
          "text": "<p><span style=\"font-size:14.0pt;\">NMDA glutamate receptors</span></p>"
        },
        {
          "id": 323319,
          "text": "<p><span style=\"font-size:14.0pt;\">GABA-A receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man is prescribed mirtazapine for major depressive disorder. After a few days, he reports excessive sleepiness, increased appetite, and noticeable weight gain. These side effects are most likely due to mirtazapine's antagonistic action at which of the following receptors?&nbsp;</span></p>",
      "unique_key": "Q9922970",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;Histamine H1 receptors</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Mirtazapine</strong> is a <strong>noradrenergic and specific serotonergic antidepressant (NaSSA)</strong> that exerts its effects by <strong>blocking presynaptic alpha-2 receptors</strong>, thereby increasing <strong>norepinephrine and serotonin</strong>. It also <strong>antagonizes serotonin receptors (5-HT2 and 5-HT3)</strong> and <strong>histamine H1 receptors</strong>. <strong>Blockade of H1 receptors</strong> leads to:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Sedation (excessive sleepiness)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Increased appetite</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Weight gain</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">These <strong>antihistaminergic effects</strong> are particularly <strong>prominent at lower doses</strong> and are commonly used to advantage in <strong>depressed patients with insomnia or low appetite</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Dopamine D2 receptors:</strong> Mirtazapine <strong>does not block D2 receptors</strong> — this is the primary mechanism of <strong>antipsychotics</strong>, not mirtazapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;NMDA glutamate receptors:</strong> Blockade is associated with <strong>ketamine</strong> and similar agents, not mirtazapine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;GABA-A receptors:</strong> These are the target of <strong>benzodiazepines and barbiturates</strong>, not involved in mirtazapine’s action.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Mirtazapine&nbsp;</strong>is a <strong>noradrenergic and specific serotonergic antidepressant (NaSSA)&nbsp;</strong>with a unique receptor profile. Its antidepressant and side effect profile is due to actions at multiple receptor sites:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>α2-adrenergic antagonism</strong> → Increases norepinephrine and serotonin release, enhancing antidepressant effect.</span></li><li><span style=\"font-size:14.0pt;\"><strong>5-HT2 and 5-HT3 antagonism</strong> → Reduces anxiety, GI symptoms, and sexual side effects.</span></li><li><span style=\"font-size:14.0pt;\"><strong>H1 histamine receptor antagonism</strong> → Causes sedation, increased appetite, and weight gain.</span></li></ul></li></ul>",
      "correct_choice_id": 323317,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81159/Psychiatry_Mock_1_Q1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81159/Psychiatry_Mock_1_Q1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81088,
      "choices": [
        {
          "id": 323032,
          "text": "<p><span style=\"font-size:14.0pt;\">Chronic myelogenous leukemia</span></p>"
        },
        {
          "id": 323033,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute lymphoblastic leukemia B subtype</span></p>"
        },
        {
          "id": 323034,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute myelogenous leukemia</span></p>"
        },
        {
          "id": 323035,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute lymphoblastic leukemia T subtype</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-year-old male is brought in due to increasing fatigue and bruising over the past few weeks. On evaluation, he appears pale and has multiple petechiae over his lower extremities. He also has palpable cervical and axillary lymph nodes. Lab results reveal hemoglobin of 8.0 g/dL, platelet count of 40,000/µL, and white blood cell count of 120,000/µL. A peripheral smear reveals numerous blasts, and flow cytometry identifies the blasts as TdT-positive, CD10-positive, and CD19-positive. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5574529",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Acute lymphoblastic leukemia B subtype</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This child presents with <strong>classic signs of bone marrow failure</strong> (fatigue from anemia, petechiae from thrombocytopenia, infections from neutropenia), and a significantly elevated white blood cell count composed primarily of <strong>blasts</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The diagnosis of <strong>acute lymphoblastic leukemia (ALL)</strong> is confirmed by the <strong>presence of TdT</strong>, a marker of lymphoid precursors.</span></li><li><span style=\"font-size:14.0pt;\">Further <strong>immunophenotyping with flow cytometry</strong> reveals <strong>CD10</strong> and <strong>CD19</strong> positivity, which are markers <strong>specific to the B-cell lineage</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, this is consistent with <strong>B-cell subtype of acute lymphoblastic leukemia (B-ALL)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">B-ALL is the <strong>most common childhood malignancy</strong> and is typically seen between ages 2–10 years.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chronic myelogenous leukemia (CML):</strong> CML is exceedingly rare in children and typically presents with <strong>mature granulocytes</strong> and a <strong>left-shifted myeloid series</strong> rather than blasts. It is also associated with the <strong>Philadelphia chromosome (t(9;22))</strong>, not CD10 or TdT positivity. CML would not present with lymphoblast markers such as CD19.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acute myelogenous leukemia (AML):</strong> AML may occur in children but is <strong>less common than ALL</strong>. AML blasts are <strong>negative for TdT</strong> (which is specific to lymphoid lineage) and instead may express <strong>myeloperoxidase (MPO)</strong>. CD10 and CD19 are not found in AML blasts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acute lymphoblastic leukemia T subtype:</strong> T-ALL is also TdT-positive but typically expresses <strong>CD2, CD3, CD5, and CD7</strong> markers rather than CD10 and CD19. T-ALL often presents with a <strong>mediastinal (thymic) mass</strong>, which is absent in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Acute lymphoblastic leukemia B subtype is identified by TdT, CD10, and CD19 positivity and is the most common malignancy in children presenting with anemia, thrombocytopenia, lymphadenopathy, and blasts in peripheral blood.</span></p>",
      "correct_choice_id": 323033,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81088/NEET_PG_Mock_1_Q10_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81088/NEET_PG_Mock_1_Q10_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81139,
      "choices": [
        {
          "id": 323236,
          "text": "<p><span style=\"font-size:14.0pt;\">A–2, B–3, C–1, D–4</span></p>"
        },
        {
          "id": 323237,
          "text": "<p><span style=\"font-size:14.0pt;\">A–3, B–1, C–2, D–4</span></p>"
        },
        {
          "id": 323238,
          "text": "<p><span style=\"font-size:14.0pt;\">A–2, B–1, C–3, D–4</span></p>"
        },
        {
          "id": 323239,
          "text": "<p><span style=\"font-size:14.0pt;\">A–1, B–2, C–3, D–4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the following brain areas and their functions:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A (Brain Area)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Wernicke’s Area</span></li><li><span style=\"font-size:14.0pt;\">Broca’s Area</span></li><li><span style=\"font-size:14.0pt;\">Angular Gyrus</span></li><li><span style=\"font-size:14.0pt;\">Postcentral Gyrus</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B (Function)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Speech production</span></li><li><span style=\"font-size:14.0pt;\">Language comprehension&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Processing of written language&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Primary somatosensory processing</span></li></ol>",
      "unique_key": "Q3215744",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A–2, B–1, C–3, D–4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A–2. Wernicke’s Area:&nbsp;</strong>Located in the <strong>superior temporal gyrus</strong> (Brodmann area 22), it is responsible for <strong>comprehension of speech and language</strong>, both spoken and written.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B–1. Broca’s Area: </strong>Located in the <strong>inferior frontal gyrus</strong> (Brodmann areas 44 and 45), responsible for <strong>speech production</strong>, particularly motor planning of language.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C–3. Angular Gyrus:&nbsp;</strong>Found in the <strong>parietal lobe</strong>, involved in <strong>reading and writing</strong>, integrating visual, auditory, and language inputs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D–4. Postcentral Gyrus:&nbsp;</strong>Corresponds to the <strong>primary somatosensory cortex</strong> (Brodmann areas 3, 1, 2), responsible for <strong>processing tactile sensory information</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Different regions of the brain are specialized for specific aspects of <strong>language</strong> and <strong>sensory function</strong>. <strong>Wernicke’s area</strong> is key for language comprehension, while <strong>Broca’s area</strong> enables speech production.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>angular gyrus</strong> plays a role in reading and writing, and the <strong>postcentral gyrus</strong> is responsible for primary somatic sensation.</span></li></ul>",
      "correct_choice_id": 323238,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81139/NEET_PG_Mock_1_Q4_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81139/NEET_PG_Mock_1_Q4_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81026,
      "choices": [
        {
          "id": 322788,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-B, 4-A</span></p>"
        },
        {
          "id": 322789,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-A, 4-B</span></p>"
        },
        {
          "id": 322790,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
        },
        {
          "id": 322791,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-D, 4-C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Asch's forceps</span></li><li><span style=\"font-size:14.0pt;\">Walsham's forceps</span></li><li><span style=\"font-size:14.0pt;\">Tilly's forceps</span></li><li><span style=\"font-size:14.0pt;\">Citelli's forceps</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B.</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:14.0pt;\">Used for punching bones and other tissues</span></li><li><span style=\"font-size:14.0pt;\">Used for insertion or removal of nasal packing or dressings</span></li><li><span style=\"font-size:14.0pt;\">Mainly used to reduce a fracture of the nasal septum</span></li><li><span style=\"font-size:14.0pt;\">Mainly used to reduce nasal bone fractures</span></li></ol>",
      "unique_key": "Q6414123",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1-C, 2-D, 3-B, 4-A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Asch's forceps - C. Mainly used to reduce a fracture of the nasal septum:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Asch's forceps are specifically designed to handle and manipulate fractures of the nasal septum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They are commonly used in septoplasty procedures to realign or reshape the septum when it is fractured or deviated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their structure allows for precise control and manipulation within the confined nasal cavity, making them ideal for treating septal fractures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_H9gCsny.png\" width=\"415\" height=\"414\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Walsham's forceps - D. Mainly used to reduce nasal bone fractures:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Walsham's forceps are robust and designed to handle fractures of the nasal bones rather than the septum.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They are particularly useful in cases of nasal trauma where the bones need to be reset to restore nasal structure and function.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These forceps provide the necessary leverage and grip to manipulate and reduce bone fractures effectively.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20161831.jpg\" width=\"175\" height=\"414\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Tilly's forceps - B. Used for insertion or removal of nasal packing or dressings:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tilly's forceps are commonly used in ENT practices for inserting and removing nasal packing or dressings in the nasal cavity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their design allows for safe and controlled placement and retrieval of packing materials, which are often used post-surgery or to control nasal bleeding.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Tilly's forceps are essential in managing nasal dressings without causing additional trauma to the delicate nasal structures.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20161854.jpg\" width=\"512\" height=\"269\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Citelli's forceps - A. Used for punching bones and other tissues</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Citelli's forceps are more aggressive instruments designed to punch through bone and other dense tissues.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These forceps are utilized when bony structures need to be removed or shaped, such as during certain sinus or nasal surgeries.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their sturdy build and cutting edge make them suitable for punching through tough tissue structures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pMT9TTh.png\" width=\"490\" height=\"292\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Asch’s</strong> – For <strong>septal fractures</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Walsham’s</strong> – For <strong>nasal bone fractures</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Tilly’s</strong> – For <strong>nasal packing</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Citelli’s</strong> – For <strong>bone punching</strong> during nasal/sinus procedures.</span></li></ul>",
      "correct_choice_id": 322788,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81026/Neet_Pg_Mock_1_Q4_Ent.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81026/Neet_Pg_Mock_1_Q4_Ent.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81115,
      "choices": [
        {
          "id": 323140,
          "text": "<p><span style=\"font-size:14.0pt;\">VR medium</span></p>"
        },
        {
          "id": 323141,
          "text": "<p><span style=\"font-size:14.0pt;\">Thioglycollate medium</span></p>"
        },
        {
          "id": 323142,
          "text": "<p><span style=\"font-size:14.0pt;\">Cary-Blair transport medium</span></p>"
        },
        {
          "id": 323143,
          "text": "<p><span style=\"font-size:14.0pt;\">Selenite F broth</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An outbreak of acute gastroenteritis has been reported in a community following a public event. Multiple individuals presented with fever, abdominal cramps, and diarrhea. Stool specimens have been collected and sent to the microbiology laboratory to isolate the likely causative organism, Salmonella spp. Which of the following enrichment media is most appropriate to facilitate the isolation of Salmonella from stool samples in this context?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4047031",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Selenite F broth</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Selenite F broth</strong> is the <strong>enrichment medium of choice</strong> for isolating <strong>Salmonella</strong> species from <strong>fecal specimens</strong>, especially during <strong>gastroenteritis outbreaks</strong>. It works by:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Suppressing the growth</strong> of <strong>normal intestinal flora</strong> (like E. coli)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Enhancing the growth</strong> of <strong>Salmonella</strong>, which may be present in <strong>small numbers</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">It is ideal for use in early phases of infection when prompt and accurate identification is critical.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. VR medium (Violet Red Bile Agar):</strong> Used for the <strong>enumeration of coliforms</strong>, not for <strong>enrichment of Salmonella</strong>.</span> <span style=\"font-size:14.0pt;\">It is used for Vibrio. It is a <strong>selective differential medium</strong>, not suitable in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Thioglycollate medium:</strong> A <strong>reducing medium</strong> used for culturing <strong>anaerobic bacteria</strong>, not for <strong>enteric pathogens</strong> like Salmonella.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cary-Blair medium:</strong> A <strong>transport medium</strong>, not an enrichment medium. It is used to <strong>preserve enteric pathogens</strong> during transportation but <strong>does not promote selective growth</strong>. It is used for Vibrio.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Selenite F broth is the enrichment medium of choice for isolating Salmonella from stool samples, especially in suspected outbreaks of foodborne gastroenteritis.</span></p>",
      "correct_choice_id": 323143,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81115/Microbiology_NEET_PG_Mock_Q8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81115/Microbiology_NEET_PG_Mock_Q8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80963,
      "choices": [
        {
          "id": 322536,
          "text": "<p><span style=\"font-size:14.0pt;\">Propranolol for migraine</span></p>"
        },
        {
          "id": 322537,
          "text": "<p><span style=\"font-size:14.0pt;\">Ergotamine for migraine</span></p>"
        },
        {
          "id": 322538,
          "text": "<p><span style=\"font-size:14.0pt;\">Salbutamol for asthma</span></p>"
        },
        {
          "id": 322539,
          "text": "<p><span style=\"font-size:14.0pt;\">Atropine for bradycardia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;34-year-old man&nbsp;experiences an&nbsp;anaphylactic reaction&nbsp;and receives a&nbsp;subcutaneous injection of epinephrine, which is the standard first-line treatment due to its&nbsp;vasoconstrictive (α1)&nbsp;and&nbsp;bronchodilatory (β2)&nbsp;effects. However, instead of vasoconstriction, the patient develops&nbsp;further vasodilation&nbsp;after the injection. Which of the following medications is the patient&nbsp;most likely already taking, thereby&nbsp;interfering with the expected response to epinephrine?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1817309",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ergotamine for migraine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ergotamine is an alpha-adrenergic receptor antagonist, not an agonist as sometimes misunderstood. It blocks alpha-1 receptors, which are the primary receptors through which epinephrine exerts its vasoconstrictive effects.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In a patient taking ergotamine, the vasoconstrictive action of epinephrine is blunted or even reversed, leading to unopposed beta-2 stimulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This results in vasodilation, particularly in skeletal muscle vessels, which explains the paradoxical worsening of vasodilation in this patient after epinephrine administration. Even ergotamine was the one of the first drugs, and a significant one, that demonstrated the phenomenon known as “Vasomotor reversal of Dale”&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, ergotamine use best explains the clinical finding described in the scenario.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Propranolol for migraine:&nbsp;</strong>Propranolol, a non-selective beta-blocker, would block beta-1 and beta-2 receptors. In anaphylaxis, this might worsen the situation by reducing bronchodilation and cardiac output. However, it would lead to unopposed alpha-1 stimulation, which typically causes vasoconstriction, not vasodilation. Thus, propranolol would not explain the vasodilation observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Salbutamol for asthma:&nbsp;</strong>Salbutamol is a beta-2 agonist that causes bronchodilation and vasodilation. However, it would not interfere with epinephrine's alpha-1 mediated vasoconstriction and would not prevent epinephrine from reversing vasodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Atropine for bradycardia:&nbsp;</strong>Atropine is a muscarinic receptor antagonist that affects the parasympathetic nervous system, increasing heart rate and reducing secretions. It has no effect on alpha- or beta-adrenergic receptors and therefore does not interfere with epinephrine's vasoconstrictive actions. Thus, ergotamine is the only drug among the options that would specifically block epinephrine’s vasoconstrictive action and lead to further vasodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Epinephrine produces vasodilation when administered in the presence of an alpha-adrenergic blocker like ergotamine due to unopposed beta-2 receptor-mediated effects, a phenomenon known as vasomotor reversal of Dale.</span></p>",
      "correct_choice_id": 322537,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80963/Pharma_Mock_1_NEET_PG18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80963/Pharma_Mock_1_NEET_PG18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80923,
      "choices": [
        {
          "id": 322376,
          "text": "<p><span style=\"font-size:14.0pt;\">It is experiencing rapid growth and will double in 35–47 years</span></p>"
        },
        {
          "id": 322377,
          "text": "<p><span style=\"font-size:14.0pt;\">It is growing moderately with a doubling time of less than 70 years</span></p>"
        },
        {
          "id": 322378,
          "text": "<p><span style=\"font-size:14.0pt;\">Its population is stationary</span></p>"
        },
        {
          "id": 322379,
          "text": "<p><span style=\"font-size:14.0pt;\">It has slow growth and will double in more than 139 years</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A newly industrializing country conducts a demographic review and finds that its Annual Growth Rate (AGR) is 0.6%. Based on standard classifications of population growth patterns, which of the following statements best reflects this country's current demographic status?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5720572",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) It is growing moderately with a doubling time of less than 70 years</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An <strong>AGR of 0.6%</strong> places the country in the <strong>“moderate growth”</strong> category, which corresponds to an <strong>approximate doubling time between 139 and 70 years</strong> (as per standard demographic classification). Since the AGR is <strong>greater than 0.5% but less than 1.0%</strong>, the <strong>doubling time is less than 139 years</strong> but more than 70 years — making <strong>Option B the most accurate</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Population doubling time is calculated using the <strong>Rule of 70</strong>, a demographic shortcut:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_D0LBoVk.png\" width=\"747\" height=\"251\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This confirms <strong>moderate growth</strong> and <strong>eliminates slow growth (&gt;139 years)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is experiencing rapid growth and will double in 35–47 years: </strong>Incorrect. <strong>Rapid growth</strong> corresponds to an AGR of <strong>1.0–1.5%</strong>, not 0.6%. A doubling time of 35–47 years would suggest <strong>very rapid to explosive growth</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Its population is stationary:&nbsp;</strong>Incorrect. A <strong>stationary population</strong> has <strong>no net growth</strong> (AGR ≈ 0%). Since AGR is 0.6%, this population is clearly growing, though moderately.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It has slow growth and will double in more than 139 years:&nbsp;</strong>Incorrect. <strong>Slow growth</strong> corresponds to AGR &lt; 0.5%. At 0.6%, the doubling time is <strong>under 139 years</strong>, not over.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">An AGR of 0.6% reflects moderate growth, with the population expected to double in less than 139 but more than 70 years — a key demographic indicator for planning health, education, and infrastructure needs.</span></p>",
      "correct_choice_id": 322377,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80923/PSM_Mock_1_Q5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80923/PSM_Mock_1_Q5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81122,
      "choices": [
        {
          "id": 323168,
          "text": "<p><span style=\"font-size:14.0pt;\">Histoplasma capsulatum</span></p>"
        },
        {
          "id": 323169,
          "text": "<p><span style=\"font-size:14.0pt;\">Blastomyces dermatitidis</span></p>"
        },
        {
          "id": 323170,
          "text": "<p><span style=\"font-size:14.0pt;\">Coccidioides immitis</span></p>"
        },
        {
          "id": 323171,
          "text": "<p><span style=\"font-size:14.0pt;\">Talaromyces (Penicillium) marneffei</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old man presents with fever, cough, and chest pain. Chest X-ray reveals consolidation, and sputum microscopy demonstrates large, round, thick-walled yeast cells with broad-based budding and a double-contoured cell wall. Which of the following organisms is most likely responsible for his pneumonia?</span></p>",
      "unique_key": "Q3842574",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Blastomyces dermatitidis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Blastomyces dermatitidis</strong> is a <strong>dimorphic fungus</strong> found in moist soil, especially in regions of the <strong>Ohio and Mississippi River valleys</strong> and <strong>Great Lakes</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It exists as a <strong>mold in the environment</strong> and transforms into a <strong>broad-based budding yeast</strong> at <strong>body temperature (37°C)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The yeast form is <strong>thick-walled, double-contoured</strong>, and <strong>spherical</strong>, which is a <strong>key diagnostic clue</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It often causes <strong>pulmonary blastomycosis</strong>, presenting with <strong>fever, productive cough, and lung infiltrates</strong>, and can <strong>disseminate</strong> to skin, bone, and GU tract.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Histoplasma capsulatum:</strong> Also, a <strong>dimorphic fungus</strong>, but appears in tissues as <strong>small, oval yeast cells</strong> <strong>within macrophages</strong>. Does <strong>not show broad-based budding</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Coccidioides immitis:</strong> Found in the <strong>southwestern U.S.</strong>, causes <strong>valley fever</strong>. In tissues, it forms <strong>spherules with endospores</strong>, not yeast with broad-based buds.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Talaromyces (Penicillium) marneffei:</strong> Seen in <strong>immunocompromised hosts</strong> (e.g., HIV patients in Southeast Asia). Appears as <strong>oval yeast cells with central transverse septum</strong>, not broad-based budding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Blastomyces dermatitidis is identified in tissue by its broad-based budding yeast with a thick, double-contoured wall and is a known cause of fungal pneumonia in endemic areas.</span></p>",
      "correct_choice_id": 323169,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81122/Microbiology_NEET_PG_Mock_Q15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81122/Microbiology_NEET_PG_Mock_Q15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80907,
      "choices": [
        {
          "id": 322312,
          "text": "<p><span style=\"font-size:14.0pt;\">Phenytoin</span></p>"
        },
        {
          "id": 322313,
          "text": "<p><span style=\"font-size:14.0pt;\">Dofetilide</span></p>"
        },
        {
          "id": 322314,
          "text": "<p><span style=\"font-size:14.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 322315,
          "text": "<p><span style=\"font-size:14.0pt;\">Procainamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old patient with a history of paroxysmal atrial fibrillation is being evaluated for pharmacological rhythm control. The cardiologist wishes to prescribe an agent that prolongs the cardiac action potential duration by selectively blocking delayed rectifier potassium channels, without exhibiting additional sodium, beta-blocking, or calcium channel-blocking activity. Which of the following is the most appropriate agent?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1877219",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Dofetilide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Dofetilide</strong> is a <strong>class III antiarrhythmic</strong> that works by <strong>purely blocking the delayed rectifier potassium current (IKr)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This <strong>selectively prolongs the repolarization phase (phase 3)</strong> of the cardiac action potential, thereby <strong>increasing action potential duration and the QT interval</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Importantly, <strong>dofetilide does not affect sodium channels, beta-adrenergic receptors, or calcium channels</strong>, making it a <strong>pure action potential–prolonging drug</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is particularly used for <strong>maintenance or conversion to sinus rhythm in atrial fibrillation or flutter</strong>, especially in patients with <strong>structural heart disease</strong>, as it has <strong>minimal negative inotropic effect</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Phenytoin:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A class IB antiarrhythmic that <strong>shortens</strong> the action potential duration by <strong>blocking sodium channels</strong>, particularly in <strong>ischemic tissues</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It <strong>does not prolong</strong> the action potential.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Amiodarone:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Although classified as a class III agent, <strong>amiodarone has properties of all four Vaughan-Williams classes</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Class I: Sodium channel blockade</span></li><li><span style=\"font-size:14.0pt;\">Class II: Beta-blocking</span></li><li><span style=\"font-size:14.0pt;\">Class III: Potassium channel blockade</span></li><li><span style=\"font-size:14.0pt;\">Class IV: Calcium channel blockade</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Therefore, it <strong>affects multiple phases</strong> of the action potential—not a <strong>pure action potential–prolonging agent</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Procainamide:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A class IA antiarrhythmic that <strong>prolongs the action potential</strong> but also has significant <strong>sodium channel-blocking activity</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It also has <strong>some anticholinergic properties</strong>, making it <strong>not selective</strong> for action potential prolongation alone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Dofetilide is a class III antiarrhythmic that selectively prolongs the cardiac action potential without affecting sodium, beta, or calcium channels, making it the purest action potential–prolonging agent.</span></p>",
      "correct_choice_id": 322313,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80907/Pharma_Mock_1_NEET_PG2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80907/Pharma_Mock_1_NEET_PG2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80947,
      "choices": [
        {
          "id": 322472,
          "text": "<p><span style=\"font-size:14.0pt;\">Gestational diabetes</span></p>"
        },
        {
          "id": 322473,
          "text": "<p><span style=\"font-size:14.0pt;\">Pre-eclampsia</span></p>"
        },
        {
          "id": 322474,
          "text": "<p><span style=\"font-size:14.0pt;\">Placental abruption</span></p>"
        },
        {
          "id": 322475,
          "text": "<p><span style=\"font-size:14.0pt;\">Antiphospholipid antibody syndrome (APLA)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What obstetric complication is this test most specifically being developed to detect?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105409.jpg\" width=\"631\" height=\"540\"></strong></span></p>",
      "unique_key": "Q7517450",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Pre-eclampsia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image displays the <strong>Congo Red Dot (CRD) test</strong>, which is a novel point-of-care diagnostic tool being developed to detect <strong>pre-eclampsia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition is characterized by <strong>abnormal placental development</strong>, leading to oxidative stress and release of <strong>misfolded proteins</strong> into the maternal circulation and urine.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These misfolded proteins have a high affinity for <strong>Congo red dye</strong>, which allows their detection using this simple test.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A strongly or weakly positive result indicates the presence of these misfolded proteins, supporting a diagnosis of pre-eclampsia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gestational diabetes: </strong>This is diagnosed via <strong>glucose tolerance testing</strong> and does not involve misfolded proteins in the urine. The CRD test has no role in its evaluation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Abruption (Placental abruption): </strong>Abruption refers to premature separation of the placenta and presents with <strong>painful bleeding</strong> and fetal distress. Diagnosis is clinical and ultrasonographic; it is <strong>not associated with Congo red–binding proteins</strong> in urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. APLA (Antiphospholipid Antibody Syndrome): </strong>APLA is an autoimmune condition associated with <strong>recurrent miscarriages</strong>, thrombosis, and pregnancy complications. It is diagnosed by serological tests (anticardiolipin, lupus anticoagulant, β2 glycoprotein I), <strong>not by urinary markers or Congo red dye tests</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Congo Red Dot (CRD) test</strong> is a novel; rapid diagnostic test being evaluated for early identification of <strong>pre-eclampsia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It detects <strong>misfolded proteins</strong> in maternal urine that are pathognomonic for placental dysfunction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This low-cost, bedside tool may improve diagnosis and management of pre-eclampsia, especially in resource-limited settings.</span></li></ul>",
      "correct_choice_id": 322473,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80947/OBG_Mock_1_Q10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80947/OBG_Mock_1_Q10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80958,
      "choices": [
        {
          "id": 322516,
          "text": "<p><span style=\"font-size:14.0pt;\">Acceleration</span></p>"
        },
        {
          "id": 322517,
          "text": "<p><span style=\"font-size:14.0pt;\">Deceleration</span></p>"
        },
        {
          "id": 322518,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal tracing</span></p>"
        },
        {
          "id": 322519,
          "text": "<p><span style=\"font-size:14.0pt;\">None</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the finding in the cardiotocography (CTG) graph shown?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105612.jpg\" width=\"639\" height=\"465\"></span></p>",
      "unique_key": "Q9321952",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Deceleration</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The graph shows a decrease in fetal heart rate below the baseline, characteristic of <strong>deceleration</strong>. The type of deceleration can be determined by its relationship to uterine contractions:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Early deceleration</strong>: Mirrors uterine contractions and is caused by fetal head compression. It is usually physiological.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Late deceleration</strong>: Occurs after the peak of uterine contractions and indicates uteroplacental insufficiency. It is pathological and may require immediate intervention.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Variable deceleration</strong>: Unrelated to contractions and caused by umbilical cord compression.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acceleration</strong>: Represents an increase in fetal heart rate above baseline, which indicates fetal well-being.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Normal tracing</strong>: A normal CTG includes baseline variability of 10–25 bpm with no decelerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Decelerations on CTG are classified as early, late, or variable, and their interpretation helps determine fetal well-being.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Late and variable decelerations may require prompt intervention to prevent fetal compromise.</span></li></ul>",
      "correct_choice_id": 322517,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80958/OBG_Mock_1_Q15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80958/OBG_Mock_1_Q15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81153,
      "choices": [
        {
          "id": 323292,
          "text": "<p><span style=\"font-size:14.0pt;\">Increasing the refractory period in ventricular myocytes</span></p>"
        },
        {
          "id": 323293,
          "text": "<p><span style=\"font-size:14.0pt;\">Increasing sympathetic tone in systemic arteries</span></p>"
        },
        {
          "id": 323294,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreasing the firing rate of carotid baroreceptors</span></p>"
        },
        {
          "id": 323295,
          "text": "<p><span style=\"font-size:14.0pt;\">Slowing conduction in AV node</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old male presents to emergency with severe sudden-onset heart palpitations. The patient reports symptoms of chest pain, fatigue, and dizziness. Upon examination, his heart rate is 165/min and regular. His blood pressure is 106/74 mmHg. A gentle massage below the level of the left mandible elicits an immediate improvement in the patient, as his heart rate returns to 60/min. What was the mechanism of action of this manoeuvre?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1548701",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Slowing conduction in AV node</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Suggesting a supraventricular tachyarrhythmia, such as AV nodal reentrant tachycardia (AVNRT), which is commonly seen in young individuals with no structural heart disease.</span></li><li><span style=\"font-size:14.0pt;\">His blood pressure was 106/74 mmHg, which is on the lower side, and further supports the likelihood of a hemodynamically significant arrhythmia.</span></li><li><span style=\"font-size:14.0pt;\">The key diagnostic maneuver in the case is the gentle massage below the level of the left mandible, which elicited immediate improvement — specifically, the heart rate returned to 60/min. This clearly refers to carotid sinus massage, a physical technique used to stimulate the baroreceptors in the carotid sinus.</span></li><li><span style=\"font-size:14.0pt;\">Stimulation of these baroreceptors activates the parasympathetic (vagal) tone, which predominantly affects the atrioventricular (AV) node by:</span><ul><li><span style=\"font-size:14.0pt;\">Decreasing AV node conduction velocity</span></li><li><span style=\"font-size:14.0pt;\">Increasing AV node refractory period</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This action interrupts the reentrant circuit in AVNRT or slows down conduction in other types of supraventricular tachycardia. Thus, the mechanism of action of this manoeuvre is slowing conduction in AV node</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increasing the refractory period in ventricular myocytes:</strong> Incorrect. Because the ventricular myocytes are not the primary site of action in this scenario. The carotid sinus massage affects parasympathetic activity, which predominantly influences the SA and AV nodes, not the ventricular muscle fibers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increasing sympathetic tone in systemic arteries:</strong> Incorrect. Because the carotid massage stimulates parasympathetic tone, not sympathetic. An increase in sympathetic tone would increase heart rate and vascular resistance, which is the opposite of the therapeutic effect seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decreasing the firing rate of carotid baroreceptors:</strong> Incorrect. This option is not physiologically consistent with the maneuver. Carotid sinus massage increases the firing rate of baroreceptors by simulating increased blood pressure, leading to reflex vagal activation and decreased heart rate. Therefore, the firing rate is increased, not decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Carotid sinus massage increases parasympathetic tone, leading to slowed AV node conduction and termination of supraventricular tachycardias such as AVNRT.</span></p>",
      "correct_choice_id": 323295,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81153/Neet_Pg_Mock_1_Q4_Physiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81153/Neet_Pg_Mock_1_Q4_Physiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81135,
      "choices": [
        {
          "id": 323220,
          "text": "<p><span style=\"font-size:14.0pt;\">The patient experiences limited abduction and adduction</span></p>"
        },
        {
          "id": 323221,
          "text": "<p><span style=\"font-size:14.0pt;\">There is a widening of the palpebral fissure on abduction</span></p>"
        },
        {
          "id": 323222,
          "text": "<p><span style=\"font-size:14.0pt;\">Head tilt is more common than other types</span></p>"
        },
        {
          "id": 323223,
          "text": "<p><span style=\"font-size:14.0pt;\">Sixth nerve palsy is associated with this condition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is a true characteristic of Duane Retraction Syndrome Type 1?</span></p>",
      "unique_key": "Q5659240",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) There is a widening of the palpebral fissure on abduction</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Duane Retraction Syndrome Type 1 (DRS Type 1)</strong> is characterized by <strong>limited abduction</strong> of the affected eye and the <strong>widening of the palpebral fissure</strong> when the patient attempts to abduct the eye.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-05-20%20at%2012.41.37%20PM.jpeg\" width=\"239\" height=\"357\"></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20174541.jpg\" width=\"706\" height=\"651\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This occurs because of an abnormal development of the sixth cranial nerve, which affects the lateral rectus muscle, causing a restricted outward movement of the eye.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The widening of the palpebral fissure is a distinctive feature of <strong>DRS Type 1</strong> and occurs during <strong>abduction</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The patient experiences limited abduction and adduction:</strong> This is incorrect for <strong>Duane Retraction Syndrome Type 1</strong>. In <strong>Type 1</strong>, <strong>adduction</strong> (the inward movement of the eye) is often normal or even exaggerated, while <strong>abduction</strong> is restricted. Limited <strong>abduction and adduction</strong> is seen more commonly in <strong>Types 2 and 3</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Head tilt is more common than other types:</strong> Head<strong>&nbsp;</strong>tilt is not a predominant feature of <strong>DRS Type 1</strong>. It is more common in <strong>Duane Retraction Syndrome Type 2 and Type 3</strong>, where both abduction and adduction are affected, often requiring the patient to compensate by tilting their head. In <strong>Type 1</strong>, the main issue is restricted abduction and widened palpebral fissure, so head tilt is less frequent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sixth nerve palsy is associated with this condition:</strong> Sixth<strong>&nbsp;</strong>nerve<strong>&nbsp;</strong>palsy is not associated with <strong>Duane Retraction Syndrome</strong>. In <strong>DRS</strong>, the problem is due to <strong>abnormal innervation of the lateral rectus muscle</strong>, which prevents normal abduction of the eye. While the <strong>sixth nerve</strong> is involved, it is not a true palsy, as the nerve is structurally present but does not develop appropriately.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Duane Retraction Syndrome Type 1</strong> is characterized by <strong>limited abduction</strong> of the affected eye and <strong>widening of the palpebral fissure on abduction</strong>, caused by abnormal development of the sixth cranial nerve affecting the lateral rectus muscle.</span></p>",
      "correct_choice_id": 323221,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81135/NEET_PG_Mock_1_Q5_Optha.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81135/NEET_PG_Mock_1_Q5_Optha.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80976,
      "choices": [
        {
          "id": 322588,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-D, 3-C, 4-A</span></p>"
        },
        {
          "id": 322589,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-C, 4-A</span></p>"
        },
        {
          "id": 322590,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-B, 3-A, 4-C</span></p>"
        },
        {
          "id": 322591,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-D, 3-A, 4-C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the scenario with the preferred surgical intervention</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105758.jpg\" width=\"1209\" height=\"463\"></span></p>",
      "unique_key": "Q4429944",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1-D, 2-B, 3-C, 4-A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1-D. 27y P3L3 lady with uterocervical prolapse -</strong> <strong>Manchester repair:</strong> The 1<sup>st</sup> scenario is of a woman with family probably complete (She has 3 children) but is quite young (27y). Prolapse in such a patient can be treated by Manchester repair (which involves cervical amputation with plication of the cardinal ligaments over the cervical stump)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2-B. 34y nulliparous lady with uterocervical prolapse -</strong> <strong>Hystero-sacrocpexy:</strong> The 2<sup>nd</sup> scenario is one of nulliparous prolapse. This can be treated with sling surgeries and nowadays, hystero-sacropexy/ cervico-sacropexy (laparoscopic or laparotomy) is done. Another procedure called cervico-pectopexy is done (the cervix is attached to the iliopectineal ligaments)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3-C. 52y P2L2 with uterocervical prolapse with cystocele and rectocele - Ward-Mayo’s repair:</strong> The 3<sup>rd</sup> scenario is a peri-menopausal woman with prolapse. Here Ward Mayo is preferred. This includes vaginal hysterectomy with anterior colporrhaphy and posterior colpo-perineorrhaphy</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4-A. 45y P2L1 with cystocele - Anterior colporrhaphy:</strong> The 4<sup>th</sup> scenario is a&nbsp;with cystocele. Here Anterior colporrhaphy is preferred. If old and unfit for major surgery: Colpocleisis</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Surgeries for uterine prolapse include:&nbsp;</strong></span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">If family complete and elderly/ postmenopausal: Vaginal hysterectomy with anterior colporrhaphy (cystocele repair) and posterior colpoperineorrhaphy (rectocele repair)</span></li><li><span style=\"font-size:14.0pt;\">If family complete and young: Manchester repair/ Fothergill repair or Shirodkar modification of Manchester&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If young and nulliparous: Sling surgeries or hysteropexy surgery</span></li><li><span style=\"font-size:14.0pt;\">If old and unfit for major surgery: Colpocleisis</span></li></ol></li></ul>",
      "correct_choice_id": 322589,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80976/OBG_Mock_1_Q19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80976/OBG_Mock_1_Q19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81119,
      "choices": [
        {
          "id": 323156,
          "text": "<p><span style=\"font-size:14.0pt;\">Plasmodium falciparum</span></p>"
        },
        {
          "id": 323157,
          "text": "<p><span style=\"font-size:14.0pt;\">Plasmodium malariae</span></p>"
        },
        {
          "id": 323158,
          "text": "<p><span style=\"font-size:14.0pt;\">Plasmodium vivax</span></p>"
        },
        {
          "id": 323159,
          "text": "<p><span style=\"font-size:14.0pt;\">Plasmodium ovale</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old traveller returns from East Africa and is evaluated for fever, chills, and malaise. Blood smear reveals ring-stage parasites inside red blood cells. Further testing is ordered to confirm the species. The patient is found to be negative for Duffy blood group antigen. This genetic trait provides resistance against which of the following Plasmodium species?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8720113",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Plasmodium vivax</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Duffy antigen</strong> (also known as <strong>Duffy blood group antigen</strong> or <strong>DARC: Duffy Antigen Receptor for Chemokines</strong>) is a <strong>receptor on red blood cells</strong> that is <strong>essential for Plasmodium vivax to invade RBCs</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Individuals who are Duffy-negative (FyFy genotype)</strong>—common in many people of <strong>West and Central African descent</strong>—are <strong>resistant to P. vivax infection</strong> because the parasite <strong>cannot bind to and enter red cells</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>P. vivax</strong> specifically requires the <strong>Duffy antigen</strong> to initiate erythrocyte invasion and complete its <strong>lifecycle in humans</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Plasmodium falciparum:</strong> Uses different erythrocyte receptors (e.g., <strong>PfEMP1</strong>, <strong>glycophorins</strong>) for RBC invasion and is <strong>not dependent</strong> on the Duffy antigen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Plasmodium malariae:</strong> Invades red cells independently of the Duffy antigen; infection is <strong>not restricted</strong> by Duffy status.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Plasmodium ovale:</strong> Like <strong>P. malariae</strong>, it does <strong>not require the Duffy antigen</strong> for erythrocyte invasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Plasmodium vivax requires the Duffy antigen to invade red blood cells; individuals lacking this antigen are naturally resistant to P. vivax infection.</span></p>",
      "correct_choice_id": 323158,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81119/Microbiology_NEET_PG_Mock_Q12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81119/Microbiology_NEET_PG_Mock_Q12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81035,
      "choices": [
        {
          "id": 322824,
          "text": "<p><span style=\"font-size:14.0pt;\">Wet clothing should be dried with heat before packaging to prevent bacterial degradation</span></p>"
        },
        {
          "id": 322825,
          "text": "<p><span style=\"font-size:14.0pt;\">Wet clothing should be placed in airtight plastic bags to preserve moisture-sensitive evidence</span></p>"
        },
        {
          "id": 322826,
          "text": "<p><span style=\"font-size:14.0pt;\">Wet clothing may still yield biological evidence but must be air-dried before packaging in paper bags</span></p>"
        },
        {
          "id": 322827,
          "text": "<p><span style=\"font-size:14.0pt;\">Biological evidence cannot be recovered from wet clothing due to dilution and contamination</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old woman reports a sexual assault that occurred outdoors during heavy rain. She arrives at the emergency department 12 hours later, still wearing the same wet clothes. Which of the following is the&nbsp;most accurate about evidence collection from her clothing?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5431287",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Wet clothing may still yield biological evidence but must be air-dried before packaging in paper bags.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Wet clothing&nbsp;<strong>can retain</strong>&nbsp;semen, blood, or epithelial cells. However, to&nbsp;<strong>prevent mold and bacterial degradation</strong>, the clothing should be&nbsp;<strong>air-dried at room temperature</strong>&nbsp;before being stored in&nbsp;<strong>breathable paper bags</strong>&nbsp;— not plastic because plastic bag traps moisture which leads to decomposition.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This preserves the evidence better for lab analysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Wet clothing should be dried with heat before packaging to prevent bacterial degradation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Drying with heat (e.g., dryers, hair dryers, or direct sunlight) can&nbsp;<strong>destroy or denature DNA</strong>&nbsp;and&nbsp;<strong>degrade biological stains</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Heat may also cause&nbsp;<strong>cross-contamination</strong>&nbsp;or alter trace patterns.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Wet clothing should be placed in airtight plastic bags to preserve moisture-sensitive evidence:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Plastic bags&nbsp;<strong>trap moisture</strong>, which creates a&nbsp;<strong>perfect environment for bacterial growth</strong>, accelerating&nbsp;<strong>DNA degradation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Also, they can&nbsp;<strong>smear or spread stains</strong>, ruining evidence integrity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Biological evidence cannot be recovered from wet clothing due to dilution and contamination:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While&nbsp;<strong>rain or water</strong>&nbsp;may dilute stains,&nbsp;<strong>DNA can still bind to fibers</strong>, especially if fluids soaked into inner layers of clothing.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Partial profiles</strong>&nbsp;may still be obtained, especially if the fabric wasn’t washed or agitated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In forensic evidence collection, <strong>wet clothing with potential biological stains (e.g., semen, blood, epithelial cells)</strong> should be <strong>air-dried at room temperature and stored in paper bags</strong>, not plastic, to avoid bacterial growth and preserve DNA integrity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Proper handling ensures evidence remains admissible and testable.</span></li></ul>",
      "correct_choice_id": 322826,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81035/NEET_PG_Mock_1_Q5_FMT.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81035/NEET_PG_Mock_1_Q5_FMT.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81006,
      "choices": [
        {
          "id": 322708,
          "text": "<p><span style=\"font-size:14.0pt;\">Aquaporin-4</span></p>"
        },
        {
          "id": 322709,
          "text": "<p><span style=\"font-size:14.0pt;\">Double-stranded DNA</span></p>"
        },
        {
          "id": 322710,
          "text": "<p><span style=\"font-size:14.0pt;\">Myeloperoxidase</span></p>"
        },
        {
          "id": 322711,
          "text": "<p><span style=\"font-size:14.0pt;\">tRNA synthetase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 39-year-old woman presents with repeated bilateral optic neuritis and weakness of both the legs. MRI is shown below. Which autoantibody is most likely to be positive?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hoUtarI.png\" width=\"373\" height=\"373\"></span></p>",
      "unique_key": "Q7910982",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Aquaporin-4</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Neuromyelitis optica spectrum disorder (NMOSD) is characterized by longitudinal spinal cord lesions and optic neuritis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Anti–aquaporin-4 antibodies are diagnostic and pathogenic.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early diagnosis and immunosuppression are essential.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In patients with features of NMO but negative AchRAb – Do not forget to test for anti-MOG.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Double-stranded DNA:</strong> Seen in lupus, not NMOSD.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Myeloperoxidase:</strong> Found in ANCA-associated vasculitis.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. tRNA synthetase:</strong> Associated with antisynthetase syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Anti–aquaporin-4 antibodies are diagnostic for NMOSD and should be tested in patients with optic-spinal demyelination.</span></p>",
      "correct_choice_id": 322708,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81006/NEET_MOCK_-_1_Question_-_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81006/NEET_MOCK_-_1_Question_-_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81027,
      "choices": [
        {
          "id": 322792,
          "text": "<p><span style=\"font-size:14.0pt;\">Thoracic Outlet Syndrome (TOS)</span></p>"
        },
        {
          "id": 322793,
          "text": "<p><span style=\"font-size:14.0pt;\">Cervical Radiculopathy</span></p>"
        },
        {
          "id": 322794,
          "text": "<p><span style=\"font-size:14.0pt;\">Pancoast Tumor</span></p>"
        },
        {
          "id": 322795,
          "text": "<p><span style=\"font-size:14.0pt;\">Carpal Tunnel Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman presents with a 4-month history of intermittent numbness, tingling, and weakness in her right hand, particularly after performing overhead activities such as painting or lifting objects. She also reports a sensation of heaviness in the arm, which improves when she rests the arm. On physical examination, there is weakness in the intrinsic hand muscles and diminished sensation in the ulnar aspect of the hand. A radiograph shown below. Which of the following is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20110324.jpg\" width=\"702\" height=\"521\"></span></p>",
      "unique_key": "Q4532792",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;Thoracic Outlet Syndrome (TOS)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">TOS results from compression of the brachial plexus, subclavian artery, or subclavian vein as they pass through the thoracic outlet (between the clavicle and first rib).</span></li><li><span style=\"font-size:14.0pt;\">Common causes include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Cervical rib</span></li><li><span style=\"font-size:14.0pt;\">Scalene muscle hypertrophy</span></li><li><span style=\"font-size:14.0pt;\">Trauma or repetitive overhead motion</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Neurogenic TOS is most common and presents with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Numbness, tingling, and weakness, especially in the ulnar distribution</span></li><li><span style=\"font-size:14.0pt;\">Symptoms worsened by overhead activity or prolonged arm elevation</span></li><li><span style=\"font-size:14.0pt;\">Heaviness or fatigue in the arm</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cervical Radiculopathy:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Caused by compression of cervical nerve roots (e.g., herniated disc, spondylosis).</span></li><li><span style=\"font-size:14.0pt;\">Presents with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Neck pain that radiates to the arm</span></li><li><span style=\"font-size:14.0pt;\">Dermatomal sensory loss and weakness</span></li><li><span style=\"font-size:14.0pt;\">Often worsened by neck movement</span></li></ul></li><li><span style=\"font-size:14.0pt;\">If the patient has no neck pain, and the symptoms are activity-related, not positional with neck.</span></li><li><span style=\"font-size:14.0pt;\">Also, cervical radiculopathy typically would not be improved by resting the arm down.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pancoast Tumour:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A superior sulcus tumor at the lung apex that can invade the brachial plexus, causing:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Shoulder and arm pain</span></li><li><span style=\"font-size:14.0pt;\">Weakness</span></li><li><span style=\"font-size:14.0pt;\">Horner's syndrome (ptosis, miosis, anhidrosis)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Seen most often in smokers, with constitutional symptoms (weight loss, cough).</span></li><li><span style=\"font-size:14.0pt;\">Rare in a healthy 32-year-old woman with no systemic signs.</span></li><li><span style=\"font-size:14.0pt;\">Imaging would show a mass in the lung apex, not just a bony anomaly.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Carpal Tunnel Syndrome:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Caused by compression of the <strong>median nerve</strong> at the wrist.</span></li><li><span style=\"font-size:14.0pt;\">Presents with:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Numbness and tingling in the thumb, index, middle, and radial half of ring finger</span></li><li><span style=\"font-size:14.0pt;\">Worse at night and with wrist flexion</span></li><li><span style=\"font-size:14.0pt;\">Thenar muscle weakness</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This patient has ulnar distribution symptoms (not median), and worsening with overhead activity, which does not fit carpal tunnel.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The Thoracic Outlet Syndrome has:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Symptoms worsened by overhead activity</span></li><li><span style=\"font-size:14.0pt;\">Ulnar nerve distribution of numbness and weakness</span></li><li><span style=\"font-size:14.0pt;\">X-ray likely showing a cervical rib</span></li></ul>",
      "correct_choice_id": 322792,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81027/NEET_MOCK_-_1_Question_-_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81027/NEET_MOCK_-_1_Question_-_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81138,
      "choices": [
        {
          "id": 323232,
          "text": "<p><span style=\"font-size:14.0pt;\">Vertebral artery</span></p>"
        },
        {
          "id": 323233,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior cerebral artery</span></p>"
        },
        {
          "id": 323234,
          "text": "<p><span style=\"font-size:14.0pt;\">Middle cerebral artery</span></p>"
        },
        {
          "id": 323235,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior cerebral artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman visits the emergency department with sudden onset dizziness, nausea, and difficulty maintaining balance. She reports that the symptoms began while she was having her hair washed in a salon with her head extended backward over a sink. Physical examination reveals nystagmus, ataxia, and dysarthria. A neurological assessment suggests possible artery damage. Which of the following arteries is most likely damaged in this scenario?</span></p>",
      "unique_key": "Q9608954",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Vertebral artery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>vertebral artery</strong> is susceptible to damage or dissection in situations involving <strong>sudden or prolonged neck extension</strong>, such as during a hair wash with the head extended backward over a sink.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The vertebral artery supplies blood to the <strong>posterior circulation</strong> of the brain, including the <strong>cerebellum</strong> and <strong>brainstem</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Damage to this artery can result in <strong>vertebrobasilar insufficiency</strong>, leading to symptoms such as <strong>dizziness</strong>, <strong>nystagmus</strong>, <strong>ataxia</strong>, and <strong>dysarthria</strong>.</span></li><li><span style=\"font-size:14.0pt;\">These symptoms occur because of reduced blood flow to the brainstem and cerebellum, which are critical for balance and coordination.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8nzG4L3.png\" width=\"1319\" height=\"596\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Anterior cerebral artery:</strong> Incorrect. The anterior cerebral artery supplies the medial portions of the frontal and parietal lobes, and damage to this artery typically presents with symptoms like <strong>contralateral leg weakness</strong> and <strong>personality changes</strong>, not with dizziness and ataxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Middle cerebral artery:</strong> Incorrect. The middle cerebral artery supplies the lateral aspects of the frontal, parietal, and temporal lobes, and damage here is typically associated with <strong>contralateral hemiparesis</strong>, <strong>aphasia</strong>, or <strong>sensory deficits</strong>, rather than balance and coordination issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Posterior cerebral artery:</strong> Incorrect. While the posterior cerebral artery supplies parts of the <strong>occipital lobe</strong> and <strong>thalamus</strong>, its damage typically causes <strong>visual disturbances</strong> or <strong>sensory loss</strong> rather than the cerebellar symptoms (e.g., ataxia and nystagmus) seen with vertebral artery damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Vertebral artery damage</strong> can occur due to <strong>sudden neck hyperextension</strong>, leading to <strong>vertebrobasilar insufficiency</strong> and symptoms such as <strong>dizziness</strong>, <strong>nystagmus</strong>, <strong>ataxia</strong>, and <strong>dysarthria</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Recognizing the relationship between neck positioning and vertebral artery vulnerability is crucial for diagnosis and management.</span></li></ul>",
      "correct_choice_id": 323232,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81138/NEET_PG_Mock_1_Q3_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81138/NEET_PG_Mock_1_Q3_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81097,
      "choices": [
        {
          "id": 323068,
          "text": "<p><span style=\"font-size:14.0pt;\">Rotenone</span></p>"
        },
        {
          "id": 323069,
          "text": "<p><span style=\"font-size:14.0pt;\">Oligomycin</span></p>"
        },
        {
          "id": 323070,
          "text": "<p><span style=\"font-size:14.0pt;\">Atractyloside</span></p>"
        },
        {
          "id": 323071,
          "text": "<p><span style=\"font-size:14.0pt;\">Antimycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher is studying the effect of various mitochondrial toxins on cellular respiration and energy metabolism. One particular compound is found to disrupt the transfer of ADP into the mitochondria and ATP out of it, thereby inhibiting ATP synthesis indirectly. Which of the following compounds is most likely responsible for this effect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7713601",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Atractyloside</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Atractyloside</strong> is a <strong>toxic glycoside</strong> that specifically inhibits the <strong>adenine nucleotide translocase (ANT)</strong>, a transporter embedded in the <strong>inner mitochondrial membrane</strong>. This transporter plays a vital role in <strong>cellular energy homeostasis</strong> by:</span><ul><li><span style=\"font-size:14.0pt;\">Importing <strong>ADP</strong> from the cytosol into the mitochondrial matrix</span></li><li><span style=\"font-size:14.0pt;\">Exporting <strong>ATP</strong> generated by oxidative phosphorylation back into the cytosol</span></li></ul></li><li><span style=\"font-size:14.0pt;\">By inhibiting this exchange, atractyloside <strong>prevents the proper utilization of ATP</strong> and <strong>blocks mitochondrial energy output</strong>, leading to <strong>energy crisis in tissues</strong> dependent on oxidative phosphorylation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rotenone:</strong> Inhibits <strong>Complex I (NADH dehydrogenase)</strong> of the <strong>electron transport chain</strong>, blocking electron transfer from NADH to ubiquinone. It disrupts proton pumping and reduces ATP synthesis, but it does <strong>not interfere with ADP/ATP exchange</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Oligomycin:</strong> Inhibits <strong>ATP synthase ( F<sub>0</sub> component of&nbsp;Complex V)</strong> by blocking the <strong>proton channel</strong>, directly preventing ATP formation, but <strong>does not block ADP or ATP transport across the mitochondrial membrane</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Antimycin:</strong> Inhibits <strong>Complex III (cytochrome bc1 complex)</strong> of the <strong>electron transport chain</strong>, blocking electron transfer from ubiquinol to cytochrome c. This reduces ATP production but does <strong>not affect ADP/ATP translocase activity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Atractyloside</strong> inhibits the <strong>ADP/ATP translocase</strong> in the <strong>inner mitochondrial membrane</strong>, disrupting the <strong>exchange of ADP and ATP</strong>, and thereby impairs <strong>mitochondrial energy output</strong> without directly affecting the electron transport chain.</span></p>",
      "correct_choice_id": 323070,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81097/NEET_PG_Mock_1_Q4_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81097/NEET_PG_Mock_1_Q4_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81161,
      "choices": [
        {
          "id": 323324,
          "text": "<p><span style=\"font-size:14.0pt;\">Add aripiprazole&nbsp;</span></p>"
        },
        {
          "id": 323325,
          "text": "<p><span style=\"font-size:14.0pt;\">Add sertraline&nbsp;</span></p>"
        },
        {
          "id": 323326,
          "text": "<p><span style=\"font-size:14.0pt;\">Add clomipramine&nbsp;</span></p>"
        },
        {
          "id": 323327,
          "text": "<p><span style=\"font-size:14.0pt;\">Add lithium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old male with obsessive-compulsive disorder (OCD) has been on fluoxetine 60 mg/day for 10 weeks. While he reports about 30% reduction in his symptoms, he continues to have significant intrusive thoughts and compulsive hand-washing that interfere with his daily functioning. What is the most appropriate next step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9881122",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;Add aripiprazole</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For OCD patients who show partial response to an adequate trial of an SSRI (appropriate dose for at least 8-12 weeks), <strong>augmentation with an atypical antipsychotic</strong> such as risperidone, aripiprazole is the recommended next step.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Atypical antipsychotics, particularly aripiprazole, have shown efficacy as augmenting agents in treatment-resistant OCD with response rates of 30-40% in patients who have had inadequate response to SSRIs alone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Add sertraline:&nbsp;</strong>Incorrect. Combining two SSRIs (fluoxetine and sertraline in this case) is not a standard approach for treatment-resistant OCD and increases the risk of serotonin syndrome without clear evidence of additional benefit. When one SSRI has shown partial response, switching to another SSRI might be considered if the first was not tolerated, but augmentation strategies are preferred when there is partial response.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Add clomipramine:</strong> Incorrect. While clomipramine is effective for OCD, combining it with an SSRI significantly increases the risk of serotonin syndrome and cardiac side effects due to additive serotonergic and anticholinergic effects. Clomipramine could be considered as monotherapy if an SSRI trial fails completely, but not typically as an augmentation agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Add lithium:</strong> Incorrect. Lithium has minimal evidence for efficacy in OCD augmentation. It is not considered a standard augmentation strategy for treatment-resistant OCD and carries significant side effect and monitoring burdens.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For patients with OCD who show partial response to an adequate trial of an SSRI, augmentation with an atypical antipsychotic (particularly aripiprazole) is the recommended next pharmacological step before considering more invasive interventions.</span></p>",
      "correct_choice_id": 323324,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81161/Psychiatry_Mock_1_Q3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81161/Psychiatry_Mock_1_Q3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81082,
      "choices": [
        {
          "id": 323008,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, and the Reason is the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 323009,
          "text": "<p><span style=\"font-size:14.0pt;\">Both Assertion and Reason are true, but the Reason is not the correct explanation of the Assertion</span></p>"
        },
        {
          "id": 323010,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is true, but the Reason is false</span></p>"
        },
        {
          "id": 323011,
          "text": "<p><span style=\"font-size:14.0pt;\">Assertion is false, but the Reason is true</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\"><strong>Assertion (A):</strong> In a patient with microcytic hypochromic anemia and elevated red blood cell (RBC) count, a Mentzer index less than 13 suggests thalassemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason (R):</strong> Measuring HbA2 levels is the next best step to confirm the diagnosis of beta-thalassemia minor.<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9786858",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Both Assertion and Reason are true, but the Reason is not the correct explanation of the Assertion.</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Assertion (A): In a patient with microcytic hypochromic anemia and elevated red blood cell (RBC) count, a Mentzer index less than 13 suggests thalassemia:&nbsp;</strong>True.</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Mentzer index</strong> is calculated by dividing the <strong>MCV by the RBC count</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A value <strong>&lt;13 typically suggests thalassemia</strong>, whereas <strong>&gt;13 suggests iron deficiency anemia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Patients with thalassemia often have a <strong>higher RBC count</strong> than expected for their degree of anemia.</span> <span style=\"font-size:14.0pt;\">This is responsible for the decrease in Mentzer Index value.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reason (R): Measuring HbA2 levels is the next best step to confirm the diagnosis of beta-thalassemia minor:</strong> Also, True.</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In suspected <strong>beta-thalassemia minor</strong>, the next step is to <strong>quantify HbA2</strong> using hemoglobin electrophoresis or HPLC.</span></li><li><span style=\"font-size:14.0pt;\">HbA2 is typically <strong>elevated (&gt;3.5%)</strong> in beta-thalassemia trait.</span></li></ul><p><span style=\"font-size:14.0pt;\">Although <strong>both statements are individually true</strong>, the <strong>Reason is not the direct explanation</strong> for the Assertion.&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Mentzer index</strong> is based on RBC count and MCV, not HbA2 levels.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">HbA2 measurement is used <strong>after the suspicion of beta-thalassemia is raised</strong>, but it does <strong>not explain how</strong> the Mentzer index works.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients with microcytic anemia and high RBC count, a Mentzer index &lt;13 suggests thalassemia, and elevated HbA2 confirms beta-thalassemia minor.</span></p>",
      "correct_choice_id": 323009,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81082/NEET_PG_Mock_1_Q4_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81082/NEET_PG_Mock_1_Q4_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80961,
      "choices": [
        {
          "id": 322528,
          "text": "<p><span style=\"font-size:14.0pt;\">Rupture of the uterus</span></p>"
        },
        {
          "id": 322529,
          "text": "<p><span style=\"font-size:14.0pt;\">Maternal exhaustion</span></p>"
        },
        {
          "id": 322530,
          "text": "<p><span style=\"font-size:14.0pt;\">Inadequate uterine contractions</span></p>"
        },
        {
          "id": 322531,
          "text": "<p><span style=\"font-size:14.0pt;\">Cephalopelvic disproportion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old primigravida in active labor has her progress monitored using the partograph. Based on the partograph findings, what is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105637.jpg\" width=\"367\" height=\"742\"></strong></span></p>",
      "unique_key": "Q8200631",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Inadequate uterine contractions</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The partograph indicates prolonged active phase of the first stage of labor with a dilation rate of &lt;1 cm/hour, which improved after oxytocin administration.</span></li><li><span style=\"font-size:14.0pt;\">This pattern is consistent with inadequate uterine contractions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Rupture of the uterus:&nbsp;</strong>Rupture of the uterus would cause a loss of fetal station, with the descent curve moving upward.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Maternal exhaustion:&nbsp;</strong>Maternal exhaustion typically shows normal contractions initially, followed by a later decline in their intensity, which is not observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Cephalopelvic disproportion:&nbsp;</strong>Cephalopelvic disproportion (CPD) would result in a lack of fetal head descent, regardless of contraction intensity or oxytocin augmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Inadequate uterine contractions are a common cause of prolonged labor, characterized by a slow cervical dilation rate (&lt;1 cm/hour) that responds to oxytocin augmentation.</span></p>",
      "correct_choice_id": 322530,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80961/OBG_Mock_1_Q16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80961/OBG_Mock_1_Q16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81000,
      "choices": [
        {
          "id": 322684,
          "text": "<p><span style=\"font-size:14.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 322685,
          "text": "<p><span style=\"font-size:14.0pt;\">Low-dose dopamine</span></p>"
        },
        {
          "id": 322686,
          "text": "<p><span style=\"font-size:14.0pt;\">Endothelin receptor antagonists</span></p>"
        },
        {
          "id": 322687,
          "text": "<p><span style=\"font-size:14.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man with E. coli septic shock is on vasopressors and ventilation. By day 4, serum creatinine rises from 1.1 to 3.2 mg/dL. Urine output falls despite stable BP. Urinalysis is shown. Which therapy has been proven to improve clinical outcomes in this setting?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_rUIoloD.png\" width=\"833\" height=\"314\"></strong></span></p>",
      "unique_key": "Q5721517",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) None of the above</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acute Tubular Necrosis (ATN) in critical illness is managed supportively.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">No drug, including furosemide or dopamine, improves renal recovery or mortality.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Key strategies include fluid management, MAP maintenance, and avoiding nephrotoxins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Furosemide:</strong> Increases urine output but does not improve outcomes.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Low-dose</strong> <strong>Dopamine:</strong> No renal benefit demonstrated in trials.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Endothelin</strong> <strong>receptor antagonists:</strong> Not effective in AKI treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">There is no pharmacologic agent proven to improve renal recovery in acute tubular injury; management is supportive.</span></p>",
      "correct_choice_id": 322687,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81000/Neet_Mock_-_1_Question_-_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81000/Neet_Mock_-_1_Question_-_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80937,
      "choices": [
        {
          "id": 322432,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 322433,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 322434,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 322435,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman is undergoing routine gynecological examination. On speculum examination, a small, painless, cystic swelling is noted as shown in the image. She denies any urinary or menstrual complaints. Which of the following statements are correct?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105119.jpg\" width=\"712\" height=\"660\"></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Gartner’s duct cyst is a remnant of the mesonephric (Wolffian) duct.</span></li><li><span style=\"font-size:14.0pt;\">It is commonly located on the posterior vaginal wall.</span></li><li><span style=\"font-size:14.0pt;\">It may present with dyspareunia or urinary obstruction if large.</span></li><li><span style=\"font-size:14.0pt;\">Surgical excision is indicated only if the cyst is symptomatic.</span></li></ol>",
      "unique_key": "Q9348493",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Gartner’s duct cyst is a remnant of the mesonephric (Wolffian) duct:&nbsp;</strong>Correct<strong>.</strong> Gartner’s duct cyst is derived from <strong>mesonephric (Wolffian) duct remnants</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>It may present with dyspareunia or urinary obstruction if large:&nbsp;</strong>Correct<strong>.</strong> Although often asymptomatic, a large cyst can cause <strong>dyspareunia</strong>, <strong>urinary symptoms</strong>, or <strong>obstruction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Surgical excision is indicated only if the cyst is symptomatic:&nbsp;</strong>Correct<strong>.</strong> <strong>Excision is indicated</strong> if the cyst becomes <strong>symptomatic</strong>; otherwise, observation is sufficient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>It is commonly located on the posterior vaginal wall:&nbsp;</strong>Incorrect<strong>.</strong> It is located on the <strong>anterolateral wall</strong> of the <strong>upper vagina</strong>, not the posterior wall.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Gartner’s duct cysts are mesonephric duct remnants commonly found on the anterolateral vaginal wall.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They are usually asymptomatic but can cause symptoms based on size or location.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Treatment is conservative unless symptomatic.</span></li></ul>",
      "correct_choice_id": 322432,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80937/OBG_Mock_1_Q6_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80937/OBG_Mock_1_Q6_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80944,
      "choices": [
        {
          "id": 322460,
          "text": "<p><span style=\"font-size:14.0pt;\">1,250</span></p>"
        },
        {
          "id": 322461,
          "text": "<p><span style=\"font-size:14.0pt;\">2,500</span></p>"
        },
        {
          "id": 322462,
          "text": "<p><span style=\"font-size:14.0pt;\">625</span></p>"
        },
        {
          "id": 322463,
          "text": "<p><span style=\"font-size:14.0pt;\">5,000</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a population of 20,000 adults, hypertension prevalence is 25%. Among hypertensives:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Awareness: 50%,&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Treatment among those aware: 50%,&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Control among those treated: 50%.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">How many individuals in the total population have their hypertension under control?</span></p>",
      "unique_key": "Q2429019",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 625</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">We apply the \"Rule of Halves\" step by step:</span><ol><li><span style=\"font-size:14.0pt;\"><strong>Total hypertensives =</strong></span><br><span style=\"font-size:14.0pt;\">25% of 20,000 = <strong>5,000</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Awareness among hypertensives =</strong></span><br><span style=\"font-size:14.0pt;\">50% of 5,000 = <strong>2,500</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Treatment among those aware =</strong></span><br><span style=\"font-size:14.0pt;\">50% of 2,500 = <strong>1,250</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Control among those treated =</strong></span><br><span style=\"font-size:14.0pt;\">50% of 1,250 = <strong>625</strong></span></li></ol></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>625 individuals</strong> out of the total population have their <strong>hypertension under control</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The \"Rule of Halves\" highlights a common scenario in chronic disease management: only about half of patients are aware, half of those are treated, and half of those achieve control — often leading to a small fraction of the total burden being well-managed.</span></p>",
      "correct_choice_id": 322462,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80944/PSM_Mock_1_Q12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80944/PSM_Mock_1_Q12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81003,
      "choices": [
        {
          "id": 322696,
          "text": "<p><span style=\"font-size:14.0pt;\">Genetic testing for HFE mutation</span></p>"
        },
        {
          "id": 322697,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver MRI</span></p>"
        },
        {
          "id": 322698,
          "text": "<p><span style=\"font-size:14.0pt;\">Transferrin saturation and serum ferritin</span></p>"
        },
        {
          "id": 322699,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man whose father died of cirrhosis at age 55 asks about screening for hereditary hemochromatosis. He is asymptomatic and takes no medications except a multivitamins. Which of the following is the most appropriate initial screening test?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1061669",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Transferrin saturation and serum ferritin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">First-line screening for hereditary hemochromatosis involves serum transferrin saturation and ferritin to detect iron overload.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Genetic testing is confirmatory.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Liver imaging or biopsy is used in advanced or unclear cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Genetic testing for HFE mutation:</strong> Confirmatory, not initial screening.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Liver MRI:</strong> Used for quantifying hepatic iron but not for screening.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Liver biopsy:</strong> Invasive; not suitable for initial workup in asymptomatic individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Initial screening for hemochromatosis involves transferrin saturation and ferritin levels before pursuing genetic or imaging studies.</span></p>",
      "correct_choice_id": 322698,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81003/NEET_MOCK_-_1_Question_-_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81003/NEET_MOCK_-_1_Question_-_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81017,
      "choices": [
        {
          "id": 322752,
          "text": "<p><span style=\"font-size:14.0pt;\">Time of last meal</span></p>"
        },
        {
          "id": 322753,
          "text": "<p><span style=\"font-size:14.0pt;\">Any known allergies</span></p>"
        },
        {
          "id": 322754,
          "text": "<p><span style=\"font-size:14.0pt;\">Events that led to the trauma</span></p>"
        },
        {
          "id": 322755,
          "text": "<p><span style=\"font-size:14.0pt;\">Asking to speak a sentence</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">After having completed the primary survey of a patient of RTA and sending all relevant blood investigations, securing 2 large-bore IV lines, checking vitals, and catheterizing the patient, the doctor moves on to seek some additional history. Which of these does not form a part of this next history taking?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5918175",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Asking to speak a sentence</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The secondary survey in trauma care is a comprehensive head-to-toe evaluation that follows the primary survey and resuscitation efforts.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The secondary survey includes a complete history and physical examination.</span></li><li><span style=\"font-size:14.0pt;\">Asking to speak a sentence forms a part of the assessment for airway obstruction, which is performed in the primary survey.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">History taking in this phase should include the following elements, which are remembered by the mnemonic AMPLE:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Time of last meal:</strong> Knowing the time of the last meal helps assess the risk of aspiration and informs decisions about the timing of surgery if needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Any known allergies:</strong> It's essential to know about any allergies the patient may have, especially to medications, which may influence the choice of drugs used for treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Events that led to the trauma:</strong> Understanding the mechanism of injury can provide crucial information about potential injuries, even those that are not immediately apparent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To understand the components of history taking during the secondary survey in trauma care.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This includes assessing for allergies, medications currently used, past illnesses or pregnancies, the last meal, and the events or environment related to the injury.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">All these aspects can have significant implications for patient care and management, making them critical components of the secondary survey.</span></li></ul>",
      "correct_choice_id": 322755,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81017/Surgery_NEET_PG_Mock_114.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81017/Surgery_NEET_PG_Mock_114.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81091,
      "choices": [
        {
          "id": 323044,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 3 and 4 are correct</span></p>"
        },
        {
          "id": 323045,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 2 and 5 are correct</span></p>"
        },
        {
          "id": 323046,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 2, 3 and 5 are correct</span></p>"
        },
        {
          "id": 323047,
          "text": "<p><span style=\"font-size:14.0pt;\">Only 1, 3 and 5 are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Paroxysmal Nocturnal Hemoglobinuria (PNH) are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The absence of glycosylphosphatidylinositol (GPI) anchors leads to the loss of decay-accelerating factor (DAF), predisposing cells to complement-mediated lysis.</span></li><li><span style=\"font-size:14.0pt;\">Intravascular hemolysis in PNH predominantly affects only red blood cells due to their high complement sensitivity.</span></li><li><span style=\"font-size:14.0pt;\">Flow cytometry showing absence of CD55 and CD59 on blood cells is used as a confirmatory diagnostic test for PNH.</span></li><li><span style=\"font-size:14.0pt;\">Thrombosis in unusual sites, such as hepatic and portal veins, is a major cause of mortality in PNH.</span></li><li><span style=\"font-size:14.0pt;\">Complement activation during REM sleep due to sympathetic overactivity is the key trigger of hemolysis in PNH.</span></li></ol>",
      "unique_key": "Q7710947",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Only 1, 3 and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>The absence of glycosylphosphatidylinositol (GPI) anchors leads to the loss of decay-accelerating factor (DAF), predisposing cells to complement-mediated lysis:</strong> Correct. GPI anchors are necessary for surface expression of DAF; their absence causes complement susceptibility.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Flow cytometry showing absence of CD55 and CD59 on blood cells is used as a confirmatory diagnostic test for PNH:</strong> &nbsp;Correct. Flow cytometry detecting absence of CD55 (DAF) and CD59 (protectin) is the gold standard. It gives a biphenotypic appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Thrombosis in unusual sites, such as hepatic and portal veins, is a major cause of mortality in PNH:</strong> Correct. Thrombosis, especially in hepatic/portal/cerebral veins, is the most common cause of death.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Intravascular hemolysis in PNH predominantly affects only red blood cells due to their high complement sensitivity:&nbsp;</strong>Incorrect. PNH affects <strong>RBCs, WBCs, and platelets</strong>, not just RBCs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>Complement activation during REM sleep due to sympathetic overactivity is the key trigger of hemolysis in PNH:</strong> Incorrect. The complement is activated during <strong>sleep-related respiratory acidosis</strong>, not REM sleep or sympathetic overactivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PNH is caused by the absence of GPI anchors, resulting in loss of complement regulatory proteins (CD55 and CD59), leading to complement-mediated lysis of all blood cell lineages.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis is confirmed by flow cytometry, and thrombosis in unusual sites is a major cause of mortality.</span></li></ul>",
      "correct_choice_id": 323044,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81091/NEET_PG_Mock_1_Q13_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81091/NEET_PG_Mock_1_Q13_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81123,
      "choices": [
        {
          "id": 323172,
          "text": "<p><span style=\"font-size:14.0pt;\">Benzoyl peroxide</span></p>"
        },
        {
          "id": 323173,
          "text": "<p><span style=\"font-size:14.0pt;\">Topical metronidazole</span></p>"
        },
        {
          "id": 323174,
          "text": "<p><span style=\"font-size:14.0pt;\">High-potency topical steroids</span></p>"
        },
        {
          "id": 323175,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral isotretinoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman comes to the dermatology clinic complaining of persistent redness and visible blood vessels on her cheeks and nose. She also has small erythematous papules and pustules clustered over the central face but notes no blackheads or whiteheads. The symptoms worsen after drinking hot tea or exercising, and she has become increasingly self-conscious about the facial changes. On physical examination, there is facial flushing, telangiectasias, and inflammatory papules, but no comedones. Which of the following is the most appropriate first-line treatment for this condition?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XUtRLpn.png\" width=\"442\" height=\"245\"></span></p>",
      "unique_key": "Q3255054",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Topical metronidazole</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">This is a classic case of <strong>rosacea</strong>, particularly the <strong>papulopustular subtype</strong>, which presents with:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Central facial erythema and flushing</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Telangiectasias</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Papules and pustules</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Absence of comedones</strong>, distinguishing it from acne vulgaris</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Common <strong>triggers</strong>: sun, heat, spicy foods, alcohol, stress</span></li><li><span style=\"font-size:14.0pt;\"><strong>Topical metronidazole</strong> is the <strong>first-line treatment</strong> for mild to moderate rosacea due to its <strong>anti-inflammatory and antimicrobial</strong> properties.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Benzoyl peroxide:</strong> More appropriate for acne vulgaris. Can be irritating in rosacea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. High-potency topical steroids:&nbsp;</strong>Contraindicated — can <strong>worsen rosacea</strong> and cause <strong>steroid-induced rosacea</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Oral isotretinoin:</strong> Reserved for <strong>severe, refractory rosacea</strong>, not a first-line choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Rosacea is a chronic inflammatory condition of the <strong>central face</strong>, presenting with <strong>erythema, telangiectasias, and inflammatory papules without comedones</strong>.</span><ul><li><span style=\"font-size:14.0pt;\">First-line therapy: <strong>topical metronidazole</strong></span></li><li><span style=\"font-size:14.0pt;\">Avoid triggers (heat, sun, alcohol)</span></li><li><span style=\"font-size:14.0pt;\">Severe cases may require oral antibiotics or isotretinoin</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-05-20%20at%2011.13.38%20AM.jpeg\" width=\"680\" height=\"272\"></span></p>",
      "correct_choice_id": 323173,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81123/Dermatology_Mock_1_Q1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81123/Dermatology_Mock_1_Q1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81089,
      "choices": [
        {
          "id": 323036,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 323037,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, and 4 only</span></p>"
        },
        {
          "id": 323038,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4, and 5 only</span></p>"
        },
        {
          "id": 323039,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Membranoproliferative Glomerulonephritis (MPGN) is/are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">MPGN is characterized by thickening of the glomerular basement membrane with a tram-track appearance seen on staining.</span></li><li><span style=\"font-size:14.0pt;\">It commonly shows a linear immunofluorescence pattern due to anti-GBM antibody deposition.</span></li><li><span style=\"font-size:14.0pt;\">Type I MPGN features subendothelial immune complex deposits and is frequently associated with hepatitis B and C infections.</span></li><li><span style=\"font-size:14.0pt;\">Type II MPGN (dense deposit disease) is linked to an autoantibody that stabilizes C3 convertase, resulting in hypocomplementemia.</span></li><li><span style=\"font-size:14.0pt;\">MPGN typically responds well to corticosteroid therapy and rarely progresses to chronic renal failure.</span></li></ol>",
      "unique_key": "Q5437999",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>MPGN is characterized by thickening of the glomerular basement membrane with a tram-track appearance seen on staining:&nbsp;</strong>Correct. MPGN shows <strong>thickened glomerular basement membrane</strong> with a <strong>tram-track</strong> appearance on H&amp;E due to mesangial cell interposition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Type I MPGN features subendothelial immune complex deposits and is frequently associated with hepatitis B and C infections: </strong>Correct. Type I MPGN is associated with <strong>subendothelial immune complex deposits</strong> and is frequently linked to <strong>hepatitis B and C viruses</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Type II MPGN (dense deposit disease) is linked to an autoantibody that stabilizes C3 convertase, resulting in hypocomplementemia:&nbsp;</strong>Correct. Type II (dense deposit disease) involves <strong>intramembranous deposits</strong> and is associated with <strong>C3 nephritic factor</strong>, an autoantibody that <strong>stabilizes C3 convertase</strong>, leading to <strong>complement overactivation</strong>, <strong>inflammation</strong>, and <strong>low C3 levels</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>It commonly shows a linear immunofluorescence pattern due to anti-GBM antibody deposition:&nbsp;</strong>Incorrect. MPGN exhibits a <strong>granular</strong> immunofluorescence (IF) pattern due to <strong>immune complex deposition</strong>, <strong>not linear</strong>. A linear IF pattern is more typical of <strong>Goodpasture syndrome</strong>, not MPGN.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>MPGN typically responds well to corticosteroid therapy and rarely progresses to chronic renal failure:&nbsp;</strong>Incorrect. MPGN has a <strong>poor response to steroids</strong> and often <strong>progresses to chronic renal failure</strong>, making this statement false.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Membranoproliferative Glomerulonephritis (MPGN) shows a granular IF pattern due to immune complex deposition, has subendothelial or intramembranous deposits depending on type, is associated with hepatitis viruses or C3 nephritic factor, and often progresses to chronic renal failure despite poor steroid responsiveness.</span></p>",
      "correct_choice_id": 323036,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81089/NEET_PG_Mock_1_Q11_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81089/NEET_PG_Mock_1_Q11_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81157,
      "choices": [
        {
          "id": 323308,
          "text": "<p><span style=\"font-size:14.0pt;\">Segment A&nbsp;</span></p>"
        },
        {
          "id": 323309,
          "text": "<p><span style=\"font-size:14.0pt;\">Segment B</span></p>"
        },
        {
          "id": 323310,
          "text": "<p><span style=\"font-size:14.0pt;\">Segment C&nbsp;</span></p>"
        },
        {
          "id": 323311,
          "text": "<p><span style=\"font-size:14.0pt;\">Segment E&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a patient with severe central diabetes insipidus caused by a lack of antidiuretic hormone (ADH) secretion, which part of the nephron would have the lowest tubular fluid osmolarity?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_70J7iwr.png\" width=\"673\" height=\"443\"></strong></span></p>",
      "unique_key": "Q3153450",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Segment E</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In central diabetes insipidus, <strong>ADH is absent</strong>, so water reabsorption in the <strong>late distal tubule and collecting duct</strong> does <strong>not occur</strong>. Here's how this affects each segment:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Segment A (Proximal tubule):</strong> Isoosmotic reabsorption of solutes and water → Osmolarity remains similar to plasma.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Segment B (Descending limb):</strong> Permeable to water but not solutes → Tubular fluid becomes <strong>more concentrated</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Segment C (Thick ascending limb):</strong> Impermeable to water; active reabsorption of Na⁺, K⁺, Cl⁻ → Tubular fluid becomes <strong>dilute</strong> (~100 mOsm/L).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Segment E (Cortical collecting duct):</strong> In the <strong>absence of ADH</strong>, this segment becomes <strong>impermeable to water</strong>. Electrolytes continue to be reabsorbed without water, making the <strong>final urine extremely dilute</strong> (osmolarity &lt;100 mOsm/L).</span></li></ul></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20180758.jpg\" width=\"811\" height=\"565\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the <strong>absence of ADH</strong>, the collecting ducts become <strong>impermeable to water</strong>, preventing reabsorption and allowing continued solute reabsorption.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This results in <strong>maximally dilute urine</strong>, with the <strong>lowest osmolarity</strong> found in the <strong>cortical collecting duct</strong>.</span></li></ul>",
      "correct_choice_id": 323311,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81157/Neet_Pg_Mock_1_Q8_Physiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81157/Neet_Pg_Mock_1_Q8_Physiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81146,
      "choices": [
        {
          "id": 323264,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 2 and 3 are correct</span></p>"
        },
        {
          "id": 323265,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1, 3 and 4 are correct</span></p>"
        },
        {
          "id": 323266,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 2, 3 and 4 are correct</span></p>"
        },
        {
          "id": 323267,
          "text": "<p><span style=\"font-size:14.0pt;\">All four statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding sugammadex are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Sugammadex is a modified γ-cyclodextrin used to reverse neuromuscular blockade induced by depolarizing agents like succinylcholine.</span></li><li><span style=\"font-size:14.0pt;\">It works by encapsulating non-depolarizing neuromuscular blockers, primarily rocuronium and vecuronium.</span></li><li><span style=\"font-size:14.0pt;\">Sugammadex binds rocuronium or vecuronium in a 1:1 ratio at all levels of neuromuscular blockade.</span></li><li><span style=\"font-size:14.0pt;\">Compared to neostigmine, sugammadex provides a faster and more complete reversal of neuromuscular block.</span></li></ol>",
      "unique_key": "Q7402027",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Only statements 2, 3 and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>It works by encapsulating non-depolarizing neuromuscular blockers, primarily rocuronium and vecuronium:</strong> Correct. Sugammadex works on an <strong>encapsulation principle</strong>, inactivating <strong>non-depolarizing neuromuscular blockers</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Sugammadex binds rocuronium or vecuronium in a 1:1 ratio at all levels of neuromuscular blockade:</strong> Correct. It binds rocuronium/vecuronium in a <strong>1:1 molar ratio</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qwxxi27.png\" width=\"940\" height=\"365\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Compared to neostigmine, sugammadex provides a faster and more complete reversal of neuromuscular block:</strong> Correct. Compared to neostigmine, sugammadex is <strong>faster and more effective</strong>, especially at deep levels of blockade. If the patient is just anesthetized, Sugammadex can be given at a higher dose and the anesthesia can be reversed completely post-surgery. This is not possible with neostigmine as it can reverse the neuromuscular blockade only when more than 70-80% of non-depolarizing agents have left the receptors already.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Sugammadex is a modified γ-cyclodextrin used to reverse neuromuscular blockade induced by depolarizing agents like succinylcholine:&nbsp;</strong>Incorrect. Sugammadex is <strong>not effective against depolarizing agents</strong> like <strong>succinylcholine</strong>. It is used specifically for <strong>non-depolarizing agents</strong> like <strong>rocuronium</strong> and <strong>vecuronium</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Sugammadex</strong> is a <strong>modified γ-cyclodextrin</strong> that selectively binds and inactivates <strong>rocuronium and vecuronium</strong>, providing rapid reversal of neuromuscular blockade even at profound levels.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>not effective</strong> against <strong>depolarizing agents</strong> like <strong>succinylcholine</strong>.</span></li></ul>",
      "correct_choice_id": 323266,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81146/NEET_PG_Mock_1_Q1_Anesthesia.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81146/NEET_PG_Mock_1_Q1_Anesthesia.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81001,
      "choices": [
        {
          "id": 322688,
          "text": "<p><span style=\"font-size:14.0pt;\">Allergic interstitial nephritis</span></p>"
        },
        {
          "id": 322689,
          "text": "<p><span style=\"font-size:14.0pt;\">IgG4-related tubulointerstitial nephritis</span></p>"
        },
        {
          "id": 322690,
          "text": "<p><span style=\"font-size:14.0pt;\">Reflux nephropathy</span></p>"
        },
        {
          "id": 322691,
          "text": "<p><span style=\"font-size:14.0pt;\">Sjögren syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old man with no symptoms is referred for elevated serum creatinine (1.5 mg/dL). Childhood history includes multiple UTIs. Ultrasound shows small, asymmetric kidneys with cortical scarring. What is the most likely underlying cause?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8024128",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Reflux nephropathy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Reflux nephropathy arises from vesicoureteral reflux during childhood. Recurrent UTIs lead to scarring, asymmetric renal size, and later CKD.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Imaging typically shows cortical thinning and focal hypertrophy. No systemic autoimmune features are present.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Allergic interstitial nephritis:&nbsp;</strong>Usually drug-induced with active urine sediment.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>IgG4-related tubulointerstitial nephritis:&nbsp;</strong>Seen in older adults with multi-organ involvement.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Sjögren syndrome:&nbsp;</strong>Typically presents with sicca symptoms and systemic autoimmunity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Reflux nephropathy is a leading cause of adult CKD due to childhood VUR and UTIs, characterized by small, scarred, asymmetric kidneys.</span></p>",
      "correct_choice_id": 322690,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81001/NEET_MOCK_-_1_Question_-_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81001/NEET_MOCK_-_1_Question_-_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80977,
      "choices": [
        {
          "id": 322592,
          "text": "<p><span style=\"font-size:14.0pt;\">Fetal distress</span></p>"
        },
        {
          "id": 322593,
          "text": "<p><span style=\"font-size:14.0pt;\">Fetal sleep cycle</span></p>"
        },
        {
          "id": 322594,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine contractions&nbsp;</span></p>"
        },
        {
          "id": 322595,
          "text": "<p><span style=\"font-size:14.0pt;\">Maternal dehydration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A pregnant woman at 38 weeks' gestation presents with prolonged and severe uterine contractions and reduced variability in the fetal heart rate tracing. The baseline fetal heart rate is normal. What is the most likely cause of this fetal heart rate pattern?</span></p>",
      "unique_key": "Q2293521",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Fetal distress</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A pattern of prolonged and severe uterine contractions, along with reduced variability in the fetal heart rate tracing, is concerning for fetal distress.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Reduced variability can be a sign of fetal compromise, and further evaluation is needed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Fetal sleep cycle:</strong> This will present with absent accelerations (Reactivity) on the fetal heart rate tracing. Baseline and variability is usually normal</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Uterine contractions:</strong> A fetus who is not hypoxic will tolerate uterine contractions</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Maternal dehydration:</strong> This usually presents as fetal tachycardia</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Reduced variability is seen in:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Fetal hypoxia/ acidosis</span></li><li><span style=\"font-size:14.0pt;\">Fetal CNS depression</span></li><li><span style=\"font-size:14.0pt;\">Drugs in pregnancy</span></li></ul></li></ul>",
      "correct_choice_id": 322592,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80977/OBG_Mock_1_Q20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80977/OBG_Mock_1_Q20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80917,
      "choices": [
        {
          "id": 322352,
          "text": "<p><span style=\"font-size:14.0pt;\">Mirabegron</span></p>"
        },
        {
          "id": 322353,
          "text": "<p><span style=\"font-size:14.0pt;\">Trospium</span></p>"
        },
        {
          "id": 322354,
          "text": "<p><span style=\"font-size:14.0pt;\">Tamsulosin</span></p>"
        },
        {
          "id": 322355,
          "text": "<p><span style=\"font-size:14.0pt;\">Bethanechol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old woman with Alzheimer’s disease presents to the outpatient clinic complaining of frequent urges to urinate, especially during the day and sometimes at night. She denies pain, fever, or hematuria. Urinalysis is normal. She has no signs of infection, and bladder ultrasound shows no residual urine post-void. She is diagnosed with overactive bladder syndrome. The physician prescribes a medication that works by inhibiting muscarinic receptors to reduce bladder muscle contractions. Which of the following drugs is most likely being talked about?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2947062",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Trospium</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Trospium</strong> is an <strong>antimuscarinic agent</strong> specifically used for the <strong>treatment of overactive bladder</strong> (OAB).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It works by <strong>blocking M2 and M3 muscarinic receptors</strong> in the <strong>detrusor muscle</strong>, leading to <strong>reduced bladder contractions</strong> and <strong>increased bladder capacity</strong>, which helps relieve symptoms such as urinary urgency, frequency, and urge incontinence.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It has minimum entry in brain, so can be used in patients with Alzheimer’s disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Although mirabegron would have been drug of choice in this patient because it can treat overactive bladder (OAB) without affecting the Alzheimer’s condition, but this is not the answer because mirabegron does not inhibit muscarinic receptors. Rather it is beta 3 agonist.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mirabegron:</strong> A Beta 3 agonist used for OAB, particularly in patients with dementia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tamsulosin:</strong> An <strong>alpha-1 blocker</strong> used to <strong>relax prostatic and bladder neck smooth muscle</strong> in men with BPH. While it improves urinary flow in BPH, it has <strong>no role in treating detrusor overactivity</strong> in overactive bladder syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bethanechol:</strong> A <strong>muscarinic agonist</strong> used to <strong>stimulate bladder contraction</strong> in cases of <strong>urinary retention due to neurogenic bladder</strong> or <strong>atonic bladder</strong>. It would <strong>worsen overactive bladder symptoms</strong>, making it contraindicated in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Trospium is an antimuscarinic drug used to manage overactive bladder by reducing involuntary detrusor muscle contractions through muscarinic receptor inhibition. It has minimum CNS penetration.</span></p>",
      "correct_choice_id": 322353,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80917/Pharma_Mock_1_NEET_PG8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80917/Pharma_Mock_1_NEET_PG8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81130,
      "choices": [
        {
          "id": 323200,
          "text": "<p><span style=\"font-size:14.0pt;\">Double PCL sign</span></p>"
        },
        {
          "id": 323201,
          "text": "<p><span style=\"font-size:14.0pt;\">Ghost meniscus sign</span></p>"
        },
        {
          "id": 323202,
          "text": "<p><span style=\"font-size:14.0pt;\">McMurray sign</span></p>"
        },
        {
          "id": 323203,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral discoid meniscus sign</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following MRI signs is also commonly associated with a bucket handle meniscal tear, as shown in the image?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_lsaZDVW.png\" width=\"350\" height=\"335\"></strong></span></p>",
      "unique_key": "Q6100251",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Double PCL sign</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The MRI shows a classic <strong>bucket handle tear</strong> of the <strong>medial meniscus</strong>, where a displaced meniscal fragment (B) lies <strong>anterior and parallel to the posterior cruciate ligament (PCL)</strong> (A), creating the <strong>illusion of a second PCL</strong> — the so-called <strong>\"Double PCL sign\"</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is a highly specific MRI finding for <strong>displaced longitudinal bucket handle tears</strong> of the <strong>medial meniscus</strong>, typically seen in the sagittal plane.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ghost meniscus sign:</strong> This is seen on sagittal MRI where the <strong>normal triangular meniscal morphology is absent</strong>, suggesting a <strong>non-displaced tear</strong> — not specific for bucket handle tears.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. McMurray sign:</strong> This is a <strong>clinical test</strong>, not an imaging finding. It elicits pain or a click on knee flexion-extension and rotation — useful but not diagnostic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lateral discoid meniscus sign:</strong> Refers to a <strong>widened, disc-shaped lateral meniscus</strong>, seen in children or adolescents, unrelated to bucket handle tears.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The double PCL sign on sagittal MRI is pathognomonic for a bucket handle tear of the medial meniscus, where the displaced fragment mimics a second PCL.</span></p>",
      "correct_choice_id": 323200,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81130/NEET_PG_Mock_1_Q4_Radiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81130/NEET_PG_Mock_1_Q4_Radiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80999,
      "choices": [
        {
          "id": 322680,
          "text": "<p><span style=\"font-size:14.0pt;\">PPV with bag and mask</span></p>"
        },
        {
          "id": 322681,
          "text": "<p><span style=\"font-size:14.0pt;\">Consider CPAP</span></p>"
        },
        {
          "id": 322682,
          "text": "<p><span style=\"font-size:14.0pt;\">SpO2 monitoring</span></p>"
        },
        {
          "id": 322683,
          "text": "<p><span style=\"font-size:14.0pt;\">Consider ECG monitor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following are components of step A except:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_T8aCYvl.png\" width=\"799\" height=\"658\"></strong></span></p>",
      "unique_key": "Q4380815",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Consider CPAP</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Step A</strong> in the neonatal resuscitation algorithm is initiated <strong>when a neonate is apneic, gasping, or has a heart rate below 100 bpm</strong>. The goal is <strong>effective ventilation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">CRAP is used only if the baby has labored breathing or persistent cyanosis with HR &gt;100 bpm, and is not part of algorithm when HR is &lt;100 bpm or baby is apneic/ gasping.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. PPV with bag and mask:</strong> Correct<strong>.</strong> PPV is the primary intervention for any neonate with apnea, gasping, or HR &lt;100 bpm</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. SpO₂ monitoring:</strong> Correct<strong>.</strong> Pulse oximetry is initiated to monitor oxygen saturation continuously during resuscitation</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Consider ECG monitor:</strong> Correct. ECG monitoring may be considered to provide accurate and rapid assessment of the heart rate during resuscitation</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aMqp19i.png\" width=\"1011\" height=\"307\"></strong></span></p>",
      "correct_choice_id": 322681,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80999/Pediatrics_NEET_MOCK_-_1_Question_-_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80999/Pediatrics_NEET_MOCK_-_1_Question_-_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80951,
      "choices": [
        {
          "id": 322488,
          "text": "<p><span style=\"font-size:14.0pt;\">Tick paralysis</span></p>"
        },
        {
          "id": 322489,
          "text": "<p><span style=\"font-size:14.0pt;\">Rocky Mountain spotted fever (RMSF)</span></p>"
        },
        {
          "id": 322490,
          "text": "<p><span style=\"font-size:14.0pt;\">Kala-azar</span></p>"
        },
        {
          "id": 322491,
          "text": "<p><span style=\"font-size:14.0pt;\">Tularemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following diseases are transmitted by tick shown in the image, except:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_y3SntGs.png\" width=\"273\" height=\"378\"></strong></span></p>",
      "unique_key": "Q3318887",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Kala-azar</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Kala-azar (Visceral leishmaniasis)</strong> is a <strong>protozoal disease</strong> caused by Leishmania donovani, transmitted by the <strong>female sandfly</strong> (Phlebotomus argentipes), not by ticks.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It typically presents with <strong>prolonged fever, hepatosplenomegaly, pancytopenia, and hypergammaglobulinemia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Since this disease involves <strong>sandfly transmission</strong>, it is not associated with the <strong>hard tick</strong> shown in the image, making it the correct answer to the “EXCEPT” question.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Tick paralysis:</strong> Tick paralysis is caused by a <strong>neurotoxin</strong> secreted in the saliva of feeding <strong>hard ticks</strong> (e.g., Dermacentor spp.). It presents with <strong>rapid-onset, ascending, flaccid paralysis</strong>, and resolves completely after tick removal. It primarily affects children or individuals exposed to outdoor tick habitats.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Rocky Mountain spotted fever (RMSF):</strong> RMSF is caused by Rickettsia rickettsii and transmitted by <strong>hard ticks</strong> such as Dermacentor variabilis and Dermacentor andersoni. It presents with <strong>fever, petechial rash starting on the wrists and ankles</strong>, and can be fatal without treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tularemia:</strong> Tularemia is a <strong>bacterial zoonosis</strong> caused by Francisella tularensis, transmitted via <strong>hard ticks</strong>, contact with infected animals, or inhalation. Symptoms vary based on the route but commonly include <strong>ulceroglandular lesions, lymphadenopathy, and fever</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Hard ticks</strong> transmit a variety of diseases including:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Tularemia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Babesiosis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Kyasanur Forest Disease (KFD – India)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Tick paralysis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Tick encephalitis</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>RMSF</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Indian tick typhus</strong></span></li></ul></li></ul>",
      "correct_choice_id": 322490,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80951/PSM_Mock_1_Q14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80951/PSM_Mock_1_Q14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81099,
      "choices": [
        {
          "id": 323076,
          "text": "<p><span style=\"font-size:14.0pt;\">Heparan sulphate</span></p>"
        },
        {
          "id": 323077,
          "text": "<p><span style=\"font-size:14.0pt;\">Dermatan sulphate</span></p>"
        },
        {
          "id": 323078,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyaluronic acid</span></p>"
        },
        {
          "id": 323079,
          "text": "<p><span style=\"font-size:14.0pt;\">Keratan sulphate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A middle-aged man presents with a diagnosis of mucopolysaccharidosis, characterized by the accumulation of glycosaminoglycans (GAGs). One GAG that has accumulated is known to play a critical role in the charge selectiveness of the renal glomerular membrane. Which of the following GAGs is responsible for maintaining the charge selectiveness of the renal glomerular membrane?</span></p>",
      "unique_key": "Q3255816",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;Heparan sulphate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Heparan sulphate is a glycosaminoglycan composed of repeating disaccharide units of glucosamine and either glucuronic acid.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is highly negatively charged due to its numerous sulphate and carboxyl groups.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In the kidney, heparan sulphate proteoglycans (HSPGs) are integral components of the glomerular basement membrane, where they:</span><ul><li><span style=\"font-size:14.0pt;\">Contribute significantly to the negative charge barrier of the glomerular filtration system</span></li><li><span style=\"font-size:14.0pt;\">Help determine charge selectivity by repelling negatively charged proteins (like albumin)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Dermatan sulphate:</strong> Found in skin, blood vessels and heart valves and determines the elasticity of heart valve and skin. It predisposes to atherosclerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Hyaluronic acid:</strong> Present in connective tissues, tendons, synovial fluid and vitreous humor and acts as a lubricant and shock absorber in joint cavities. It does not contain a sulfate group as it is not processed by the Golgi apparatus. It help in wound healing and can reduce scarring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Keratan sulphate:</strong> Only GAG, which does not contain uronic acid and found in cornea and tendons, thereby maintaining corneal transparency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Heparan sulfate is a key component of the glomerular basement membrane (GBM) and contributes to its negative charge.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This charge barrier is essential for the selective filtration of molecules based on size and charge.&nbsp;</span></li></ul>",
      "correct_choice_id": 323076,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81099/NEET_PG_Mock_1_Q6_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81099/NEET_PG_Mock_1_Q6_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80997,
      "choices": [
        {
          "id": 322672,
          "text": "<p><span style=\"font-size:14.0pt;\">TRAM flap</span></p>"
        },
        {
          "id": 322673,
          "text": "<p><span style=\"font-size:14.0pt;\">DIEP flap</span></p>"
        },
        {
          "id": 322674,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterolateral thigh flap</span></p>"
        },
        {
          "id": 322675,
          "text": "<p><span style=\"font-size:14.0pt;\">Latissimus dorsi flap</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of these is not a free flap for breast reconstruction?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4352169",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Latissimus dorsi flap</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Latissimus dorsi flap this is not a free flap but a pedicled flap, meaning it remains attached to its original blood supply as it is moved to the breast area. It involves taking muscle, skin, and fat from the upper back.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. TRAM (Transverse Rectus Abdominis Myocutaneous) Flap:</strong> This flap involves transferring skin, fat, and part of the underlying rectus abdominis muscle to reconstruct the breast. It can be done as a free flap or a pedicled flap.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. DIEP (Deep Inferior Epigastric Perforator) Flap:</strong> Similar to the free TRAM flap but spares the rectus muscle. It uses the skin and fat from the lower abdomen, along with the accompanying blood vessels, and is reattached to the chest blood vessels to form a new breast mound. This is the best free flap for breast reconstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anterolateral thigh (ALT) Flap:</strong> This flap uses skin and fat from the thigh to reconstruct the breast. It is less commonly used than abdominal tissue but is an option for patients who do not have enough abdominal tissue or prefer not to use it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A free flap involves detaching tissue from one area of the body with its blood supply and reattaching it to blood vessels at the reconstruction site using microsurgery. In contrast, a pedicled flap maintains its original blood supply during the transfer.&nbsp;</span></p>",
      "correct_choice_id": 322675,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80997/Surgery_NEET_PG_Mock_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80997/Surgery_NEET_PG_Mock_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80995,
      "choices": [
        {
          "id": 322664,
          "text": "<p><span style=\"font-size:14.0pt;\">A–2, B–4, C–1, D–3</span></p>"
        },
        {
          "id": 322665,
          "text": "<p><span style=\"font-size:14.0pt;\">A–4, B–2, C–1, D–3</span></p>"
        },
        {
          "id": 322666,
          "text": "<p><span style=\"font-size:14.0pt;\">A–4, B–1, C–2, D–3</span></p>"
        },
        {
          "id": 322667,
          "text": "<p><span style=\"font-size:14.0pt;\">A–2, B–1, C–3, D–4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the Following: Syndromes and Chromosomal/Genetic Associations:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A (Syndrome)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-latin;\"><li><span style=\"font-size:14.0pt;\">WAGR Syndrome</span></li><li><span style=\"font-size:14.0pt;\">Denys-Drash Syndrome</span></li><li><span style=\"font-size:14.0pt;\">Beckwith-Wiedemann Syndrome</span></li><li><span style=\"font-size:14.0pt;\">Down Syndrome</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B (Chromosomal/Genetic Feature)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Involves abnormalities in the WT2 gene located at 11p15.5</span></li><li><span style=\"font-size:14.0pt;\">Caused by mutations or deletions affecting the WT1 gene at 11p13</span></li><li><span style=\"font-size:14.0pt;\">Associated with trisomy involving chromosome 21</span></li><li><span style=\"font-size:14.0pt;\">Characterized by microdeletions affecting both PAX6 and WT1 genes at 11p13</span></li></ol>",
      "unique_key": "Q4316036",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) A–4, B–2, C–1, D–3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A – 4. WAGR Syndrome</strong> is caused by a <strong>contiguous gene deletion at chromosome 11p13</strong>, involving the <strong>PAX6</strong> gene (responsible for aniridia) and the <strong>WT1 gene</strong> (associated with Wilms tumor).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>B – 2. Denys-Drash Syndrome</strong> is caused by a <strong>mutation in the WT1 gene</strong> located on <strong>chromosome 11p13</strong>, and presents with <strong>nephropathy, Wilms tumor, and gonadal dysgenesis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>C – 1. Beckwith-Wiedemann Syndrome</strong> is associated with <strong>imprinting defects or overexpression at the WT2 locus on chromosome 11p15.5</strong>, and is characterized by <strong>macrosomia, organomegaly</strong>, and an increased <strong>risk of Wilms tumor</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D – 3. Down Syndrome</strong> is due to <strong>trisomy of chromosome 21</strong>, most commonly from <strong>nondisjunction</strong> (95%), but may also result from a <strong>Robertsonian translocation</strong> or <strong>mosaicism</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Evt0eN2.png\" width=\"1609\" height=\"362\"></strong></span></p>",
      "correct_choice_id": 322665,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80995/Pediatrics__NEET_MOCK_-_1_Question_-_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80995/Pediatrics__NEET_MOCK_-_1_Question_-_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80994,
      "choices": [
        {
          "id": 322660,
          "text": "<p><span style=\"font-size:14.0pt;\">To evaluate for carpal tunnel syndrome&nbsp;</span></p>"
        },
        {
          "id": 322661,
          "text": "<p><span style=\"font-size:14.0pt;\">To assess for cervical rib</span></p>"
        },
        {
          "id": 322662,
          "text": "<p><span style=\"font-size:14.0pt;\">To determine the presence of De Quervain's tenosynovitis&nbsp;</span></p>"
        },
        {
          "id": 322663,
          "text": "<p><span style=\"font-size:14.0pt;\">To check for patency of radial and ulnar arteries</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 23-year-old male presents with complaints of numbness and tingling in his right hand, especially when playing the violin. Adson’s test is performed. What is the purpose of this test?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8233107",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) To assess for cervical rib</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>For cervical rib</strong>: Adson's test is used to assess for thoracic outlet syndrome/cervical rib, which occurs when the blood vessels or nerves between the thoracic outlet are compressed, leading to symptoms like those described.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. To evaluate for carpal tunnel syndrome:</strong> Typically assessed using Tinel's sign (tapping over the median nerve at the wrist) or Phalen's maneuver (flexing the wrists and pressing the backs of the hands together).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. To determine the presence of De Quervain's tenosynovitis:</strong> Finkelstein's test is used, where the patient makes a fist with the fingers over the thumb and then ulnar deviates the wrist, eliciting pain if positive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. To check for patency of radial and ulnar arteries:&nbsp;</strong>The Allen’s test is performed for this purpose.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Adson's test is used to diagnose thoracic outlet syndrome, a condition that can be aggravated by certain postures or activities that involve repetitive arm or shoulder movements.&nbsp;</span></p>",
      "correct_choice_id": 322661,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80994/Surgery_NEET_PG_Mock_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80994/Surgery_NEET_PG_Mock_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80982,
      "choices": [
        {
          "id": 322612,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudotumor cerebri</span></p>"
        },
        {
          "id": 322613,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypothalamic hamartoma</span></p>"
        },
        {
          "id": 322614,
          "text": "<p><span style=\"font-size:14.0pt;\">Racemose NCC</span></p>"
        },
        {
          "id": 322615,
          "text": "<p><span style=\"font-size:14.0pt;\">Tectal glioma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old male child presents to the pediatric clinic with complaints of recurrent headaches and vomiting. Parents report that the headaches have been progressively worsening over the past few weeks, and vomiting episodes now occur almost daily. They also note a developmental regression, including loss of speech and unstable gait. On examination, the child's head circumference is above the 97th percentile, and there is a tense and bulging anterior fontanelle. He shows \"sunsetting\" eyes, where the sclera is visible above the irises. He also has difficulty walking without support. An MRI is performed, and axial and sagittal views are shown. What is the most likely cause of hydrocephalus in this child?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_rENbqTf.png\" width=\"949\" height=\"455\"></span></p>",
      "unique_key": "Q5809511",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Tectal glioma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tectal gliomas</strong> are <strong>slow-growing brainstem tumors</strong> that typically present in children <strong>with hydrocephalus due to aqueductal stenosis</strong>. <strong>MRI</strong> shows a <strong>lesion in the tectum (posterior midbrain</strong>), which <strong>obstructs CSF flow and causes ventricular dilation</strong>, as seen here.</span></li><li><span style=\"font-size:14.0pt;\">The clinical picture of <strong>progressive headache, vomiting, developmental regression, macrocephaly, sunsetting sign</strong>, and gait instability points to <strong>obstructive (non-communicating) hydrocephalus</strong>. The MRI shows <strong>dilated lateral and third ventricles</strong> with a <strong>lesion in the tectal region</strong> (midbrain), confirming the diagnosis.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-05-20%20at%2010.00.46%20AM.jpeg\" width=\"772\" height=\"519\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pseudotumor cerebri:&nbsp;</strong>Incorrect<strong>. </strong>It is also known as IIH. Typically occurs in obese females and presents with increased ICP without ventricular dilation. It doesn't cause hydrocephalus or developmental regression. MRI would show normal ventricles. Mnemonic: FAT-P (F: Female; A: Abnormal pressure; T: Transient vision loss; P: Papilledema + Palsy of CN VI).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hypothalamic hamartoma:&nbsp;</strong>Incorrect<strong>.</strong> It usually presents with precocious puberty or gelastic seizures, not obstructive hydrocephalus. It arises near the tuber cinereum, not the tectum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Racemose NCC (Neurocysticercosis):&nbsp;</strong>Incorrect<strong>.</strong> Though it can cause hydrocephalus (especially when cysts obstruct foramina), it usually occurs in endemic regions and shows multiple cystic lesions in subarachnoid spaces or ventricles, which are not visible here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Jvf919J.png\" width=\"1266\" height=\"491\"></strong></span></p>",
      "correct_choice_id": 322615,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80982/Pediatrics_Neet_Mock_-_1_Question_-_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80982/Pediatrics_Neet_Mock_-_1_Question_-_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81086,
      "choices": [
        {
          "id": 323024,
          "text": "<p><span style=\"font-size:14.0pt;\">Optic glioma</span></p>"
        },
        {
          "id": 323025,
          "text": "<p><span style=\"font-size:14.0pt;\">Schwannoma</span></p>"
        },
        {
          "id": 323026,
          "text": "<p><span style=\"font-size:14.0pt;\">Meningioma</span></p>"
        },
        {
          "id": 323027,
          "text": "<p><span style=\"font-size:14.0pt;\">Metastatic lung cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 33-year-old man experiences progressive hearing difficulty and occasional imbalance. MRI of the head reveals a well-circumscribed mass at the cerebellopontine angle. Surgical excision is performed. Histological examination shows spindle-shaped cells with uniform oval nuclei arranged in areas of dense cellularity alternating with hypocellular zones. Immunohistochemical staining is positive for S-100 protein. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9498010",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Schwannoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The described tumor demonstrates hallmark features of a <strong>schwannoma</strong>, a benign peripheral nerve sheath tumor. These tumors often arise at the <strong>cerebellopontine angle</strong>, typically affecting cranial nerve VIII (vestibulocochlear nerve), leading to <strong>hearing loss and imbalance</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Histologically, <strong>schwannomas</strong> are composed of <strong>elongated spindle cells</strong> with <strong>regular, oval nuclei</strong>. The tumor characteristically shows <strong>alternating patterns of dense (Antoni A) and loose (Antoni B) growth areas</strong>, a key microscopic clue. Additionally, <strong>S-100 protein immunoreactivity</strong> is strongly positive due to the <strong>neural crest origin</strong> of Schwann cells.</span></li><li><span style=\"font-size:14.0pt;\">These collective findings (patient age, symptoms, tumor location, histology, and immunostaining) point definitively toward <strong>schwannoma</strong>.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-21%20172344.jpg\" width=\"870\" height=\"574\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Optic glioma:</strong> Incorrect. Optic gliomas are most commonly associated with <strong>neurofibromatosis type 1</strong> and typically occur in <strong>children</strong>, not adults. They involve the <strong>optic nerve</strong>, not the cerebellopontine angle. Histologically, they consist of astrocytic cells and do <strong>not exhibit S-100 positivity</strong> as a defining feature, nor the dense and loose areas seen in schwannoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Meningioma:</strong> Incorrect. Meningiomas arise from <strong>arachnoid cap cells</strong> and may occur near the cerebellopontine angle, but they show <strong>psammoma bodies</strong>, <strong>whorled cell arrangements</strong>, and <strong>EMA positivity</strong>, not <strong>S-100 positivity</strong>. Meningiomas do not typically have <strong>dense and loose zones</strong> or the <strong>spindle cells with oval nuclei</strong> described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metastatic lung cancer:</strong> Incorrect. Metastatic lung cancer to the brain is possible but usually presents with <strong>multiple lesions</strong> and often lacks the well-circumscribed nature seen here. Additionally, <strong>metastases do not show S-100 positivity</strong> and lack the <strong>biphasic Antoni A/B histologic pattern</strong>. The <strong>presence of S-100 positive spindle cells</strong> excludes this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Schwannoma is a benign tumor of Schwann cells showing S-100 positivity and biphasic Antoni A and B areas on histology.</span></li><li><span style=\"font-size:14.0pt;\">It commonly presents as a cerebellopontine angle mass causing hearing loss and imbalance.</span></li></ul>",
      "correct_choice_id": 323025,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81086/NEET_PG_Mock_1_Q8_Pathology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81086/NEET_PG_Mock_1_Q8_Pathology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81129,
      "choices": [
        {
          "id": 323196,
          "text": "<p><span style=\"font-size:14.0pt;\">1–A, 2–B, 3–C</span></p>"
        },
        {
          "id": 323197,
          "text": "<p><span style=\"font-size:14.0pt;\">1–B, 2–C, 3–A</span></p>"
        },
        {
          "id": 323198,
          "text": "<p><span style=\"font-size:14.0pt;\">1–C, 2–A, 3–B</span></p>"
        },
        {
          "id": 323199,
          "text": "<p><span style=\"font-size:14.0pt;\">1–A, 2–C, 3–B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match each ultrasound image to the most appropriate artifact it represents.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A (Artifacts):</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Ring down artifact</span></li><li><span style=\"font-size:14.0pt;\">Comet tail artifact</span></li><li><span style=\"font-size:14.0pt;\">Twinkling artifact</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B (ultrasound image):</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3KuMnKW.png\" width=\"302\" height=\"642\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Which of the following is the correct match?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6444701",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1-C, 2-A, 3-B&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1-C. Ring down artifact → Image C: </strong>Ring down artifact appears as a <strong>long, continuous, echogenic streak</strong> deep to gas collections or air bubbles, caused by resonance of gas trapped between fluid layers or septae.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2-A. Comet tail artifact → Image A: </strong>Comet tail artifact is a <strong>type of reverberation artifact</strong>, seen as tapering echogenic lines extending posteriorly from a strong reflector (like cholesterol crystals or metallic objects). Common in adenomyomatosis of the gallbladder. This is seen due to deposition of cholesterol on the wall of the gallbladder.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3-B. Twinkling artifact → Image B: </strong>Seen on <strong>color Doppler</strong>, it presents as a <strong>rapidly alternating color signal</strong> posterior to a highly reflective structure like a <strong>renal calculus</strong>. This is due to intrinsic machine noise rather than true flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Ring down artifact:</strong> Continuous echo from gas resonance.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Comet tail artifact:</strong> Tapering echo from strong reflectors.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Twinkling artifact:</strong> Color Doppler clue for calcifications.</span></li></ul>",
      "correct_choice_id": 323198,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81129/NEET_PG_Mock_1_Q3_Radiology.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81129/NEET_PG_Mock_1_Q3_Radiology.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81144,
      "choices": [
        {
          "id": 323256,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior interosseus nerve</span></p>"
        },
        {
          "id": 323257,
          "text": "<p><span style=\"font-size:14.0pt;\">Median nerve</span></p>"
        },
        {
          "id": 323258,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior interosseus nerve</span></p>"
        },
        {
          "id": 323259,
          "text": "<p><span style=\"font-size:14.0pt;\">Ulnar nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which nerve provides innervation to the structure arrow indicated in the image below?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Ys2LMjs.png\" width=\"581\" height=\"573\"></strong></span></p>",
      "unique_key": "Q5932065",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Median nerve&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The <strong>lumbrical muscles</strong> of the hand are four small intrinsic muscles that play a critical role in coordinated finger movement.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They flex the <strong>metacarpophalangeal joints (MCP)</strong> and extend the <strong>proximal and distal interphalangeal joints (PIP and DIP)</strong>.</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Lateral 2 lumbricals (1st and 2nd)</strong>: Arise from the <strong>lateral two tendons</strong> of the flexor digitorum profundus (index and middle fingers). These are <strong>unipennate</strong> and are innervated by the <strong>median nerve</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Medial 2 lumbricals (3rd and 4th)</strong>: Arise from the <strong>medial two tendons</strong> (ring and little fingers). These are <strong>bipennate</strong> and are innervated by the <strong>deep branch of the ulnar nerve</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, the <strong>second lumbrical</strong>, shown in the image and located on the <strong>radial side of the middle finger</strong>, is innervated by the <strong>median nerve</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Posterior interosseous nerve:</strong> A branch of the radial nerve that supplies <strong>extensor muscles</strong> of the forearm, not intrinsic hand muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anterior interosseous nerve:</strong> Branch of the median nerve that supplies <strong>deep flexor muscles</strong> in the forearm (e.g., FDP, FPL), but <strong>not lumbricals</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ulnar nerve:</strong> Does innervate <strong>lumbricals 3 &amp; 4</strong>, but <strong>not</strong> the second lumbrical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>median nerve</strong> innervates the <strong>first and second lumbricals</strong>, which flex the MCP joints and extend the IP joints of the <strong>index and middle fingers</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This innervation pattern is critical for fine motor control, particularly precision grip.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_c7vVtF7.png\" width=\"987\" height=\"677\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_k006ilL.png\" width=\"698\" height=\"631\"></span></p>",
      "correct_choice_id": 323257,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81144/NEET_PG_Mock_1_Q9_Anatomy.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81144/NEET_PG_Mock_1_Q9_Anatomy.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81095,
      "choices": [
        {
          "id": 323060,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxidized form of nicotinamide adenine dinucleotide</span></p>"
        },
        {
          "id": 323061,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucose 6-phosphate</span></p>"
        },
        {
          "id": 323062,
          "text": "<p><span style=\"font-size:14.0pt;\">Ribose 5-phosphate</span></p>"
        },
        {
          "id": 323063,
          "text": "<p><span style=\"font-size:14.0pt;\">Decrease Level of Reduced Glutathione&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A middle-aged woman visited a region with known chloroquine-resistant malaria. As a prophylactic measure, she was administered primaquine. Shortly after starting the medication, she exhibited signs of hemolytic anemia and was later diagnosed with a deficiency in glucose 6-phosphate dehydrogenase (G6PD). Given the role of G6PD in cellular metabolism, what is the underlying cause of her hemolytic symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4459503",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)&nbsp;Decrease Level of Reduced Glutathione</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Glucose 6-phosphate dehydrogenase (G6PD)</strong> is the <strong>rate-limiting enzyme</strong> of the <strong>pentose phosphate pathway (hexose monophosphate shunt),</strong> especially important in <strong>red blood cells.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>G6PD’s main role:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Catalyzes the conversion of <strong>glucose 6-phosphate to 6-phosphogluconolactone,</strong></span></li><li><span style=\"font-size:14.0pt;\">While reducing <strong>NADP⁺ to NADPH.</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Why is NADPH critical?</strong></span><ul><li><span style=\"font-size:14.0pt;\">NADPH maintains <strong>glutathione (GSH) in its reduced form.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Reduced glutathione (GSH)</strong> is essential for <strong>neutralizing reactive oxygen species (ROS)</strong> and <strong>protecting red blood cells from oxidative damage.</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">In <strong>G6PD deficiency:</strong></span><ul><li><span style=\"font-size:14.0pt;\">RBCs can’t generate enough <strong>NADPH, l</strong>eading to <strong>decreased reduced glutathione levels, </strong>making cells highly vulnerable to oxidative stress (e.g., from <strong>primaquine, sulfa drugs, fava beans</strong>), resulting in <strong>hemolysis (breakdown of RBCs),</strong> as seen in this patient.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.&nbsp;Oxidized form of nicotinamide adenine dinucleotide (NAD⁺):&nbsp;</strong>NAD⁺ is used in glycolysis and the TCA cycle, not in the <strong>pentose phosphate pathway</strong> or <strong>glutathione regeneration</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Glucose 6-phosphate:</strong> Substrate for both <strong>glycolysis</strong> and <strong>HMP shunt</strong>, but <strong>not directly involved in antioxidant defense</strong> or in the cause of hemolysis here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.&nbsp;Ribose 5-phosphate:</strong> Product of the <strong>non-oxidative phase</strong> of the HMP shunt, important for <strong>nucleotide synthesis</strong>, but not relevant to <strong>oxidative stress handling</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In <strong>G6PD deficiency</strong>, red blood cells have:</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Impaired ability to handle oxidative stress</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Low NADPH levels</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Decreased reduced glutathione (GSH)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This makes them susceptible to <strong>hemolysis</strong>, especially after exposure to <strong>oxidant drugs like primaquine</strong>.</span></li></ul>",
      "correct_choice_id": 323063,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81095/NEET_PG_Mock_1_Q2_Biochemistry.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81095/NEET_PG_Mock_1_Q2_Biochemistry.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 80988,
      "choices": [
        {
          "id": 322636,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 1</span></p>"
        },
        {
          "id": 322637,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 2</span></p>"
        },
        {
          "id": 322638,
          "text": "<p><span style=\"font-size:14.0pt;\">Grade 3</span></p>"
        },
        {
          "id": 322639,
          "text": "<p><span style=\"font-size:14.0pt;\">Tokyo classification does not apply here</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient who has a history of gallstones is undergoing an emergency laparoscopic cholecystectomy for severe pain. Intra-operative findings are as shown. What is the Tokyo classification of this disease?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-16%20105917.jpg\" width=\"781\" height=\"534\"></strong></span></p>",
      "unique_key": "Q9677726",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;Grade 2</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows gangrenous cholecystitis with an omental lump (phlegmon) over the GB.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Grade 2 (Moderate)</strong>:&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Features such as <strong>leukocytosis &gt;18,000</strong>, palpable mass, or local inflammatory spread.</span></li><li><span style=\"font-size:14.0pt;\">Requires early cholecystectomy but usually <strong>without systemic failure</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Grade 1 (Mild):</strong> Incorrect<strong>.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acute cholecystitis without signs of organ dysfunction or systemic complications.</span></li><li><span style=\"font-size:14.0pt;\">Can be managed with antibiotics and elective cholecystectomy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Grade 3 (Severe)</strong>: Incorrect<strong>.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Gangrenous GB</strong>, perforation, or emphysematous cholecystitis alone doesn’t fall under Grade 3.</span></li><li><span style=\"font-size:14.0pt;\">Characterized by <strong>organ dysfunction</strong> such as hypotension, renal failure, or respiratory distress.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Tokyo classification does not apply here:&nbsp;</strong>Incorrect<strong>.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tokyo classification is used for severity of acute cholecystitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Grade%20III.jpg\" width=\"1539\" height=\"1869\"></p>",
      "correct_choice_id": 322637,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80988/Surgery_NEET_PG_Mock_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/80988/Surgery_NEET_PG_Mock_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 81147,
      "choices": [
        {
          "id": 323268,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1, 2, and 4 are correct</span></p>"
        },
        {
          "id": 323269,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 1 and 3 are correct</span></p>"
        },
        {
          "id": 323270,
          "text": "<p><span style=\"font-size:14.0pt;\">Only statements 2, 3, and 4 are correct</span></p>"
        },
        {
          "id": 323271,
          "text": "<p><span style=\"font-size:14.0pt;\">All four statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Pediatric Advanced Life Support (PALS) during cardiac arrest are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">The recommended compression rate is 100–120/min, pushing at least one-third of the anteroposterior chest diameter.</span></li><li><span style=\"font-size:14.0pt;\">If an advanced airway is placed, compressions should be paused for ventilation at a 15:2 ratio.</span></li><li><span style=\"font-size:14.0pt;\">For the first defibrillation attempt, 2 J/kg is recommended; subsequent shocks should be ≥4 J/kg, up to 10 J/kg max.</span></li><li><span style=\"font-size:14.0pt;\">The IV/IO dose of epinephrine is 0.1 mg/kg (0.1 mL/kg of 0.1 mg/mL), repeated every 3–5 minutes.</span></li></ol>",
      "unique_key": "Q5984560",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Only statements 1 and 3 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. The recommended compression rate is 100–120/min, pushing at least one-third of the anteroposterior chest diameter:</strong> Correct. High-quality pediatric CPR requires compressions at<strong> 100–120/min</strong> and at least <strong>1/3 the AP diameter</strong> of the chest.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>For the first defibrillation attempt, 2 J/kg is recommended; subsequent shocks should be ≥4 J/kg, up to 10 J/kg max:&nbsp;</strong>Correct. Initial shock is <strong>2 J/kg</strong>, followed by <strong>4 J/kg</strong>, and subsequent shocks should be <strong>≥4 J/kg (up to 10 J/kg or adult dose)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>If an advanced airway is placed, compressions should be paused for ventilation at a 15:2 ratio:&nbsp;</strong>Incorrect. Once an <strong>advanced airway</strong> is in place, you <strong>do not pause</strong> compressions. Instead, give <strong>continuous compressions with 1 breath every 2–3 seconds</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>The IV/IO dose of epinephrine is 0.1 mg/kg (0.1 mL/kg of 0.1 mg/mL), repeated every 3–5 minutes:&nbsp;</strong>Incorrect. <strong>Epinephrine IV/IO dose</strong> is <strong>0.01 mg/kg</strong> of 0.1 mg/mL solution every <strong>3–5 minutes</strong>. Max dose is <strong>1 mg</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>PALS guidelines:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>CPR Quality:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Push hard (≥⅓ of anteroposterior diameter of chest) and fast (100–120/min) and allow complete chest recoil</span></li><li><span style=\"font-size:14.0pt;\">Minimize interruptions in compressions</span></li><li><span style=\"font-size:14.0pt;\">Change compressor every 2 minutes, or sooner if fatigued</span></li><li><span style=\"font-size:14.0pt;\">If no advanced airway, 15:2 compression-ventilation ratio</span></li><li><span style=\"font-size:14.0pt;\">If advanced airway, provide continuous compressions and give a breath every 2–3 seconds</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Shock Energy for Defibrillation:</strong></span><ul><li><span style=\"font-size:14.0pt;\">First shock 2 J/kg</span></li><li><span style=\"font-size:14.0pt;\">Second shock 4 J/kg</span></li><li><span style=\"font-size:14.0pt;\">Subsequent shocks ≥4 J/kg, maximum 10 J/kg or adult dose</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Drug Therapy:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Epinephrine IV/IO dose:</span><ul><li><span style=\"font-size:14.0pt;\">mg/kg (0.1 mL/kg of the 0.1 mg/mL concentration).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Max dose 1 mg.</span></li><li><span style=\"font-size:14.0pt;\">Repeat every 3–5 minutes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If no IV/IO access, may give endotracheal dose: 0.1 mg/kg (0.1 mL/kg of the 1 mg/mL concentration).</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Amiodarone IV/IO dose:</strong></span><ul><li><span style=\"font-size:14.0pt;\">5 mg/kg bolus during cardiac arrest.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">May repeat up to 3 total doses for refractory VF/pulseless VT</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Lidocaine IV/IO dose:</strong></span><ul><li><span style=\"font-size:14.0pt;\">Initial: 1 mg/kg loading dose</span></li></ul></li></ul></li></ul>",
      "correct_choice_id": 323269,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81147/NEET_PG_Mock_1_Q2_Anesthesia.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/81147/NEET_PG_Mock_1_Q2_Anesthesia.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}